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ABSTRACT: 1,1-Bis(boronic) esters have attracted significant attention these days due to 
their unique reactivity. In this thesis, I will show that readily available reagents can undergo 
deborylative alkylation to deliver synthetically useful primary, secondary and tertiary boronic 
esters. 1,1-Diboryl alkanes can also engage in base-promoted deborylative cyclization to 
afford diversified cyclopentane rings with boron motifs attached. This transformation is very 
appealing because of the prevalence of five-membered rings in natural products. Lastly, it 
will be showed that geminal bis(boronic) esters can act as an important cornerstone in 
constructing relatively complicated structures such as natural product Arenolide. 
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Chapter 1  
1 Development of 1,1-Bis(boronic) Esters and Their 
Transformations 
 
1.1 Introduction 
Transformations of geminal bis(boronic) esters have been studied intensively 
during the past decade, and the product boronic esters obtained from these methodologies 
are of great synthetically value.1 Boronic esters can be converted into various functional 
groups such as alcohols,2 amines,3 and halides4 in a stereorententive fashion. In this 
chapter, a short review about the past and present methods that involved geminal 
bis(boronic) esters will be presented. 
1.2 Development of 1,1-Bis(boronic) Esters and Their Transformations 
The chemistry of geminal bis(borane) can be dated back to 1966, when Zweifel 
and coworkers5 revealed that the terminal alkyne 1.1 could undergo hydroboration 
                                                
 
1 Hall, D. G. Boronic Acids, 2nd ed.; Wiley-VCH: Weinheim, 2011. 
2 Brown, H. C.; Snyder, C.; Subba Rao, B. C.; Zweifel, G. Tetrahedron 1986, 42, 5505-5510. 
3 Mlynarski, S. N.; Karns, A. S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449-16451. 
4 Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2011, 133, 16794-16797. 
5 Zweifel, G.; Arzoumanian, H. Tetrahedron Lett. 1966, 2535-2538. 
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consecutively with dimethyl borane 1.2 to afford 1,1-diboryl alkane 1.3. After treating 
diboryl compound 1.3 with methyl lithium and trapping with bromoethane, the 
deborylative alkylated product was furnished, which was then oxidized to the 
corresponding alcohol 1.5 in good yield (Scheme 1.1).  
Zweifel proposed a possible mechanism for this transformation based on 1H NMR 
studies (Scheme 1.2).6 They observed a resonance at high field with chemical shift -0.7 
ppm, which proposed to be the ate complexes 1.7 and 1.12. After bromoethane was added, 
this peak at -0.7 ppm decreased by 85%. This observation was consistent with the 
scenario that the generated carbonanion 1.8 (in resonance with borate alkene structure) 
further reacted with bromoethane to afford the alkylated product 1.11; while ate complex 
1.12 was unreactive towards bromoethane, which accounted for the residual signal peak 
at -0.7 ppm.  
Scheme 1.1 Intermolecular Alkylation with 1,1-Diboryl Alkane 
R H
B
CH3
H3C H
C C
B
B
H3C
CH3
CH3
H3C
R 1, CH3Li
2, C2H5Br C C
C2H5
B CH3
H3C
R
NaOH/H2O2
C C
C2H5
OH
R
75% yield
1.1
1.2
1.3 1.4
1.5
HH
H
H
H
H
H
H
H
(2.0 equiv)
 
                                                
 
6 Zweifel, G.; Fisher, R. P.; Horng, A. Synthesis 1973, 37-38. 
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Scheme 1.2 Mechanism for Deborylative Alkylation Reaction 
H2C CH
R B
B
CH3Li
H2C CH
R B
B
Me
H2C CH
R B
H2C C
R B
CH3
B
C2H5Br CH3Li
H2C CH
R B
C2H5
CH3
B CH3
NaOH/H2O2H2C CH
C2H5
OH
R
1.5
1.6 1.7
1.8
1.9
1.10
1.11 1.12  
 
In 1969, Brown and coworkers developed an interesting intramolecular 
transformation of these 1,1-diboryl compounds (Scheme 1.3).7 The geminal bis(boranes) 
                                                
 
7 Brown, H. C.; Rhodes, S. P. J. Am. Chem. Soc. 1969, 91, 4306-4307. 
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1.14 bearing a bromide leaving group was treated with methyl lithium to generate 
boronate 1.15, which could then react with the electrophilic halide to form 
three-membered ring product 1.16 with a synthetically useful borane motif still appended.  
Scheme 1.3 Intramolecular Alkylation with 1,1-Diboryl Alkane 
Br
H 9-BBN Br MeLiB
B
Br B
BMe
B
NaOH/H2O2
OH
70% yield
1.13
1.14 1.15
1.16 1.17
 
 
Subsequent to these early reports with boranes, Matteson and co-workers 8 
disclosed a route to synthesize geminal bis(boronic) ester 1.19. After treating trimethyl 
borate 1.18 with lithium metal and dichloromethane at -30 oC in THF, the desired product 
diboronic ester 1.19 could be obtained. Although the yield was low for this route, it 
nonetheless provided material to study. 
                                                
 
8 Castle, R. B.; Matteson, D. S. J. Organomet. Chem. 1969, 20, 19-28. 
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Scheme 1.4 Matteson’s Method to Synthesize Geminal Bis(boronate) 
B
H3CO
OCH3
OCH3 +4 4 Li CH2Cl2+
THF, -30 oC
H3CO
B
H3CO
B
OCH3
OCH3H
H
2 LiCl 2LiB(OCH3)4++
1.18
1.19 1.20  
 
With the 1,1-diboryl methane 1.21 obtained on large scale, Matteson explored its 
applications.9 First, they found that a bulky base such as lithium tetramethylpiperidide 
(LiTMP) could deprotonate the acidic α-H of 1,1-diboryl methane 1.21, and the resulting 
anion would then react with 1-bromopentane to afford the substituted geminal 
bis(boronate) 1.22. Second, the α-H of the carbon in compound 1.22 could be 
deprotonated again, and subsequent reaction with benzaldehyde delivered vinyl boronate 
1.23. After being oxidized into an alcohol, the tautomeric product ketone 1.24 was 
obtained in 84% yield. 
 
 
 
 
                                                
 
9 Matteson, D. S.; Moody, R. J. Organometallics, 1982, 1, 20-28. 
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Scheme 1.5 Further Transformations of Geminal Bis(boronate) 1.21 
Me B
B
O
O
OO
LiTMP
PhCHO Me B
CHPh
O
O
NaBO3
Me
Ph
O
84% yield
1.21 1.22
1.24
B
B
O
O
OO LiTMP
Me
Br Me B
B
O
O
OO
1.22 1.23
 
The chemistry of geminal bis(boranates) had been rarely visited for several 
decades until 2010, when Shibata and Endo10 reported a boron-Wittig reaction in which 
1,1-organoboronates 1.25 could undergo nucleophilic addition to ketones after 
deprotonation with LiTMP. This furnished tetra-substituted alkenyl boronic esters, which 
were proven to be useful building blocks because they could readily cross couple with 
                                                
 
10 Endo, K.; Hirokami, M.; Shibata, T. J. Org. Chem. 2010, 75, 3469-3472. 
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aryl electrophiles for further functionalization, as demonstrated by the synthesis of 
Tamoxifen derivatives. (Scheme 1.6) 
 
Scheme 1.6 Boron Wittig Reaction Starting from 1,1-Organoboronate Compound 
1.25 
Ph
B(pin)
B(pin)
1.5 equiv
LiTMP (1.5 equiv)
THF, 0 oC, 5 min
Ph Et
Othen
Ph
B(pin)
PhEt
95% yield, 
E/Z > 99/1
1.25
1.26
1.27
 
In the same year, Shibata and Endo11 also reported that geminal bis(boronic) 
esters bearing an sp3-hybridized carbon could undergo cross-coupling reaction with aryl 
halides at room temperature. This reaction occurred with high chemoselectively to afford 
mono-substituted boronic ester 1.30 in a racemic form. Notably, the reaction would not 
undergo further Suzuki coupling reaction. A set of mechanistic studies using boron NMR 
was carried out, which revealed that a boron ate complex was the reactive intermediate. 
 
 
 
 
 
                                                
 
11 Endo, K.; Ohkubo, T.; Hirokami, M.; Shibata, T. J. Am. Chem. Soc. 2010, 132, 11033-11035. 
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Scheme 1.7 Pd-Catalyzed Suzuki Coupling between 1,1-Diboryl Alkanes and Aryl 
Halides 
Me
B(pin)
B(pin)
I
OMe 5 mol % Pd[P(t-Bu)3]2
KOH (4.5 equiv)
dioxane/H2O
25 oC, 2 h
OMe
B(pin)
Me
94% NMR yield
1.5 equiv
1.28
1.29 1.30
 
 
In 2013, Hall and coworkers12 disclosed a stereospecific Suzuki coupling reaction 
between enantioenriched 1,1-diboryl alkane 1.31 and 4-fluoroiodobenzene to furnish a 
stereocenter-inverted product 1.32. Through the study of the corresponding X-ray 
structure, they reasoned that the lone pairs of electrons from the carbonyl oxygen might 
donate to the empty p orbital of the adjacent boronic acid, which could facilitate the 
transmetallation step. In addition, stabilization of the intermediate alkylpallladium 
species by the B(dan) moiety made it possible to accomplish the Suzuki coupling reaction 
efficiently. 
 
 
 
 
 
                                                
 
12 Lee, J. C. H.; McDonald, R.; Hall, D. G. Nat. Chem. 2011, 3, 894-899. 
9 
 
Scheme 1.8 Stereospecific Suzuki Coupling between Geminal Bis(boronate) 
Ester and Aryl Halides 
Me
O
O BF3K
B
HN
H
N
I
(1 equiv)
10 mol % Pd(OAc)2 
20 mol % XPhos
K2CO3 (3 equiv)
toluene/H2O (1:0.1)
80 oC, 6 h
Me
O
O
B
HN
H
N
1.31 1.32
F
F
86% yield, 99% ee
PCy2
iPriPr
iPr
XPhos:
 
In 2014, our group 13  developed an enantioselective version of the Suzuki 
coupling reaction between 1,1-diboryl alkane 1.33 and aryl halides to furnish 
mono-substituted boronic ester 1.34 in a good yield with high enantioselectivity. Later, 
the electrophiles for the coupling reaction were extended from aryl halides to 
tri-substituted vinyl halides by switching the chiral ligand from a phosphoramidite to a 
Josiphos derivative.14 
 
                                                
 
13 Sun, C.; Porter, B.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 6534-6537. 
14  Potter, B.; Szymaniak, A. A.; Edelstein, E. K.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 
17918-17921. 
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Scheme 1.9 Pd-Catalyzed Enantioselective Suzuki Coupling between Geminal 
Bisboronate and Aryl Halides 
BnO
B(pin)
B(pin)
5 mol % Pd(OAc)2
10 mol % (R,R)-TADDOL-NMe2
KOH (15 equiv)
dioxane/H2O
rt, 12 h
BnO
B(pin)
I
74% yield
93:7 er
O
O
O
O
P
Me
Me
Ar
Ar
NMe2
Ar
p-tol
L:
1.33 1.34
 
 
In 2015, Meek and coworkers15 demonstrated that copper complexes could 
catalyze the nucleophilic addition of substituted geminal bis(boronate) derivative to 
aryl/vinyl aldehydes in the presence of a chiral monodentate phosphoramidite ligand, 
delivering the syn-1,2-hydroxyboronates with excellent control of both enantio- and 
diastereoselectivity. The enantioeneriched mono boronic ester compound could be easily 
converted into syn-1,2 diol product 1.35 upon oxidative workup (Scheme 1.10). 
Later, Meek found that silver (I) acetate 16  could also catalyze the 1,2- 
nucleophilic addition of geminal bis(boronic) ester 1.33 to aldehydes (Scheme 1.11). 
However, in contrast to the copper-catalyzed reaction, the adjacent hydroxyl group and 
                                                
 
15 Joannou, M. V.; Moyer, B. S.; Meek, S. J. J. Am. Chem. Soc. 2015, 137, 6176-6179. 
16 Joannou, M. V.; Moyer, B. S.; Goldfogel, M. J.; Meek, S. J. Angew. Chem. Int. Ed. 2015, 54, 
14141-14145. 
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boryl group were installed with anti-stereoselectivity 1.37. Notably, different aldehydes 
including aryl, alkenyl and alkyl aldehydes were all suitable electrophiles. 
 
Scheme 1.10 Copper-Catalyzed 1,2-Addition of 1,1-Diboryl Alkanes to Aldehydes 
1.34
1.35Ph
Me
O
H
7.5 mol % Cu(NCMe)4PF6-Chiral Ligand
LiOtAm (0.6 equiv)
THF, 22 oC, 48 h;
then NaOH, H2O2
(pin)B B(pin)
1.33
Ph
Me
OH
Me
OH
54% yield
93:7 dr (syn:anti)
90:10 er
O
P
O
NMe2
L:
 
 
Scheme 1.11 Silver-Catalyzed 1,2-Addition of 1,1-Diboryl Alkanes to Aldehydes 
1.36
1.37H
O
(pin)B B(pin)
1.33 10 mol % AgOAcnBuLi(1.0 equiv) OH
Me
B(pin)
51% yield
88:12 dr (anti:syn)
THF, -25oC, 24 h
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While only a few reports had shown reaction between geminal bis(boronate) 1.33 
and allyl electrophiles,17 Hoveyda and coworkers18 reported an elegant copper-catalyzed 
enantioselective allylic substitution reaction by using sulfonate-containing chiral NHC as 
ligand (Scheme 1.12). They found that the more Lewis acidic the metal salt was, the 
higher ratio of branched products they obtained. Applying this methodology, they 
constructed branched homoallylic boronic ester 1.39 in good yield with excellent 
enantioselectivity, which was further elaborated into the natural product rhopaloic acid A. 
 
 
 
 
 
 
 
 
 
                                                
 
17 (a) Endo, K.; Ohkubo, T.; Ishioka, T.; Shibata, T. J. Org. Chem. 2012, 77, 4826-4831. (b) Kim, J.; Park, 
S.; Park, J.; Cho, S. H. Angew. Chem. Int. Ed. 2016, 55, 1498-1501. (c) Zhan, M.; Li, R.-Z.; Mou, Z.-D.; 
Cao, C.-G.; Liu, J.; Chen, Y.- W.; Niu, D. ACS Catal. 2016, 6, 3381-3386. (d) Zhang, Z.-Q.; Zhang, B.; Lu, 
X.; Liu, J.-H.; Lu, X.-Y.; Xiao, B.; Fu, Y. Org. Lett. 2016, 18, 952-955. 
18 Shi, Y.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2016, 55, 3455-3458. 
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Scheme 1.12 Cu/NHC-Catalyzed Allylic Substitution Reaction of Geminal 
Bis(boronate) 
(pin)B B(pin)
TBSO
OPO(OEt)2
1.5 equiv
2.75% mol chiral NHC ligand
5% mol CuCl
NaOMe (1.5 equiv)
THF, 22 oC, 18 h
TBSO
B(pin)
89% yield
96:4 er
1.33
1.38
1.39
N
Ph
S
O
N
Ag
O
O
Ag
O
N
N
S
O
O Ph
Ph
Ph
Ar
Ar
Ar
Ar
L:
 
 
In 2016, Cho and coworkers19 reported that 1,1-diboryl methane 1.33 could add 
to Ellman’s aldimines20 in a highly diastereoselective manner under the catalysis of 
copper bromide and a bidentate phosphine ligand. This was a beautiful design because 
without copper as the catalyst, the 1,2-addition reaction usually suffered from low 
diastereoselectivities. The resulting primary boronic ester product could then be oxidized 
into a protected 1,2-amino alcohol (Scheme 1.13). 
 
                                                
 
19 Park, J.; Lee, Y.; Kim, J.; Cho, S. H. Org. Lett. 2016, 18, 1210-1213. 
20 Robak, M. T.; Herbage, M. A.; Ellman, J. A. Chem. Rev. 2010, 110, 3600-3740. 
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Scheme 1.13 Copper Catalyzed 1,2 Addition of Geminal Bis(Boronate) to 
Ellman’s Imine 
 10 mol % CuBr 
10 mol % dppbenz
LiOtBu (3.0 equiv)
toluene, 50 oC
H
N O
tBu NaBO3 4H2O
THF/H2O, rt
HN O
tBu
OH
Br
Br
(pin)B B(pin)
1.33
1.40
1.41
70% yield
98:2 dr
PPh2
PPh2
L:
 
 
Earlier this year, Murakami and coworkers21 reported that 1,1-diborylalk-3-ene 
could undergo palladium-catalyzed alkene transposition, followed by allylation reaction 
with aldehydes in the presence of a chiral phosphoric acid, to afford 
(Z)-δ-boryl-substituted anti-homoallylic alcohols (Scheme 1.14). This Z-alkene was then 
isomerized into the E configuration by a palladium catalyst. Mechanistic studies 
suggested the major product was generated from the transposed (E)-1,1-diborylalk-2-ene, 
which was more reactive compared to (Z)-1,1-diborylalk-2-ene. The authors proposed 
that a gauche interaction between geminal bis(boronic) ester 1.46 in the six-membered 
cyclic transition state made the formation of (E)-δ-boryl-substituted product less favored, 
and thus resulted in the formation of (Z)-δ-boryl-substituted anti-homoallylic alcohol. 
                                                
 
21 Miura, T.; Nakahashi, J.; Murakami, M. Angew. Chem., Int. Ed. 2017, 56, 6989-6993. 
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The substrate scope of aldehydes was not limited to aromatic ones; but could also be 
expanded to aliphatic substrates. 
 
Scheme 1.14 Enantioselective Synthesis of (E)-δ-Boryl-Substituted 
anti-Homoallylic Alcohols 
PhCHO
B(pin)
B(pin)
2.0 equiv
2.5% [{Pd(µ-Br)(PtBu)3}2]
5% (R)-TRIP
DCE/toluene
molecular sieves
22 oC, 17 h
Ph
B(pin)
OH
Me
1.42
1.43 1.44
82% yield
anti/syn = 98:2
E/Z = 98:2
99:1 dr
BO
H
Ph
H
Me
H
B(pin)
OO
MeMe Me
Me
gauche
interaction
BO
H
Ph
H
Me
B(pin)
H
OO
MeMe Me
Me
1.45
1.46
favored
 
1.3 Conclusions 
In conclusion, geminal bis(boronic) esters can undergo a wide array of 
transformations to deliver diversified synthetically useful products. With the readily 
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accessibility of 1,1-diborylalkanes, useful new reactions of these compounds will emerge 
more and more in the foreseeable future. 
17 
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Chapter 2 
2 Development of Base-Promoted Deborylative Alkylation of 
1,1-Bis(boronic) Esters	
 
2.1 Introduction 
Alkylboronic esters can undergo oxidation or amination to deliver synthetically valuable 
building blocks such as alcohols1 or amines2 in a stereoretentive fashion. Hence, 
development of synthetic routes to efficiently access alkylboronic esters is highly 
desirable. Traditionally, boronic esters could be obtained through hydroboration of 
alkenes with transition metal-based catalysts such as rhodium or iridium,3 or even 
without a metal catalyst,4 to afford the anti-Markovnikov products. The regioselectivity 
and enantioselectivity of these hydroboration transformations can be tuned with the 
appropriate combination of transition metal complex and ligands (Scheme 2.1).5 
                                                
 
1 Brown, H. C.; Snyder, C.; Subba Rao, B. C.; Zweifel, G. Tetrahedron 1986, 42, 5505-5510. 
2 Mlynarski, S. N.; Karns, A. S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449-16451. 
3 Carroll, A.-M.; O’Sullivan, T. P.; Guiry, P. J. Adv. Synth. Catal. 2005, 347, 609-631. 
4 Brown, H. C.; Subba Rao, B. C. J. Am. Chem. Soc. 1956, 78, 2582-2588. 
5 (a) Burgess, K.; Ohlmeyer, M. J. Chem. Rev. 1991, 91, 1179-1191. (b) Crudden, C. M.; Edwards, D. Eur. 
J. Org. Chem. 2003, 4695-4712. 
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Scheme 2.1 Regio- and Enantioselective Hydroboration of Alkenes Promoted by 
Rhodium-Based Catalyst 
O
BH
O
1. 2 mol % [Rh(COD)2]BF4 
     2 mol % (R)-BINAP, 
DME, -78 oC
2. MeOH/NaOH/H2O2
Me
OH
92% yield, 
94% ee, 
> 99/1 (α/β)
PPh2
PPh2
L:
 
 
As mentioned above, one powerful method of constructing alkylboronic esters is 
hydroboration of alkenes. In 2009, Hoveyda6 and Yun7 independently reported that 
chiral copper-based complexes could catalyze enantioselective hydroboration of styrene 
derivatives to afford nonracemic benzylic boronic esters (Scheme 2.2). These two 
different systems delivered different regioisomeric products and were complementary to 
each other. In addition, Yun and coworkers disclosed a phosphine-Cu-catalyzed protocol 
for enantioselective β-boration of esters, amides and nitriles. 
                                                
 
6 Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3160-3161. 
7 Noh, D.; Chea, H.; Ju, J.; Yun, J. Angew. Chem., Int. Ed. 2009, 48, 6062-6064. 
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Scheme 2.2 Enantioselective Hydroboration of Alkenes Catalyzed by Chiral 
Copper-Based Complexes 
Me
N
Ph
S
O
NO
O
Ph
i-Pr
i-Pr
i-Pr
7.5 mol %
THF, -78 oC, 48 h
Me
B(pin)
80% yield, 98% ee
(1)
Me
 toluene
 rt, 24 h
3 mol % CuCl, 6% NaOtBu
3 mol % (R)-DTBM-Segphos
HB(pin) (1.2 equiv) Me
B(pin)
100% conv, > 99% ee
(2)
O
O
O
O
P
P
tBu
OCH3
tBu
tBu
OCH3
tBu
2
2
(R)-DTBM-Segphos
Hoveyda :
Yun :
7.5 mol % CuCl, 30 mol % KOtBu
B2(pin)2 (1.1 equiv), MeOH (2 equiv)
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In 2009, Hoveyda and coworkers reported the first transition metal-free 
β-boration of cyclic and acyclic α, β-unsaturated ketones8 to construct tertiary and 
quaternary boronic esters efficiently (Scheme 2.3) with catalytic amounts of 
N-heterocyclic carbene (NHC) ligand. Five-, six-, seven-, and eight-membered- ring 
enones were all suitable substrates, affording β-boryl carbonyls with tertiary 
B-substituted carbons in good yield. Of note, this NHC-catalyzed process has better 
functional group tolerance than the Cu-catalyzed variant. 
 
Scheme 2.3 First Metal-Free Borylation of Cyclic and Acyclic α,β-Unsaturated 
Ketones 
O
Me
CyN NCy
BF4
2.5 mol %
THF, 22 oC, 6 h
O
Me
B(pin)
96% yield
(1)
Me
Me
O
Me
CyN NCy
BF4
2.5 mol %
THF, 22 oC, 6 h
Me
Me
O
Me
(pin)B (2)
92% yield
2.5 mol % NaOtBu
B2(pin)2 (1.1 equiv)
2.5 mol % NaOtBu
B2(pin)2 (1.1 equiv)
 
                                                
 
8 Lee, K. S.; Zhugralin, A. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 7253-7255. 
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In 2007, Aggarwal and coworkers developed a stereospecific 1,2-metallate 
rearrangement9 to assemble alkylboronates in a highly enantioselective fashion by using 
Hoppe-type lithiated carbamates (Scheme 2.4).10 This is a highly effective method of 
making these compounds, however, a limitation of this methodology is the reliance of 
stoichiometric amounts of chiral sparteine that is not readily available. More recently, 
Marder and Liu developed a transition metal-catalyzed Miyaura-type boration11 between 
primary, secondary and tertiary alkyl electrophiles with B2(pin)2 to furnish mono boronic 
esters (Scheme 2.5).  
In this chapter, I will present a new strategy to make alkylboronic esters. 
 
 
 
 
 
 
                                                
 
9 Stymiest, J. L.; Dutheuil, G.; Mahmood, A.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2007, 46, 
7491-7494. 
10 Hoppe, D.; Hintze, F.; Tebben, P.; Paetow, M.; Ahrens, H.; Schwerdtfeger, J.; Sommerfeld, P.; Haller, J.; 
Guarnieri, W.; Kolczewksi, S.; Hense, T.; Hoppe, D. Pure Appl. Chem. 1994, 66, 1479-1486. 
11 Yang, C.-T.; Zhang, Z.-Q.; Tajuddin, H.; Wu, C.-C.; Liang, J.; Liu, J.-H.; Fu, Y.; Czyzewska, M.; Steel, 
P. G.; Marder, T. B.; Liu, L. Angew. Chem., Int. Ed. 2012, 51, 528-532. 
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Scheme 2.4 Lithiation and Borylation of Hoppe-type Carbamates  
Ph OCb
 sBuLi (1.3 equiv) 
(-)-sparteine (1.3 equiv)
Li
O
O
NiPr2H
Ph
N N
EtB(pin) (1.3 equiv)
Ph
B(pin)
Me
78% yield, 96% ee
Et2O, -78 oC, 6 h
Et2O, -78 oC, 40 mins
 
 
Scheme 2.5 Copper Catalyzed Borylation of Alkyl Halides 
Cl
Br
10 mol% CuI
13 mol% PPh3
B2(pin)2 (1.5 equiv)
LiOMe (2 equiv)
DMF, rt
Cl
B(pin)
91% yield
 
 
2.2 Background 
Matteson and co-workers accomplished the synthesis of a variety of geminal 
bis(boronic) esters 12  from trimethyl borate, dichloromethane and lithium reagents 
(Scheme 2.6, Equation 1). The obtained germinal bis(boronates) were then allowed to 
                                                
 
12 Castle, R. B.; Matteson, D. S. J. Organomet. Chem. 1969, 20, 19-28. 
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react with aldehydes, followed by oxidation to deliver carbonyl compounds13 (Scheme 
2.6, Equation 2). However, this strategy to access 1,1-dibory alkanes was neither 
convenient nor safe to operate; also, functional group compatibility was found to be 
limited.  
Scheme 2.6 Synthesis of Geminal Bis(Boronates) and Further Transformations 
B
H3CO
OCH3
OCH3
4
4 Li
CH2Cl2
THF, -30 oC
H3CO
B
H3CO
B
OCH3
OCH3H
H
2 LiCl 2LiB(OCH3)4++
Me B
B
O
O
OO LiTMP
PhCHO
Me B
CHPh
O
O
NaBO3
Me
Ph
O
84% yield
(1)
(2)
25% yield
THF
 
 
                                                
 
13 Matteson, D. S.; Moody, R. J. Organometallics, 1982, 1, 20-28. 
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In 2002, Srebnik and coworkers14 reported that bis(pinacolato)diborane could 
insert into diazoalkanes with a platinum-based catalyst to afford 1,1-diboryl compounds 
(Scheme 2.7). In 2009, Shibata et al15 revealed that Rh(I)Cl–DPPB-complex could 
promote consecutive hydroboration of alkynes to furnish 1,1-bis(boronic) esters (Scheme 
2.8). However, both methods suffered from limited substrate scope. Utility of 
1,1-bis(boronic) esters in organic synthesis was probably hampered due to the associated 
difficulties in their preparation during that time. 
Scheme 2.7 Synthesis of Geminal Bis(Boronates) From Diazo Compounds 
B2(pin)2 +
H
H
N2
Pt(PPh3)4
Et2O
 0 oC /overnight
H H
(pin)B B(pin)
B2(pin)2 +
Ph
Ph
N2
Pt(PPh3)4
toluene
 110 oC /overnight
Ph Ph
(pin)B B(pin)
78% yield
83% yield
 
Scheme 2.8 Synthesis of Geminal Bis(Boronates) From Alkynes 
Ph
5 mol % [RhCl(cod)]2
6 mol % DPPB
HB(pin) (2.4 equiv)
DCE, rt, 24 h
Ph
B(pin)
B(pin)
62% yield  
                                                
 
14 (a) Abu Ali, H.; Goldberg, I.; Srebnik, M. Organometallics 2001, 20, 3962-3965. (b) Abu Ali, H.; 
Goldberg, I.; Kaufmann, D.; Burmeister, C.; Srebnik, M. Organometallics 2002, 21, 1870-1876. 
15 Endo, K.; Hirokami, M.; Shibata, T. Synlett 2009,1331-1335. 
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In 2014, our group reported that 1,1-dibromoalkanes can be converted to geminal 
bis(boronates) using copper iodide as the catalyst. Following that, we were able to scale 
up this transformation to obtain 1,1-diborylmethane. Following the precedence 
established by Matteson,16 the generated 1,1-bis(boronates) could be deprotonated by 
lithium tetramethylpiperidide (LiTMP) and subsequently alkylated with electrophiles to 
furnish a diverse range of substituted 1,1-diborylalkanes (Scheme 2.9). These geminal 
bis(boronates) were then subjected to deborylative alkylation reaction to deliver 
mono-substituted boronic ester products. At the same time, Marder and Fu developed 
similar Cu-catalyzed methods to obtain 1,1-diborylalkanes.17 
 
Scheme 2.9 Synthesis of Geminal Bis(Boronates) On Gram Scale 
Br
Br
B(pin)
B(pin)
CuI, LiOMe LTMP, THF
Ph Br
B(pin)
B(pin)
 5.4 g, 53%
B2(pin)2, DMF
6.5 g, 87%  
 
                                                
 
16 Matteson, D. S.; Moody, R. J. Organometallics, 1982, 1, 20-28. 
17 Zhang, Z.-Q.; Yang, C.-T.; Liang, L.- J.; Xiao, B.; Lu, X.; Liu, J.-H.; Marder, T. B.; Fu, Y. Org. Lett. 
2014, 16, 6342-6345. 
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1,1-Bis(boronic) esters18 constitute a valuable class of compounds because of 
their unique reactivity. In 2010, Shibata and coworkers19 reported that alkyl geminal 
bis(boronates) can undergo Suzuki coupling with aryl halides to afford secondary boronic 
esters (Scheme 2.10). It was reasoned that after rapid transmetallation, the empty p orbital 
of boron could help to stabilize the σ-alkylpalladium intermediate, thus reducing the 
propensity of β-H elimination. 
 
Scheme 2.10 First Suzuki Coupling Between Alkyl Geminal Bis(Boronates) and 
Aryl Halides 
Me
B(pin)
B(pin) I
OMe
5 mol % Pd[P(t-Bu)3]2
KOH (4.5 equiv)
H2O/dioxane
25 oC, 2 h
OMe
B(pin)
Me
80% yield  
 
In 2014, Morken and coworkers20 developed an enantioselective variant of this 
Suzuki coupling between geminal bis(boronates) and aryl halides in the presence of 
Pd(OAc)2 and a taddol-derived phosphoramidite ligand (Scheme 2.11). A broad scope of 
                                                
 
18 Hall, D. G. Boronic Acids, 2nd ed.; Wiley-VCH: Weinheim, 2011. 
19 Endo, K.; Ohkubo, T.; Hirokami, M.; Shibata, T. J. Am. Chem. Soc. 2010, 132, 11033-11035. 
20 Sun, C.; Porter, B.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 6534-6537. 
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substrates ranging from electron-donating to slightly electron-withdrawing aryl halides 
could be employed. Studies were also carried out to gain mechanistic insights (Scheme 
2.12). Enantioenriched 10boron-labeled 1,1-diboryl alkanes were subjected to the reaction 
conditions, and the mono-substituted boronic ester products were then collected and 
analyzed by mass spectrometry. From the obtained data, it was concluded that 
transmetallation from the putative boron ate complex to palladium occurred in a 
stereoinvertive fashion. 
 
Scheme 2.11 First Enantioselective Suzuki Cross Coupling between Geminal 
Bis(Boronates) and Aryl Halides 
Ph
B(pin)
B(pin)
5 mol % Pd(OAc)2
10 mol % Ligand
KOH (15 equiv)
dioxane/H2O
rt, 12 h
Ph
B(pin)
82% yield, 86% ee
I
O
O
O
O
P
Me
Me
Ar
Ar
NMe2
Ar
p-tol
L:
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Scheme 2.12 Mechanistic Studies Revealed the Carbon Center Inverted 
Transmetallation 
10B(pin)
pentyl B(pin)
5 mol % Pd(OAc)2
10 mol % (R,R)-TADDOL-NMe2
4-iodoanisole
KOH (15 equiv)
dioxane/H2O
rt, 12 h
B(pin)
pentyl p-anisyl
(S)-10B
98:2 er
(R)-11B
75% yield
92:8 er
10B(pin)
pentyl B(pin)
5 mol % Pd(OAc)2
10 mol % (S,S)-TADDOL-NMe2
4-iodoanisole
KOH (15 equiv)
dioxane/H2O
rt, 12 h
10B(pin)
pentyl p-anisyl
(S)-10B
98:2 er
(S)-10B
60% yield
92:8 er  
 
Our efforts focused on expanding the scope of the aforementioned Suzuki 
coupling from aryl halides to alkyl halides. We envisioned that such transformations that 
merge 1,1-diboryl alkanes with alkyl electrophiles enantioselectively could have a 
profound impact in synthetic chemistry. We anticipated that β-H elimination is a likely 
competitive side pathway that needs to be circumvented for the success of our proposed 
method. 
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2.3 Development of Deborylative Alkylation Reaction 
2.3.1 Preliminary Studies Involving Pd-Catalyzed Suzuki Coupling Between 
Alkyl Bis(boronates) and Alkyl Halides 
On the basis of our earlier studies, Suzuki coupling reactions between alkyl 
geminal bis(boronic) esters and 1-bromododecane were initially examined (Scheme 2.13) 
using monodentate ligands such as PCy3 and Ruphos. However, none of the desired cross 
coupling products were detected in any attempts. We then proceeded to probe the 
background reaction in the presence of base, but without the Pd-based catalyst (Scheme 
2.14, equation 1). This experiment revealed only the presence of protodeborylation 
product. 
 
Scheme 2.13 Attempt Enantioselective Suzuki Coupling Between Alkyl Geminal 
Bis(Boronates) and Alkyl Halides 
Ph
B(pin)
B(pin)
5 mol % Pd2(dba)3
40 mol % PCy3
KOH (15 equiv)
dioxane/H2O
rt, 12 h
Ph n-C12H25
B(pin)
n-C12H25Br
Not observed  
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Scheme 2.14 Background Reaction of Suzuki Coupling Between Alkyl Geminal 
Bis(Boronates) and Alkyl Halides 
Ph
B(pin)
B(pin)
KOtBu (1 equiv)
THF, rt, 12 h
Ph H
B(pin)
then H2O
87% conversion
(1)
 
Ph
B(pin)
B(pin)
KOtBu (1 equiv)
iodoethane (5 equiv)
Ph H
B(pin)
> 98%  conversion, 1.4 : 1
(2)
Ph
B(pin)
Me
THF, rt, 12 h
 
To learn about the capacity for protodeborylation under anhydrous conditions, 
and the potential for cross-coupling in the absence of water, we examined background 
reaction in the THF solvent. As demonstrated in Scheme 2.14, we observed significant 
amount of protodeborylation byproduct when the background reaction was performed 
overnight and quenched with wet diethyl ether. At this point, we wondered if other 
electrophiles such as alky halides could be utilized as an electrophile in place of water to 
forge a carbon-carbon bond instead of carbon-hydrogen bond. To test this, the 
aforementioned reaction was repeated in the presence of excess iodoethane (Scheme 2.14, 
equation 2). Full consumption of starting material and 58% conversion to the desired 
deborylative alkylated product was observed. While our initial attempts to achieve 
enantioselective Suzuki coupling appeared fraught with complication, the base-promoted 
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deborylative alkylation reaction21 as a tool to construct primary, secondary, and tertiary 
alkyl boronic esters for synthetic chemistry was then developed. 
2.3.2 Reaction Optimization 
With preliminary results in hand, we tested different bases and solvents in order to 
find the optimal reaction conditions (Table 2.1). Potassium hydroxide, the requisite base 
for enantioselective Suzuki cross coupling between geminal bis(boronates) and aryl 
halides, was discovered to be inefficient in our system. Among LiOtBu, NaOtBu and 
KOtBu, we found out that NaOtBu served as the optimal base, as it possesses the best 
balance of base strength to ensure good reactivity without promoting adventitious side 
reactions (such as elimination of the alkyl halides). Experiments also showed that 
reactions performed in polar solvents were generally more efficient (vs. non-polar 
solvents), which led us to conclude that NaOtBu in THF were the best reaction conditions 
for the deborylative alkylation. 
Table 2.1 Full Optimization Table 
Ph
B(pin)
B(pin) solvent
rt, 3 h
Ph n-C12H25
B(pin)n-C12H25Br
base
Ph n-C12H25
B(pin)(pin)B
2.1 2.2 2.3  
 
                                                
 
21 Hong, K.; Liu, X.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 10581-10584. 
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entry base solvent conversion (%) yield of 2.2 (%) 
1 KOH THF <5 -b 
2 LiOtBu THF <5 -b 
3 NaOiPr THF <5 -b 
4 NaOtBu THF 100 91 
5 NaOtAmyl THF 85 72 
6 NaN(SiMe3)2 THF 100d - 
7 KOMe THF 30 - 
8 KOtBu THF 100 68 
9 NaOtBu THF 65 46c 
10 NaOtBu dioxane 75 70 
11 NaOtBu ether <5 -b 
12 NaOtBu CH2Cl2 <5 -b 
13 NaOtBu hexanes <5 -b 
14 NaOtBu toluene <5 -b 
15 KOtBu toluene 80 76 
16 NaOtBu THF 100 97e 
17 NaOtBu THF 67 -f, g 
18 KOtBu toluene 100 97f, h 
a Reaction conditions: 1-bromododecane (0.10 mmol, 0.2 M), 2.1 (0.13 mmol) and base (0.30 
mmol). Conversion refers to consumption of 1-bromododecane and was determined by 1H NMR 
with 1,3,5-trimethoxybenzene as the internal standard. Yield refers to the isolated yield of 
purified material. b partial protodeboronation of 2.1. c 1.5 equiv. NaOtBu employed instead of 3.0 
equiv. d exclusively 2.3. e 14 hours. f 1-chlorododecane employed instead of 1-bromododecane. g 
2.2:double alkylation product = 2.5:1. h 2.0 equiv. 2.1, 5.0 equiv. KOt-Bu, toluene, 14 hours.  
 
2.3.3 Substrate Scope  
With the established conditions in hand, we proceeded to assess the generality of 
the protocol with a wide array of electrophiles (Scheme 2.14). Alkyl chlorides, bromides 
and iodides were effective substrates for this transformation, delivering desired product 
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2.2 in good yields. Alkyl iodides gave lower yields of 2.2 due to competitive elimination 
side reactions. Secondary alkyl halides could also be employed to give 2.4 in 75% yield. 
For substrates bearing both primary and secondary alkyl halides, reaction occurred 
chemoselectively at the primary position (2.5). Not surprisingly, allylic halides (2.6, 2.7, 
2.8 and 2.9) and benzylic halides (2.11 and 2.12) afforded deborylative alkylated 
products efficiently in 74−91% yield. Non-substituted 1,1-diborylalkanes can similarly 
undergo reaction to furnish primary boronic ester products (2.10, 2.11 and 2.12), and 
sterically hindered geminal bis(boronate) ester was efficiently converted to desired 
product 2.13 in 87% yield. 
The substrate scope for deborylative alkylation reaction was extended from 
terminal bis(boronates) to more sterically congested internal geminal bis(boronic) esters 
(Scheme 2.15). To our surprise, the steric hindrance did not jeopardize reactivity, as the 
alkylated product (2.14) could be isolated in 95% yield. The tethered alkene (2.16) and 
cyclopropyl group (2.18) were found to be intact under the reaction conditions, 
suggesting that radical intermediates are unlikely to be generated during the course of the 
reaction. Geminal bis(boryl) cyclopropanes were also effective substrates in this protocol, 
delivering alkylated products in good yields and high diastereoselectivities (2.17 and 
2.19).  
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Scheme 2.14 Substrate Scope for Building Primary and Secondary Boronic 
Esters 
R'X NaO
tBu (3.0 equiv)
THF, rt, 3 h
Ph
B(pin)
C12H25
    X = Br   91%(gram scale)
    X = Cl   97%
    X = I     76%
Ph
B(pin)
Me
Me
X = Br, 75%
Ph
B(pin)
 X = Cl, 86%
R B(pin)
B(pin)
R
B(pin)
R'
1.3 equiv
Ph
B(pin)
Me
Br
X = Cl, 84%
1.0 equiv
B(pin)
C12H25
 X = Br, 87%
Ph
B(pin)
Ph
B(pin)
Me
(pin)B
 X = Cl, 74%
X = Cl, 78%
 X = Cl, 90%
Me
Me
OMe
B(pin)
C12H25
 X = Cl, 90%
OMe
(pin)B
Br
 X = Cl, 77%
Ph
B(pin)
 X = Cl, 91%
Me
2.2 2.4 2.5
2.6 2.7 2.8
2.9 2.10
2.11 2.12 2.13
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Scheme 2.15 Substrate Scope for Constructing Tertiary Boronic Esters 
 
NaOtBu (3.0 equiv)
THF, rt, 3 h
B(pin)
R3R1 R2
R3X
B(pin)
B(pin)R1 R2
1.3 equiv 1.0 equiv
Ph C12H25
B(pin)
Ph
Ph
B(pin)
Me
MePh
Ph
B(pin)
C12H25
 X = Br, 99% X = Br, 95%
X = Br, 66%
Ph
B(pin)
 X = Cl, 74%
Ph C12H25
B(pin)
Ph C12H25
B(pin)
3
X = Br, 91%
 X = Br, 56%
OMe
2.14 2.15 2.16
2.17 2.18 2.19
 
 
Intramolecular variants of the deborylative alkylation reaction to afford 
carbocyclic boronic esters could also be accomplished. As demonstrated below (Scheme 
2.16), products ranging from three-membered to seven-membered ring systems could be 
prepared, although yields appeared to diminish with the size of the carbocycles. This 
could be due to the increased conformational flexibility in substrates bearing longer alkyl 
chains, rendering undesired intermolecular reactions to be competitive with 
intramolecular cyclization. Of note, the secondary bromide substrate afforded the 
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cyclopentane ring 2.25 in high diastereoselectivity. The steric interaction between methyl 
group at C1 and C4 shown in Int 2.1 might be the origin of the diastereoselectivity, also, 
the proton would prefer the spot near sterically congested boronic ester.  
Scheme 2.16 Substrate Scope for Intramolecular Deborylative Alkylation 
Reactions 
NaOtBu (3.0 equiv)
THF, rt, 3 hPh
B(pin)(pin)B
Ph
B(pin)
Xn nn = 1, 2, 3, 4, 5
B(pin)
Ph
(pin)B
Ph
(pin)B
Ph
Me
X = Cl, 93% X = Br, 88%
    X = Br, 76%, 7:1 dr
B(pin)
Ph
X = Br, 72%
B(pin)
Ph
 X = Br, 61%
(pin)B
 X = Br, 60%
2.20 2.21
2.25
2.22 2.23 2.24
B(pin)
Ph
Me
H
3 Int 2.1Br
B(pin)
H
Ph
Me
Br
4Int 2.1
4 1
1
Na
Na
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2.3.4 Mechanistic Studies 
Based on the aforementioned observations, we proposed two possible mechanistic 
pathways for this transformation (Scheme 2.18). The first possible pathway involves 
deprotonation of geminal bis(boronic) ester 2.1 with NaOtBu to generate carbanion 
species 2.23 and tert-butanol. 2.23 may then react with 1-bromododecane to afford 
geminal bis(boronic) ester 2.3, which subsequently undergoes protodeborylation with 
tert-butanol to deliver desired product 2.2. Alternatively, NaOtBu may first react with one 
of the B(pin) (pin: pinacolato) units through coordination to furnish either boron ate 
complex 2.24 or a-boryl carbanion 2.25 before reacting with 1-bromododecane to give 
2.2.  
To distinguish between these two pathways (Scheme 2.19), we prepared 
deuterium-labeled substrate 2.26 and non-deuterated 1,1-bisborylalkane 2.27. These two 
compounds were subjected to the established reaction conditions in the same flask. If 
Pathway A was to be operative, the generated deuterium-labeled tert-butanol could react 
with both substrates through deuterium-boron exchange to furnish two products with 
significant amounts of deuterium incorporation. If pathway B was the dominant process, 
no deuterium scrambling shall be expected. In the event, the crossover experiment 
revealed minimal loss of deuterium content within product 2.28 and <5% deuterium 
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incorporation in product 2.29. These results were indicative of Pathway B being the most 
likely mechanism through which the deborylative alkylation proceeds.  
Scheme 2.18 Two Possible Pathways for Deborylative Alkylation Reaction 
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Scheme 2.19 Crossover Experiment to Differentiate Pathway A and Pathway B 
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Question that remains is whether the transformation proceeds through the 
intermediacy of boron ate complex 2.24 or carbanion 2.25. Based on literature 
precedence, we found that borate complexes usually react with electrophiles through a 
SE2 inverted manner,22 while a carbanion would give rise to racemic product (Scheme 
2.20). 
 
Scheme 2.20 Different Mechanisms Leading to Different Stereochemical 
Outcomes  
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To distinguish between these two possibilities, we synthesized 10B-labeled 
enantioenriched 1,1-diborylalkane 2.39 (Scheme 2.21). Starting from commercial 
                                                
 
22 Larouche-Gauthier, R.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2011, 133, 16794-16797. 
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available phenylacetylene 2.35, nickel-catalyzed regioselective hydroalumination 23 
followed by trapping with 10B-labeled MeO10B(pin) furnished E-alkenyl-10B(pin) 2.36. 
The B(pin) motif was oxidatively cleaved and the resulting boronic acid was refluxed 
with 1,8-diaminonaphthalene to give E-alkenyl-10B(dan) 2.37. Copper-catalyzed 
enantioselective hydroboration24 with styrene derivative 2.37 gave 1,1-bisborylalkane 
2.38, which was then converted to the desired 10B-labeled geminal bis(boronic) ester 
2.39. 
 
Scheme 2.21 Synthesis of 10B-Labeled Enantioenriched Geminal Bis(boronate) 
Ester 2.39 
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23 Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10961-10963. 
24 Feng, X.; Jeon, H.; Yun, J. Angew. Chem., Int. Ed. 2013, 52, 3989-3992. 
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Enantioenriched 1,1-diborylalkane 2.39 was treated with NaOtBu and 
1-bromododecane. After silica gel column chromatography, the obtained products were 
separated by supercritical fluid chromatography (SFC), and the isolated (S)- and 
(R)-enantiomers were then analyzed by mass spectrometry. The hypothesis is that if 
deborylative alkylation occurs through stereoinvertive electrophilic substitution, the mass 
balance for the two enantiomers (S)-2.40 and (R)-2.41 should be different. On the other 
hand, the isotopic composition for both enantiomers should be identical if racemization 
does happen. (For (S)-enantiomer, there would be 10B-2.41 and 11B-2.40; for 
(R)-enantiomer, there would be 10B-2.41 and 11B-2.40).  
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Scheme 2.22 Calculated Results for Possible Pathways 
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The two almost identical mass spectra (Scheme 2.23 and Scheme 2.24) obtained 
for (S)-enantiomer and (R)-enantiomer led us to conclude that the carbon stereocenter 
was racemized during the reaction process, implying that carbanion 2.33 was most likely 
generated as the reactive intermediate. 
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Scheme 2.23 Mass Spectrum of Product (S) Enantiomer from 10B-labeled 
Experiment Using (S)-10B-2.39: 
 
Scheme 2.24 Mass Spectrum of Product (R) Enantiomer from 10B-labeled 
Experiment Using (S)-10B-2.39: 
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To further support our hypothesis for the existence of carbanion 2.33, we 
synthesized 13C-labeled geminal bis(boronate) ester 2.42 and subjected it to NaOtBu and 
d8-THF in an NMR tube in the glovebox. Reaction progress was monitored by 13C NMR 
spectrometry (Scheme 2.25). After adding base for 30 minutes, two new signals appeared. 
The smaller resonance at 27.1 ppm was attributed to protodeborylation byproduct 2.43, 
and the broad one at 35.5 ppm was assigned as the boron-ate complex 2.44. After 90 
minutes, a new broad signal emerged at 49.1 ppm, which was believed to be the 
carbanion species 2.45. The chemical shift is significantly downfield compared to typical 
carbanions (-15.3 ppm for MeLi25), which may be rationalized by the double bond 
character of the carbon-boron bond in 2.46. As reaction proceeds, the peak at 49.1 ppm 
grew in size. As soon as 1-bromododecane was added, the broad signal that corresponds 
to 2.45 disappeared immediately and a new large peak at 31.4 ppm (later found to be due 
to the desired product 2.47) was observed. This 13C NMR study clearly demonstrated that 
base-promoted deborylative alkylation proceeds through the intermediacy of 
boron-stabilized carbanion species. 
                                                
 
25 Al-Humydi, A.; Garrison, J. C.; Youngs, W. J.; Collins, S. Organometallics 2005, 24, 193-196. 
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We also attempted to obtain evidence of the boron-stabilized carbanion 
intermediate via 11B NMR spectrometry. However, the spectra were not very informative 
due to the presence of byproduct 2.48 occuring around 6 ppm. 13Carbon-11Boron 
correlation NMR spectra might be helpful in the further studies. 
 
Scheme 2.25 13C NMR Study of 13C-Labeled Geminal Bis(boronate) Ester 2.42 
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2.4 Conclusions 
The base-promoted deborylative alkylation reactions can afford synthetically 
useful primary, secondary and tertiary organoboronic esters from readily accessible 
1,1-diboryl alkanes, and these products are amenable to further transformations to amines 
and alcohols in a stereoretentive fashion. Through extensive mechanistic studies, we 
found that these transformations proceed through the intermediacy of boron-stabilized 
carbanions.  
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2.5 Experimental Section 
2.5.1 General Information 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), or a 
Varian Inova-500 (500 MHz) spectrometer. Chemical shifts are reported in ppm with the 
solvent resonance as the internal standard (CDCl3: 7.26 ppm, THF-d8: 3.58 ppm). Data 
are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, qi = quintet, sx = sextet, sp = septet, m = multiplet, br = broad), and 
coupling constants (Hz). 13C NMR spectra were recorded on either a Varian Gemini-500 
(125 MHz), or a Varian Inova-500 (125 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm with the solvent resonance as the 
internal standard (CDCl3: 77.0 ppm, THF-d8: 67.57 ppm). Infrared (IR) spectra were 
recorded on a Bruker alpha-P Spectrometer. Frequencies are reported in wavenumbers 
(cm-1) as follows: strong (s), broad (br), medium (m), and weak (w). High-resolution 
mass spectrometry (DART+) was performed at the Mass Spectrometry Facility, Boston 
College, Chestnut Hill, MA. 
Liquid chromatography was performed using forced flow (flash chromatography) 
on silica gel (SiO2, 230 − 400 Mesh) purchased from Silicycle. Thin layer 
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chromatography (TLC) was performed on 25 µm silica gel glass backed plates from 
Silicycle. Visualization was performed using ultraviolet light (254 nm), 
phosphomolybdic acid (PMA) in ethanol and ceric ammonium molybdate (CAM) in 
ethanol. 
Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector.  
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), diethyl ether, dichloromethane 
and toluene were purified using Pure Solv MD-4 solvent purification system, from 
Innovative Technology, Inc., by passing the solvent through two activated alumina 
columns after being purged with argon. 
Bis(pinacolato)diboron was generously donated by Allychem Co., Ltd. and used 
without further purification. Triethylamine was purchased from Alfa Aesar and distilled 
over calcium hydride prior to use. The following reagents were purchased and used 
without purification: copper(I) iodide (CuI) (Aldrich), lithium 
2,2,6,6-tetramethylpiperidide (LTMP) (Aldrich), sodium tert-butoxide (NaOt-Bu) 
(Strem), palmitic acid-1-13C (Cambridge Isotope Laboratories), and 
N,N-dimethylformamide (DMF) (Acros). All other reagents were purchased from either 
Aldrich, Alfa Aesar or Acros and used without further purification.  
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2.5.2 Representative Procedures for Preparation of Geminal Diboronate Esters 
Method A: 
Br
Br
B(pin)
B(pin)
CuI, LiOMe
B2(pin)2, DMF  
In the glove box, an oven-dried 500 mL round-bottom flask with magnetic stir bar 
was charged with CuI (1.428 g, 7.500 mmol), LiOMe (8.543 g, 225 mmol) and B2(pin)2 
(38.09 g, 150.0 mmol). The flask was sealed with a rubber septum, removed from the 
glove box, followed by the addition of DMF (150 mL) under N2. After stirring at room 
temperature for 10 min, dibromomethane (10.53 mL, 150.0 mmol) was added via syringe 
at room temperature. The reaction mixture was allowed to stir at room temperature for 12 
hours. Upon completion, 200 mL diethyl ether was added. The slurry was filtered through 
a silica gel plug, rinsed with diethyl ether, and concentrated in vacuo. The crude reaction 
mixture in DMF was diluted with hexanes (300 mL), washed with H2O (75 mL × 4), 
dried over Na2SO4, then concentrated in vacuo. The desired product 
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane was obtained as a white solid 
(15.72 g, 78%) and used without further purification. 
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Method B:  
B(pin)
B(pin)
LTMP, THF
Ph Br
B(pin)
B(pin)
2.1  
In the glove box, an oven-dried 25 mL round-bottom flask with magnetic stir bar 
was charged with LTMP (773 mg, 5.25 mmol). The flask was sealed with a rubber 
septum, removed from the glove box, followed by the addition of THF (20 mL) under N2. 
The reaction mixture was cooled to 0 oC, and a solution of 1,1-diborylmethane (1.34 g, 
5.00 mmol) in THF (5 mL) was added via syringe and the mixture was allowed to stir at 
0 °C for 10 minutes. (2-Bromoethyl)benzene (751 µL, 5.50 mmol) was added dropwise 
and the reaction was allowed to stir at 0 oC for 15 min. Upon completion, the reaction 
mixture was warmed to room temperature, filtered through a silica gel plug, rinsed with 
diethyl ether, and concentrated in vacuo. The crude reaction mixture was purified on 
silica gel (hexanes: diethyl ether = 9:1) to afford the desired product 2.1 as a colorless oil 
(1.54 g, 83%). 
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Method C:  
Ph
Br
Br
nBuLi, THF
B2Pin2
-78 oC to rt Ph B(pin)
B(pin)
 
The gem-diboryl cyclopropane was prepared according to the literature procedure 
with some modification.26 An oven-dried 25 mL round-bottom flask with magnetic stir 
bar was charged with B2(pin)2 (508 mg, 2.0 mmol) and (2,2-dibromocyclopropyl)benzene 
(607 mg, 2.20 mmol). The flask was sealed with a rubber septum and purged with N2. 
THF (6 mL) was added and the reaction mixture was cooled to −78 oC. n-BuLi (2.50 M 
in hexanes, 0.88 mL, 2.20 mmol) was added dropwise and the reaction was allowed to 
stir at −78 oC for 10 min, then warmed to room temperature and stirred for 12 hours. The 
reaction mixture was quenched by H2O at 0 oC, extracted with diethyl ether, dried over 
Na2SO4, and concentrated in vacuo. The crude reaction mixture was purified on silica gel 
(hexanes: diethyl ether = 9:1) to afford the desired product as a white solid (471 mg, 
64%). 
 
                                                
 
26 Shimizu, M.; Schelper, M.; Nagao, I.; Shimono, K.; Kurahashi, T.; Hiyama, T. Chem. Lett. 2006, 35, 
1222-1223. 
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2.5.3 Full Characterization of Geminal Diboronate Esters 
2,2'-(3-phenylpropane-1,1-diyl)bis(4,4,5,5-tetramethyl-1,
3,2-dioxaborolane) (2.1). Prepared according to 
Representative Procedure (Method B). 1H NMR (500 MHz, 
CDCl3): δ 7.26-7.23 (2H, m), 7.18-7.14 (3H, m), 2.60-2.57 
(2H, m), 1.88-1.83 (2H, m), 1.24 (12H, s), 1.23 (12H, s), 0.81 (1H, t, J = 7.8 Hz). The 1H 
NMR spectrum was in accord with previously reported data.27  
 
2,2'-(2-phenylethane-1,1-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (S2.1). Prepared according to Representative 
Procedure (Method B) with LTMP (424 mg, 2.88 mmol), 
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (734 
mg, 2.74 mmol), benzyl bromide (356 µL, 3.01 mmol), and THF (13 mL). The crude 
reaction mixture was purified on silica gel (hexanes: diethyl ether = 9:1) to afford the 
desired product as a colorless oil (753 mg, 77%). 1H NMR (500 MHz, CDCl3): δ 
7.25-7.20 (4H, m), 7.13-7.09 (1H, m), 2.88 (2H, d, J = 8.3 Hz), 1.20-1.15 (1H, m), 1.18 
(12H, s), 1.17 (12H, s); 13C NMR (125 MHz, CDCl3): δ 144.5, 128.3, 128.0, 125.3, 83.1, 
                                                
 
27 Sun, C.; Porter, B.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 6534-6537. 
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31.3, 24.8, 24.5; IR (neat): 2976.9 (w), 2930.2 (w), 1454.0 (w), 1357.5 (m), 1311.7 (s), 
1267.1 (m), 1135.9 (s), 969.6 (m), 850.9 (m), 732.2 (w), 697.6 (m), 528.3 (w) cm-1; 
HRMS-(DART+) for 12C201H3311B216O4 [M+H]+: calculated: 359.2565, found: 359.2565. 
 
2,2'-(cyclohexylmethylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxa
borolane) (S2.2). The reaction was performed according to 
Representative Procedure (Method A) with CuI (19.1 mg, 0.1 
mmol), LiOMe (94.9 mg, 2.5 mmol), B2(pin)2 (508 mg, 2.0 
mmol), (dibromomethyl) cyclohexane (313 mg, 1.2 mmol) and DMF (2 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (10:1 
hexanes/diethyl ether, stain in CAM) to afford a white solid (239 mg, 68%). 1H NMR 
(500 MHz, CDCl3): δ 1.78-1.57 (6H, m), 1.35-1.20 (2H, m), 1.23 (12H, s), 1.22 (12H, s), 
1.12-1.04 (1H, m), 0.95-0.87 (2H, m), 0.64 (1H, d, J = 10.3 Hz). The 1H NMR spectrum 
was in accord with previously reported data.27 
 
2,2'-(1,4-diphenylbutane-2,2-diyl)bis(4,4,5,5-tetramethyl-1,
3,2-dioxaborolane) (S2.3). The reaction was performed 
according to Representative Procedure (Method C) with 
diboronate ester 2.1 (372 mg, 1.00 mmol), LTMP (155 mg, 
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1.05 mmol), benzyl bromide (131 µL, 1.10 mmol) and THF (5 mL). The crude reaction 
mixture was purified by column chromatography on silica gel (20:1 – 10:1 
hexanes/diethyl ether, stain in CAM) to afford a white solid (353 mg, 76%). 1H NMR 
(500 MHz, CDCl3): δ 7.34-7.32 (2H, m), 7.24-7.19 (4H, m), 7.16-7.09 (4H, m), 3.08 (2H, 
s), 2.66-2.63 (2H, m), 1.82-1.79 (2H, m), 1.27 (12H, s), 1.23 (12H, s); 13C NMR (125 
MHz, CDCl3): δ 143.5, 141.7, 129.7, 128.5, 128.1, 127.8, 125.6, 125.4, 83.3, 34.8, 33.9, 
31.7, 25.1, 24.7; IR (neat): 2976.9 (w), 2926.6 (w), 1452.6 (m), 1350.0 (m), 1308.0 (s), 
1247.6 (m), 1207.6 (m), 1134.4 (s), 967.8 (w), 848.6 (m), 698.0 (s), 578.9 (w), 492.7 (w) 
cm-1; HRMS-(DART+) for 12C281H4111B216O4 [M+H]: calculated: 463.3191, found: 
463.3204. 
 
2,2'-(1-phenyloct-7-ene-3,3-diyl)bis(4,4,5,5-tetramethyl-1,3,
2-dioxaborolane) (3.1). The reaction was performed according 
to Representative Procedure (Method B) with diboronate ester 
2.1 (186 mg, 0.50 mmol), LTMP (77.3 mg, 0.525 mmol), 
5-bromo-1-pentene (65 µL, 0.55 mmol) and THF (2.5 mL). The crude reaction mixture 
was purified by column chromatography on silica gel (20:1 hexanes/diethyl ether, stain in 
CAM) to afford a white solid (195.2 mg, 89%). 1H NMR (500 MHz, CDCl3): δ 7.26-7.23 
(2H, m), 7.20-7.19 (2H, m), 7.15-7.12 (1H, m), 5.86 (1H, ddt, J = 17.1, 10.3, 6.9 Hz), 
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5.01 (1H, ddt, J = 17.1, 2.0, 1.5 Hz), 4.93 (1H, ddt, J = 10.3, 2.4, 1.0 Hz), 2.52-2.49 (2H, 
m), 2.10-2.06 (2H, m), 1.91-1.88 (2H, m), 1.74-1.71 (2H, m), 1.41-1.35 (2H, m), 1.23 
(24H, s); 13C NMR (125 MHz, CDCl3): δ 143.8, 139.3, 128.5, 128.1, 125.4, 114.0, 83.0, 
34.5, 33.8, 31.9, 28.7, 26.6, 24.8, 24.7; IR (neat): 2975.6 (w), 2917.6 (w), 1354.0 (w), 
1309.2 (s), 1249.5 (m), 1135.3 (s), 966.9 (w), 849.1 (m), 750.5 (w), 699.6 (m), 669.0 (w) 
cm-1. 
 
2,2'-(cyclopropylmethylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxa
borolane) (S2.4). The reaction was performed according to 
Representative Procedure (Method C) with (dibromomethyl) 
cyclopropane (470.6 mg, 2.20 mmol), B2(pin)2 (508.0 mg, 2.00 
mmol), n-BuLi (2.50 M, 0.88 mL, 2.20 mmol) and THF (6 mL). The crude reaction 
mixture was purified by column chromatography on silica gel (15:1 – 9:1 hexanes/diethyl 
ether, stain in CAM) to afford a white solid (116.8 mg, 19%). The 1H NMR spectrum was 
in accord with previously reported data.28 
 
                                                
 
28 Li, H.; Shangguan, X.; Zhang, Z.; Huang, S.; Zhang, Y.; Wang, J. Org. Lett. 2014, 16, 448-451. 
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2,2'-(1-cyclopropyl-3-phenylpropane-1,1-diyl)bis(4,4,5,5-tet
ramethyl-1,3,2-dioxaborolane) (S2.5). The reaction was 
performed according to Representative Procedure (Method B) 
with diboronate ester S2.4 (116.0 mg, 0.377 mmol), LiTMP 
(58.3 mg, 0.396 mmol), (2-bromoethyl)benzene (0.057 mL, 0.415 mmol) and THF (2 
mL). The crude reaction mixture was purified by column chromatography on silica gel 
(30:1 – 20:1 hexanes/diethyl ether, stain in CAM) to afford a white solid (116.2 mg, 
75%). 1H NMR (500 MHz, CDCl3): δ 7.26-7.21 (4H, m), 7.15-7.12 (1H, m), 2.73-2.70 
(2H, m), 1.90-1.86 (2H, m), 1.22 (24H, s), 0.97-0.91 (1H, m), 0.46-0.38 (4H, m); 13C 
NMR (125 MHz, CDCl3): δ 144.2, 128.5, 128.1, 125.3, 82.8, 35.9, 34.8, 24.8, 24.7, 12.9, 
3.6; IR (neat): 2977.0 (w), 1345.8 (m), 1311.2 (s), 1247.3 (m), 1213.1 (w), 1187.6 (w), 
1131.8 (s), 967.6 (m), 848.2 (s), 826.2 (w), 757.5 (w), 741.6 (w), 699.8 (m), 668.5 (w), 
601.8 (w), 494.2 (w) cm-1; HRMS-(DART+) for 12C241H3811B216O4 [M]+·: calculated: 
412.2956, found: 412.2967. 
 
2,2'-(2-phenylcyclopropane-1,1-diyl)bis(4,4,5,5-tetramethyl-1,
3,2-dioxaborolane) (S2.6). The reaction was performed 
according to Representative Procedure (Method C). 1H NMR 
(500 MHz, CDCl3): δ 7.25-7.23 (2H, m), 7.21-7.17 (2H, m), 
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7.12-7.08 (1H, m), 2.47 (1H, dd, J = 7.3, 5.9 Hz), 1.52 (1H, dd, J = 5.4, 3.4 Hz), 
1.27-1.22 (1H, m), 1.222 (6H, s, overlap), 1.215 (6H, s, overlap), 0.99 (6H, s), 0.94 (6H, 
s); 13C NMR (125 MHz, CDCl3): δ 140.9, 128.3, 127.8, 125.8, 82.88, 82.86, 26.7, 24.83, 
24.81, 24.7, 24.2, 14.1; IR (neat): 2977.5 (m), 2930.2 (w), 1379.1 (s), 1342.6 (s), 1298.8 
(m), 1215.2 (w), 1148.2 (s), 1113.9 (m), 968.0 (w), 851.2 (m), 696.3 (w) cm-1; 
HRMS-(DART+) for 12C211H3311B216O4 [M+H]+: calculated: 371.2565, found: 371.2568. 
 
2,2'-(1-chloro-5-phenylpentane-3,3-diyl)bis(4,4,5,5-tetramet
hyl-1,3,2-dioxaborolane) (S2.7). The reaction was performed 
according to Representative Procedure (Method B) with 
diboronate ester 2.1 (186 mg, 0.50 mmol), LTMP (77.3 mg, 
0.525 mmol), 1-bromo-2-chloro ethane (83 µL, 1.0 mmol) and THF (2.5 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (10:1 
hexanes/diethyl ether, stain in CAM) to afford a white solid (178 mg, 82%). 1H NMR 
(500 MHz, CDCl3): δ 7.27-7.24 (2H, m), 7.19 (2H, d, J = 7.3 Hz), 7.15 (1H, t, J = 7.3 
Hz), 3.62 (2H, t, J = 8.3 Hz), 2.57-2.53 (2H, m), 2.20 (2H, t, J = 8.3 Hz), 1.90-1.87 (2H, 
m), 1.23 (24H, s); 13C NMR (125 MHz, CDCl3): δ 143.1, 128.4, 128.2, 125.6, 83.3, 43.5, 
33.9, 33.1, 32.4, 24.8, 24.7; IR (neat): 2977.8 (m), 2931.0 (w), 2865.6 (w), 1454.9 (w), 
1353.5 (m), 1317.0 (s), 1243.1 (m), 1137.0 (s), 967.5 (w), 852.1 (m), 699.6 (w) cm-1; 
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HRMS-(DART+) for 12C231H3811B235Cl116O4 [M+H]+: calculated: 435.2645, found: 
435.2665. 
2,2'-(6-bromo-1-phenylhexane-3,3-diyl)bis(4,4,5,5-tetramet
hyl-1,3,2-dioxaborolane) (S2.8). The reaction was performed 
according to Representative Procedure (Method B) with 
diboronate ester 2.1 (186 mg, 0.50 mmol), LTMP (77.3 mg, 
0.525 mmol), 1,3-dibromo propane (0.12 mL, 1.2 mmol) and THF (2.5 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (10:1 
hexanes/diethyl ether, stain in CAM) to afford a white solid (217 mg, 88%). 1H NMR 
(500 MHz, CDCl3): δ 7.26-7.24 (2H, m), 7.20 (2H, d, J = 7.3 Hz), 7.14 (1H, t, J = 7.3 
Hz), 3.42 (2H, t, J = 6.8 Hz), 2.54-2.51 (2H, m), 1.90-1.85 (4H, m), 1.81-1.78 (2H, m), 
1.23 (24H, s); 13C NMR (125 MHz, CDCl3): δ 143.5, 128.5, 128.2, 125.5, 83.2, 34.5, 
33.8, 32.1, 30.9, 28.0, 24.8, 24.7; IR (neat): 2977.3 (m), 2930.7 (w), 2863.3 (w), 1454.7 
(w), 1353.9 (m), 1308.9 (m), 1250.2 (m), 1213.8 (w), 11369 (s), 967.8 (w), 853.6 (m), 
699.6 (w) cm-1; HRMS-(DART+) for 12C241H4011B279Br116O4 [M+H]+: calculated: 
493.2296, found: 493.2309. 
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2,2'-(7-bromo-1-phenyloctane-3,3-diyl)bis(4,4,5,5-tetrameth
yl-1,3,2-dioxaborolane) (S2.9). The reaction was performed 
according to Representative Procedure (Method B). 1H NMR 
(500 MHz, CDCl3): δ 7.26-7.23 (2H, m), 7.21-7.20 (2H, m), 
7.16-7.12 (1H, m), 4.23-4.16 (1H, m), 2.57-2.46 (2H, m), 
1.94-1.84 (3H, m), 1.81-1.64 (3H, m), 1.71 (3H, d, J = 6.8 Hz), 1.53-1.38 (2H, m), 1.24 
(12H, s), 1.23 (12H, s); 13C NMR (125 MHz, CDCl3): δ 143.7, 128.5, 128.1, 125.4, 83.0, 
52.0, 41.8, 33.8, 31.9, 28.3, 26.5, 25.3, 24.83, 24.79, 24.72, 24.70; IR (neat): 2979.3 (w), 
2923.1 (w), 2862.9 (w), 1452.7 (w), 1304.5 (s), 1246.6 (m), 1137.1 (s), 968.4 (w), 860.1 
(m), 743.1 (m), 696.6 (m), 668.0 (w), 522.7 (w) cm-1; HRMS-(DART+) for 
12C261H4411B279Br116O4 [M+H]+: calculated: 521.2609, found: 521.2609. 
 
2,2'-(8-bromo-1-phenyloctane-3,3-diyl)bis(4,4,5,5-tetra
methyl-1,3,2-dioxaborolane) (S2.10). The reaction was 
performed according to Representative Procedure 
(Method B) with diboronate ester 2.1 (372 mg, 1.00 
mmol), LTMP (155 mg, 1.05 mmol), 1,5-dibromopentane (0.272 mL, 2.00 mmol) and 
THF (5 mL). The crude reaction mixture was purified by column chromatography on 
silica gel (15:1 – 10:1 hexanes/diethyl ether, stain in CAM) to afford a white solid (436 
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mg, 84%). 1H NMR (500 MHz, CDCl3): δ 7.26-7.23 (2H, m), 7.20-7.19 (2H, m), 
7.16-7.12 (1H, m), 3.42 (2H, t, J = 6.9 Hz), 2.52-2.49 (2H, m), 1.92-1.87 (4H, m), 
1.72-1.69 (2H, m), 1.49-1.43 (2H, m), 1.36-1.27 (2H, m), 1.23 (24H, s); 13C NMR (125 
MHz, CDCl3): δ 143.7, 128.5, 128.1, 125.4, 83.0, 34.0, 33.8, 32.7, 31.9, 28.80, 28.75, 
26.1, 24.8, 24.7; IR (neat): 2972.1 (w), 2929.4 (w), 2856.6 (w), 1451.9 (w), 1348.8 (m), 
1307.4 (s), 1244.1 (s), 1133.9 (s), 1047.7 (w), 1020.2 (w), 968.4 (m), 848.5 (s), 754.2 (m), 
699.8 (s), 666.9 (m), 558.0 (w), 502.6 (w) cm-1; HRMS-(DART+) for 
12C261H4411B279Br116O4 [M+H]+: calculated: 521.2609, found: 521.2634. 
 
2,2'-(6-bromohexane-1,1-diyl)bis(4,4,5,5-tetramethyl
-1,3,2-dioxaborolane) (S2.11). The reaction was 
performed according to Representative Procedure 
(Method B) with 
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (375 mg, 1.40 mmol), LTMP 
(216 mg, 1.47 mmol), 1,5-dibromopentane (0.245 mL, 1.80 mmol) and THF (7 mL). The 
crude reaction mixture was purified by column chromatography on silica gel (10:1 
hexanes/diethyl ether, stain in CAM) to afford a white solid (496 mg, 85%). 1H NMR 
(500 MHz, CDCl3): δ 3.39 (2H, t, J = 7.1 Hz), 1.84 (2H, q, J = 7.3 Hz), 1.54 (2H, q, J = 
7.8 Hz), 1.44-1.38 (2H, m), 1.35-1.27 (2H, m), 1.224 (12H, s), 1.216 (12H, s), 0.70 (1H, t, 
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J = 7.8 Hz); 13C NMR (125 MHz, CDCl3): δ 82.9, 33.9, 32.6, 31.4, 28.1, 25.3, 24.8, 24.5; 
IR (neat): 2976.6 (w), 2929.7 (w), 1462.6 (w), 1356.7 (m), 1307.8 (s), 1266.9 (m), 1234.5 
(m), 1137.3 (s), 968.9 (m), 849.0 (m), 669.8 (w), 578.4 (w) cm-1; HRMS-(DART+) for 
12C181H3611B279Br116O4 [M+H]+: calculated: 417.1983, found: 417.1975. 
2,2'-(9-bromo-1-phenylnonane-3,3-diyl)bis(4,4,5,5-te
tramethyl-1,3,2-dioxaborolane) (S2.12). The reaction 
was performed according to Representative Procedure 
(Method B) with 2.1 (186 mg, 0.50 mmol), LTMP (77.3 
mg, 0.525 mmol), 1,6-dibromohexane (154 µL, 1.0 mmol) and THF (2.5 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (10:1 
hexanes/diethyl ether, stain in CAM) to afford a white solid (206 mg, 77%). 1H NMR 
(500 MHz, CDCl3): δ 7.26-7.23 (2H, m), 7.19 (2H, d, J = 6.8 Hz), 7.14 (1H, t, J = 6.8 
Hz), 3.41 (2H, t, J = 6.9 Hz), 2.52-2.49 (2H, m), 1.91-1.83 (4H, m), 1.71-1.68 (2H, m), 
1.47-1.42 (2H, m), 1.36-1.23 (4H, m), 1.23 (24H, s, overlap); 13C NMR (125 MHz, 
CDCl3): δ 143.8, 128.5, 128.1, 125.4, 83.0, 34.0, 33.8, 32.9, 31.9, 29.5, 28.9, 28.2, 26.9, 
24.8, 24.7; IR (neat): 2976.8 (m), 2929.6 (m), 2857.4 (w), 1454.8 (w), 1306.6 (s), 1253.3 
(m), 1137.2 (s), 968.3 (w), 853.8 (w), 749.7 (w), 699.4 (w) cm-1; HRMS-(DART+) for 
12C271H4611B279Br116O4 [M+H]+: calculated: 535.2766, found: 535.2781. 
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2.5.4 Representative Procedure for Deborylative Alkylation 
Ph
B(pin)
B(pin) solvent
rt, 3 h
Ph n-C12H25
B(pin)n-C12H25Br
base
2.1 2.2  
In the glove box, an oven-dried 2-dram vial with magnetic stir bar was charged with 
1,1-diboronate ester 2.1 (48.4 mg, 0.13 mmol), 1-bromododecane (24.0 µL, 0.10 mmol) 
and THF (0.50 mL), followed by the NaOtBu (0.30 mmol). The vial was sealed with a 
polypropylene cap, removed from the glove box, and was allowed to stir at room 
temperature for 3 hours. Upon completion, the reaction mixture was diluted with diethyl 
ether (2 mL), filtered through a silica gel plug, rinsed with diethyl ether, and concentrated 
in vacuo. The crude reaction mixture was purified on silica gel (hexanes: diethyl ether = 
75:1) to afford the desired product 2.2 as a colorless oil. 
 
2.5.5 Full Characterization of Deborylative Alkylation Products and Proof of 
Stereochemistry 
4,4,5,5-tetramethyl-2-(1-phenylpentadecan-3-yl)-1,3,2-dioxa
borolane (2.2). 1H NMR (500 MHz, CDCl3): δ 7.28-7.25 (2H, 
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m), 7.19-7.14 (3H, m), 2.65-2.54 (2H, m), 1.78-1.70 (1H, m), 1.68-1.61 (1H, m), 
1.47-1.34 (2H, m), 1.33-1.20 (32H, m), 1.07-1.01 (1H, m), 0.88 (3H, t, J = 6.9 Hz); 13C 
NMR (125 MHz, CDCl3): δ 143.2, 128.4, 128.2, 125.5, 82.9, 35.7, 33.5, 31.9, 31.3, 29.9, 
29.70, 29.67, 29.65, 29.61, 29.59, 29.4, 29.2, 24.9, 24.8, 22.7, 14.1; IR (neat): 2976.6 (w), 
2921.8 (s), 2852.4 (m), 1456.1 (w), 1385.8 (m), 1314.5 (m), 1143.4 (s), 966.5 (w), 746.5 
(w), 698.0 (m) cm-1; HRMS-(DART+) for 12C271H4811B116O2 [M+H]+: calculated: 
415.3747, found: 415.3744. 
 
2-(1-cyclohexyltridecyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.13). The reaction was performed according to Representative 
Procedure for Deborylative Alkylation with 1,1-diboronate ester 
S2.2 (45.5 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 0.30 mmol), 
1-bromododecane (24.0 µL, 0.10 mmol) and THF (0.5 mL) at 40 oC for 14 hours. The 
crude reaction mixture was purified by column chromatography on silica gel (100:1 
hexanes/diethyl ether, stain in CAM) to afford a colorless oil (34.3 mg, 87%). 1H NMR 
(500 MHz, CDCl3): δ 1.77-1.60 (5H, m), 1.43-0.81 (44H, m); 13C NMR (125 MHz, 
CDCl3): δ 82.7, 39.7, 32.9, 32.6, 31.9, 30.0, 29.70, 29.68, 29.66, 29.64, 29.62, 29.60, 29.4, 
28.8, 26.8, 25.0, 24.8, 22.7, 14.1; IR (neat): 2977.4 (w), 2920.9 (s), 2851.6 (m), 1447.8 
(w), 1378.7 (m), 1312.4 (m), 1238.0 (w), 1144.8 (m), 970.9 (w), 865.3 (w) cm-1; 
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HRMS-(DART+) for 12C251H5311B114N116O2 [M+NH4]+: calculated: 410.4169, found: 
410.4175. 
 
4,4,5,5-tetramethyl-2-(4-methyl-1-phenylpentan-3-yl)-1,3,2-diox
aborolane (2.4). The reaction was performed according to 
Representative Procedure for Deborylative Alkylation with 
1,1-diboronate ester 2.1 (48.4 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 
0.30 mmol), 2-bromopropane (9.4 µL, 0.10 mmol) and THF (0.5 mL). The crude reaction 
mixture was purified by column chromatography on silica gel (75:1 – 50:1 
hexanes/diethyl ether, stain in CAM) to afford a colorless oil (21.7 mg, 75%). 1H NMR 
(500 MHz, CDCl3): δ 7.28-7.25 (2H, m), 7.20-7.14 (3H, m), 2.67-2.61 (1H, m), 2.54-2.48 
(1H, m), 1.80-1.72 (2H, m), 1.70-1.63 (1H, m), 1.28 (12H, s), 0.94-0.90 (7H, m); 13C 
NMR (125 MHz, CDCl3): δ 143.2, 128.4, 128.2, 125.5, 82.9, 36.0, 31.4, 29.6, 25.1, 24.9, 
22.3, 21.7; IR (neat): 2976.7 (w), 2955.3 (w), 2929.6 (w), 2867.2 (w), 1454.7 (w), 1379.4 
(m), 1314.1 (m), 1213.4 (w), 1143.1 (s), 967.5 (w), 848.2 (w), 747.9 (w), 698.5 (m) cm-1; 
HRMS-(DART+) for 12C181H3011B116O2 [M+H]+: calculated: 289.2339, found: 289.2353. 
 
2-(7-bromo-1-phenyloctan-3-yl)-4,4,5,5-tetramethyl-1,3,2
-dioxaborolane (2.5). The reaction was performed 
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according to Representative Procedure for Deborylative Alkylation with 1,1-diboronate 
ester S2.9 (48.4 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 0.30 mmol), 1,4-dibromopentane 
(13.6 µL, 0.10 mmol) and THF (0.5 mL). The crude reaction mixture was purified by 
column chromatography on silica gel (25:1 hexanes/diethyl ether, stain in CAM) to 
afford a colorless oil (39.4 mg, mixture of the desired product (1:1 dr) and 
Ph(CH2)3B(pin), 3.3:1, calculated yield = 84%). 1H NMR (500 MHz, CDCl3): δ 
7.28-7.24 (2H, m), 7.19-7.15 (3H, m), 4.16-4.09 (1H, m), 2.66-2.54 (2H, m), 1.87-1.61 
(4H, m), 1.69 (3H, dd, J = 6.4, 1.5 Hz, overlap), 1.57-1.34 (4H, m), 1.27 (12H, s), 
1.08-1.03 (1H, m); 13C NMR (125 MHz, CDCl3): δ 142.9, 128.4, 128.2, 125.6, 83.0, 
51.84, 51.79, 41.4, 41.3, 35.6, 33.40, 33.37, 30.52, 30.51, 27.3, 27.2, 26.4, 24.88, 24.87, 
24.85; IR (neat): 2976.9 (w), 2926.0 (w), 2858.0 (w), 1454.0 (w), 1378.4 (m), 1316.5 (m), 
1213.4 (m), 1143.0 (s), 966.3 (w), 853.5 (w), 746.8 (w), 698.9 (m) cm-1; HRMS-(DART+) 
for 12C201H3311B179Br116O2 [M+H]+: calculated: 395.1757, found: 395.1757. 
 
4,4,5,5-tetramethyl-2-(1-phenylhex-5-en-3-yl)-1,3,2-dioxaborola
ne (2.6). The reaction was performed according to Representative 
Procedure for Deborylative Alkylation with 1,1-diboronate ester 2.1 
(96.7 mg, 0.26 mmol), NaOt-Bu (57.7 mg, 0.60 mmol), allyl chloride (16.3 µL, 0.20 
mmol) and THF (1.0 mL). The crude reaction mixture was purified by column 
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chromatography on silica gel (50:1 hexanes/diethyl ether, stain in CAM) to afford a 
colorless oil (49.7 mg, 87%). 1H NMR (500 MHz, CDCl3): δ 7.28-7.25 (2H, m), 
7.19-7.15 (3H, m), 5.81 (1H, ddt, J = 17.1, 10.3, 6.9 Hz), 5.02 (1H, app dq, J = 17.1, 2.0 
Hz), 4.94 (1H, app dt, J = 10.3, 1.0 Hz), 2.67-2.56 (2H, m), 2.26-2.14 (2H, m), 1.79-1.72 
(1H, m), 1.71-1.63 (1H, m), 1.26 (12H, s), 1.18-1.12 (1H, m); 13C NMR (125 MHz, 
CDCl3): δ 142.9, 138.4, 128.4, 128.2, 125.6, 114.9, 83.1, 35.4, 35.3, 32.9, 24.9, 24.8; IR 
(neat): 2977.0 (w), 2924.5 (w), 2857.2 (w), 1453.9 (w), 1379.8 (m), 1317.8 (m), 1242.3 
(w), 1142.7 (s), 966.8 (w), 908.9 (w), 862.8 (w), 747.1 (w), 698.5 (m) cm-1; 
HRMS-(DART+) for 12C181H2811B116O2 [M+H]+: calculated: 287.2182, found: 287.2178. 
 
(E)-4,4,5,5-tetramethyl-2-(1-phenylhept-5-en-3-yl)-1,3,2-dio
xaborolane (2.7). The reaction was performed according to 
Representative Procedure for Deborylative Alkylation with 2.1 
(48.4 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 0.30 mmol), crotyl chloride (9.8 µL, 0.10 
mmol, 5.8:1 E/Z isomers) and THF (0.5 mL). The crude reaction mixture was purified by 
column chromatography on silica gel (50:1 hexanes/diethyl ether, stain in CAM) to 
afford a colorless oil (27.9 mg, 93%, 6.0:1 E/Z, determined by oxidizing the boronate 
ester to the corresponding alcohol). 1H NMR (500 MHz, CDCl3) (mixture of E/Z 
isomers): δ 7.28-7.25 (2H, m), 7.19-7.14 (3H, m), 5.47-5.37 (2H, m), 2.65-2.55 (2H, m), 
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2.43-2.08 (2H, m), 1.78-1.70 (1H, m), 1.69-1.61 (4H, m), 1.25 (12H, s), 1.14-1.08 (1H, 
m); 13C NMR (125 MHz, CDCl3) (mixture of E/Z isomers): δ 143.0, 130.9, 130.2, 128.4, 
128.2, 125.5, 125.3, 124.1, 83.01, 82.96, 35.6, 35.5, 34.2, 33.04, 33.02, 28.3, 24.88, 24.81, 
24.77, 17.8, 12.9; IR (neat): 2977.1 (w), 2924.7 (w), 2855.5 (w), 1453.3 (w), 1379.8 (m), 
1317.1 (m), 1238.3 (w), 1143.3 (s), 965.9 (m), 862.1 (w), 746.8 (w), 698.5 (w) cm-1; 
HRMS-(DART+) for 12C181H2811B116O2 [M+H]+: calculated: 287.2182, found: 287.2178. 
 
(E)-2-(6-(4-methoxyphenyl)-1-phenylhex-5-en-3-yl)
-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.8). The 
reaction was performed according to Representative 
Procedure for Deborylative Alkylation with 1,1-diboronate ester 2.1 (48.4 mg, 0.13 
mmol), NaOt-Bu (28.8 mg, 0.30 mmol), (E)-1-(3-chloroprop-1-en- 
1-yl)-4-methoxybenzene (18.3 mg, 0.10 mmol) and THF (0.5 mL). The crude reaction 
mixture was purified by column chromatography on silica gel (20:1 – 10:1 
hexanes/diethyl ether, stain in CAM) to afford a colorless oil (28.3 mg, 72% yield). 1H 
NMR (500 MHz, CDCl3): δ 7.28-7.24 (4H, m), 7.19-7.15 (3H, m), 6.84-6.81 (2H, m), 
6.34 (1H, d, J = 15.7 Hz), 6.07 (1H, dt, J = 15.7, 7.3 Hz), 3.80 (3H, s), 2.70-2.59 (2H, m), 
2.38-2.28 (2H, m), 1.84-1.77 (1H, m), 1.75-1.68 (1H, m), 1.25 (6H, s), 1.24 (6H, s), 
1.29-1.21 (1H, m, overlap); 13C NMR (125 MHz, CDCl3): δ 158.6, 142.9, 130.8, 129.7, 
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128.4, 128.3, 128.2, 127.0, 125.6, 113.8, 83.1, 55.2, 35.5, 34.6, 33.1, 24.88, 24.87; IR 
(neat): 2976.6 (w), 2925.8 (w), 1607.0 (w), 1510.2 (s), 1454.8 (w), 1380.7 (m), 1319.4 
(m), 1246.6 (s), 1173.9 (w), 1143.0 (s), 1035.9 (w), 965.6 (w), 848.4 (w), 699.6 (w) cm-1; 
HRMS-(DART+) for 12C251H3311B116O3 [M]+·: calculated: 392.2523, found: 392.2540. 
 
(E)-2-(6,10-dimethyl-1-phenylundeca-5,9-dien-3-y
l)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.9). 
The reaction was performed according to 
Representative Procedure for Deborylative 
Alkylation with 1,1-diboronate ester 2.1 (48.4 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 0.30 
mmol), geranyl chloride (18.5 µL, 0.10 mmol) and THF (0.5 mL). The crude reaction 
mixture was purified by column chromatography on silica gel (50:1 hexanes/diethyl ether, 
stain in CAM) to afford a colorless oil (34.8 mg, 91%). 1H NMR (500 MHz, CDCl3): δ 
7.27-7.24 (2H, m), 7.19-7.14 (3H, m), 5.15-5.08 (2H, m), 2.66-2.55 (2H, m), 2.19-2.10 
(2H, m), 2.08-2.04 (2H, m), 1.98-1.95 (2H, m), 1.79-1.63 (2H, m), 1.67 (3H, d, J = 1.0 
Hz, overlap), 1.61 (3H, s), 1.59 (3H, s), 1.25 (12H, s), 1.13-1.08 (1H, m); 13C NMR (125 
MHz, CDCl3): δ 143.1, 135.1, 131.2, 128.4, 128.2, 125.5, 124.4, 124.1, 82.9, 39.8, 35.6, 
33.1, 29.4, 26.7, 25.7, 24.9, 24.8, 17.6, 16.2; IR (neat): 2976.2 (m), 2923.8 (m), 2855.3 
(w), 1453.0 (w), 1379.8 (m), 1317.6 (m), 1240.9 (w), 1143.8 (s), 967.3 (w), 866.9 (w), 
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746.3 (w), 698.5 (m) cm-1; HRMS-(DART+) for 12C251H4011B116O2 [M+H]+: calculated: 
383.3121, found: 383.3136. 
 
4,4,5,5-tetramethyl-2-tridecyl-1,3,2-dioxaborolane (2.10). The 
reaction was performed according to Representative Procedure for 
Deborylative Alkylation with 
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (53.6 mg, 0.20 mmol), KOt-Bu 
(56.1 mg, 0.50 mmol), 1-bromododecane (24.0 µL, 0.10 mmol) and toluene (0.5 mL) at 
room temperature for 14 hours. The crude reaction mixture was purified by column 
chromatography on silica gel (75:1 – 50:1 hexanes/diethyl ether, stain in CAM) to afford 
a colorless oil (28.2 mg, 91%). 1H NMR (500 MHz, CDCl3): δ 1.41-1.37 (2H, m), 
1.31-1.24 (30H, m), 0.88 (3H, t, J = 6.9 Hz), 0.76 (2H, t, J = 7.8 Hz); 13C NMR (125 
MHz, CDCl3): δ 82.8, 32.4, 31.9, 29.70, 29.68, 29.66, 29.65, 29.59, 29.41, 29.35, 24.8, 
24.0, 22.7, 14.1; IR (neat): 2977.8 (w), 2922.1 (s), 2853.1 (m), 1465.8 (w), 1376.7 (s), 
1316.8 (m), 1145.9 (s), 968.4 (w), 847.0 (w), 720.6 (w) cm-1; HRMS-(DART+) for 
12C191H4011B116O2 [M+H]+: calculated: 311.3121, found: 311.3121. 
 
2-(4-methoxyphenethyl)-4,4,5,5-tetramethyl-1,3,2-dioxabo
rolane (2.11). The reaction was performed according to 
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Representative Procedure for Deborylative Alkylation with 
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (53.6 mg, 0.20 mmol), KOt-Bu 
(56.1 mg, 0.50 mmol), 4-methoxybenzyl chloride (13.6 µL, 0.10 mmol) and toluene (0.5 
mL) at room temperature for 14 hours. The crude reaction mixture was purified by 
column chromatography on silica gel (20:1 – 10:1 hexanes/diethyl ether, stain in CAM) 
to afford a colorless oil (19.2 mg, 73%). 1H NMR was in accord with literature.29 
 
2-(4-bromophenethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborola
ne (2.12). The reaction was performed according to 
Representative Procedure for Deborylative Alkylation with 
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (53.6 mg, 0.20 mmol), KOt-Bu 
(56.1 mg, 0.50 mmol), 4-bromobenzyl chloride (20.5 mg, 0.10 mmol) and toluene (0.5 
mL) at room temperature for 14 hours. The crude reaction mixture was purified by 
column chromatography on silica gel (20:1 hexanes/diethyl ether, stain in CAM) to 
afford a white solid (23.9 mg, 77%). 1H NMR (500 MHz, CDCl3): δ 7.38-7.35 (2H, m), 
7.10-7.07 (2H, m), 2.69 (2H, t, J = 8.1 Hz), 1.22 (12H, s), 1.11 (2H, t, J = 8.1 Hz); 13C 
NMR (125 MHz, CDCl3): δ 143.3, 131.2, 129.8, 119.2, 83.2, 29.4, 24.8; IR (neat): 
                                                
 
29 Yamamoto, Y.; Fujikawa, R.; Umemoto, T.; Miyaura, N. Tetrahedron, 2004, 60, 10695-10700. 
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2977.4 (w), 2930.8 (w), 1487.4 (m), 1369.5 (s), 1315.5 (s), 1239.1 (w), 1141.9 (s), 
1071.6 (m), 1010.7 (m), 966.8 (m), 866.8 (w), 849.2 (m), 798.1 (m), 672.3 (w), 484.1 (w) 
cm-1; HRMS-(DART+) for 12C141H2111B179Br116O2 [M+H]+: calculated: 311.0819, found: 
311.0811. 
 
2-(3-benzyl-1-phenylpentadecan-3-yl)-4,4,5,5-tetramethyl-1,3
,2-dioxaborolane (2.15). The reaction was performed according 
to Representative Procedure for Deborylative Alkylation with 
diboronate ester S2.3 (60.1 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 
0.30 mmol), 1-bromododecane (24.0 µL, 0.10 mmol) and THF (0.5 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (50:1 
hexanes/diethyl ether, stain in CAM) to afford a colorless oil (49.9 mg, 99%). 1H NMR 
(500 MHz, CDCl3): δ 7.27-7.22 (6H, m), 7.18-7.14 (4H, m), 2.80 (1H, d, J = 13.7 Hz), 
2.76 (1H, d, J = 13.7 Hz), 2.64-2.60 (2H, m), 1.68-1.58 (2H, m), 1.45-1.36 (4H, m), 
1.32-1.21 (30H, m), 0.89 (3H, t, J = 6.8 Hz); 13C NMR (125 MHz, CDCl3): δ 143.5, 
140.0, 130.2, 128.3, 128.2, 127.8, 125.7, 125.5, 83.2, 40.2, 36.7, 34.5, 31.9, 31.5, 30.5, 
29.72, 29.68, 29.4, 25.15, 25.10, 24.8, 22.7, 14.1; IR (neat): 2976.9 (w), 2924.7 (s), 
2853.3 (m), 1495.4 (w), 1456.2 (w), 1380.2 (m), 1311.3 (m), 1143.7 (m), 855.3 (w), 
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735.4 (w), 699.7 (m) cm-1; HRMS-(DART+) for 12C341H5411B116O2 [M+H]+: calculated: 
505.4217, found: 505.4237. 
 
4,4,5,5-tetramethyl-2-(6-phenethyloctadec-1-en-6-yl)-1,3,2-dio
xaborolane (2.16). The reaction was performed according to 
Representative Procedure for Deborylative Alkylation with 
diboronate ester 3.1 (57.2 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 
0.30 mmol), 1-bromododecane (24.0 µL, 0.10 mmol) and THF (0.5 mL) at 50 oC for 14 
hours. The crude reaction mixture was purified by column chromatography on silica gel 
(100:1 hexanes/diethyl ether, stain in CAM) to afford a colorless oil (44.0 mg, 91%). 1H 
NMR (500 MHz, CDCl3): δ 7.27-7.24 (2H, m), 7.19-7.14 (3H, m), 5.84 (1H, ddt, J = 
17.1, 10.3, 6.9 Hz), 5.01 (1H, ddt, J = 17.1, 2.0, 1.5 Hz), 4.94 (1H, ddt, J = 10.3, 2.0, 1.5 
Hz), 2.50-2.47 (2H, m), 2.05 (2H, q, J = 7.0 Hz), 1.66-1.62 (2H, m), 1.45-1.19 (26H, m), 
1.25 (12H, s, overlap), 0.88 (3H, t, J = 6.8 Hz); 13C NMR (125 MHz, CDCl3): δ 143.8, 
139.2, 128.3, 128.2, 125.4, 114.2, 83.0, 36.7, 34.7, 34.4, 33.8, 31.9, 31.4, 30.6, 29.72, 
29.68, 29.65, 29.4, 24.9, 24.7, 24.2, 22.7, 14.1; IR (neat): 2922.9 (s), 2852.7 (m), 1458.2 
(w), 1385.2 (m), 1345.1 (w), 1305.9 (m), 1260.9 (w), 1142.6 (s), 966.6 (w), 908.0 (w), 
857.4 (w), 744.7 (w), 696.2 (s) cm-1; HRMS-(DART+) for 12C321H5611B116O2 [M+H]+: 
calculated: 483.4373, found: 483.4384. 
74 
 
 
2-(3-benzyl-4-methyl-1-phenylpentan-3-yl)-4,4,5,5-tetramethyl-1
,3,2-dioxaborolane (2.14). The reaction was performed according 
to Representative Procedure for Deborylative Alkylation with 
diboronate ester S2.3 (60.1 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 
0.30 mmol), 2-bromopropane (9.4 µL, 0.10 mmol) and THF (0.5 mL). The crude reaction 
mixture was purified by column chromatography on silica gel (100:1 – 75:1 
hexanes/diethyl ether, stain in CAM) to afford a colorless oil (35.9 mg, 95%). 1H NMR 
(500 MHz, CDCl3): δ 7.35 (2H, d, J = 7.3 Hz), 7.26-7.22 (4H, m), 7.18-7.10 (4H, m), 
3.09 (1H, d, J = 13.7 Hz), 2.68 (1H, d, J = 14.2 Hz), 2.65-2.55 (2H, m), 1.78 (1H, sp, J = 
6.8 Hz), 1.70-1.60 (2H, m), 1.28 (6H, s), 1.24 (6H, s), 1.06 (3H, d, J = 6.8 Hz), 0.99 (3H, 
d, J = 6.8 Hz); 13C NMR (125 MHz, CDCl3): δ 143.8, 140.8, 130.5, 128.4, 128.2, 127.7, 
125.6, 125.4, 83.2, 37.9, 34.5, 32.4, 31.2, 25.4, 25.0, 19.6, 19.2; IR (neat): 2975.2 (w), 
2930.7 (w), 2870.3 (w), 1455.1 (w), 1380.6 (m), 1305.3 (m), 1257.7 (m), 1139.7 (s), 
973.7 (w), 846.7 (w), 738.4 (m), 699.9 (s), 670.6 (w), 502.6 (w) cm-1; HRMS-(DART+) 
for 12C251H3611B116O2 [M+H]+: calculated: 379.2808, found: 379.2804. 
 
2-(3-cyclopropyl-1-phenylpentadecan-3-yl)-4,4,5,5-tetrameth
yl-1,3,2-dioxaborolane (2.18). The reaction was performed 
according to Representative Procedure for Deborylative 
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Alkylation with diboronate ester S2.5 (53.6 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 0.30 
mmol), 1-bromododecane (24.0 µL, 0.10 mmol) and THF (0.5 mL) at 50 oC for 14 hours. 
The crude reaction mixture was purified by column chromatography on silica gel (200:1 
hexanes/diethyl ether, stain in CAM) to afford a colorless oil (25.3 mg, 56%). 1H NMR 
(500 MHz, CDCl3): δ 7.28-7.25 (2H, m), 7.22-7.20 (2H, m), 7.17-7.14 (1H, m), 2.68-2.62 
(2H, m), 1.77-1.71 (1H, m), 1.67-1.60 (1H, m), 1.46-1.42 (2H, m), 1.37-1.26 (20H, m), 
1.22 (12H, s), 0.88 (3H, t, J = 6.9 Hz), 0.65-0.59 (1H, m), 0.43-0.30 (4H, m); 13C NMR 
(125 MHz, CDCl3): δ 144.3, 128.4, 128.2, 125.3, 82.8, 39.1, 36.4, 32.2, 31.9, 30.7, 29.72, 
29.69, 29.66, 29.4, 25.4, 24.9, 22.7, 18.0, 14.1, 2.3, 1.9; IR (neat): 2922.9 (s), 2852.6 (m), 
1455.7 (w), 1388.5 (w), 1370.8 (w), 1302.7 (m), 1142.8 (s), 1016.8 (w), 967.5 (w), 855.6 
(w), 748.1 (w), 697.9 (m) cm-1; HRMS-(DART+) for 12C301H5211B116O2 [M+H]+: 
calculated: 455.4060, found: 455.4080. 
 
2-(1-dodecyl-2-phenylcyclopropyl)-4,4,5,5-tetramethyl-1,3,2
-dioxaborolane (2.17). The reaction was performed according 
to Representative Procedure for Deborylative Alkylation with 
diboronate ester S2.6 (48.1 mg, 0.13 mmol), NaOt-Bu (28.8 mg, 
0.30 mmol), 1-bromododecane (24.0 µL, 0.10 mmol) and THF (0.5 mL) at 60 oC for 14 
hours. The crude reaction mixture was purified by column chromatography on silica gel 
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(50:1 hexanes/diethyl ether, stain in CAM) to afford a colorless oil (26.8 mg, 65%). 1H 
NMR (500 MHz, CDCl3): δ 7.24-7.23 (2H, m), 7.20-7.17 (2H, m), 7.11-7.07 (1H, m), 
1.98-1.93 (2H, m), 1.51-1.35 (3H, m), 1.32-1.25 (18H, m), 0.97 (6H, s), 0.93-0.88 (1H, 
m), 0.88 (3H, t, J = 6.8 Hz, overlap), 0.83 (6H, s), 0.77 (1H, dd, J = 7.3, 4.4 Hz); 13C 
NMR (125 MHz, CDCl3): δ 140.7, 128.8, 127.6, 125.5, 82.8, 38.4, 31.9, 29.9, 29.8, 29.72, 
29.69, 29.66, 29.63, 29.4, 29.3, 24.7, 24.3, 22.7, 15.7, 14.1; IR (neat): 2977.1 (w), 2923.0 
(s), 2852.9 (m), 1447.0 (w), 1408.4 (m), 1371.1 (m), 1312.7 (m), 1141.3 (s), 856.3 (w), 
694.8 (w) cm-1; HRMS-(DART+) for 12C271H4611B116O2 [M+H]+: calculated: 413.3591, 
found: 413.3612. The relative stereochemistry was assigned by analogy. 
 
2-(1-(4-methoxybenzyl)-2-phenylcyclopropyl)-4,4,5,5-t
etramethyl-1,3,2-dioxaborolane (2.19). The reaction was 
performed according to Representative Procedure for 
Deborylative Alkylation with diboronate ester S2.6 (48.1 
mg, 0.13 mmol), NaOt-Bu (28.8 mg, 0.30 mmol), 4-methoxybenzyl chloride (13.6 µL, 
0.10 mmol) and THF (0.5 mL) at 50 oC for 14 hours. The crude reaction mixture was 
purified by column chromatography on silica gel (25:1 hexanes/diethyl ether, stain in 
CAM) to afford a white solid (26.8 mg, 74%). 1H NMR (500 MHz, CDCl3): δ 7.26-7.19 
(6H, m), 7.12-7.09 (1H, m), 6.82-6.79 (2H, m), 3.79 (3H, s), 3.37 (1H, d, J = 14.2 Hz), 
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2.20 (1H, d, J = 14.7 Hz), 2.09 (1H, dd, J = 7.8, 5.9 Hz), 1.55 (1H, t, J = 4.9 Hz), 1.00 
(1H, dd, J = 8.3, 4.4 Hz), 0.88 (6H, s), 0.73 (6H, s); 13C NMR (125 MHz, CDCl3): δ 
157.8, 140.3, 133.8, 129.9, 128.8, 127.7, 125.7, 113.4, 83.0, 55.2, 42.0, 29.3, 24.6, 24.3, 
15.6. IR (neat): 2978.5 (w), 2910.8 (w), 1609.2 (w), 1510.6 (s), 1442.4 (w), 1407.1 (m), 
1315.4 (m), 1300.9 (m), 1248.4 (s), 1130.1 (s), 1029.8 (m), 967.9 (w), 852.3 (w), 770.2 
(w), 691.6 (w) cm-1; HRMS-(DART+) for 12C231H3011B116O3 [M+H]+: calculated: 
365.2288, found: 365.2285. The relative stereochemistry was assigned by X-ray 
crystallography. 
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4,4,5,5-tetramethyl-2-(1-phenethylcyclopropyl)-1,3,2-dioxabo
rolane (2.20). The reaction was performed according to 
Representative Procedure for Deborylative Alkylation with 
diboronate ester S2.7 (43.5 mg, 0.10 mmol), NaOt-Bu (28.8 mg, 0.30 mmol) and THF 
(0.5 mL). The crude reaction mixture was purified by column chromatography on silica 
gel (20:1 hexanes/diethyl ether, stain in CAM) to afford a colorless oil (25.4 mg, 93%). 
1H NMR (500 MHz, CDCl3): δ 7.27-7.24 (2H, m), 7.19-7.13 (3H, m), 2.74-2.71 (2H, m), 
1.54-1.50 (2H, m), 1.22 (12H, s), 0.67-0.66 (2H, m), 0.30-0.28 (2H, m); 13C NMR (125 
MHz, CDCl3): δ 143.2, 128.4, 128.1, 125.4, 82.9, 38.7, 35.8, 24.7, 11.5; IR (neat): 2977.8 
(w), 2926.6 (w), 1453.5 (w), 1416.9 (s), 1371.1 (w), 1311.8 (m), 1193.8 (m), 1132.8 (s), 
967.6 (w), 858.9 (w), 698.9 (m), 684.2 (m) cm-1; HRMS-(DART+) for 12C171H2611B116O2 
[M+H]+: calculated: 273.2026, found: 273.2035. 
  
4,4,5,5-tetramethyl-2-(1-phenethylcyclobutyl)-1,3,2-dioxabor
olane (2.21). The reaction was performed according to 
Representative Procedure for Deborylative Alkylation with 
diboronate ester S2.8 (49.3 mg, 0.10 mmol), NaOt-Bu (28.8 mg, 0.30 mmol) and THF 
(0.5 mL) at room temperature for 14 hours. The crude reaction mixture was purified by 
column chromatography on silica gel (75:1 hexanes/diethyl ether, stain in CAM) to 
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afford a colorless oil (25.0 mg, 87%). 1H NMR (500 MHz, CDCl3): δ 7.28-7.25 (2H, m), 
7.20-7.14 (3H, m), 2.50-2.47 (2H, m), 2.18-2.13 (2H, m), 1.99-1.84 (4H, m), 1.736-1.70 
(2H, m), 1.29 (12H, s); 13C NMR (125 MHz, CDCl3): δ 143.3, 128.3, 128.2, 125.5, 83.0, 
42.0, 33.3, 30.2, 24.7, 18.2; IR (neat): 3026.0 (w), 2975.2 (m), 2929.5 (m), 2854.5 (w), 
1454.1 (w), 1371.5 (s), 1343.3 (w), 1211.3 (m), 1142.6 (s), 965.1 (w), 860.7 (w), 698.3 
(m) cm-1; HRMS-(DART+) for 12C181H2811B116O2 [M+H]+: calculated: 287.2182, found: 
287.2179. 
 
4,4,5,5-tetramethyl-2-(2-methyl-1-phenethylcyclopentyl)-1,3,2-
dioxaborolane (2.22, major diastereomer). The reaction was 
performed according to Representative Procedure for 
Deborylative Alkylation with diboronate ester S2.9 (208.5 mg, 
0.40 mmol), NaOt-Bu (115.3 mg, 1.20 mmol) and THF (2.0 mL) at 50 oC for 14 hours. 
The crude reaction mixture was purified by column chromatography on silica gel (50:1 
hexanes/diethyl ether, stain in CAM) to afford a colorless oil (95.7 mg, 76%, 7.5:1 dr). 
The diastereomers were separated by a second column (75:1 hexanes/diethyl ether). 1H 
NMR (500 MHz, CDCl3): δ 7.27 (2H, t, J = 7.3 Hz), 7.21 (2H, d, J = 7.3 Hz), 7.18-7.15 
(1H, m), 2.58-2.49 (2H, m), 2.04 (1H, sx, J = 7.3 Hz), 1.89-1.83 (1H, m), 1.79-1.54 (5H, 
m), 1.44-1.36 (1H, m), 1.31-1.24 (1H, m), 1.27 (12H, s, overlap), 0.91 (3H, dd, J = 7.3, 
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1.4 Hz); 13C NMR (125 MHz, CDCl3): δ 143.9, 128.3, 128.2, 125.4, 82.9, 40.3, 34.2, 
33.5, 33.1, 32.6, 24.9, 24.6, 22.9, 15.1; IR (neat): 2949.5 (m), 2868.7 (w), 1454.3 (w), 
1380.5 (s), 1304.3 (s), 1195.0 (w), 1143.5 (s), 967.1 (w), 856.4 (w), 747.3 (w), 698.3 (m) 
cm-1; HRMS-(DART+) for 12C201H3211B116O2 [M+H]+: calculated: 315.2495, found: 
315.2500. 
 
4,4,5,5-tetramethyl-2-(2-methyl-1-phenethylcyclopentyl)-1,3,2
-dioxaborolane (2.22, minor diastereomer). 1H NMR (500 
MHz, CDCl3): δ 7.28-7.25(2H, m), 7.20 (2H, d, J = 7.3 Hz), 7.16 
(1H, t, J = 7.3 Hz), 2.59-2.53 (2H, m), 2.05-1.95 (2H, m), 
1.84-1.78 (1H, m), 1.77-1.70 (1H, m), 1.64-1.56 (2H, m), 1.40-1.22 (3H, m), 1.27 (12H, s, 
overlap), 1.00 (3H, d, J = 6.9 Hz); 13C NMR (125 MHz, CDCl3): δ 143.9, 128.3, 128.2, 
125.4, 82.9, 45.0, 41.2, 34.26, 34.23, 34.15, 25.3, 24.8, 22.7, 17.8; IR (neat): 2976.1 (w), 
2928.4 (m), 2856.0 (w), 1454.3 (w), 1387.4 (m), 1297.8 (m), 1200.8 (w), 1142.3 (s), 
965.6 (w), 856.9 (w), 747.5 (w), 697.8 (m) cm-1; HRMS-(DART+) for 12C201H3211B116O2 
[M+H]+: calculated: 315.2495, found: 315.2502. 
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4,4,5,5-tetramethyl-2-(1-phenethylcyclohexyl)-1,3,2-dioxaboro
lane (2.24). The reaction was performed according to 
Representative Procedure for Deborylative Alkylation with 
diboronate ester S2.10 (52.1 mg, 0.10 mmol), NaOt-Bu (28.8 mg, 
0.30 mmol) and THF (0.5 mL) at 50 oC for 14 hours. The crude reaction mixture was 
purified by column chromatography on silica gel (75:1 hexanes/diethyl ether, stain in 
CAM) to afford a colorless oil (21.8 mg, 69%). 1H NMR (500 MHz, CDCl3): δ 7.27-7.24 
(2H, m), 7.17-7.14 (3H, m), 2.58-2.54 (2H, m), 1.95 (2H, d, J = 12.7 Hz), 1.68-1.60 (3H, 
m), 1.58-1.54 (2H, m), 1.37-1.26 (2H, m), 1.29 (12H, s), 1.19-1.14 (1H, m), 0.99 (2H, td, 
J = 12.7, 2.9 Hz); 13C NMR (125 MHz, CDCl3): δ 143.7, 128.3, 128.2, 125.5, 83.0, 43.3, 
35.3, 32.2, 26.7, 25.2, 24.9; IR (neat): 2977.3 (w), 2924.9 (s), 2850.6 (w), 1453.3 (w), 
1387.7 (m), 1337.2 (w), 1304.6 (s), 1234.0 (m), 1143.1 (s), 968.5 (w), 696.5 (m) cm-1; 
HRMS-(DART+) for 12C201H3211B116O2 [M+H]+: calculated: 315.2495, found: 315.2496. 
 
2-cyclohexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.23). The 
reaction was performed according to Representative Procedure for 
Deborylative Alkylation with diboronate ester S2.11 (116.8 mg, 0.40 
mmol), NaOt-Bu (115.3 mg, 1.20 mmol) and THF (2.0 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (100:1 
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pentane/diethyl ether, stain in CAM) to afford a colorless oil (50.4 mg, 60%). The 1H and 
13C NMR spectra were in accord with previously reported data.30 
 
4,4,5,5-tetramethyl-2-(1-phenethylcycloheptyl)-1,3,2-dioxabor
olane (2.25). The reaction was performed according to 
Representative Procedure for Deborylative Alkylation with 
diboronate ester S2.12 (53.5 mg, 0.10 mmol), NaOt-Bu (28.8 mg, 
0.30 mmol) and THF (0.5 mL). The crude reaction mixture was purified by column 
chromatography on silica gel (100:1 hexanes/ diethyl ether, stain in CAM) to afford a 
colorless oil (19.1 mg, 58%). 1H NMR (500 MHz, CDCl3): δ 7.28-7.25 (2H, m), 
7.18-7.14 (3H, m), 2.56-2.53 (2H, m), 1.91-1.86 (2H, m), 1.63-1.58 (4H, m), 1.56-1.44 
(6H, m), 1.36-1.32 (2H, m), 1.27 (12H, s); 13C NMR (125 MHz, CDCl3): δ 143.7, 128.3, 
128.2, 125.4, 82.9, 42.7, 36.2, 33.0, 29.7, 24.9, 24.6; IR (neat): 2976.9 (w), 2918.6 (m), 
2851.0 (w), 1458.4 (w), 1386.5 (m), 1304.1 (m), 1263.3 (w), 1141.7 (s), 966.0 (w), 853.4 
(m), 746.9 (w), 697.6 (m) cm-1; HRMS-(DART+) for 12C211H3411B116O2 [M+H]+: 
calculated: 329.2652, found: 329.2653. 
                                                
 
30 Clary, J. W.; Rettenmaier, T. J.; Snelling, R.; Bryks, W.; Banwell, J.; Wipke, W. T.; Singaram, B. J. Org. 
Chem. 2011, 76, 9602-9610. 
 
83 
 
 
2.5.6 Procedure for Deborylative Alkylation Crossover Experiment: 
In the glove box, an oven-dried 10 mL round-bottom flask with magnetic stir bar 
was charged with lithium 2,2,6,6-tetramethylpiperidide (125 mg, 0.85 mmol). The flask 
was sealed with a rubber septum, removed from the glove box, followed by the addition 
of THF (2.5 mL) under N2. The reaction mixture was cooled to 0 oC, and a solution of 
1,1-diboronate ester 2.1 (264 mg, 0.71 mmol) in THF (1 mL) was added via syringe and 
the mixture was allowed to stir at 0 °C for 10 minutes. D2O (26 µL, 1.42 mmol) was 
added in one portion and the reaction was allowed to stir at 0 oC for 10 min. Upon 
completion, the reaction mixture was warmed to room temperature, filtered through a 
silica gel plug, rinsed with diethyl ether, and concentrated in vacuo. The crude reaction 
mixture was purified on silica gel (hexanes: diethyl ether = 9:1) to afford the desired 
product as a white solid (206 mg, 78%).   
 
2,2'-(3-phenylpropane-1,1-diyl-1-d)bis(4,4,5,5-tetramethyl-1
,3,2-dioxaborolane) (2.26). 1H NMR (500 MHz, CDCl3): δ 
7.26-7.23 (2H, m), 7.18-7.12 (3H, m), 2.60-2.57 (2H, m), 
1.86-1.83 (2H, m), 1.24 (12H, s), 1.23 (12H, s); 
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HRMS-(DART+) for 12C211H342H111B216O4 [M+H]+: calculated: 374.2784, found: 
374.2781. 
 
THF, rt, 3 h
Ph
B(pin)
B(pin) n-C12H25Br
Ph
B(pin)
C12H25
+
NaOtBu
D D
BnO
B(pin)
B(pin)H
BnO
B(pin)
C12H25H
+
93% yield
94% D-incorporation
50% yield
< 5% D-incorporation
2.26
2.27
2.28
2.29  
 
In the glove box, an oven-dried 2-dram vial with magnetic stir bar was charged 
with deuterated 1,1-diboronate ester 2.26 (48.5 mg, 0.13 mmol), 2.27 (52.3 mg, 0.13 
mmol), NaOt-Bu (57.7 mg, 0.60 mmol), and THF (0.50 mL). The reaction mixture was 
allowed to stir at room temperature for 15 min, followed by the addition of 
1-bromododecane (48.0 µL, 0.20 mmol). The vial was sealed with a polypropylene cap, 
removed from the glove box, and was allowed to stir at room temperature for 3 hours. 
Upon completion, the reaction mixture was diluted with diethyl ether (2 mL), filtered 
through a silica gel plug, rinsed with diethyl ether, and concentrated in vacuo. The crude 
reaction mixture was purified on silica gel (hexanes: diethyl ether = 75:1 to 15:1) to 
isolate the desired product 2.28 (38.6 mg, 93%) and 2.29 (22.4 mg, 50%). 
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4,4,5,5-tetramethyl-2-(1-phenylpentadecan-3-yl-3-d)-1,3,2-dio
xaborolane (2.28). 1H NMR (500 MHz, CDCl3): δ 7.28-7.25 
(2H, m), 7.19-7.14 (3H, m), 2.65-2.54 (2H, m), 1.76-1.70 (1H, 
m), 1.66-1.60 (1H, m), 1.46-1.34 (2H, m), 1.33-1.21 (32H, m), 0.88 (3H, t, J = 6.9 Hz); 
HRMS-(DART+) for 12C271H472H111B116O2 [M+H]+: calculated: 416.3810, found: 
416.3802. 
 
2-(1-(benzyloxy)pentadecan-3-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.29). 1H NMR (500 MHz, CDCl3): δ 
7.35-7.31 (4H, m), 7.27-7.24 (1H, m), 4.50 (2H, s), 3.44 (2H, t, 
J = 6.8 Hz), 1.79-1.72 (1H, m), 1.70-1.63 (1H, m), 1.44-1.25 (22H, m), 1.20 (12H, s), 
1.07-1.02 (1H, m), 0.88 (3H, t, J = 6.8 Hz); 13C NMR (125 MHz, CDCl3): δ 138.8, 128.3, 
127.6, 127.3, 82.8, 72.7, 70.0, 31.9, 31.4, 31.3, 29.9, 29.70, 29.66, 29.64, 29.61, 29.57, 
29.3, 29.1, 24.8, 24.7, 22.7, 14.1; IR (neat): 2922.3 (s), 2852.4 (s), 1455.0 (w), 1379.7 
(m), 1313.9 (m), 1242.6 (w), 1144.7 (s), 1104.0 (m), 967.9 (w), 854.6 (w), 733.7 (m), 
696.8 (m) cm-1; HRMS-(DART+) for 12C281H4911B116O3 [M+H]+: calculated: 445.3853, 
found: 445.3872. 
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2.5.7 Mass Spectrometry Studies with 10B-labeled Enantioenriched Diboronate 
Esters 
a) Preparation of 10B-labeled Enantioenriched Starting Material: 
Ph
Ni(PPh3)2Cl2
DIBAL-H, THF
then MeO10B(pin)
Ph
10B(pin)
1), NaIO4, HCl
     THF, H2O
2) toluene, reflux
NH2NH2
Ph
10B(dan)
3% CuCl
3% (R)-DTBM-Segphos
6% NaOtBu
HB(pin), toluene, rt
Ph
B(pin)
10B(dan)
Ph
B(pin)
10B(pin)pinacol2M H2SO4
THF, rt
2.35 2.36 2.37
2.38 2.39  
 
10B-Labeled-(E)-4,4,5,5-tetramethyl-2-styryl-1,3,2-dioxaborolane 2.36 was 
prepared according to the literature procedure. To an oven-dried 10 mL round-bottom 
flask with magnetic stir bar was charged with Ni(PPh3)2Cl2 (8.2 mg, 12.5 µmol). The 
flask was sealed with a rubber septum and purged with N2. THF (2.5 mL) was added via 
syringe, followed by dropwise addition of DIBAL-H (0.49 mL, 2.75 mmol) at room 
temperature. The resulting black solution was cooled to 0 oC, and phenylacetylene (0.275 
mL, 2.50 mmol) was added dropwise over 5 minutes. The reaction mixture was allowed 
to warmed to room temperature and stirred for 6 hours. Upon completion, MeO10B(pin) 
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(786 mg, 5.00 mmol) was added via syringe. The reaction mixture was allowed to stir for 
additional 24 hours, then quenched at 0 oC by dropwise addition of a saturated solution of 
Rochelle’s salt (2.5 mL), then stirred for 1 hour at room temperature. The layers were 
separated, and the aqueous layer was extracted with diethyl ether (10 mL×3). The 
combined organic layers were dried over anhydrous Na2SO4, filtered and concentrated in 
vacuo. The crude reaction mixture was purified on silica gel (hexanes: diethyl ether = 
25:1 to 10:1) to afford the (E)-isomer as a yellow oil in 61% yield (349 mg, 1.52 mmol). 
The NMR spectra were in accord with previously reported data. HRMS-(DART+) for 
12C141H2010B116O2 [M+H]+: calculated: 230.1593, found: 230.1598. 
 
Ph
10B(pin)
1), NaIO4, HCl
     THF, H2O
2) toluene, reflux
NH2NH2
Ph
10B(dan)
2.36 2.37
 
10B-Labeled-(E)-2-styryl-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine 
2.37 was prepared according to the literature procedure with modification.31 2.36 (330 
mg, 1.43 mmol) and NaIO4 (918 mg, 4.29 mmol) were stirred in a mixture of THF (4 mL) 
                                                
 
31 Koyanagi, M.; Eichenauer, N.; Ihara, H.; Yamamoto, T.; Suginome, M. Chem. Lett. 2013, 42, 541-543. 
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and water (1.3 mL) for 30 minutes. Then aqueous HCl was added (1.00 mL, 1.0 M, 1.00 
mmol). The reaction was stirred for 17 hours at room temperature. Upon completion, the 
reaction mixture was diluted with water (3 mL) and extracted with ethyl acetate (6 mL×3). 
The combined organic layers were washed with water (3 mL×2) and brine (3 mL), dried 
over Na2SO4, filtered, and concentrated. 
The unpurified boronic acid and 1,8-diaminonaphthalene (215 mg, 1.36 mmol) 
were dissolved in toluene (5 mL), equipped with a Dean-Stark apparatus, and heated to 
reflux for 1.5 h. After cooled to room temperature, the reaction mixture was concentrated 
in vacuo, and purified on silica gel (hexanes: ethyl acetate = 30:1) to afford 2.37 as a 
yellow solid (267 mg, 69% yield in two steps). The 1H NMR spectrum was in accord 
with reported data in literature.32 
 
3% CuCl
3% (R)-DTBM-Segphos
6% NaOtBu
HB(pin), toluene, rt
Ph
B(pin)
10B(dan)
2.38
Ph
10B(dan)
2.37  
10B-Labeled-2-(2-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)- 
2,3-dihydro-1H- naphtho[1,8-de][1,3,2]diazaborinine (2.38) was prepared according to 
                                                
 
32 Iwadate, N.; Suginome, M. Org. Lett. 2009, 11, 1899-1902. 
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the literature procedure.33 In the glove box, an oven-dried 2-dram vial with magnetic stir 
bar was charged with CuCl (1.5 mg, 0.015 mmol), NaOt-Bu (2.9 mg, 0.030 mmol), 
(R)-DTBM-Segphos (17.7 mg, 0.015 mmol), and toluene (0.4 mL). The mixture was 
stirred for 10 minutes at room temperature, then pinacolborane (87.0 µL, 0.60 mmol) was 
added and stirred for an additional 10 minutes. Substrate 2.37 (135.1 mg, 0.50 mmol) in 
toluene (1.2 mL) was added to the reaction mixture. The reaction was allowed to stir at 
room temperature for 20 hours. The reaction mixture was filtered through a pad of Celite, 
washed with diethyl ether, and concentrated in vacuo. The crude reaction mixture was 
purified on silica gel (hexanes:ethyl acetate = 10:1) to afford 2.38 as a pale grey solid 
(181 mg, 91% yield, 98:2 er). The 1H NMR spectrum was in accord with reported data in 
literature.33 
 
Analysis of Stereochemistry  
The enantioselectivity was determined by SFC analysis of the reaction product. 
The analogous racemic material was prepared using dppBz as the achiral ligand in the 
hydroboration reaction. The absolute stereochemistry was assigned according to the 
literature. 
                                                
 
33 Feng, X.; Jeon, H.; Yun, J. Angew. Chem., Int. Ed. 2013, 52, 3989-3992. 
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Chiral SFC (OD-H, Chiraldex, 3 mL/min, 20% i-PrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
 
 
Ph
B(pin)
10B(dan)
Ph
B(pin)
10B(pin)pinacol2M H2SO4
THF, rt2.38 2.39  
2.39 was prepared according to the literature procedure.34 To a stirred solution of 
2.38 (143 mg, 0.36 mmol) in THF (3.6 mL) was added aqueous 2 M H2SO4 (0.54 mL, 
1.08 mmol) and pinacol (213 mg, 1.80 mmol) sequentially. The reaction mixture was 
stirred at room temperature for 24 hours before quenched by the addition of water (4 
                                                
 
34 Lee, J. C. H.; McDonald, R.; Hall, D. G. Nature Chemistry, 2011, 3, 894-899. 
racemic enantioenriched 
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mL).The reaction mixture was extracted with diethyl ether (3×5 mL), dried over Na2SO4, 
filtered, and concentrated in vacuo. The crude reaction mixture was purified by 
chromatography on silica gel (hexanes: diethyl ether = 9:1) to afford the desired product 
as a colorless oil (103 mg, 80%).  
 
b) Deborylative Alkylation Using 10B-Labeled Enantioenriched Diboronate Ester: 
Ph 11B(pin)
10B(pin)
THF, rt, 3 h
n-C12H25Br
NaOtBu
Ph
n-C12H25
10B(pin)
Ph
n-C12H25
11B(pin)
+
R-11BS-10B
m/z + 1 : 400.35 m/z + 1 : 401.35
Ph
n-C12H25
11B(pin)
Ph
n-C12H25
10B(pin)+
R-10BS-11B
m/z + 1 : 401.35 m/z + 1 : 400.35
2.39
S-2.41 R-2.40
S-2.40 R-2.41
 
The reaction was performed according to Representative Procedure for 
Deborylative Alkylation with (S)-10B-2.39 (46.4 mg, 0.13 mmol), 1-bromododecane (24.0 
µL, 0.10 mmol), NaOt-Bu (28.8 mg, 0.30 mmol) and THF (0.50 mL) in 90% yield.  
The enantiomers of the product were separated on chiral SFC. Fractions were 
collected directly from the waste end of SFC instrument (10 seconds for each fraction) 
and the product (neat) could be easily observed as an oil on the wall of the test tubes. The 
separated enantiomers were characterized by mass spectrometry. 
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Chiral SFC (ODR-H, Chiraldex, 3 mL/min, 2% i-PrOH, 100 bar, 35 oC)-analysis of the 
reaction product. 
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c) Calculation of Mass Spectrometry: 
Ph 11B(pin)
10B(pin)
THF, rt, 3 h
n-C12H25Br
NaOtBu
Ph
n-C12H25
10B(pin)
Ph
n-C12H25
11B(pin)
+
m/z + 1 : 400.35 m/z + 1 : 401.35
Ph
n-C12H25
11B(pin)
Ph
n-C12H25
10B(pin)+
m/z + 1 : 401.35 m/z + 1 : 400.35
2.39
S-2.41 R-2.40
S-2.40 R-2.41
Ph
n-C12H25
10/11B(pin)
m/z: 400   45.1%
m/z: 401   44.4%
m/z: 402     9.2%
m/z: 403     1.3%
Separated 
by SFC
m/z: 400   44.6%
m/z: 401   44.2%
m/z: 402     9.5%
m/z: 403     1.6%
m/z: 400   45.2%
m/z: 401   44.0%
m/z: 402     9.3%
m/z: 403     1.6%
S isomer R isomer
 
Natural abundance of carbon isotopes is 12C:13C = 0.989:0.011; 
Natural abundance of boron isotope is 10B:11B = 0.199:0.801; 
Abundance of boron isotope for the 10B-labeled product is 10B:11B =  
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(0.500+0.500×19.9%):0.500×80.1% = 0.600:0.400 
Calculated [M+H]+ distributions for 10B-labeled product: 
m/z 
Formula of 
[M+H]+ 
calculated distribution (assuming 
racemization) 
combined 
400 12C26H4610B1O2 0.98926×0.600 = 45.0% 45.0% 
401 
12C2513C1H4610B1O2 (26×0.98925×0.011)×0.600 = 13.0% 
43.0% 
12C26H4611B1O2 0.98926×0.400 = 30.0% 
402 
12C2413C2H4610B1O2 (26×25/2×0.98924× 0.0112)×0.600 = 1.8% 
10.5% 
12C2513C1H4611B1O2 (26×0.98925×0.011)×0.400 = 8.7% 
403 
12C2313C3H4610B1O2 
(26×25×24/3/2×0.98923× 0.0113)×0.600 = 
0.2% 1.4% 
12C2413C2H4611B1O2 (26×25/2×0.98924× 0.0112)×0.400 = 1.2% 
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Mass Spectrum of product (±)-2.40 using from non-labeled compound 2.39: 
 
Mass Spectrum of product (±)-2.40 and (±)-2.41 using 10B-labeled compound 
(S)-10B-2.39: 
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Mass Spectrum of product (S)-2.40 and (S)-2.41 from 10B-labeled experiment using 
(S)-10B-2.39: 
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Mass Spectrum of product (R)-2.40 and (R)-2.41 from 10B-labeled experiment using 
(S)-10B-2.39: 
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2.5.8 Analysis of Reaction Intermediates by 13C-Labeled Experiments 
a) Preparation of 13C-Labeled Geminal Diboronate Ester: 
The 13C-labeled diboronate ester S2.13 was prepared according to Representative 
Procedure for Preparation of Geminal Diboronate Esters (Method A) with CuI (17.3 mg, 
0.091 mmol), LiOMe (82.0 mg, 2.16 mmol), B2(pin)2 (438 mg, 1.73 mmol), 
1,1-dibromide (348 mg, 0.91 mmol) and DMF (2 mL). The crude reaction mixture (DMF 
solution) was directly purified on silica gel (hexanes: diethyl ether = 15:1) to afford the 
desired product S2.13 as a colorless oil (261.3 mg, 60%). 
2,2'-(1λ3-hexadecane-1,1-diyl-1-13C)bis(4,4,5,5-tetrameth
yl-1,3,2-dioxaborolane) (S2.13). 1H NMR (500 MHz, 
CDCl3): δ 1.55-1.53 (2H, m), 1.31-1.22 (50H, m), 0.88 
(3H, t, J = 6.9 Hz), 0.71 (1H, dt, J = 111.5, 7.8 Hz). 1H 
NMR (500 MHz, THF-d8): δ 1.48 (2H, br s), 1.33-1.27 (26H, m), 1.181 (12H, s), 1.176 
(12H, s), 0.89 (3H, t, J = 6.9 Hz), 0.56 (1H, dt, J = 111.0, 7.6 Hz). 13C NMR (125 MHz, 
CDCl3): δ 82.8, 32.6, 31.9, 29.71, 29.70, 29.67, 29.65, 29.62, 29.59, 29.55, 29.4, 25.8, 
25.6, 24.8, 24.5, 22.7, 14.1, 10.7 (br, C-B); 13C NMR (125 MHz, THF-d8): δ 83.4, 33.5, 
33.0, 30.87, 30.84, 30.81, 30.79, 30.76, 30.70, 30.5, 26.9, 26.7, 25.4, 25.1, 23.7, 14.6, 
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11.5 (br, C-B); IR (neat): 2976.9 (w), 2922.5 (s), 2852.9 (m), 1465.8 (w), 1350.5 (m), 
1310.3 (s), 1265.4 (m), 1215.0 (w), 1140.2 (s), 969.4 (w), 849.2 (w) cm-1; 
HRMS-(DART+) for 12C2713C11H5711B216O4 [M+H]+: calculated: 480.4477, found: 
480.4480. 
 
The 13C-labeled diboronate ester 2.42 was prepared according to Representative 
Procedure for Preparation of Geminal Diboronate Esters (Method C) with S2.13 (118 
mg, 0.25 mmol), LTMP (40 mg, 0.27 mmol), benzyl bromide (36 µL, 0.30 mmol) and 
THF (2.5 mL). The crude reaction mixture was purified by column chromatography on 
silica gel (20:1 hexanes/diethyl ether, stain in CAM) to afford a colorless oil (95.2 mg, 
67%), which turned to a white solid after stored in freezer overnight. 
 
2,2'-(1-phenylheptadecane-2,2-diyl-2-13C)bis(4,4,5,5-tetr
amethyl-1,3,2-dioxaborolane)  (2.42). 1H NMR (500 
MHz, CDCl3): δ 7.24-7.18 (4H, m), 7.13-7.10 (1H, m), 
2.97 (2H, d, JC-H = 3.9 Hz), 1.54-1.48 (2H, m), 1.37-1.24 
(38H, m), 1.20 (12H, s), 0.88 (3H, t, J = 6.8 Hz); 1H NMR (500 MHz, THF-d8): δ 
7.21-7.20 (2H, m), 7.16-7.13 (2H, m), 7.07-7.04 (1H, m), 2.91 (2H, d, JC-H = 3.4 Hz), 
1.48-1.44 (2H, m), 1.39-1.25 (26H, m), 1.21 (12H, s), 1.17 (12H, s), 0.89 (3H, t, J = 6.9 
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Hz); 13C NMR (125 MHz, CDCl3): δ 142.0, 129.7, 127.6, 125.4, 83.1, 34.6, 34.4, 31.9, 
30.3, 30.2, 29.71, 29.66, 29.4, 28.8, 28.6, 27.2, 25.0, 24.7, 22.7, 21.6 (br, C-B), 14.1; 13C 
NMR (125 MHz, THF-d8): δ 143.2, 130.7, 128.5, 126.3, 83.8, 36.0, 35.8, 33.0, 31.61, 
31.57, 30.9, 30.83, 30.79, 30.72, 30.5, 30.1, 29.9, 28.2, 25.7, 25.2, 23.7, 22.6 (br, C-B), 
14.6; IR (neat): 2977.9 (w), 2924.1 (s), 2853.4 (m), 1465.4 (w), 1370.9 (m), 1346.6 (m), 
1309.8 (m), 1257.4 (m), 1213.1 (w), 1138.8 (s), 972.0 (w), 856.5 (w), 698.7 (w) cm-1; 
HRMS-(DART+) for 12C3413C11H6311B216O4 [M+H]+: 570.4946, found: 570.4954. 
 
b) 13C NMR Experiments  
Ph B(pin)
B(pin)
13C
n-C15H31
NaOtBu
THF-d8
rt
Ph n-C12H25
B(pin)
13C
n-C15H31
Na OtBu
Ph B(pin)
(pin)B
13C
n-C15H31
n-C12H25Br
NaPh
B(pin)
13C n-C15H31
NaPh
B(pin)
13C n-C15H31
Ph
B(pin)
13C n-C15H31
2.42 2.44
2.43
2.45
2.47
H
2.46
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In the glove box, an oven-dried NMR tube was charged with diboronate ester 2.42 
(44.4 mg, 0.078 mmol), NaOt-Bu (17.3 mg, 0.18 mmol) and THF-d8 (0.60 mL). The 
NMR tube was sealed with a rubber septum, removed from the glove box, and monitored 
by 13C NMR at 25 oC. After 3 hours, 1-bromododecane (14.4 µL, 0.060 mmol) was 
added via syringe, and the reaction was again tracked by 13C NMR. After 14 hours, the 
reaction mixture was diluted with diethyl ether, filtered through a silica gel plug, rinsed 
with diethyl ether, and concentrated in vacuo. The crude reaction mixture was purified on 
silica gel (hexanes: diethyl ether = 100:1) to afford the desired product 2.47 (24.2 mg, 
66% yield) and the protodeboronation product 2.43 (5.3 mg). 
 
13C NMR Spectra of the Reaction (125 MHz, THF-d8, δ 60−10 ppm): 
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Na
Ph
B(pin)
13C n-C15H31
2.45
Na OtBu
Ph B(pin)
(pin)B
13C
n-C15H31
2.44
Ph B(pin)
B(pin)
13C
n-C15H31
2.42
Ph
B(pin)
13C n-C15H31
2.43
H
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NaPh
B(pin)
13C n-C15H312.46
Na
Ph
B(pin)
13C n-C15H31
2.45
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Ph n-C12H25
B(pin)
13C
n-C15H31
2.47
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2-(13-benzyloctacosan-13-yl-13-13C)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (2.47). 1H NMR (500 MHz, CDCl3): 
δ 7.24-7.21 (2H, m), 7.18-7.13 (3H, m), 2.70 (2H, d, JC-H = 
4.4 Hz), 1.29-1.27 (50H, m), 1.21 (12H, s), 0.89 (6H, t, J = 
7.3 Hz); 1H NMR (500 MHz, THF-d8): δ 7.17-7.16 (4H, m), 7.11-7.07 (1H, m), 2.67 (2H, 
d, JC-H = 3.9 Hz), 1.36-1.30 (50H, m), 1.20 (12H, s), 0.89 (6H, t, J = 7.3 Hz); 13C NMR 
(125 MHz, CDCl3): δ 140.2, 130.3, 127.6, 125.5, 83.0, 40.0, 39.7, 34.4, 34.2, 31.9, 30.5, 
30.4, 30.3 (br, C-B), 29.72, 29.69, 29.67, 29.4, 25.1, 24.8, 22.7, 14.1; 13C NMR (125 
MHz, THF-d8): δ 141.3, 141.2, 131.21, 131.20, 128.5, 126.5, 83.96, 83.95, 41.3, 41.0, 
35.7, 35.4, 33.0, 31.69, 31.65, 31.4 (br, C-B), 30.84, 30.83, 30.82, 30.79, 30.78, 30.76, 
30.5, 26.0, 25.6, 23.7, 14.6; IR (neat): 2921.2 (s), 2851.7 (m), 1463.9 (m), 1376.8 (m), 
1307.3 (m), 1264.9 (w), 1211.6 (w), 1143.5 (m), 966.3 (w), 854.1 (w), 721.6 (w), 701.3 
(m) cm-1; HRMS-(DART+) for 12C4013C11H7611B116O2 [M+H]+: calculated: 612.5972, 
found: 612.5984. 
 
2-(13-benzyloctacosan-13-yl-13-13C)-4,4,5,5-tetramethyl-1,3
,2-dioxaborolane (2.43). 1H NMR (500 MHz, THF-d8): δ 
7.19-7.14 (4H, m), 7.09-7.05 (1H, m), 2.72-2.66 (1H, m), 
2.61-2.56 (1H, m), 1.42-1.29 (28H, m), 1.20-1.14 (1H, m), 1.14 (6H, s), 1.11 (6H, s), 
106 
 
 
0.89 (3H, t, J = 7.3 Hz); 13C NMR (125 MHz, THF-d8): δ 143.6, 129.8, 128.8, 126.4, 
83.7, 38.5, 38.3, 33.0, 32.3, 32.1, 31.01, 30.98, 30.81, 30.77, 30.7, 30.5, 30.1, 27.1 (br, 
C-B), 25.5, 25.32, 25.28, 23.7, 14.6; IR (neat): 2921.9 (s), 2852.2 (m), 1455.8 (w), 
1371.2 (m), 1317.3 (m), 1143.8 (m), 967.3 (w), 862.4 (w), 743.1 (w), 698.3 (w) cm-1; 
HRMS-(DART+) for 12C2813C11H5211B116O2 [M+H]+: calculated: 444.4094, found: 
444.4094. 
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Chapter 3 
3 Development of A Boron Alkylidene-Alkene Cycloaddition 
Reaction 
 
3.1 Introduction 
For the deborylative alkylation of geminal bis(boronate) esters, it was proposed 
that a boron stabilized carbanion, rather than a radical is the reactive intermediate based 
on mechanistic studies. 56  For example, in the presence of an alkene, the desired 
base-promoted deborylative alkylated product (2.16) was obtained in 91% yield (Scheme 
3.1) with no cyclized product observed. However, not fully convinced of the anion 
pathway, it was considered that the radical pathway could also operate for this 
transformation. To gain further insight for this hypothesis, a deborylative alkylation 
reaction of 1,1-diboryl-alkane 3.1 in the absence of electrophile was performed. Upon 
quenching the reaction with diethyl ether and purification with silica gel column 
chromatography, the cyclized five-membered ring product (3.2) was obtained in high 
diastereoselectivity (13:1 dr), but relatively low yield (13%) (Scheme 3.2).  
 
                                                
 
56 Hong, K.; Liu, X.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 10581-10584. 
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Scheme 3.1 Deborylative Alkylation Reaction of Geminal Bis(boronic) Ester with 
An Electrophile 
NaOtBu (3.0 equiv)
n-C12H25Br (1.0 equiv)
THF (0.2 M)
rt, 3 h
1.3 equiv yield = 91%
Ph B(pin)
B(pin)
Ph B(pin)
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3.1 2.16
 
 
Scheme 3.2 Deborylative Alkylation Reaction of Geminal Bis(boronic) Ester 
without An Electrophile 
NaOtBu (2.0 equiv)
THF (0.2 M)
rt, 12 h
1.0 equiv yield = 13%, 13:1 dr
Ph
Me(pin)BPh
B(pin)
B(pin)
3.1 3.2
 
 
Alkyl boronic esters are of great synthetic value as they can be easily converted 
into a wide array of functional groups such as amines, 57  alkynes, 58  ketones, 59 
homologated boronic esters, 60  alcohols, 61  carboxylic acids, 62  alkenes 63  and allylic 
                                                
 
57 Mlynarski, S. N.; Karns, A. S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449-16451. 
58 Wang, Y.; Noble, A.; Myers, E. L.; Aggarwal, V. K. Angew. Chem., Int. Ed. 2016, 55, 4270-4274. 
59 Pulis, A. P.; Blair, D. J.; Torres, E.; Aggarwal, V. K. J. Am. Chem. Soc. 2013, 135, 16054-16057. 
60 (a) Sadhu, K. M.; Matteson, D. S. Organometallics 1985, 4, 1687-1689. (b) Matteson, D. S. J. Org. 
Chem. 2013, 78, 10009-10023. (e) Matteson, D. S. Chem. Rev. 1989, 89, 1535-1551. 
61 Brown, H. C.; Snyder, C.; Subba Rao, B. C.; Zweifel, G. Tetrahedron 1986, 42, 5505-5510. 
62 Chen, A. C.; Ren, L.; Crudden, C. M. J. Org. Chem. 1999,  64, 9704-9710. 
63 Zweifel, G.; Arzoumanian, H.; Whitney, C. C. J. Am. Chem. Soc. 1967, 89, 3652-3653. 
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alcohols64 (Scheme 3.3). Also, five-membered rings are prevalent in natural products65 
(Shown in Scheme 3.4). Based on these facts, we considered that the development of this 
deborylative cyclization method would be meaningful and synthetically useful.  
 
 
 
 
 
 
 
 
 
 
 
 
                                                
 
64 Sonawane, R. P.; Jheengut, V.; Rabalakos, C.; Larouche-Gauthier, R.; Scott, H. K.; Aggarwal, V. K. 
Angew. Chem. Int. Ed. 2011, 50, 3760-3763. 
65 (a) Hudlicky, T.; Price, J. D. Chem. Rev. 1989, 89, 1467-1486. (b) Ai, Y.; Kozytska, M. V.; Zou, Y.; 
Khartulyari, A. S.; Smith, A. B., III J. Am. Chem. Soc. 2015, 137, 15426-15429. (c) Yahata, K.; Ye. N.; Iso. 
K.; Ai, Y.; Lee. J.; Kishi. Y. J. Org. Chem. 2017, 87, 8808-8830. (d) Yahata, K.; Ye, N.; Ai, Y.; Iso. K.; 
Kishi, Y. Angew. Chem. Int. Ed. 2017, 56, 10796-10800. 
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Scheme 3.3 Different Transformations of Alkyl Boronic Esters 
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Scheme 3.4 Selected Natural Products Containing Five-Membered Rings 
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3.2 Background 
There were few reports of a stabilized carbanion adding to an unactivated alkene 
in the literature. Knochel and coworkers demonstrated one of the few examples (Scheme 
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3.5).66 They revealed that in the presence of a catalytic amount of KOtBu, ketones, 
imines and nitriles could add to styrenes intermolecularly to afford the addition products 
in good yield (Scheme 3.5, equation 1-3). Notably, they also obtained cyclized products 
(Scheme 3.5, equation 4) in moderate yield but poor diastereoselectivity with catalytic 
amount of KOtBu. Considering the substrates and the reaction conditions, this 
transformation was not likely to involve the intermediacy of radicals and likely benefits 
from the effective participation of the styrene. Of note, 2,6-di-tert-butyl-4-methylphenol 
did not inhibit the reaction, which was further evidence to rule out the possibility of 
radical intermediates. 
 
 
 
 
 
 
 
 
 
 
                                                
 
66 Rodriguez, A. L.; Bulaksananusorn, T.; Knochel, P. Org. Lett. 2000, 2, 3285-3287. 
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Scheme 3.5 Stabilized Carbanion Adding to Unactivated Alkenes 
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Bailey and coworkers67 illustrated that 5-hexenyllithium cyclizes on itself. They 
noted hydrogen, phenyl, trimethylsilyl and cyclopropyl substituents are tolerated to 
furnish five-membered ring products through 5-exo cyclization, which positions lithium 
at the primary carbon position (Scheme 3.6). This alkyl lithium intermediate could further 
                                                
 
67 (a) Bailey, W. F.; Khanolkar, A. D.; Gavaskar, K.; Ovaska, T. V.; Rossi, K.; Thiel, Y.; Wiberg, K. B. J. 
Am. Chem. Soc. 1991, 113, 5720-5727. (b) Bailey, W. F.; Gavaskar, K. V. Tetrahedron 1994, 50, 
5957-5970. 
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be trapped by a variety of electrophiles, leading to cyclized products containing 
diversified functionalities such alcohols and carboxylic acids. 
 
Scheme 3.6 Cyclization of Unsaturated Alkyllithium 
I
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3.3 Development of Deborylative Cyclization of Olefinic Geminal 
Bis(boronates) 
3.3.1 Screening for Optimal Reaction Condition 
Even though we were deeply intrigued by the mechanism behind this boron 
alkylidene-alkene cycloaddition, we first decided to optimize the reaction conditions. 
After screening bases, we found KOtBu offered the highest reactivity, while NaOtBu 
provided us the highest diastereoselectivity (Table 3.1, Entry 1 vs Entry 7). For optimal 
solvents, even though toluene afforded better reactivity (Entry 9), THF delivered the best 
balance between reactivity and selectivity (Entry 7). Thus, the combination of KOtBu and 
THF was applied in further substrate scope investigations and mechanistic studies.68 
 
Table 3.1 Optimization of Deborylative Cyclization of 1,1-Diboryl Alkenes 
Base
Solvent
Temperature
Ph
Me(pin)BPh B(pin)
B(pin)
3.1 3.2 Major
Ph
Me(pin)B
3.2 Minor  
 
 
                                                
 
68 Liu, X.; Deaton, T. M.; Haeffner, F.; Morken, J. P. Angew. Chem., Int. Ed. 2017, 56, 11485-11489. 
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entry base solvent yield (%) 
d.r. (3.2 
major : 3.2 
minor) 
1 NaOt-Bu THF 12 13 : 1 
2 NaOt-Bu toluene <5 N/A 
3 KOMe toluene <5 N/A 
4 KOt-Bu DCE <5 N/A 
5 KOt-Bu hexanes 39 2.2 : 1 
6 KOt-Bu THF 51 5 : 1 b 
7 KOt-Bu THF 52 4 : 1 
8 KOt-Bu toluene 52 2 : 1 b 
9 KOt-Bu toluene 61 1.2 : 1 
a Reaction conditions: 1,1-diboronate ester (0.10 mmol, 0.2 M), base (0.20 mmol), and 
room temperature. Yield refers to the isolated yield of purified material. Diastereoselectivity was 
determined based on NMR integration. b Reaction conducted at 50 °C. 
 
3.3.2 Substrate Scope for Deborylative Cyclization Reaction 
With the optimized deborylative cyclization reaction conditions in hand, we 
probed different substrates to learn more about the scope of the reaction. For geminal 
bis(boronate) esters containing terminal alkenes such as 3.6, the alkylidene-alkene 
cycloaddition occured very efficiently affording the desired product 3.5 in good yield. 
H2O, D2O, NBS and I2 were very good electrophiles, delivering the desired cyclized 
products 3.10, 3.7, 3.8, and 3.9, respectively, in good yield and diastereoselectivity. A 
coordinating oxygen atom did not interfere with this transformation, affording cyclized 
product 3.12 in 55% yield. 
 
 
 
 122 
Scheme 3.3 Substrate Scope for Mono-substituted Alkenes 
R
(pin)B
H
R
B(pin)
B(pin)
KOtBu (2 equiv) E
R
(pin)B E
R1
R2
R1
R2 R1
R2
THF, rt, 12 h
Ph
(pin)B Br
Ph
(pin)B I
Ph
(pin)B D
51%, > 20:1 dr 49%, > 20:1 dr52%, > 20:1 dr
Ph
(pin)B H
65%, > 20:1 dr
1-2 h
R3
Ph
(pin)B I
55%, 2.9:1 dr (C2:C3)
OBn
1 2
3Ph
(pin)B H
52%, 4:1 dr
R
B(pin)
B(pin)
R3
substrate
R R
3.3 3.4 3.5
3.6
3.7 3.8 3.9
3.10 3.11 3.12
 
 
This boron alkylidene-alkene cycloaddition methodology does not only work well 
for monosubstituted alkenes, but also works well for 1,2-disubstituted cis-styrene 
derivatives such as 3.13. For electrophiles, they can be as simple as proton to deliver 
cyclized product 3.14, or as bulky as benzyl bromide to give product 3.15. The R 
substituent in compound 3.3 seems to have little effects on the result; they can range from 
sterically hindered cyclohexyl 3.16 to silyl protected alcohol 3.17, and to simple proton 
3.19. All substrates provided cyclized products in good yield and synthetically useful 
diastereoselectivity. 
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Scheme 3.4 Substrate Scope for cis-Styrene Type Alkenes 
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With the good performance of cis-styrene derivatives in this system, we were 
curious about how trans-styrenes would behave. Tetra-substituted-1,1-diborylalkane 3.20 
was synthesized and treated with the standard reaction conditions. Surprisingly, 
trans-substrate 3.20 performed equally well as the cis-styrene 3.13 (68% yield, 4:1 dr) to 
give the same diastereomer in similar yield and diastereoselectivity. The 
mono-substituted alkene could also be extended to conjugated 1,3-diene 3.22, which 
furnished the ring cyclized product 3.23 in good yield (55%) and excellent selectivity (> 
20:1 dr). For tri-substituted alkene 3.24, the yield was diminished, as well as the 
diastereoselectivity. We hypothesized that the steric difference between methyl and 
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phenyl group was not big enough to induce a large enough bias for a high 
diastereoselectivity. 
 
Scheme 3.5 Substrate Scope for Other Type Alkenes 
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While we obtained a wide array of products in good yield and diastereoselectivity, 
not all substrates were well behaved. Some substrates did not afford the desired products, 
namely, with 1,2-disubstituted aliphatic alkenes, neither cis nor trans (3.26 and 3.27) 
underwent cylization. Substrates 3.28 or 3.29 did not deliver the four-membered ring or 
six-membered ring products respectively. The substrates in Scheme 3.6 usually led to 
protodeborylation byproducts. 
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Scheme 3.6 Alkenes Did Not Yield the Expected Products 
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3.4 Mechanistic Studies 
3.4.1 Evidence for a Four-Membered Ring Intermediate 
Because 1,3-diene substrate 3.22 delivered the cyclized product with the 
trans-alkene geometry, we proposed a four-membered ring intermediate 3.26 instead of 
six-membered ring intermediate 3.27, based on this stereochemical outcome. We 
attempted to grow crystals of this four membered-ring intermediate, however, were never 
successful even after many attempts. 13C NMR spectroscopy was put forward to confirm 
the existence of this intermediate. 
 
 
 
 
 
 
 126 
Scheme 3.8 Proposed Four-membered Ring Intermediate 
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13C labeled geminal bis(boronic) ester 3.28 was synthesized. It was treated with 
KOtBu in d8-THF and monitored by 13C NMR spectrometry. This revealed a new broad 
resonance at 44 ppm that replaced the starting material (20.1 ppm), after adding base. 
This new resonance was believed to correspond to the four membered-ring intermediate 
3.29 based on chemical shift and line width. The 13C-11B-correlation spectroscopy might 
be another piece of strong evidence. After water was added as the electrophile, a new 
peak at 38.4 ppm replaced the previously broad peak at 44 ppm. The peak at 38.4 ppm 
was confirmed to be the cyclized product 3.30 after being isolated. An additional 
mechanistic experiment employed 13C labeled alkene 3.31, which showed up at 114.5 
ppm due to its double bond character. After subjection of alkene 3.31 to the reaction 
conditions, the sharp peak at 114.5 ppm vanished immediately, and a new broad peak 
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emerged at 26.9 ppm. Of note, carbon signals normally are not broad unless they are 
coordinated to a boron atom (quadrupole effects). The chemical shift and peak shape 
matched very well with a four membered-ring intermediate 3.32, which supported our 
hypothesis. After the reaction was quenched with D2O, the broad peak at 26.9 ppm 
disappeared immediately, and a triplet showed up at 20.6 ppm. This peak indicated the 
formation of the cyclized five-membered ring product 3.33, with the splitting pattern 
attributed to the incorporation of deuterium. 
 
Scheme 3.9 13C NMR Studies Supporting Four-membered Ring Intermediates 
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13C NMR Spectra of the Reaction Mixture (125 MHz, THF-d8, δ 10-60 ppm): 
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i. Diboronate ester 3.28 ii. 3.28 and KOtBu for 30 minutes 
 
 
  
iii. 3.28 and KOtBu for 180 minutes iv. 3.28 and KOtBu for 7 hours 
  
  
v. 1 minute after H2O was added vi. Isolated product, 3.30 
  
C15H31
13C
BB O
OO
O
Me Me
Me
Me
MeMe
Me
Me
Ph
13C
B
OO
Me
Me
Me
Me
Ph
C15H31
 129 
  
 
Ph
(pin)B B(pin)
13CH2
B 13CH2
Ph
O
O
MeMe
Me
Me
13C δ = 114.5 ppm
(sharp)
13C δ = 26.9 ppm
(broad)
13C δ = 20.6 ppm
(triplet)
Ph
13CH2DB
O
O
Me
Me
Me Me
KOtBu
THF-d8, rt
D2O
3.31 3.32 3.33
 
 
 
 
Figure 1 - 13C labeled starting material (3.31) in d8-THF  
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(pin)B B(pin)
13CH2
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Figure 2 – 3.31 with KOtBu for 20 minutes in d8-THF (zoomed in on significant region for clarity) 
  
Figure 3 – 1 minute after addition of H2O 
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Figure 4 - Isolated major product (non-13C labeled) in d8-THF 
 
3.4.2 Distinguishing between Radical and Anionic Pathways 
A very revealing experiment was performed below, starting from deuterium 
labeled cis-alkene 3.34. This compound was treated with KOtBu and THF for 3 hours to 
generate four-membered ring intermediate 3.38, followed by trapping with I2 to afford 
deuterium incorporated cyclized product 3.35. Although the diastereoselectivity is high 
between C1 and C2 carbons, the stereocenter at C6 was formed non-selectively, resulting 
in epimers in a ratio of 1:1. According to literature, the trapping of electrophiles from 
Ph
13CH2DB
O
O
Me
Me
Me Me
3.33
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boron-ate complexes usually occurs through a stereoinvertive process.69 This indicated 
that the stereocenter at C6 position was not formed selectively during the formation of 
four-membered ring intermediate 3.38. We proposed two possible pathways leading to 
this stereochemical outcome (Scheme 3.10). The first pathway is a pathway involving 
radical intermediates. The boron-stabilized carbanion, generated from 1,1-diborylalkane 
3.34 and KOtBu, might undergo homolysis to form diradicals between carbon and boron 
atoms. The carbon radical would then react with terminal alkene to give primary radical 
species 3.36, which does not have a stereogenic C6 carbon center. Alternatively, the 
carbanion generated from base-promoted deborylation might add to the alkene through a 
two-electron process, leading to primary carbanion 3.37, which then undergoes fast 
racemization to deliver two epimers. 
 
 
 
 
 
 
 
 
                                                
 
69 Larouche-Gauthier, R.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2011, 133, 16794-16797. 
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Scheme 3.7 Two Possible Pathways for Deborylative Cyclization 
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To distinguish between these two possible pathways, we designed 1,1-diboryl 
alkane substrate 3.39 with a tethered cyclopropyl group (Scheme 3.11). If the pathway 
involving radical intermediates were operative, the three-membered ring would open 
under standard reaction conditions; while anion pathway would provide a product with 
the cyclopropyl group intact. The experiment result is that the cyclized product was 
obtained in good yield under the standard deborylative cyclization reaction conditions 
with the cyclopropyl ring intact. However, this result was not sufficient to rule out the 
radical pathway. There is a possibility that the boron alkylidene 3.41 could react by way 
of a thermally accessible diradical 3.42,70 which could open the cyclopropyl ring to 
                                                
 
70 Nonhebel, D. Chem. Soc. Rev. 1993, 347-359. 
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afford 3.43. However, with no reaction available for 3.43, the structure might revert back 
to 3.42 prior to conversion to 3.40. 
 
Scheme 3.11 Cyclopropyl Attached Bis(boronate) Ester as Radical Probe 
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To address the aforementioned concerns, we synthesized a geminal bis(boronic) 
ester containing a stereodefined diphenyl substituted cyclopropane ring 3.44. If the 
cyclopropyl ring opened and reclosed, we might observe the epimerized product of the 
cyclopropyl substituent. Surprisingly, we isolated the cyclopropyl ring opened product in 
23% yield. In a related fashion, a cyclopropyl group fragment included at the end of the 
conjugated alkene, as shown by substrate 3.47. After subjected into the standard reaction 
conditions, (3.47) afforded the ring-opened product 3.48 in 25% yield and 1.1:1 dr. 
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However, since Bailey and coworkers demonstrated that lithium anions could open 
cyclopropane rings,71 no definite conclusion could be drawn here. 
 
Scheme 3.12 More Substrates as Radical Probes 
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To gain further information about the properties of the intermediate carbanion, we 
undertook additional investigations. Enantioenriched secondary alkyl halide 3.50 was 
treated with the deborylative alkylation conditions. The desired product was isolated in 
49% yield, and it was shown that the electrophilic stereocenter in 3.50 reacted with 
inversion (Scheme 3.13). This SN2 reaction pathway indicated that the boron stabilized 
                                                
 
71 Bailey, W. F.; Gavaskar, K. V. Tetrahedron 1994, 50, 5957-5970. 
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carbanion did not react through single electron transfer pathway, instead, a two-electron 
pathway was most likely operating. 
 
Scheme 3.13 Radical Probe Experiment 
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3.4.3 Concerted or Stepwise 2+2 Pathway 
For the anionic pathway, two possibilities were considered. The first one is that 
the anion could add to the unactivated alkene through a stepwise pathway. The second is 
that the boron alkylidene might react with the alkene in a 2+2 concerted way. To 
determine which pathway is more likely the dominant one, we designed the following 
experiments. The cis and trans-styrene derivatives 3.55 and 3.20 were synthesized. If a 
2+2 concerted pathway is the operating one, after cyclization and trapping with allyl 
bromide, two different stereoisomers would be anticipated, assuming that trapping with 
electrophiles occurs in a stereoinvertive fashion.72 However, after subjecting these two 
substrates to the reaction conditions in parallel, we obtained the stereoconverged product 
3.56. This stereochemical outcome suggested that the deborylative cyclization reaction 
                                                
 
72 Larouche-Gauthier, R.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2011, 133, 16794-16797. 
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went through a two-electron, stepwise pathway. To explain the origin of this 
stereochemical outcome, we proposed that after generation of benzylic carbanion 3.57, 
carbon-carbon bond rotational would occur, and the phenyl group would likely avoid 
eclipsing interactions with the cyclopentane ring. This effect would result in the 
four-membered ring intermediate configuration 3.58 as demonstrated in Scheme 3.14, 
which after reacting with allyl bromide would lead to the desired product 3.56. 
 
Scheme 3.14 Experiments to Differentiate between Concerted and Stepwise 
Pathway 
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3.4.4 DFT Analysis of the Boron Alkylidene-alkene [2+2]-Cycloadddition 
Reaction 
To gain more insight about the feasibility of the proposed stepwise reaction, 
collaborator Professor Fredrik Haeffner performed computational calculations for this 
transformation. From the same starting material boron alkylidene, the transition state 
energy for both the cis and trans intermediates are very similar (20.7 and 19.8 kcal/mol 
respectively). After cyclization, a primary carbanion INTsyn (10.9 kcal/mol) was 
generated, and carbon-carbon bond rotation explained the stereoconverged products 3.35 
and 3.56 we observed before. The big difference between the cis pathway (leading to 
major product) and trans pathway (leading to minor product) is the energy of the 
four-membered ring intermediate PDTsyn (-11.1 kcal/mol) and PDTanti (1.2 kcal/mol). 
This difference in energy supported our hypothesis that the cis four-membered ring 
intermediate is stable and can persist until trapped by electrophiles. The trans 
intermediate is so unstable that it is likely quenched by adventitious water during the 
reaction course. This theory was further supported by comparison between products 3.8 
and 3.10, where the trans minor intermediate was trapped with water, becoming a 
byproduct, and leading to a higher diastereoselectivity of 3.8 relative to product 3.10. 
Another possibility worth considering is that the trans minor four-membered ring 
intermediate might never form because of high-energy barrier of the trans five-four fused 
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bicyclic ring systems. The structure of trans minor intermediate might be five-membered 
ring with its carbanion stabilized by the potassium cation. This intermediate was then 
quenched by water, leading to the byproduct. 
 
Scheme 3.15 DFT Analysis of the Boron Alkylidene-alkene 2+2 Cycloadddition 
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3.5 Total Synthesis of Aphanamal 
My coworker Max Deaton demonstrated the synthetic utility of this methodology 
by accomplishing the total synthesis of natural product Aphanamal. 73  Since this 
synthesis was already discussed in his thesis,74 it will not be explained in detail here. Of 
note, three stereocenters were established in one step for product 3.60 with high 
diastereoselectivity (> 7:1) from readily accesible geminal bis(boronic) ester 3.59. 
 
 
 
 
 
 
 
 
 
 
                                                
 
73 (a) Mehta, G.; Krishnamurthy, N.; Karra, S. R. J. Chem. Soc. Chem. Commun. 1989, 129-130. (b) 
Hansson, T.; Wickberg, B. J. Org. Chem. 1992, 57, 5370-5376. (c) Harmata, M.; Carter, K. W. 
Tetrahedron Lett. 1997, 38, 7985-8120. (d) Wender, P. A.; Zhang, L. Org. Lett. 2000, 2, 2323-2326. (e) 
Ferrara, S. J.; Burton, J. W. Chem. Eur. J. 2016, 22, 11597-11600. 
74 Deaton, Timothy Maxwell. “A Boron Alkylidene-Alkene Cycloaddition Reaction: Application to the 
Synthesis of Aphanamal”, MS, Boston College, 2017. http://hdl.handle.net/2345/bc-ir:107597. 
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Scheme 3.16 Total Synthesis of Natural Product Aphanamal 
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3.6 Conclusions 
We have developed a boron alkylidene-alkene cyclization reaction to construct 
synthetically versatile five-membered ring containing boronic esters. After mechanistic 
studies, we believe that this deborylative cylization reaction possibily occur by a 
two-electron, stepwise pathway. DFT calculations were also performed to help us gain 
more insight into this transformation.  
 
 
3.7 Experimental Sections 
3.7.1 General Information 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), or a 
Varian Inova-500 (500 MHz) spectrometer. Chemical shifts are reported in ppm with the 
solvent resonance as the internal standard (CDCl3: 7.26 ppm, THF-d8: 3.58 ppm). Data 
are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, qi = quintet, sx = sextet, sp = septet, m = multiplet, br = broad), and 
coupling constants (Hz). 13C NMR spectra were recorded on either a Varian Gemini-500 
(125 MHz), or a Varian Inova-500 (125 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm with the solvent resonance as the 
internal standard (CDCl3: 77.0 ppm, THF-d8: 67.57 ppm). Infrared (IR) spectra were 
recorded on a Bruker alpha-P Spectrometer. Frequencies are reported in wavenumbers 
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(cm-1) as follows: strong (s), broad (br), medium (m), and weak (w). High-resolution 
mass spectrometry (DART+) was performed at the Mass Spectrometry Facility, Boston 
College, Chestnut Hill, MA. 
Liquid chromatography was performed using forced flow (flash chromatography) 
on silica gel (SiO2, 230 − 400 Mesh) purchased from Silicycle. Thin layer 
chromatography (TLC) was performed on 25 µm silica gel glass backed plates from 
Silicycle. Visualization was performed using ultraviolet light (254 nm), 
phosphomolybdic acid (PMA) in ethanol and ceric ammonium molybdate (CAM) in 
ethanol. 
Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector.  
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), diethyl ether, dichloromethane 
and toluene were purified using Pure Solv MD-4 solvent purification system, from 
Innovative Technology, Inc., by passing the solvent through two activated alumina 
columns after being purged with argon. 
Bis(pinacolato)diboron was generously donated by Allychem Co., Ltd. and used 
without further purification. Triethylamine was purchased from Alfa Aesar and distilled 
over calcium hydride prior to use. The following reagents were purchased and used 
without purification: copper(I) iodide (CuI) (Aldrich), lithium 
2,2,6,6-tetramethylpiperidide (LTMP) (Aldrich), sodium tert-butoxide (NaOt-Bu) 
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(Strem), palmitic acid-1-13C (Cambridge Isotope Laboratories), and 
N,N-dimethylformamide (DMF) (Acros). All other reagents were purchased from either 
Aldrich, Alfa Aesar or Acros and used without further purification.  
 
3.7.2 Representative Procedures for Preparation of Geminal Diboronate Esters 
Method A: 
Br
Br
B(pin)
B(pin)
CuI, LiOMe
B2(pin)2, DMF  
In the glove box, an oven-dried 500 mL round-bottom flask with magnetic stirring 
bar was charged with CuI (1.428 g, 7.500 mmol), LiOMe (8.543 g, 225 mmol) and 
B2(pin)2 (38.09 g, 150.0 mmol). The flask was sealed with a rubber septum, removed 
from the glove box, followed by the addition of DMF (150 mL) under N2. After stirring 
at room temperature for 10 min, dibromomethane (10.53 mL, 150.0 mmol) was added via 
syringe at room temperature. The reaction mixture was allowed to stir at room 
temperature for 12 hours. Upon completion, 200 mL diethyl ether was added. The slurry 
was filtered through a silica gel plug, rinsed with diethyl ether, and concentrated in vacuo. 
The crude reaction mixture in DMF was diluted with hexanes (300 mL), washed with 
H2O (75 mL × 4), dried over Na2SO4, and then concentrated in vacuo. The desired 
product bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane was obtained as a white 
solid (15.72 g, 78%) and used without further purification. 
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Method B:  
B(pin)
B(pin)
LTMP, THF
Ph Br
B(pin)
B(pin)
2.1  
In the glove box, an oven-dried 25 mL round-bottom flask with magnetic stir bar 
was charged with LTMP (773 mg, 5.25 mmol). The flask was sealed with a rubber 
septum, removed from the glove box, followed by the addition of THF (20 mL) under N2. 
The reaction mixture was cooled to 0 oC, and a solution of 1,1-diborylmethane (1.34 g, 
5.00 mmol) in THF (5 mL) was added via syringe and the mixture was allowed to stir at 
0 °C for 10 minutes. (2-Bromoethyl)benzene (751 µL, 5.50 mmol) was added dropwise 
and the reaction was allowed to stir at 0 oC for 15 min. Upon completion, the reaction 
mixture was warmed to room temperature, filtered through a silica gel plug, rinsed with 
diethyl ether, and concentrated in vacuo. The crude reaction mixture was purified on 
silica gel (hexanes: diethyl ether = 9:1) to afford the desired product 2.1 as a colorless oil 
(1.54 g, 83%) 
Method C:  
B(pin)
B(pin)
2.1
1) LTMP, THF, 0 oC
2) 5-bromo-1-pentene
Ph
(pin)B B(pin)
CH2
3.1  
In the glove box, an oven-dried 2-dram vial with magnetic stir bar was charged 
with LTMP (147 mg, 1.0 mmol). The flask was sealed with a rubber septum, removed 
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from the glove box, followed by the addition of THF (2 mL) under N2. The reaction 
mixture was cooled to 0 oC, and was transferred into a solution of 1,1-diboronate ester 
(372 mg, 1.00 mmol) in THF (2 mL) via syringe at 0 °C and the mixture was allowed to 
stir at 0 °C for 10 minutes. Then, 5-bromopent-1-ene (120 mL, 1.0 mmol) was added into 
the above mixture via syringe at 0 °C. The reaction mixture was allowed to stir at 0 oC for 
15 min, then warmed to room temperature, filtered through a silica gel plug, rinsed with 
diethyl ether, and concentrated in vacuo. The crude reaction mixture was purified on 
silica gel (hexanes: diethyl ether = 20:1) to afford 3.1 as a white solid (360 mg, 84%). 
3.7.3 Full Characterization of geminal-Diboronate Esters 
2,2'-(1-phenyloct-7-ene-3,3-diyl)bis(4,4,5,5-tetramethyl-
1,3,2-dioxaborolane) (3.1). The reaction was performed 
according to Representative Procedure (Method C) with 
diboronate ester 2.1 (372 mg, 1.0 mmol), LTMP (147 mg, 
1.0 mmol), 5-bromo-1-pentene (120 mL, 1.0 mmol) and THF (4 mL). The crude reaction 
mixture was purified by column chromatography on silica gel (20:1 hexanes/diethyl ether, 
stain in CAM) to afford a white solid (360 mg, 84%). 1H NMR (500 MHz, CDCl3): δ 
7.26-7.23 (m, 2H), 7.20-7.19 (m, 2H), 7.15-7.12 (m, 1H), 5.86 (ddt, J = 17.1, 10.3, 6.9 
Hz, 1H), 5.01 (ddt, J = 17.1, 2.0, 1.5 Hz, 1H), 4.93 (ddt, J = 10.3, 2.4, 1.0 Hz , 1H), 
2.52-2.49 (m, 2H), 2.10-2.06 (m, 2H), 1.91-1.88 (m, 2H), 1.74-1.71 (m, 2H), 1.41-1.35 
Ph B
B
O
O
OO
Me
Me
Me
Me
Me
Me
MeMe
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(m, 2H), 1.23 (s, 24H); 11B NMR (160 MHz, CDCl3) δ 33.69; The 1H NMR spectrum 
was in accord with previously reported data.75 
(Z)-tert-butyldimethyl((9-phenyl-4,4-bis(4,4,5,5-tetra
methyl-1,3,2-dioxaborolan-2-yl)non-8-en-1-yl)oxy)sila
ne) (S3.1). Prepared according to Representative 
Procedure (Method C) with LTMP (177 mg, 1.0 mmol), 
diboronate ester S3.4 (412 mg, 1.0 mmol), 
(3-bromopropoxy)-tert-butyldimethylsilane (253 mg, 1.0 mmol), and THF (5 mL). The 
crude reaction mixture was purified on silica gel (hexanes: ethyl acetate = 50:1) to afford 
the desired product as a white solid (455 mg, 77%). 1H NMR (600 MHz, CDCl3): δ 7.33 
– 7.22 (m, 4H), 7.21 – 7.16 (m,1H), δ 6.36 (d, J = 11.7 Hz, 1H), 5.68 (dt, J = 11.6, 7.3 Hz, 
1H), 3.58 (t, J = 7.2 Hz, 2H), 2.31 (dt, J = 8.4, 6.5 Hz, 2H), 1.70 – 1.62 (m, 2H), 1.60 – 
1.55 (m, 2H), 1.51 – 1.44 (m, 2H), 1.39 – 1.34 (m, 2H), 1.21 (s, 24H), 0.88 (s, 9H), 0.03 
(s, 6H); 13C NMR (150 MHz, CDCl3) δ 137.84, 133.44, 128.73, 128.38, 128.02, 126.27, 
82.92, 64.32, 30.63, 29.56, 28.95, 27.60, 26.01, 24.74, 24.70, 18.40, -5.18; 11B NMR 
(160 MHz, CDCl3) δ 34.17; IR (neat): 2977.1 (m), 2929.4 (m), 2857.6 (w), 1461.6 (w), 
1378.1.5 (m), 1371.8 (m), 1355.5 (m), 1307.2 (m), 1139.6 (s), 973.4 (w), 853.3 (m), 
853.8 (m), 774.4 (w) cm-1; HRMS-(DART+) for 12C331H5911B216O528Si1 [M+H]+: 
calculated: 585.4318, found: 585.4309. 
                                                
 
75 K. Hong, X. Liu, and J. P. Morken J. Am. Chem. Soc. 2014, 136, 10581-10584. 
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(Z)-2,2'-(2-methyl-8-phenyloct-7-ene-3,3-diyl)bis(4,4,5,5-te
tramethyl-1,3,2-dioxaborolane) (S3.2). The reaction was 
performed according to Representative Procedure (Method C) 
with 
2,2'-(2-methylpropane-1,1-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (509 mg, 1.6 mmol, made according to previous procedure76), LTMP 
(236 mg, 1.60 mmol), (Z)-(5-bromopent-1-en-1-yl)benzene (361 mg, 1.60 mmol) and 
THF (8 mL). The crude reaction mixture was purified by column chromatography on 
silica gel (100:1 – 50:1 hexanes/ethyl acetate, stain in CAM) to afford a white solid (530 
mg, 83%). 1H NMR (500 MHz, CDCl3): δ 7.37 – 7.25 (m, 4H), 7.19 (m, 1H), 6.36 (d, J = 
11.7, 1H), 5.71 (dt, J = 11.6, 7.2 Hz, 1H), 2.31 (qd, J = 7.4, 1.8 Hz, 2H), 2.04 (p, J = 6.8 
Hz, 1H), 1.68 – 1.59 (m, 2H), 1.59 – 1.45 (m, 2H), 1.21 (s, 24H), 0.98 (d, J = 6.8 Hz, 6H).  
13C NMR (125 MHz, CDCl3): δ 137.94, 133.70, 128.76, 128.24, 128.01, 126.24, 82.56, 
30.04, 29.75, 29.21, 28.42, 24.81, 24.77, 21.29;  11B NMR (160 MHz, CDCl3) δ 33.881; 
IR (neat): 2976.8 (m), 2929.6 (m), 1728.5 (w), 1459.8 (w), 1378.0 (m), 1370.6 (m), 
1296.1 (s), 1264.8 (m), 1215.1 (w), 1140.7 (s), 972.8 (w), 854.0 (w), 757.8 (s), 699.5 (w) 
cm-1; HRMS-(DART+) for 12C271H4511B216O4 [M+H]+: calculated: 455.3504, found: 
455.3504. 
                                                
 
76 Li, H.; Shangguan, X.; Zhang, Z.; Huang, S.; Zhang, Y.; Wang, J. Org. Lett. 2014, 16, 448-451. 
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(Z)-2,2'-(1-cyclohexyl-6-phenylhex-5-ene-1,1-diyl)bis(4,4
,5,5-tetramethyl-1,3,2-dioxaborolane) (S3.3). The 
reaction was performed according to Representative 
Procedure (Method C) with 
2,2'-(cyclohexylmethylene)bis(4,4,5,5-tetramethyl-1,3,2- 
dioxaborolane) (350 mg, 1.0 mmol; made according to previously reported procedure77), 
LTMP (147 mg, 1.0 mmol), (Z)-(5-bromopent-1-en-1-yl)benzene (225 mg, 1.60 mmol) 
and THF (5 mL). The crude reaction mixture was purified by column chromatography on 
silica gel (100:1 – 50:1 hexanes/ethyl acetate, stain in CAM) to afford a colorless oil (378 
mg, 76%). 1H NMR (500 MHz, CDCl3): δ 7.37 – 7.28 (m, 4H), 7.31 – 7.15 (m, 1H), 6.37 
(d, J = 11.6, 1H), 5.72 (dt, J = 11.6, 7.2 Hz, 1H), 2.30 (qd, J = 7.4, 1.8 Hz, 2H), 1.80 – 
1.73 (m, 2H), 1.73 – 1.58 (m, 6H), 1.57 – 1.46 (m, 2H), 1.21 (s, 24H), 1.31 – 1.02 (m, 
4H), 0.91 – 0.82 (m, 1H). 13C NMR (125 MHz, CDCl3): δ 137.97, 133.80, 128.77, 128.20, 
128.02, 126.24, 82.57, 40.24, 31.53, 30.13, 29.41, 28.66, 27.42, 26.96, 24.82, 24.80; 11B 
NMR (160 MHz, CDCl3) δ 33.59; IR (neat): 2977.4 (m), 2925.9 (m), 2851.9 (w), 1447.1 
(w), 1377.5 (m), 1370.6 (m), 1344.1 (m), 1293.8 (m), 1137.7 (s), 974.0 (w), 850.9 (w), 
699.5 (w) cm-1; HRMS-(DART+) for 12C301H4911B216O4 [M+H]+: calculated: 495.3817, 
found: 495.3819. 
                                                
 
77 K. Hong, X. Liu, and J. P. Morken J. Am. Chem. Soc. 2014, 136, 10581-10584. 
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(Z)-2,2'-(6-phenylhex-5-ene-1,1-diyl)bis(4,4,5,5-tetramethy
l-1,3,2-dioxaborolane)) (S3.4). The reaction was performed 
according to Representative Procedure (Method C) with 
methyl diboronate ester  (429 mg, 1.60 mmol), LTMP (236 
mg, 1.60 mmol), (Z)-(5-bromopent-1-en-1-yl)benzene (361 mg, 1.60 mmol) and THF (8 
mL). The crude reaction mixture was purified by column chromatography on silica gel 
(50:1 – 20:1 hexanes/ethyl acetate, stain in CAM) to afford a white solid (500 mg, 76%). 
1H NMR (500 MHz, CDCl3): δ 7.36 – 7.22 (m, 4H), 7.22 – 7.17 (m, 1H), 6.37 (d, J = 
11.7 Hz, 1H), 5.67 (dt, J = 11.6, 7.3 Hz, 1H), 2.31 (qd, J = 7.5, 1.9 Hz, 2H), 1.60 (q, J = 
7.8 Hz, 2H), 1.50 – 1.40 (m, 2H), 1.22 (s, 12H), 1.21 (s, 12H), 0.74 (t, J = 7.8 Hz, 1H); 
13C NMR (100 MHz, CDCl3): δ 137.80, 133.28, 128.70, 128.43, 128.02, 126.27, 82.90, 
32.88, 28.86, 25.57, 24.83, 24.48; 11B NMR (160 MHz, CDCl3) δ 33.59; IR (neat): 
2976.8 (m), 2927.3 (w), 1368.7 (m), 1311.6 (s), 1267.5 (m), 1214.5 (w), 1139.3 (s), 969.4 
(m), 849.7 (m), 699.8 (w) cm-1; HRMS-(DART+) for 12C241H3911B216O4 [M+H]+: 
calculated: 413.3034, found: 413.3052. 
 
(Z)-2,2'-(1,8-diphenyloct-7-ene-3,3-diyl)bis(4,4,5,5-tetra
methyl-1,3,2-dioxaborolane)) (3.55). The reaction was 
performed according to Representative Procedure (Method 
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C) with diboronate ester 2.1 (441 mg, 1.18 mmol), LTMP (174.5 mg, 1.18 mmol), 
(Z)-(5-bromopent-1-en-1-yl)benzene (267 mg, 1.186 mmol) and THF (6 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (20:1 
hexanes/ethyl acetate, stain in CAM) to afford a white solid (543 mg, 89%). 1H NMR 
(500 MHz, CDCl3): δ 7.37 – 7.10 (m, 10H), 6.40 (d, J = 11.7 Hz, 1H), 5.73 (dt, J = 11.6, 
7.3 Hz, 1H), 2.56 – 2.48 (m, 2H), 2.37 (qd, J = 7.4, 1.8 Hz, 2H), 1.96 – 1.88 (m, 2H), 
1.82 – 1.73 (m, 2H), 1.52 – 1.41 (m, 2H), 1.24 (two sets of singlet, 24H); 13C NMR (125 
MHz, CDCl3): δ 143.72, 137.83, 133.38, 128.73, 128.53, 128.46, 128.08, 128.04, 126.32, 
125.34, 82.98, 33.83, 31.92, 29.56, 28.95, 27.68, 24.78, 24.71; 11B NMR (160 MHz, 
CDCl3) δ 33.98; IR (neat): 2977.2 (m), 2928.4 (w), 1454.5 (w), 1370.5 (m), 1352.4 (m), 
1308.8 (s), 1254.6 (m), 1214.1 (w), 1138.1 (s), 968.9 (w), 854.6 (w), 699.2 (m) cm-1. 
HRMS-(DART+) for 12C321H4711B216O4 [M+H]+: calculated: 517.3660, found: 517.3639. 
 
(E)-2,2'-(1,8-diphenyloct-7-ene-3,3-diyl)bis(4,4,5,5-tetra
methyl-1,3,2-dioxaborolane) (3.20). The reaction was 
performed according to Representative Procedure (Method 
C) with diboronate ester 2.1 (1.0 g, 2.69 mmol), LTMP 
(417 mg, 2.83 mmol), (E)-(5-bromopent-1-en-1-yl)benzene (636 mg, 2.83 mmol) and 
THF (10.8 mL). The crude reaction mixture was purified by column chromatography on 
silica gel (20:1 hexanes/ethyl acetate, stain in CAM) to afford a white solid (543 mg, 
39%). 1H NMR (600 MHz, CDCl3): δ 7.36 (dd, J = 8.2, 1.4 Hz, 2H), 7.32 – 7.22 (m, 4H), 
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7.23 – 7.17 (m, 3H), 7.20 – 7.11 (m, 1H), 6.40 (d, J = 15.7 Hz, 1H), 6.28 (dt, J = 15.9, 
6.7 Hz, 1H), 2.56 – 2.49 (m, 2H), 2.25 (q, J = 6.9 Hz, 2H), 1.95 – 1.89 (m, 2H), 1.81 – 
1.75 (m, 2H), 1.52 – 1.43 (m, 2H), 1.24 (s, 24H); 13C NMR (150 MHz, CDCl3): δ 143.73, 
138.07, 131.42, 129.48, 128.48, 128.40, 128.09, 126.62, 125.91, 125.35, 83.00, 33.86, 
33.83, 31.91, 28.77, 27.10, 24.81, 24.71; 11B NMR (160 MHz, CDCl3) δ 33.69; IR (neat): 
2977.5 (w), 2929.4 (w), 1453.7 (w), 1378.5 (m), 1307.6 (m), 1253.4 (m), 1138.4 (s), 
967.5 (w), 851.2 (w), 751.4 (m), 698.1 (w) cm-1HRMS-(DART+) for 12C321H4711B216O4 
[M+H]+: calculated: 517.3660, found: 517.3664. 
 
(E)-2,2'-(1-phenyldeca-7,9-diene-3,3-diyl)bis(4,4,5,5-tetr
amethyl-1,3,2-dioxaborolane) (3.22). The reaction was 
performed according to Representative Procedure (Method 
C) with diboronate ester 2.1 (633 mg, 1.7 mmol), LTMP 
(250 mg, 1.7 mmol), (E)-7-bromohepta-1,3-diene (296 mg, 
1.7 mmol) and THF (7 mL). The crude reaction mixture was purified by column 
chromatography on silica gel (50:1 hexanes/ethyl acetate, stain in CAM) to afford a white 
solid (713 mg, 90%). 1H NMR (600 MHz, CDCl3): δ 7.28 – 7.10 (m, 5H), 6.32 (dt, J = 
17.0, 10.3 Hz, 1H), 6.06 (dd, J = 15.3, 10.3 Hz, 1H), 5.75 (dt, J = 14.5, 6.8 Hz, 1H), 5.08 
(dd, J = 17.0, 1.7 Hz, 1H), 4.94 (dd, J = 10.1, 1.7 Hz, 1H), 2.53 – 2.47 (m, 2H), 2.11 (q, J 
= 7.2 Hz, 2H), 1.92 – 1.86 (m, 2H), 1.75 – 1.69 (m, 2H), 1.42 – 1.34 (m, 2H), 1.23 (s, 
24H); 13C NMR (150 MHz, CDCl3): δ 143.74, 137.52, 135.85, 130.64, 128.48, 128.09, 
Ph
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125.35, 114.37, 82.99, 33.84, 33.34, 31.87, 28.76, 26.89, 24.80, 24.71; 11B NMR (160 
MHz, CDCl3) δ 33.88; IR (neat): 2976.8 (w), 2929.1 (w), 1455.0 (w), 1378.0 (m), 1305.6 
(m), 1252.2 (m), 1137.0 (s), 1003.9 (m), 852.2 (m), 699.2 (w) cm-1; HRMS-(DART+) for 
12C281H4511B216O4 [M+H]+: calculated: 467.3504, found: 467.3519. 
 
2,2'-(1-phenylhept-6-ene-2,2-diyl)bis(4,4,5,5-tetramethyl
-1,3,2-dioxaborolane)) (S3.5). The reaction was performed 
according to Representative Procedure (Method C) with 
2,2'-(2-phenylethane-1,1-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (429.7mg, 1.2 mmol, made according to previous procedure78), LTMP 
(194.3 mg, 1.32 mmol), 5-bromo-1-pentene (197 mg, 1.32 mmol) and THF (6 mL). The 
crude reaction mixture was purified by column chromatography on silica gel (50:1 
hexanes/ethyl acetate, stain in CAM) to afford a colorless oil (450 mg, 88%). 1H NMR 
(500 MHz, CDCl3): δ 7.26 – 7.17 (m, 4H), 7.15 – 7.07 (m, 1H), 5.82 (ddt, J = 16.9, 10.2, 
6.6 Hz, 1H), 4.97 (dq, J = 17.2, 1.8 Hz, 1H), 4.90 (ddt, J = 10.2, 2.4, 1.3 Hz, 1H), 2.97 (s, 
2H), 2.00 (q, J = 7.1 Hz, 2H), 1.56 – 1.51 (m, 2H), 1.49 – 1.41 (m, 2H), 1.24 (s, 12H), 
1.20 (s, 12H); 13C NMR (125 MHz, CDCl3): δ 141.82, 139.32, 129.70, 127.65, 125.41, 
113.82, 83.16, 34.58, 34.44, 28.45, 26.77, 25.00, 24.69; IR (neat): 2978.4 (m), 2931.7 (w), 
                                                
 
78 K. Hong, X. Liu, and J. P. Morken J. Am. Chem. Soc. 2014, 136, 10581-10584. 
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2862.9 (m), 1378.4 (m), 1353.4 (m), 1261.8 (m), 1138.8 (s), 854.3 (w), 699.9 (w) cm-1; 
HRMS-(DART+) for 12C251H4111B216O4 [M+H]+: calculated: 427.3191, found: 427.3189. 
 
2,2'-(6-(benzyloxy)-1-phenyloct-7-ene-3,3-diyl)bis(4
,4,5,5-tetramethyl-1,3,2-dioxaborolane)) (S3.6). The 
reaction was performed according to Representative 
Procedure (Method C) with diboronate ester 2.1 (186 
mg, 0.5 mmol), LTMP (73.6 mg, 0.5 mmol), 3-(benzyloxy)pent-4-en-1-yl 
4-methylbenzenesulfonate (193 mg, 0.56 mmol) and THF (5 mL). The crude reaction 
mixture was purified by column chromatography on silica gel (100:2 – 100:4 
hexanes/ethyl acetate, stain in CAM) to afford a colorless oil (220 mg, 81%). 1H NMR 
(500 MHz, CDCl3): δ 7.37 – 7.30 (m, 4H), 7.26 – 7.21 (m, 3H), 7.20 – 7.16 (m, 2H), 7.13 
(t, J = 7.2 Hz, 1H), 5.84 – 5.69 (m, 1H), 5.25 – 5.22 (m, 2H), 4.60 (d, J = 12.1 Hz, 1H), 
4.40 (d, J = 12.1 Hz, 1H), 3.73 (q, J = 6.8 Hz, 1H), 2.50 (td, J = 7.3, 3.7 Hz, 2H), 1.88 
(dd, J = 10.7, 6.9 Hz, 2H), 1.80 – 1.63 (m, 3H), 1.59 – 1.50 (m, 1H), 1.22 (s, 24H); 13C 
NMR (150 MHz, CDCl3): δ 143.76, 139.03, 128.51, 128.21, 128.07, 127.58, 127.20, 
125.32, 117.22, 82.99, 81.33, 69.77, 33.79, 32.81, 31.96, 24.91, 24.78, 24.65; IR (neat): 
2977.4 (m), 2932.1 (w), 1378.5 (w), 1370.5 (w), 1309.9 (s), 1138.56 (s), 851.8 (w), 698.5 
(w) cm-1; HRMS-(DART+) for 12C331H5211B216O514N1 [M+NH4]+: calculated: 564.4032, 
found: 564.4058. 
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3.7.4 Representative Procedure for Deborylative Cyclization 
Base
Solvent
Temperature
Ph
Me(pin)BPh B(pin)
B(pin)
3.1 3.2 Major
Ph
Me(pin)B
3.2 Minor  
In the glove box, an oven-dried 2-dram vial equipped with magnetic stir bar is charged 
with 1,1-diboronate ester 3.1 (48.4 mg, 0.10 mmol), base (0.20 mmol) and THF (0.50 
mL). The vial is sealed with a polypropylene cap, removed from the glove box, and 
allowed to stir at room temperature for overnight. Upon completion, the reaction mixture 
is diluted with wet diethyl ether (2 mL), filtered through a silica gel plug, rinsed with 
diethyl ether, and concentrated in vacuo. The crude reaction mixture is then purified on 
silica gel (hexanes: ethyl acetate = 100 : 0.8) to afford the desired product 3.2 major and 
3.2 minor. 
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3.7.5 Full Optimizationa 
Table S3.1. 
Base
Solvent
Temperature
Ph
Me(pin)BPh B(pin)
B(pin)
3.1 3.2 Major
Ph
Me(pin)B
3.2 Minor  
entry base solvent yield (%) d.r. (3.2 major : 3.2 minor) 
1 NaOt-Bu THF 12 13 : 1 
2 NaOt-Bu toluene <5 N/A 
3 KOMe toluene <5 N/A 
4 KOt-Bu DCE <5 N/A 
5 KOt-Bu hexanes 39 2.2 : 1 
6 KOt-Bu THF 51 5 : 1 b 
7 KOt-Bu THF 52 4 : 1 
8 KOt-Bu toluene 52 2 : 1 b 
9 KOt-Bu toluene 61 1.2 : 1 
a Reaction conditions: 1,1-diboronate ester (0.10 mmol, 0.2 M), and base (0.20 mmol). 
Yield refers to the isolated yield of purified material. Diastereoselectivity was determined 
based on NMR integration. b Reaction conducted at 50 °C. 
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3.7.6 Full Characterization of Reaction Products and Proof of Stereochemistry 
 
4,4,5,5-tetramethyl-2-(2-methyl-1-phenethylcyclopentyl)-1,3,2
-dioxaborolane (3.2, major diastereomer).The reaction was 
performed according to Representative Procedure for 
Deborylative Cyclization with 1,1-diboronate ester 3.1 (88 mg, 
0.2 mmol), KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 mL). The crude reaction mixture 
was purified on silica gel (hexanes: ethyl acetate = 100 : 0.8) to afford the desired product 
as a colorless oil (32.7 mg, 52%, 4:1 dr). 1H NMR (500 MHz, CDCl3): δ 7.28-7.25(m, 
2H), 7.20 (d, J = 7.3 Hz, 2H), 7.16 (t, J = 7.3 Hz, 1H), 2.59-2.53 (m, 2H), 2.05-1.95 (m, 
2H), 1.84-1.78 (m, 1H), 1.77-1.70 (m, 1H), 1.64-1.56 (m, 2H), 1.40-1.22 (m, 3H), 1.27 
(12H, s, overlap), 1.00 (d, J = 6.9 Hz, 3H) ; 11B NMR (160 MHz, CDCl3) δ 34.57; The 1H 
NMR spectrum was in accord with previously reported data.79 
 
4,4,5,5-tetramethyl-2-(1-phenyltetradecan-2-yl)-1,3,2-dioxab
orolane (3.2, minor diastereomer). 1H NMR (500 MHz, CDCl3): 
δ 7.27 (t, J = 7.3 Hz, 2H), 7.21 (d, J = 7.3 Hz, 2H), 7.18-7.15 (m, 
                                                
 
79 K. Hong, X. Liu, and J. P. Morken J. Am. Chem. Soc. 2014, 136, 10581-10584. 
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1H), 2.58-2.49 (m, 2H), 2.04 (sx, J = 7.3 Hz, 1H), 1.89-1.83 (m, 1H), 1.79-1.54 (m, 5H), 
1.44-1.36 (m, 1H), 1.31-1.24 (m, 1H), 1.27 (s, overlap, 12H), 0.91 (dd, J = 7.3, 1.4 Hz, 
3H); The 1H NMR spectrum was in accord with previously reported data.8 
 
4,4,5,5-tetramethyl-2-((1R,2S)-2-(methyl-d)-1-phenethylcy
clopentyl)-1,3,2-dioxaborolane (3.7). The reaction was 
performed according to Representative Procedure for 
Deborylative Cyclization with 1,1-diboronate ester 3.1 (88 mg, 
0.2 mmol), KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 mL). Upon completion, the reaction 
mixture was quenched with D2O (100 mL, 5.0 mmol), then diluted with diethyl ether (2 
mL) and filtered through a silica gel plug, rinsing with diethyl ether, and concentrated in 
vacuo. The crude reaction mixture was purified on silica gel (hexanes: ethyl acetate = 
100 : 0.8, stain in CAM) to afford the desired product as a colorless oil (28.1 mg, 45%, > 
20:1 dr). 1H NMR (500 MHz, CDCl3): δ 7.27 (t, J = 7.6 Hz, 2H), 7.23 – 7.14 (m, 3H), 
2.63 – 2.50 (m, 2H), 2.07 – 1.92 (m, 2H), 1.86 – 1.68 (m, 2H), 1.63 – 1.55 (m, 2H), 1.39 
– 1.20 (m, 3H), 1.27 (s, 12H), 0.99 (d, J = 7.0, 2H); 13C NMR (125 MHz, CDCl3):  δ 
143.88, 128.30, 128.19, 125.40, 125.40, 82.89, 44.93, 41.24, 34.26, 34.19, 34.14, 25.28, 
24.82, 22.70, 17.63, 17.50, 17.37; IR (neat): 2977.4 (m), 2931.9 (m), 2857.6 (w), 1730.2 
(w), 1454.4 (w), 1387.8 (m), 1301.7 (m), 1195.1 (w), 1143.6 (s), 966.8 (w), 855.5 (w), 
748.8 (w), 698.9 (w) cm-1;  HRMS-(DART+) for 12C201H312D111B116O2 [M+H]+: 
calculated: 316.2558, found: 316.2560. 
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2-((1R,2S)-2-(bromomethyl)-1-phenethylcyclopentyl)-4,4,5
,5-tetramethyl-1,3,2-dioxaborolane (3.8). The reaction was 
performed according to Representative Procedure for 
Deborylative Cyclization with 1,1-diboronate ester 3.1 (88 mg, 
0.2 mmol), KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 mL). Upon completion, the reaction 
mixture was quenched with NBS (71.2 mg, 0.4 mmol) in anhydrous THF (1 mL), then 
diluted with diethyl ether (2 mL) and filtered through a silica gel plug, rinsing with 
diethyl ether. Filtrate was then concentrated in vacuo and crude purified on silica gel 
(hexanes: ethyl acetate = 100 : 0.8, stain in CAM) to afford the desired product as a white 
solid (40.3 mg, 51.2%, >20:1 dr). 1H NMR (500 MHz, CDCl3): δ 7.32 – 7.23 (m, 3H), 
7.18 (dd, J = 7.7, 1.1 Hz, 2H), 3.72 (dd, J = 9.6, 3.7 Hz, 1H), 3.37 (dd, J = 11.4, 9.6 Hz, 
1H), 2.62 – 2.50 (m, 2H), 2.18 – 2.04 (m, 2H), 2.06 – 1.91 (m, 2H), 1.79 – 1.56 (m, 2H), 
1.51 – 1.37 (m, 3H), 1.26 (d, J = 1.6 Hz, 12H); 13C NMR (125 MHz, CDCl3): δ 143.13, 
128.30, 128.23, 125.64, 83.31, 53.24, 41.18, 37.96, 35.71, 33.87, 32.22, 25.10, 24.82, 
22.35; 11B NMR (160 MHz, CDCl3) δ 34.08; IR (neat): 2976.4 (m), 2956.2 (m), 2932.3 
(m), 2868.7 (w), 1454.3 (w), 1381.0 (m), 1312.3 (m), 1210.3 (m), 1142.9 (s), 967.1 (w), 
855.0 (w), 748.5 (w), 698.8 (m) cm-1; HRMS-(DART+) for 12C201H3111B179Br116O2 
[M+H]+: calculated: 393.1601, found: 393.1608. 
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2-((1R,2S)-2-(iodomethyl)-1-phenethylcyclopentyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (3.9). The reaction was 
performed according to Representative Procedure for 
Deborylative Cyclization with 1,1-diboronate ester 3.1 (88 mg, 
0.2 mmol), KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 mL). Upon completion, the reaction 
mixture was quenched with I2 (101.5 mg, 0.4 mmol) in anhydrous THF (1 mL), then 
diluted with diethyl ether (2 mL) and filtered through a silica gel plug, rinsing with 
diethyl ether. Filtrate was then concentrated in vacuo and the crude residue purified on 
silica gel (hexanes: ethyl acetate = 100 : 0.8, stain in CAM) to afford the desired product 
as a white solid (43mg, 49%, >20:1 dr, crude NMR shows the same diastereoselectivity). 
1H NMR (600 MHz, CDCl3): δ 7.30 – 7.24 (m, 2H), 7.22 – 7.14 (m, 3H), 3.53 (dd, J = 
9.4, 3.3 Hz, 1H), 3.14 (dd, J = 12.1, 9.4 Hz, 1H), 2.61 – 2.50 (m, 2H), 2.20 – 2.10 (m, 
2H), 2.04 – 1.94 (m, 2H), 1.81 – 1.70 (m, 1H), 1.69 – 1.57 (m, 1H), 1.48 – 1.40 (m, 2H), 
1.43 – 1.32 (m, 1H), 1.26 (s, 6H) , 1.26 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 143.13, 
128.30, 128.22, 125.64, 83.30, 53.97, 41.19, 36.08, 33.90, 25.11, 24.82, 21.83, 11.61; 11B 
NMR (160 MHz, CDCl3) δ 33.88; IR (neat): 2976.5 (m), 2956.3 (m), 2932.3 (m), 2867.2 
(w), 1454.1 (w), 1380.7 (m), 1345.3 (m), 1210.3 (w), 1142.4 (s), 966.8 (w), 854.2 (w), 
755.1 (m), 698.4 (m) cm-1; HRMS-(DART+) for 12C201H3111B1127I116O2 [M+H]+: 
calculated: 441.1462, found: 441.1478. The relative stereochemistry was assigned by 
X-ray crystallography. 
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2-((1R,2S)-1-benzyl-2-methylcyclopentyl)-4,4,5,5-tetramethyl-1
,3,2-dioxaborolane (3.11). The reaction was performed according 
to Representative Procedure for Deborylative Cyclization with 
1,1-diboronate ester 3.1 (85.2 mg, 0.2 mmol), KOt-Bu (44.8 mg, 
0.4 mmol) and THF (1 mL). The crude reaction mixture was purified on silica gel 
Ph
B
OO
Me
MeMeMe
CH3
 162 
(hexanes: ethyl acetate = 100 : 0.8, stain in CAM) to afford the desired product as a 
colorless oil (39.2 mg, 65%, > 20:1 dr, crude NMR shows the same diastereoselectivity). 
1H NMR (600 MHz, CDCl3): δ 7.27 – 7.18 (m, 4H), 7.17 – 7.10 (m, 1H), 2.97 (d, J = 
13.2 Hz, 1H), 2.43 (d, J = 13.3 Hz, 1H), 1.87 – 1.79 (m, 2H), 1.75 – 1.50 (m, 3H), 1.47 – 
1.36 (m, 1H), 1.30 – 1.20 (m, 1H), 1.19 (s, 6H), 1.14 (s, 6H), 1.05 (d, J = 6.9 Hz, 3H); 
13C NMR (125 MHz, CDCl3): δ 141.15, 130.14, 127.56, 125.49, 82.91, 44.35, 42.89, 
33.97, 33.77, 25.14, 24.93, 22.24, 17.55; 11B NMR (160 MHz, CDCl3) δ 33.88; IR (neat): 
2976.8 (m), 2953.6 (m), 2930.1 (m), 2869.0 (w), 1453.4 (w), 1387.9 (m), 1298.8 (m), 
1211.8 (w), 1143.0 (s), 965.7 (w), 858.5 (w), 758.5 (w), 701.1 (m) cm-1; HRMS-(DART+) 
for 12C191H2911B116O2 [M+H]+: calculated: 301.2339, found: 301.2336. 
 
(3-((1R,2R)-2-benzyl-1-(4,4,5,5-tetramethyl-1,3,2-diox
aborolan-2-yl)cyclopentyl)propoxy)(tert-butyl)dimeth
ylsilane (3.17). The reaction was performed according to 
Representative Procedure for Deborylative Cyclization 
with 1,1-diboronate ester S3.1 (58.5 mg, 0.1 mmol), KOt-Bu (22.4 mg, 0.2 mmol) and 
THF (0.5 mL). The crude reaction mixture was purified on silica gel (hexanes: ethyl 
acetate = 100 : 0.8, stain in CAM) to afford the desired product as a white solid (30 mg, 
65%, > 20:1 dr, crude NMR shows the same diastereoselectivity). 1H NMR (600 MHz, 
CDCl3) δ 7.29 – 7.22 (m, 2H), 7.18 – 7.13 (m, 3H), 3.67 – 3.54 (m, 2H), 2.98 (dd, J = 
13.2, 3.3 Hz, 1H), 2.33 (dd, J = 13.2, 11.6 Hz, 1H), 1.98 (ddd, J = 12.5, 8.7, 4.8 Hz, 1H), 
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1.82 – 1.43 (m, 7H), 1.35 – 1.21 (m, 2H), 1.27 (s, 12H), 1.21 – 1.06 (m, 1H), 0.91 (s, 9H), 
0.06 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 143.00, 128.80, 128.07, 125.41, 82.93, 
64.26, 53.02, 39.37, 34.41, 34.35, 31.36, 30.94, 26.02, 25.12, 24.89, 22.41, 18.40, -5.17; 
11B NMR (160 MHz, CDCl3) δ 34.27; IR (neat): 2975.9 (w), 2951.9 (m), 2929.1 (m), 
2856.3 (m), 1453.9 (w), 1386.9 (m), 1299.6 (m), 1253.8 (m), 1215.5 (w), 1142.3 (s), 
1098.6 (m), 990.1 (w), 835.3 (s), 775.1 (m), 698.6 (w) cm-1;  HRMS-(DART+) for 
12C271H4811B116O328Si1 [M+H]+: calculated: 459.3466, found: 459.3454. 
 
2-((1R, 
2R)-2-benzyl-1-isopropylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (3.18). The reaction was performed according to 
Representative Procedure for Deborylative Cyclization with 
1,1-diboronate ester S3.2 (90.9 mg, 0.2 mmol), KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 
mL). The crude reaction mixture was purified on silica gel (hexanes: ethyl acetate = 100 : 
0.8, stain in CAM) to afford the desired product as a white solid (34.5 mg, 52.5%, > 20:1 
dr, crude NMR shows the same diastereoselectivity). 1H NMR (500 MHz, CDCl3): δ 7.29 
– 7.22 (m, 2H), 7.19 – 7.12 (m, J = 6.9, 5.7, 1.4 Hz, 3H), 2.97 (dd, J = 13.2, 3.1 Hz, 1H), 
2.34 (dd, J = 13.3, 11.7 Hz, 1H), 2.02 – 1.75 (m, 3H), 1.74 – 1.61 (m, 1H), 1.64 – 1.52 
(m, 1H), 1.45 – 1.32 (m, 2H), 1.28 (s, 12H), 1.28 – 1.18 (m, 1H), 0.97 (d, J = 6.8 Hz, 3H), 
0.89 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 143.29, 128.77, 128.07, 125.39, 
82.83, 48.45, 39.32, 31.82, 31.14, 29.17, 25.19, 24.93, 22.49, 21.15, 17.15; 11B NMR 
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(160 MHz, CDCl3) δ 34.37; IR (neat): 2955.3 (m), 2870.1 (w), 1495.1 (w), 1380.1 (m), 
1297.7 (m), 1212.7 (w), 1140.6 (s), 982.1 (w), 864.9 (w), 745.6 (w), 699.2 (m) cm-1;  
HRMS-(DART+) for 12C211H3411B116O2 [M+H]+: calculated: 329.2652, found: 329.2655. 
 
2-((1R,2R)-2-benzyl-1-cyclohexylcyclopentyl)-4,4,5,5-tetrameth
yl-1,3,2-dioxaborolane (3.16).  The reaction was performed 
according to Representative Procedure for Deborylative 
Cyclization with 1,1-diboronate ester S3.3 (98.9 mg, 0.2 mmol), 
KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 mL). The crude reaction mixture was purified 
on silica gel (hexanes: ethyl acetate = 100 : 0.8, stain in CAM) to afford the desired 
product as a white solid (59 mg, 80%, > 20:1 dr, crude NMR shows the same 
diastereoselectivity). 1H NMR (600 MHz, CDCl3): δ 7.34 – 7.21 (m, 2H), 7.21 – 7.12 (m, 
3H), 2.97 (dd, J = 13.3, 3.2 Hz, 1H), 2.34 (dd, J = 13.3, 11.9 Hz, 1H), 2.00 – 1.91 (m, 
1H), 1.84 – 1.76 (m, 1H), 1.79 – 1.67 (m, 3H), 1.66 – 1.58 (m, 3H), 1.61 – 1.50 (m, 2H), 
1.45 – 1.31 (m, 2H), 1.33 – 1.19 (m, 14H), 1.22 – 1.17 (m, 2H), 1.17 – 1.08 (m, 1H), 1.09 
– 0.95 (m, 1H); 13C NMR (125 MHz, CDCl3): δ 143.30, 128.78, 128.05, 125.36, 82.80, 
47.14, 41.83, 39.18, 31.65, 31.56, 30.06, 27.34, 27.12, 27.08, 27.04, 25.22, 24.90, 22.39; 
11B NMR (160 MHz, CDCl3) δ 34.57; IR (neat): 2976.2 (m), 2925.3 (s), 2851.6 (m), 
1449.0 (w), 1378.7 (m), 1297.3 (m), 1212.8 (w), 1141.8 (s), 864.2 (w), 746.5 (w), 698.8 
(m) cm-1; HRMS-(DART+) for 12C241H3811B116O2 [M+H]+: calculated: 369.2965, found: 
369.2967. The relative stereochemistry was assigned by X-ray crystallography. 
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2-((1R,2R)-2-benzylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (3.19). The reaction was performed according 
to Representative Procedure for Deborylative Cyclization 
with 1,1-diboronate ester S3.4 (82.4 mg, 0.2 mmol), KOt-Bu 
(44.8 mg, 0.4 mmol) and THF (1 mL). The crude reaction mixture was purified on silica 
gel (hexanes: ethyl acetate = 100 : 0.8, stain in CAM) to afford the desired product as a 
colorless oil (25.7 mg, 45%, > 18:1 dr, crude NMR shows the same diastereoselectivity). 
1H NMR (600 MHz, CDCl3): δ 7.29 – 7.21 (m, 2H), 7.20 – 7.12 (m, 3H), 2.78 (dd, J = 
13.4, 5.9 Hz, 1H), 2.51 (dd, J = 13.4, 8.6 Hz, 1H), 2.21 – 2.11 (m, 1H), 1.87 – 1.77 (m, 
1H), 1.77 – 1.65 (m, 1H), 1.66 – 1.44 (m, 3H), 1.27 (d, J = 4.5 Hz, 1H), 1.18 (s, 6H), 1.17 
(s, 6H), 0.99 – 0.86 (m, 1H); 13C NMR (125 MHz, CDCl3): δ 142.22, 128.98, 128.05, 
125.48, 82.72, 45.07, 42.49, 33.51, 28.47, 25.84, 24.72, 24.70; IR (neat): 2956.1 (s), 
2932.8 (m), 2919.8 (m), 2876.6 (w), 2861.0 (w), 2361.0 (m), 2163.9 (s), 2013.9 (w), 
1728.4 (s), 1379.0 (m), 1290.6 (s), 1316.8 (m), 1145.8 (m), 763.7 (w) cm-1; 
HRMS-(DART+) for 12C181H2711B116O2 [M+H]+: calculated: 287.2182, found: 287.2194. 
Relative configuration was determined after oxidation and comparison with reported 
data. 80  To a 20 mL vial containing 
                                                
 
80 Simpson, A. F.; Bodkin, C. D.; Butts, C. P.; Armitage, M. A.; Gallagher, T. J. Chem. Soc., Perkin Trans. 
1 2000, 3047-3054. 
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2-((1R,2R)-2-benzylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (10 mg, 
0.035mmol), NaOH solution (3M, 1 mL) is added followed by THF (1 mL). The vial is 
then cooled to 0°C and H2O2 (30 wt%, 1 mL) is carefully added. The reaction mixture is 
then allowed to stir at room temperature for three hours, at which point, the mixture is 
cooled back to 0°C and  saturated, aqueous Na2S2O3 (1 mL) is added to degrade excess 
H2O2. The mixture is then extracted with ethyl acetate three times and the combined 
organics dried over Na2SO4, and concentrated in vacuo. 1H NMR (500 MHz, CDCl3): δ 
7.32 – 7.27 (m, 2H), 7.22 – 7.17 (m, 3H), 3.96 – 3.87 (m, 1H), 2.76 (dd, J = 13.6, 6.9 Hz, 
1H), 2.55 (dd, J = 13.6, 8.2 Hz, 1H), 2.08 – 2.00 (m, 1H), 1.99 – 1.92 (m, 1H), 1.89 – 
1.80 (m, 1H), 1.77 – 1.66 (m, 1H), 1.66 – 1.54 (m, 2H), 1.34 – 1.25 (m, 1H), 1.23 (d, J = 
4.1 Hz, 1H) ; 11B NMR (160 MHz, CDCl3) δ 34.27. 
 
2-((1R,2R)-2-benzyl-1-phenethylcyclopentyl)-4,4,5,5-tetra
methyl-1,3,2-dioxaborolane (3.14, major diastereomer). 
The reaction was performed according to Representative 
Procedure for Deborylative Cyclization with 1,1-diboronate 
ester 3.55 (103.3 mg, 0.2 mmol), KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 mL). The 
crude reaction mixture was purified on silica gel (hexanes: ethyl acetate = 100 : 0.8, stain 
in CAM) to afford the desired product as a white solid (52.7 mg, 67%, 4:1 dr, crude 
NMR shows the same diastereoselectivity). 1H NMR (500 MHz, CDCl3): δ 7.32 – 7.12 
(m, 10H), 3.01 (dd, J = 13.2, 3.3 Hz, 1H), 2.62 (ddd, J = 10.4, 5.8, 3.5 Hz, 2H), 2.36 (dd, 
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J = 13.2, 11.6 Hz, 1H), 2.20 – 2.04 (m, 2H), 1.81 – 1.47 (m, 5H), 1.46 – 1.31 (m, 2H), 
1.31 (s, 6H), 1.31 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 143.76, 142.91, 128.80, 
128.34, 128.25, 128.09, 125.50, 125.44, 83.07, 53.06, 41.31, 39.41, 34.42, 34.17, 31.42, 
25.28, 24.89, 22.49; ; IR (neat): 2976.2 (m), 2930.8 (m), 2857.6 (w), 1495.3 (w), 1453.6 
(m), 1386.7 (m), 1344.8 (w), 1300.7 (m), 1213.8 (m), 1141.2 (s), 1029.5 (w), 967.3 (w), 
855.4 (w), 746.9 (m), 697.9 (s) cm-1; HRMS-(DART+) for 12C261H3911B114N116O2 
[M+NH4]+: calculated: 408.3074, found: 408.3091. The relative stereochemistry was 
assigned by X-ray crystallography. 
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2-((1S,2R)-2-benzyl-1-phenethylcyclopentyl)-4,4,5,5-tetra
methyl-1,3,2-dioxaborolane (3.14, minor diastereomer). 1H 
NMR (600 MHz, CDCl3): δ 7.29 (t, J = 7.6 Hz, 2H), 7.29 – 
7.16 (m, 4H), 7.19 – 7.07 (m, 4H), 2.96 (dd, J = 13.1, 3.3 Hz, 
1H), 2.63 – 2.55 (m, 2H), 2.29 (dd, J = 13.1, 11.8 Hz, 1H), 2.18 – 2.10 (m, 1H), 1.87 
(ddd, J = 13.3, 10.4, 6.4 Hz, 2H), 1.74 – 1.64 (m, 2H), 1.61 – 1.44 (m, 3H), 1.38 – 1.27 
(m, 1H), 1.31 (s, 6H), 1.31 (s, 6H); 13C NMR (150 MHz, CDCl3): δ 143.80, 142.83, 
128.81, 128.38, 128.28, 128.11, 125.55, 125.42, 83.05, 48.64, 36.78, 34.07, 33.33, 32.55, 
29.80, 24.99, 24.71, 22.71; IR (neat): 2957.0 (s), 2930.9 (s), 2863.3 (m), 1728.6 (m), 
1455.6 (w), 1376.6 (m), 1272.7 (m), 1142.1 (s), 1072.5 (w), 747.1 (w), 699.6 (m) cm-1; 
HRMS-(DART+) for 12C261H3911B114N116O2 [M+NH4]+: calculated: 408.3074, found: 
408.3079. 
 
2-((1R,2R)-2-benzyl-1-phenethylcyclopentyl)-4,4,5,5-tetra
methyl-1,3,2-dioxaborolane (3.14, major diastereomer). 
The reaction was performed according to Representative 
Procedure for Deborylative Cyclization with 1,1-diboronate 
ester 3.20 (103.3 mg, 0.2 mmol), KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 mL). The 
crude reaction mixture was purified on silica gel (hexanes: ethyl acetate = 100 : 0.8, stain 
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in CAM) to afford the desired product as a white solid (53.5 mg, 68%, 4:1 dr, crude 
NMR shows the same diastereoselectivity). The spectra is the same as above.  
2-((1R,2R)-2-((R)-1,2-diphenylethyl)-1-phenethylcyclopent
yl)-4,5,5,5-tetramethyl-1,3,2-dioxaborolane (3.15). The 
reaction was performed according to Representative 
Procedure for Deborylative Cyclization with 1,1-diboronate 
ester 3.55 (103.2 mg, 0.2 mmol), KOt-Bu (44.8 mg, 0.4 mmol) and THF (1 mL). Upon 
completion, the reaction mixture is quenched with benzyl bromide (171 mg, 1.0 mmol) 
and allowed to stir for an additional two hours. Mixture is then diluted with diethyl ether 
(2 mL) and filtered through a silica gel plug, rinsing with diethyl ether, and concentrated 
in vacuo. The crude residue is then purified on silica gel (hexanes: ethyl acetate = 100 : 
0.8, stain in CAM) to afford the desired product as a white solid (64 mg, 66 %, > 6:1 dr) 
with unresolved protonated byproduct. 1H NMR (500 MHz, CDCl3): δ 7.14 (t, J = 7.5 Hz, 
2H), 7.12 – 6.98 (m, 9H), 6.86 (d, J = 7.6 Hz, 4H), 3.19 (dd, J = 13.1, 3.7 Hz, 1H), 3.13 
(ddd, J = 12.1, 8.6, 3.8 Hz, 1H), 2.69 (dd, J = 13.2, 11.6 Hz, 1H), 2.40 (td, J = 13.2, 4.5 
Hz, 1H), 2.37 – 2.29 (m, 1H), 2.17 – 2.07 (m, 1H), 2.00 (ddd, J = 12.5, 8.4, 3.9 Hz, 2H), 
1.84 – 1.67 (m, 2H), 1.68 – 1.57 (m, 1H), 1.45 – 1.33 (m, 1H), 1.32 – 1.24 (m, 1H), 1.27 
(s, 6H), 1.27 (s, 6H), 0.84 (td, J = 12.9, 5.1 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 
145.28, 143.65, 141.22, 129.02, 128.71, 128.36, 128.10, 127.86, 127.58, 127.53, 125.50, 
125.12, 125.10, 82.77, 54.97, 50.49, 41.70, 39.54, 35.68, 32.64, 30.95, 25.33, 24.83, 
21.93; 11B NMR (160 MHz, CDCl3) δ 33.49; IR (neat): 3026.1 (w), 2929.9 (m), 2859.7 
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(w), 1728.7 (w), 1495.2 (w), 1453.2 (w), 1380.2 (m), 1141.5 (s), 967.6 (w), 862.8 (w), 
746.1 (w), 697.9 (s) cm-1; HRMS-(DART+) for 12C331H4211B116O2 [M+H]+: calculated: 
481.3278, found: 481.3291. The relative stereochemistry was assigned by X-ray 
crystallography. 
 
 
4,4,5,5-tetramethyl-2-((1R,2R)-1-phenethyl-2-((E)-prop-
1-en-1-yl)cyclopentyl)-1,3,2-dioxaborolane (3.23). The 
reaction was performed according to Representative 
Procedure for Deborylative Cyclization with 
Ph
B
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Me MeMe
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H
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 172 
1,1-diboronate ester 3.22 (46.6 mg, 0.1 mmol), KOt-Bu (22.4 mg, 0.2 mmol) and THF 
(0.5 mL). Upon completion, the reaction mixture is diluted with diethyl ether (2 mL) and 
filtered through a silica gel plug, rinsing with diethyl ether, and concentrated in vacuo. 
The crude residue is then purified on silica gel (hexanes: diethyl ether = 100 : 1, stain in 
CAM) to afford the desired product as a colorless oil (18.8 mg, 55%, >20:1 dr, crude 
NMR shows the same diastereoselectivity). 1H NMR (500 MHz, CDCl3): δ 7.33 – 7.22 
(m, 2H), 7.21 – 7.13 (m, 3H), 5.52 – 5.35 (m, 2H), 2.57 (td, J = 12.8, 4.9 Hz, 2H), 2.47 
(td, J = 12.9, 5.0 Hz, 1H), 1.99 – 1.82 (m, 1H), 1.80 – 1.66 (m, 3H), 1.65 (dd, J = 4.8, 0.7 
Hz, 3H), 1.63 – 1.55 (m, 2H), 1.53 – 1.47 (m, 1H), 1.42 (td, J = 12.9, 5.0 Hz, 1H), 1.26 (s, 
12H); 13C NMR (125 MHz, CDCl3): δ 143.93, 132.52, 128.35, 128.16, 125.39, 124.38, 
82.99, 49.25, 34.75, 34.01, 33.06, 31.09, 24.86, 24.71, 23.10, 18.08; 11B NMR (160 MHz, 
CDCl3) δ 34.86; IR (neat): 2976.5 (m), 2955.3 (m), 2870.6 (m), 1726.8 (w), 1454.8 (w), 
1379.3 (s), 1304.3 (m), 1272.9 (m), 1143.3 (s), 968.1 (w), 857.0 (w), 757.3 (s), 699.3 (w) 
cm-1; HRMS-(DART+) for 12C221H3411B116O2 [M+H]+: calculated: 341.2652, found: 
341.2660. 
 
(1S,2R)-1-phenethyl-2-((E)-prop-1-en-1-yl)cyclopentan-
1-ol (S3.7). This reaction was performed to comfirm the 
structure of compound 
4,4,5,5-tetramethyl-2-((1R,2R)-1-phenethyl-2-((E)-prop-1-en-1-yl)cyclopentyl)-1,3,2-dio
xaborolane (3.23). To a 20 mL vial containing the compound (3.23) (25 mg, 0.0745 
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mmol) add THF (1 mL), NaOH (0.6 mL, 3 M, 1.8 mmol), then cool the vial to 0 °C. Add 
hydrogen peoxide (0.3 mL, 30% in H2O) into the above mixture dropwise, let the 
reaction stir for overnight. The reaction was cooled to 0 °C again, and quenched by 
Na2S2O3 (1 mL, saturated solution) slowly, stirred for 30 minutes, then extrated with 
diethyl ether, dried over Na2SO4, and evaporated in vacuo. The crude reaction mixture 
was purified by column chromatography (hexanes: ethyl acetate = 100 : 5 to 100 : 10, 
stain in CAM) on silica gel to afford desired product (11.8 mg, 70 % yield). 1H NMR 
(600 MHz, CDCl3): δ 7.32 – 7.26 (m, 2H), 7.22 – 7.16 (m, 3H), 5.49 (dqd, J = 15.1, 6.4, 
0.9 Hz, 1H), 5.29 (ddq, J = 15.1, 9.2, 1.6 Hz, 1H), 2.80 (ddd, J = 13.4, 9.4, 7.5 Hz, 1H), 
2.69 (ddd, J = 13.5, 9.6, 7.7 Hz, 1H), 2.51 – 2.40 (m, 1H), 2.10 – 2.02 (m, 1H), 1.84 – 
1.71 (m, 5H), 1.70 – 1.65 (m, overlap, 1H), 1.67 (dd, J = 6.4, 1.7 Hz, 3H), 1.53 – 1.45 (m, 
1H), 1.32 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 142.99, 131.63, 128.88, 128.37, 
125.96, 125.68, 83.62, 54.55, 39.24, 37.23, 30.28, 30.19, 21.02, 18.07. The structure was 
further confirmed by COSY spectra, shown below. 
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(1S,2R,3S)-2-(iodomethyl)-3-phenethyl-3-(4,4,5,5-tetr
amethyl-1,3,2-dioxaborolan-2-yl)cyclopentyl benzoate 
(3.12, major product). The reaction was performed 
according to Representative Procedure for Deborylative 
cyclization with diboronate ester S3.6 (55 mg, 0.1 mmol), KOt-Bu (22.4 mg, 0.20 mmol) 
and THF (0.5 mL) for overnight. Upon completion, the reaction mixture is quenched with 
a solution of I2 (50.8 mg, 0.20 mmol) in anhydrous THF (0.3 mL) and allowed to stir at 
room temperature for three hours. Reaction mixture is then diluted with diethyl ether (2 
mL) and filtered through a silica gel plug, rinsing with diethyl ether. Filtrate is then 
concentrated in vacuo and the crude residue purified by column chromatography on silica 
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gel (100 : 0.8 Hexanes/EtOAc, gradient to 100 : 3 Hexanes/EtOAc, stain in CAM) to 
afford a colorless oil (29.3 mg, 55%, product 3.12 : product S3.8 = 2.9 : 1 ). 1H NMR 
(500 MHz, CDCl3): δ 7.42 – 7.38 (m, 2H), 7.36 – 7.30 (m, 2H), 7.29 – 7.24 (m, 3H), 7.20 
– 7.14 (m, 3H), 4.55 (d, J = 1.9 Hz, 2H), 3.81 (qd, J = 4.6, 3.2 Hz, 1H), 3.52 (dd, J = 9.8, 
4.8 Hz, 1H), 3.21 (t, J = 10.1 Hz, 1H), 2.67 – 2.50 (m, 2H), 2.28 (dt, J = 10.0, 4.8 Hz, 
1H), 2.10 – 1.94 (m, 3H), 1.85 – 1.75 (m, 1H), 1.75 – 1.61 (m, 2H), 1.26 (two sets of 
singlet, 12H); 13C NMR (125 MHz, CDCl3): δ 143.05, 138.81, 128.30, 128.26, 128.24, 
127.85, 127.36, 125.59, 87.16, 83.41, 71.26, 57.60, 41.33, 33.47, 33.27, 30.50, 25.07, 
24.90, 8.22; 11B NMR (160 MHz, CDCl3) δ 33.39; IR (neat): 2975.4 (w), 2926.7 (w), 
2855.7 (w), 1495.8 (w), 1378.8 (m), 1310.9 (m), 1198.9 (m), 1166.4 (s), 1140.4 (s), 
1099.2 (m), 1066.9 (m), 856.9 (m), 735.0 (s), 697.3 (s) cm-1; HRMS-(DART+) for 
12C271H3611B116O3127I123Na1 [M+Na]+: calculated: 569.1700, found: 569.1707. The 
relative stereochemistry was assigned by COSY and NOESY spectra, shown below. 
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2-((1S,2S,3R)-3-(benzyloxy)-2-(tert-butoxymethyl
)-1-phenethylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-diox
aborolane (S3.8, minor product). This product was 
isolated along side the above product (3.12). 1H NMR (500 
MHz, CDCl3): δ 7.37 – 7.33 (m, 2H), 7.33 – 7.28 (m, 2H), 7.28 – 7.22 (m, 3H), 7.21 – 
7.17 (m, 2H), 7.17 – 7.13 (m, 1H), 4.57 (d, J = 12.3 Hz, 1H), 4.50 (d, J = 12.3 Hz, 1H), 
3.82 (dt, J = 6.9, 3.5 Hz, 1H), 3.52 (dd, J = 8.8, 5.0 Hz, 1H), 3.18 (dd, J = 9.8, 8.8 Hz, 
1H), 2.68 – 2.47 (m, 2H), 2.07 – 1.92 (m, 3H), 1.87 (ddd, J = 11.5, 7.1, 4.1 Hz, 1H), 1.83 
– 1.67 (m, 2H), 1.63 (ddd, J = 11.9, 9.5, 7.4 Hz, 1H), 1.26 (s, 12H), 1.16 (s, 9H); 13C 
NMR (125 MHz, CDCl3): δ 143.68, 139.66, 128.39, 128.17, 128.12, 127.59, 127.00, 
125.38, 84.60, 82.99, 72.49, 70.49, 62.86, 56.23, 41.83, 33.73, 32.97, 31.65, 27.66, 25.11, 
24.93; 11B NMR (160 MHz, CDCl3) δ 33.59; IR (neat): 3026.0 (w), 2972.8 (s), 2927.6 
(m), 2857.0 (m), 1496.0 (m), 1378.4 (s), 1307.1 (m), 1198.5 (m), 1143.6 (s), 1073.9 (m), 
857.5 (w), 698.5 (w) cm-1; HRMS-(DART+) for 12C311H4511B116O423Na1 [M+Na]+: 
calculated: 515.3309, found: 515.3320. The relative stereochemistry was assigned by 
X-ray crystallography, shown below: 
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3.7.7 Radical Probe Experiment I 
Procedure for Deborylative Alkylation Experiment: 
B(pin)
B(pin)
hexyl
Me
Br NaOtBu (2.6 equiv)
THF, rt
B(pin)
hexyl
Me
49% yield, 1.1:1 dr, > 98:2 er
3.49 3.50 3.51
 
4,4,5,5-tetramethyl-2-((4S)-4-methyl-1-phenyldecan-3-yl)-1,3
,2-dioxaborolane (3.51). In the glove box, an oven-dried 
2-dram vial equipped with magnetic stir bar is charged with 
1,1-diboronate ester 3.49 (96.8 mg, 0.26 mmol), NaOtBu (50 mg, 
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0.52 mmol), and THF (1 mL). The reaction mixture was allowed to stir at room 
temperature for 15 min, followed by the addition of (R)-2-bromooctane (35.1 mL, 0.20 
mmol). The vial was sealed with a polypropylene cap, removed from the glove box, and 
was allowed to stir at room temperature for overnight. Upon completion, the reaction 
mixture was diluted with diethyl ether (2 mL), filtered through a silica gel plug, rinsed 
with diethyl ether, and concentrated in vacuo. The crude reaction mixture was purified on 
silica gel (hexanes: ethyl acetate = 100:1 to 50:1) to isolate the desired product (35 mg, 
49%, 1.1:1 d.r. 98:2 er)(diastereoselectivity was determined based on NMR integration 
after oxidation). 1H NMR (600 MHz, CDCl3): δ 7.28 – 7.26 (m, 3H), 7.21 – 7.13 (m, 2H), 
2.72 – 2.57 (m, 1H), 2.57 – 2.43 (m, 1H), 1.87 – 1.68 (m, 1H), 1.68 – 1.56 (m, 2H), 1.43 
– 1.33 (m, 1H), 1.32 – 1.19 (m, 8 H, overlap), 1.27 (s, 12H), 1.18 – 1.07 (m, 1H), 1.04 - 
0.98 (m, 1H), 0.93 – 0.84 (m, 6H); 13C NMR (125 MHz, CDCl3): δ 143.26, 128.36, 
128.17, 125.48, 82.83, 36.42, 36.15, 36.09, 35.91, 34.62, 34.38, 31.89, 31.51, 30.20, 
29.58, 29.56, 27.52, 27.25, 25.08, 25.06, 24.79, 22.64, 18.75, 18.44, 14.09; IR (neat): 
2956.5 (m), 2926.9 (s), 2856.3 (m), 1729.6 (w), 1456.9 (w), 1379.1 (m), 1313.8 (m), 
1270.7 (w), 1143.9 (s), 699.1 (m) cm-1; HRMS-(DART+) for 12C231H4011B116O2 [M+H]+: 
calculated: 359.3121, found: 359.3139. 
 
 (4S)-4-methyl-1-phenyldecan-3-ol (S3.9). To a 20 mL vial 
containing the compound 3.51 and THF (1 mL), aqueous NaOH Ph
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(0.6 mL, 3 M, 1.8 mmol) is added then the vial is cooled 0 °C. Aqueous Hydrogen 
Peroxide (0.3 mL, 30% in H2O) is then slowly added to the reaction vessel and reaciton 
allowed to stir overnight. Upon return, the vessel is cooled back to 0 °C and quenched 
slowly with saturated, aqueous Na2S2O3 (1 mL), stirred for 30 minutes, then extrated with 
diethyl ether. Combined extracts are then dried over Na2SO4 and concentrated in vacuo. 
The crude residue is then purified by column chromatography on silica gel. 1H NMR 
(600 MHz, CDCl3): δ 7.32 – 7.27 (m, 4H), 7.24 – 7.16 (m, 6H), 3.54 (dt, J = 10.6, 5.5 Hz, 
1H), 3.48 (dtd, J = 9.8, 5.1, 2.9 Hz, 1H), 2.95 – 2.78 (m, 2H), 2.73 – 2.59 (m, 2H), 1.84 – 
1.73 (m, 4H), 1.57 – 1.47 (m, 2H), 1.46 – 1.38 (m, 2H), 1.38 – 1.22 (m, 17H), 1.21 –1.14 
(m, 2H), 1.14 – 1.05 (m, 1H), 0.95 – 0.84 (m, 12H); 13C NMR (150 MHz, CDCl3): δ 
142.36, 142.31, 128.42, 128.36, 125.76, 75.44, 74.72, 39.01, 38.45, 36.26, 35.19, 33.23, 
32.69, 32.56, 31.92, 31.84, 29.69, 29.60, 29.58, 27.31, 27.25, 22.65, 15.20, 14.08, 13.69; 
IR (neat): 3357.0 (w), 2956.7 (m), 2927.8 (s), 2855.0 (m), 1724.7 (m), 1455.3 (w), 
1275.3 (w), 1131.9 (w), 751.2 (m), 698.4 (m) cm-1; HRMS-(DART+) for 12C171H27 
[M+H-H2O]+: calculated: 231.2113, found: 231.2118. 
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Proof of Stereochemistry: 
 
The same title compound was prepared from Evans Alkylation as shown below: 
O NH
O
Me
Me
nBuLi, THF
then, octanoyl chloride
O N
O
Me
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O
hexyl
NaHMDS, THF
then, MeI
O N
O
MeMe
O
hexyl
Me
MeO
N
Me
Me
O
Me
NH(OCH3)CH3HCl
AlMe3
S3.10 S3.11
Ph
MgBr
THF
hexyl
Me
O
Ph
NaBH4
MeOH
Ph
OH
hexyl
Me
S3.12 S3.13
1.1:1 d.r.
>97:3 e.r.
 
 
(R)-4-isopropyl-3-((S)-2-methyloctanoyl)oxazolidin-2-one (S3.10) prepared 
according to the literature procedure.81 The product is obtained as a colorless oil (78%, 
d.r. = 88:12). The NMR spectra are in accord with previously reported data.82 Preparation 
of (S)-N-methoxy-N,2-dimethyloctanamide S3.11 adapted from literature procedure.83 
To a stirred solution of N,O-Dimethylhydroxylamine hydrochloride (312.1 mg, 3.2 mmol) 
in CH2Cl2 (5 ml) at 0 °C, neat AlMe3 (307 mL, 3.2 mmol) is carefully added. The 
                                                
 
81 Evans, D. A.; Ennis, M. D.; Le, T.; Mandel, N.; Mandel, G. J. Am. Chem. Soc. 1984, 106, 1154-1156. 
82 Minko, Y.; Pasco, M.; Lercher, L.; Botoshansky, M.; Marek, I. Nature 2012, 490, 522-526. 
83 Micalizio, G. C.; Pinchuk, A. N.; Roush, W. R. J. Org. Chem. 2000, 65, 8730-8736. 
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reaction mixture is stirred at 0 °C for 10 min and then one hour at room temperature. The 
mixture is then cooled back to 0 °C and a solution of oxazolidone S3.10 (227 mg, 0.8 
mmol) in CH2Cl2 (5 ml) is added to the reaction vessel. The resulting mixture is then 
allowed to stir overnight, gradually reaching room temperature. Upon return, the reaction 
solution is diluted with CH2Cl2 (10 mL) and poured into a separatory funnel containing 
ice-cold aqueous 0.5 N HCl (25 ml) and organics are extracted 3x with CH2Cl2. The 
combined extracts are then washed with saturated, aqueous NaHCO3 and saturated, 
aqueous NaCl, in succession, then dried over Na2SO4. Volatiles are then removed in 
vacuo and the crude, colorless oil is then purified by silica gel chromatography (8:2 
pentane/Et2O, gradient to 7:3 pentane/Et2O) to afford 
(S)-N-methoxy-N,2-dimethyloctanamide S3.11 as a colorless oil (38.2 mg, 22 %).  
 
(S)-N-methoxy-N,2-dimethyloctanamide (S3.11). 1H 
NMR (500 MHz, CDCl3): δ 3.68 (s, 3H), 3.19 (s, 3H), 
2.86 (s, 1H), 1.67 (ddd, J = 13.2, 8.3, 5.3 Hz, 1H), 
1.32 – 1.18 (m, 9H), 1.11 (d, J = 6.8 Hz, 3H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (125 
MHz, CDCl3): δ 61.40, 35.09, 33.83, 31.73, 29.68, 29.31, 27.50, 22.61, 17.45, 14.04; IR 
(neat): 2964.0 (m), 2930.4 (m), 2871.7 (m), 1779.3 (s), 1699.3 (m), 1385.5 (m), 1300.8 
(w), 1204.9 (m), 1141.6 (m), 911.6 (w), 733.4 (m) cm-1; HRMS-(DART+) for 
12C111H2414N116O2 [M+H]+: calculated: 202.1807, found: 202.1797. 
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To a dried flask fitted with magnetic stir bar and charged with Mg0 (36.5 mg, 1.5 
mmol) and anhydrous THF (5 mL), (2-bromoethyl)benzene (0.17 mL, 1.25 mmol) is 
added slowly under N2. Mixture is then stirred at 60 °C for two hours and the resulting 
Grignard solution is cooled back to room temperature where it is added to a solution of 
amide S3.11 (38.2 mg, 0.177 mmol) in anhydrous THF (1 mL) drop wise at 0 °C. The 
reaction mixture is allowed to stir for 3h, gradually warming to room temperature. Upon 
completion, reaction is cooled to 0 °C and quenched with saturated, aqueous NH4Cl (1 
mL). Organics are then extracted with diethyl ether (3 × 3 mL) and the combined extracts 
washed with brine and dried over anhydrous Na2SO4. Volatiles are then removed in vacuo 
and the crude residue was purified on silica gel (hexane: ethyl acetate= 100:1, gradient to 
20:1) to afford compound S3.12 as colorless oil (34 mg, 78%).  
 
 (S)-4-methyl-1-phenyldecan-3-one (S3.12). 1H 
NMR (500 MHz, CDCl3): δ 7.32 – 7.26 (m, 2H), 
7.21 – 7.16 (m, 3H), 2.89 (t, J = 7.6 Hz, 2H), 2.78 – 
2.70 (m, 2H), 2.48 (h, J = 6.9 Hz, 1H), 1.65 – 1.56 (m, 1H), 1.35 – 1.12 (m, 9H), 1.03 (d, 
J = 6.9 Hz, 3H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 213.81, 141.35, 
128.41, 128.33, 126.00, 46.54, 42.65, 32.94, 31.63, 29.74, 29.30, 27.18, 22.56, 16.16, 
14.03; IR (neat): 2958.0 (s), 2928.3 (s), 2858.2 (m), 1728.0 (s), 1462.1 (m), 1272.6 (s), 
1122.5 (m), 1072.6 (m), 744.7 (w), 699.4 (w) cm-1; HRMS-(DART+) for 12C171H2716O1 
[M+H]+: calculated: 247.2062, found: 247.2053. 
Me
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To a vial containing a solution of (S)-4-methyl-1-phenyldecan-3-one S3.12 (34 
mg, 0.14 mmol) in MeOH (1 mL), NaBH4 (10.6 mg, 0.28 mmol) is added at 0 °C. The 
reaction mixture is then allowed to stir for 20 min at room temperature, then quenched 
with saturated aqueous NH4Cl (1 mL). Organics are then extracted with diethyl ether (3 × 
3 mL) and the combined organic layers washed with brine and dried over anhydrous 
Na2SO4. Volatiles are then removed in vacuo and the crude residue purified on silica gel 
(hexane: ethyl acetate = 10:1) to yield (4S)-4-methyl-1-phenyldecan-3-ol S3.13 as an 
colorless oil (32 mg, 92%, 1.1:1 d.r., 97:3 er). (diastereoselectivity was determined based 
on NMR integration). The spectra data is the same as shown above. 
 
 
 
 
 
Analysis of Stereochemistry  
The enantioselectivity was determined by SFC analysis of the reaction product shown 
below.  
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SFC trace of base promoted deborylative alkylation product compound 30 (after 
oxidation): 
 
Diastereoselectivity = Area of Peak1/ Area of (Peak 2 + Peak 3) 
                = 1709.8794/ (1839.3626 + 43.2578)  
                = 1/1.1 
Enantioselectivity = Area of (Peak 2 - Peak 3)/ Area of (Peak 2 + Peak 3) 
               = (1839.3626 - 43.2578)/ (1839.3626 + 43.2578) 
               = 95 % 
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SFC trace of authentic product prepared from Evans alkylation compound S19: 
 
Diastereoselectivity = Area of Peak1/ Area of (Peak 2 + Peak 3) 
                = 782.1914/ (843.4496 + 25.2669)  
                = 1/1.1 
Enantioselectivity = Area of (Peak 2 - Peak 3)/ Area of (Peak 2 + Peak 3) 
               = (843.4496 - 25.2669)/ (843.4496 + 25.2669) 
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               = 94 % 
 
3.7.8 Radical Probe Experiment II 
(Z)-2,2'-(1-cyclopropyl-6-phenylhex-5-ene-1,1-diyl)bis(4,4,
5,5-tetramethyl-1,3,2-dioxaborolane) (3.39). The reaction 
was performed according to Representative Procedure 
(Method C) with 2,2'-(cyclopropylmethylene) 
bis(4,4,5,5-tetramethyl-1,3,2- dioxaborolane) (154 mg, 0.5 
mmol, made according to previous procedure 84 ), LTMP (77.3 mg, 0.53 mmol), 
(Z)-(5-bromopent-1-en-1-yl)benzene (118.2 mg, 0.53mmol) and THF (2 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (100:1 – 50:1 
hexanes/ethyl acetate, stain in CAM) to afford a white solid (226 mg, 86%). 1H NMR 
(500 MHz, CDCl3) δ 7.42 – 7.24 (m, 4H), 7.25 – 7.17 (m, 1H), 6.38 (d, J = 11.7 Hz, 1H), 
5.73 (dt, J = 11.5, 7.7 Hz, 1H), 2.35 (q, J = 7.0 Hz, 2H), 1.82 – 1.53 (m, 4H), 1.22 (s, 
24H), 0.86 (tt, J = 8.1, 5.6 Hz, 1H), 0.49 – 0.28 (m, 4H); 13C NMR (125 MHz, CDCl3): δ 
137.92, 133.70, 128.76, 128.28, 128.02, 126.26, 82.76, 33.04, 29.80, 28.64, 24.72, 24.71, 
12.93, 3.62; 11B NMR (160 MHz, CDCl3) δ 33.49; IR (neat): 2977.3 (m), 2931.1 (w), 
1378.7 (m), 1342.2 (m), 1305.2 (s), 1268.1 (m), 1214.4 (w), 1137.5 (s), 853.5 (w), 699.2 
                                                
 
84 K. Hong, X. Liu, and J. P. Morken J. Am. Chem. Soc. 2014, 136, 10581-10584. 
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(w) cm-1; HRMS-(DART+) for 12C301H4911B216O4 [M+H]+: calculated: 495.3817, found: 
495.3819. 
 
2-((1R,2R)-2-benzyl-1-cyclopropylcyclopentyl)-4,4,5,5-tetramet
hyl-1,3,2-dioxaborolane (3.40). The reaction was performed 
according to Representative Procedure for Deborylative 
cyclization with diboronate ester 3.39 (45.2 mg, 0.1 mmol), 
KOt-Bu (22.4 mg, 0.2 mmol), and THF (0.5 mL) for 6 hours. The crude reaction mixture 
was purified by column chromatography on silica gel (100:0.8 hexanes/ethyl acetate, 
stain in CAM) to afford a colorless oil (15 mg, 46 %, d.r. > 20:1, crude NMR shows the 
same diastereoselectivity). 1H NMR (500 MHz, CDCl3): δ 7.29 – 7.22 (m, 2H), 7.24 – 
7.12 (m, 3H), 3.07 (dd, J = 13.2, 3.5 Hz, 1H), 2.43 (dd, J = 13.2, 11.7 Hz, 1H), 1.87 (tdd, 
J = 9.0, 6.6, 3.5 Hz, 1H), 1.76 – 1.62 (m, 1H), 1.66 – 1.57 (m, 2H), 1.52 – 1.40 (m, 1H), 
1.35 – 1.19 (m, 1H), 1.26 (s, 12H), 1.15 – 1.02 (m, 1H), 0.86 (ddt, J = 11.3, 8.6, 3.7 Hz, 
1H), 0.44 – 0.26 (m, 1H), 0.29 – 0.16 (m, 3H); 13C NMR (125 MHz, CDCl3): δ 143.17, 
128.89, 128.04, 125.35, 82.84, 52.53, 39.16, 30.96, 30.57, 24.92, 24.83, 22.42, 16.75, 
2.07, 0.29; 11B NMR (160 MHz, CDCl3) δ 33.78; IR (neat): 2976.4 (w), 2954.8 (w), 
2866.4 (w), 1495.0 (w), 1387.8 (m), 1299.9 (m), 1214.2 (w), 1141.6 (s), 1013.6 (w), 
967.5 (w), 862.4 (w), 744.8 (w), 699.3 (m) cm-1;  HRMS-(DART+) for 
12C211H3211B116O2 [M+H]+: calculated: 327.2495, found: 327.2492.  
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4,4,5,5-tetramethyl-2-((1R,2R)-1-phenethyl-2-((R)-1-pheny
lbut-3-en-1-yl)cyclopentyl)-1,3,2-dioxaborolane (3.56). The 
reaction was performed according to Representative 
Procedure for Deborylative Cyclization with 
(Z)-2,2'-(1,8-diphenyloct-7- ene-3,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(3.55) (56.13 mg, 0.1 mmol), KOt-Bu (22.4 mg, 0.2 mmol) and toluene (0.5 mL). Upon 
completion, the reaction mixture is quenched with allyl bromide (60.5 mg, 0.5 mmol) and 
allowed stir an additional two hours. Mixture then diluted with diethyl ether (2 mL) and 
filtered through a silica gel plug, rinsing with diethyl ether. Filtrate is then concentrated 
in vacuo and the crude residue purified on silica gel (hexanes: ethyl acetate = 100 : 0.8, 
stain in CAM) to afford the desired product as a white solid (30.7 mg, 69%, >10:1 dr, 
crude NMR shows the same diastereoselectivity). 1H NMR (500 MHz, CDCl3): δ 7.30 – 
Ph
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7.18 (m, 4H), 7.19 – 7.11 (m, 3H), 7.14 – 7.04 (m, 1H), 6.91 – 6.85 (m, 2H), 5.50 (dddd, 
J = 18.0, 10.0, 7.4, 6.0 Hz, 1H), 4.85 (dd, J = 17.1, 1.7 Hz, 1H), 4.81 – 4.76 (d, J = 10.0, 
1H), 2.92 (td, J = 10.2, 8.8, 3.7 Hz, 1H), 2.59 – 2.47 (m, 1H), 2.40 (td, J = 13.2, 4.5 Hz, 
1H), 2.36 – 2.25 (m, 2H), 1.97 (td, J = 8.9, 8.4, 4.8 Hz, 2H), 1.87 (q, J = 8.7 Hz, 1H), 
1.73 (p, J = 9.9, 8.7 Hz, 1H), 1.66 – 1.49 (m, 2H), 1.43 – 1.31 (m, 2H), 1.29 (s, 6H), 1.28 
(s, 6H), 0.83 (td, J = 13.0, 5.2 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 145.72, 143.69, 
137.68, 128.66, 128.13, 127.90, 127.78, 125.68, 125.13, 115.16, 82.78, 55.13, 48.35, 
39.72, 39.16, 35.59, 32.69, 30.42, 25.29, 24.91, 22.08; 11B NMR (160 MHz, CDCl3) δ 
33.98; IR (neat): 2956.9 (s), 2930.5 (s), 2872.6 (m), 1729.4 (s), 1457.5 (m), 1379.2 (m), 
1288.9 (s), 1239.1 (w), 1141.6 (s), 1073.0 (m), 755.5 (m), 700.3 (m) cm-1; 
HRMS-(DART+) for 12C291H4011B16O2 [M+H]+: calculated: 431.3121, found: 431.3115. 
The relative stereochemistry was assigned by X-ray crystallography. 
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4,4,5,5-tetramethyl-2-((1R,2R)-1-phenethyl-2-((R)-1-pheny
lbut-3-en-1-yl)cyclopentyl)-1,3,2-dioxaborolane (38). The 
reaction was performed according to Representative 
Procedure for Deborylative Cyclization with 
(E)-2,2'-(1,8-diphenyloct-7- ene-3,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(3.20) (56.13 mg, 0.1 mmol), KOt-Bu (22.4 mg, 0.2 mmol) and toluene (0.5 mL). Upon 
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completion, the reaction mixture was quenched with allyl bromide (60.5 mg, 0.5 mmol), 
stir for another two hours, then diluted with diethyl ether (2 mL), filtered through a silica 
gel plug, rinsed with diethyl ether, and concentrated in vacuo. The crude reaction mixture 
was purified on silica gel (hexanes: ethyl acetate = 100 : 0.8, stain in CAM) to afford the 
desired product as a white solid (32.7 mg, 76%, >20:1 dr). 1H and 13C NMR spectral data 
and X-ray crystallographic data identical to that above. 
 
3.7.9 2D-Labeled Experiment 	
tert-butyldimethyl((pent-4-yn-1-yl-5-d)oxy)silane 
(S3.14). A flame dried 20 mL vial equipped with stir bar 
is charged with 
tert-butyldimethyl(pent-4-yn-1-yloxy)silane (1.87 g, 9.43 mmol, 1.0 equiv), then sealed 
and evacuated/backfilled with N2 3x. Anhydrous THF (9.4 mL) is then charged in the 
vessel and the clear colorless solution set to stir at -78oC. A solution of nBuLi in Hexanes 
(4.20 mL, 2.70 M, 11.3 mmol, 1.2 equiv) is then added dropwise, resulting in a clear, 
yellow solution. After stirring for 30min at -78oC, the mixture is brought to 0oC and 
allowed to stir an additional 20min. At this point, the reaction is quenched by slow 
addition of D2O (853 µL, 47.2 mmol, 5.0 equiv), resulting in a white slurry. The resulting 
mixture is allowed to stir for 4h, then directly dried over Na2SO4 and passed through a 
pad of SiO2, rinsing with Et2O. Filtrate is then concentration to yield clear, colorless oil 
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(1.88 g, 9.43 mmol, quantitative). No further purification necessary. 1H NMR (500 MHz, 
CDCl3): δ 3.70 (t, J = 6.0 Hz, 2H), 2.27 (t, J = 7.1 Hz, 2H), 1.78 – 1.68 (m, 2H), 0.89 (s, 
9H), 0.06 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 61.41, 31.51, 25.90, 18.29, 14.79, 
-5.39; IR (neat): 2988.3 (s), 2946.7 (w), 2870.2 (s), 1393.6 (w), 1142.5 (s) cm-1; 
HRMS-(DART+) for 12C111H222D129Si116O1 [M+H]+: calculated: 200.1581, found: 
200.1572. 
 
(Z)-tert-butyldimethyl((pent-4-en-1-yl-5-d)oxy)silane 
(S3.15). Adapted from published procedure.85  A flame 
dried 250 mL round bottom equipped with magnetic stir 
bar is charged with S3.14 (1.43 g, 7.2 mmol, 1.0 equiv) inside an argon-filled glovebox. 
tBuOH (990 mg, 13.4 mmol, 2.4 equiv) is then added to the vessel, followed by toluene 
(60 mL) then Polymethylhydrosiloxane (979 µL, 17.3 mmol (monomer), 2.4 equiv). The 
mixture is set to stir, then IPrCuOtBu86 (75.6 mg, 0.14 mmol, 2 mol%) is added, at 
which point bubbling is observed. The vessel is sealed with a rubber septum, then moved 
to the fume hood where it is allowed to stir for 1h at room temperature. At this point, the 
reaction mixture turns dark brown and it is passed through a pad of silica gel, rinsing with 
Et2O. The filtrate is concentrated then SiO2 chromatography performed (0% 
                                                
 
85Lalic, G.; Whittaker, A. M.	Org. Lett. 2013, 15, 1112-1115. 
86For preparation see: Sadighi, J. P.; Mankad, N. P.; Laitar, D. S. Organometallics, 2004, 23, 3369-3371. 
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Et2O/Pentanes, gradient to 2.5% Et2O/Pentanes, visualizing with KMnO4). Product 
coelutes with PMHS and yield is carried across two steps. 1H NMR (600 MHz, CDCl3) δ 
5.85 – 5.77 (m, 1H), 4.94 (d, J = 10.2 Hz, 1H), 3.62 (t, J = 6.5 Hz, 2H), 2.10 (td, J = 7.6, 
0.9 Hz, 2H), 1.64 – 1.58 (m, 2H), 0.90 (s, 9H), 0.05 (s, 6H); 13C NMR (150 MHz, CDCl3): 
138.45 (s), 114.19 (t, J=23.5 Hz), 62.53 (s), 31.99 (s), 29.97 (s), 25.95 (s), 18.34 (s), 
-5.30 (s); IR (neat): 2987.3 (m), 2871.0 (m), 1142.4 (s) cm-1; HRMS-(DART+) for 
12C111H242D129Si116O1 [M+H]+: calculated: 202.1737, found: 202.1741. 
 
(Z)-pent-4-en-5-d-1-ol (S3.16). A 50 mL round bottom equipped 
with magnetic stir bar is charged with a solution of S3.15 (1.36 g, 
6.75 mmol, 1.0 equiv; mixed with PMHS, see above) in anhydrous 
THF (6.75 mL). The vessel and contents are then brought to 0oC, at which point TBAF 
solution in THF (16.8 mL, 1 M, 16.8 mmol, 2.5 equiv) is added dropwise (exothermic 
process). After addition, the mixture is allowed to stir at room temperature for 5h. The 
reaction mixture is then poured into a seperatory funnel containing ca. 10 mL brine and 
the organics are extracted 3x with ca. 10 mL Et2O. Combined organics are then dried 
over Na2SO4 and concentrated to yield crude oil. Oil is purified by SiO2 chromatography 
(2.5% Et2O/Pentanes, gradient to 10% Et2O/Pentanes, visualized with KMnO4 to yield 
clear, colorless oil (343.9 mg, 3.95 mmol, 55% across 2 steps). 1H NMR (400 MHz, 
CDCl3): δ 5.87 – 5.79 (m, 1H), 4.97 (d, J = 10.2 Hz, 1H), 3.67 (t, J = 6.5 Hz, 2H), 2.15 
(td, J = 7.6, 0.8 Hz, 2H), 1.71 – 1.64 (m, 2H), 1.57 (br s, 1H); 13C NMR (150 MHz, 
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CDCl3): δ 138.15 (s), 114.65 (t, J=23.5 Hz), 62.50 (s), 31.80 (s), 30.04 (s); IR (neat): 
2988.5 (w), 2869.8 (w), 1141.9 (m) cm-1; HRMS-(DART+) for 12C51H102D116O1 [M+H]+: 
calculated: 88.0873, found: 88.0870. 
 
(Z)-pent-4-en-1-yl-5-d-4-methylbenzenesulfonate 
(S3.17). A flame dried 20 mL vial equipped with 
magnetic stir bar is charged with TsCl (904 mg, 4.74 
mmol, 1.10 equiv) followed by DMAP (105 mg, 0.86 
mmol, 0.20 equiv). The vial is sealed and evacuated/refilled with N2 3x, then a solution 
of S3.16 (375 mg, 4.31 mmol, 1.0 equiv) in anhydrous DCM (21.6 mL) is charged in. 
The mixture is brought to 0oC then reagent grade NEt3 (720 µL, 5.17 mmol, 1.2 equiv) is 
added dropwise. The reaction is then allowed to stir at room temperature for 2h. At this 
point, the reaction mixture is treated with ca. 5 mL H2O and the organics are extracted 3x 
with ca. 5 mL DCM. Combined organics are dried over Na2SO4 then concentrated to 
yield crude oil. Crude material is purified by SiO2 chromatography (2.5% Et2O/Pentanes, 
gradient to 10% Et2O/Pentanes, visualized with CAM stain) to render clear, colorless oil 
(666 mg, 2.76 mmol, 64%). 1H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 7.7 Hz, 2H), 7.34 
(d, J = 7.9 Hz, 2H), 5.72 – 5.64 (m, 1H), 4.94 (d, J = 10.1 Hz, 1H), 4.04 (t, J = 6.4 Hz, 
2H), 2.45 (s, 3H), 2.08 (q, J = 7.1 Hz, 2H), 1.74 (p, J = 6.9 Hz, 2H); 13C NMR (150 MHz, 
CDCl3): δ 144.66 (s), 136.51 (s), 133.19 (s), 129.80 (s), 127.89 (s), 115.56 (t, J=23.6 Hz), 
69.78 (s), 29.32 (s), 27.99 (s), 21.63 (s); IR (neat): 2957.1 (w), 1598.4 (w), 1359.0 (s), 
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1188.7 (s), 1097.8 (w), 928.0 (m), 810.6 (m), 664.2 (m), 554.6 (s) cm-1; HRMS-(DART+) 
for 12C121H152D132S116O323Na1 [M+Na]+: calculated: 264.0781, found: 264.0780. 
 
(Z)-2,2'-(1-phenyloct-7-ene-3,3-diyl-8-d)bis(4,4,5,5-t
etramethyl-1,3,2-dioxaborolane) (3.34). A flame 
dried 20 mL vial equipped with magnetic stir bar is 
charged with LTMP (405 mg, 2.75 mmol, 1.0 equiv) 
inside an argon-filled glovebox. The vial is sealed then moved to the hood where it is 
charged with anhydrous THF (9 mL). The orange solution is set to stir at 0oC then 
charged with a solution of 2.1 (1.02 g, 2.75 mmol, 1.0 equiv) in anhydrous THF (2 mL) 
where it is allowed to stir for 30 min. At this point, a solution of S3.17 (663 mg, 2.75 
mmol, 1.0 equiv) in anhydrous THF (2 mL) is added gradually. The mixture is brought to 
room temperature and allowed to stir overnight (23h). Upon return, the reaction mixture 
is diluted with Et2O and passed through a pad of silica gel, rinsing with Et2O. Filtrate is 
concentrated to render crude solid. Solid is purified by SiO2 chromatography (0% 
EtOAc/Hexanes, gradient to 3% EtOAc/Hexanes, visualized with CAM stain). Product 
isolated as a white solid (938 mg, 2.13 mmol, 77%). 1H NMR (500 MHz, CDCl3): δ 7.25 
– 7.21 (m, 2H), 7.22 – 7.16 (m, 2H), 7.16 – 7.10 (m, 1H), 5.89 – 5.80 (m, 1H), 4.92 (d, J 
= 10.3 Hz, 1H), 2.54 – 2.46 (m, 2H), 2.08 (q, J = 7.0 Hz, 2H), 1.93 – 1.86 (m, 2H), 1.75 – 
1.69 (m, 2H), 1.42 – 1.34 (m, 2H), 1.23 (s, 24H); 13C NMR (150 MHz, CDCl3): δ 143.93 
(s), 139.40 (s), 128.63 (s), 128.24 (s), 125.50 (s), 113.85 (t, J=23.5 Hz), 83.13 (s), 34.65 
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(s), 33.98 (s), 32.03 (s), 28.82 (s), 26.80 (s), 24.95 (s), 24.86 (s); IR (neat): 2978.5 (m), 
2931.5 (w), 2858.9 (w), 1456.2 (w), 1378.6 (m), 1309.7 (s), 1255.2 (w), 1138.6 (s), 968.9 
(w), 909.9 (m), 853.4 (m), 733.1 (s), 699.4 (w) cm-1; HRMS-(DART+) for 
12C261H422D111B216O4 [M+H]+: calculated: 442.3410, found: 442.3422. 
 
2-((1R,2S)-2-(iodomethyl-d)-1-phenethylcyclopentyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (3.35). The reaction was 
performed according to Representative Procedure for 
Deborylative Cyclization with 3.34 (88.2 mg, 0.2 mmol, 1.00 
equiv), KOtBu (44.9 mg, 0.4 mmol, 2.0 equiv) in THF (1 mL) for 1h 30min. Yellow 
reaction mixture was then quenched with an I2 solution in anhydrous THF (0.8 mL, 0.5 M, 
0.4 mmol, 2.0 equiv), where the reaction turns white, then purple. The crude reaction 
mixture was purified by SiO2 chromatography (0% EtOAc/Hexanes, gradient to 1% 
EtOAc/Hexanes, visualized with CAM stain) to afford a white solid (60.0 mg, 0.136 
mmol, 68%; 1:1 mixture of epimers). 1H NMR (600 MHz, CDCl3): δ 7.29 – 7.25 (m, 2H), 
7.20 – 7.15 (m, 3H), 3.52 (d, J = 3.1 Hz, 0.5H), 3.13 (d, J = 12.1 Hz, 0.5H), 2.60 – 2.51 
(m, 2H), 2.20 – 2.11 (m, 2H), 2.03 – 1.94 (m, 2H), 1.79 – 1.70 (m, 1H), 1.68 – 1.59 (m, 
1H), 1.47 – 1.40 (m, 2H), 1.40 – 1.33 (m, 1H), 1.26 (s, 12H). 13C NMR (150 MHz, 
CDCl3): δ 143.11 (s), 128.37 (s), 128.22 (s), 125.64 (s), 83.30 (s), 53.87 (s), 53.84 (s), 
41.19 (s), 41.17 (s), 36.11 (s), 36.08 (s), 33.91 (s), 33.88 (s), 25.12 (s), 24.82 (s), 21.86 (s), 
21.84 (s), 11.49 (t, J=22.9 Hz), 11.47 (t, J=22.9 Hz) ; 11B NMR (160 MHz, CDCl3) δ 
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33.98; IR (neat): 2976.1 (m), 2930.8 (m), 2867.2 (w), 1454.0 (w), 1380.7 (s), 1311.3 (s), 
1199.0 (w), 1141.5 (s), 966.9 (w), 853.6 (w), 748.3 (w), 698.5 (m) cm-1; HRMS-(DART+) 
for 12C201H292D111B116O2127I123Na1 [M+Na]+: calculated: 464.1344, found: 464.1339. 
 
Ph
B
OO
Me
Me
Me
Me
D
IH Ha
epimer 1  : epimer 2 = 1:1
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3.7.10  Analysis of Reaction Intermediates by 13C-Labeled Experiments I	
a) Preparation of 13C-Labeled geminal-Diboronate Ester: 
2,2'-(hexadecane-1,1-diyl-1-13C)bis(4,4,5,5-tetrameth
yl-1,3,2-dioxaborolane (S3.18). Prepared from palmitic 
acid-1-13C according to the literature procedure. The 1H 
and 13C NMR spectra were in accord with previously 
reported data.87 1H NMR (500 MHz, CDCl3): δ 1.55-1.53 (m, 2H), 1.31-1.22 (m, 50H), 
0.88 (t, J = 6.9 Hz, 3H), 0.71 (2dt, J = 111.5, 7.8 Hz, 1H).  
 
(Z)-2,2'-(1-phenylhenicos-1-ene-6,6-diyl-6-13C)bis(4,4,5,5
-tetramethyl-1,3,2-dioxaborolane) (3.28). Prepared 
according to Representative Procedure for Preparation of 
geminal-Diboronate Esters (Method C) with S3.18 (250 mg, 
0.52 mmol), LTMP (92 mg, 0.624 mmol), 
(Z)-(5-bromopent-1-en-1-yl)benzene (141 mg, 0.624mmol) and THF (2.5 mL). The crude 
reaction mixture was purified by column chromatography on silica gel (100:1 
hexanes/ethyl acetate, stain in CAM) to afford a colorless oil (191 mg, 59%). 1H NMR 
                                                
 
87 K. Hong, X. Liu, and J. P. Morken J. Am. Chem. Soc. 2014, 136, 10581-10584. 
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(500 MHz, CDCl3): δ 7.40 – 7.24 (m, 4H), 7.19 (t, J = 7.0 Hz, 1H), 6.36 (d, J = 11.7 Hz, 
1H), 5.70 (dt, J = 11.8, 7.2 Hz, 1H), 2.60 – 2.22 (m, 2H), 1.71 – 1.63 (m, 2H), 1.59 (dt, J 
= 7.8, 4.1 Hz, 2H), 1.37 (t, J = 7.9 Hz, 2H), 1.31 – 1.22 (m, 26H), 1.21 (s, 24H), 0.88 (t, J 
= 7.0 Hz, 3H); 1H NMR (500 MHz, THF-d8): δ 7.38 – 7.20 (m, 4H), 7.20 – 7.11 (m, 1H), 
6.48 – 6.25 (d, J = 11.8 Hz, 1H), 5.71 – 5.58 (m, 1H), 2.36 – 2.22 (m, 2H), 1.67 – 1.52 
(m, 4H), 1.48 – 1.37 (m, 2H), 1.29 (d, J = 2.6 Hz, 26H), 1.22 – 1.11 (m, 24H), 0.93 – 
0.84 (m, 3H); 13C NMR (125 MHz, CDCl3): δ 137.87, 133.55, 128.72, 128.34, 128.01, 
126.26, 82.84, 31.91, 30.40, 30.36, 29.71, 29.69, 29.66, 29.65, 29.60, 29.34, 29.01, 28.94, 
28.78, 28.70, 27.67, 27.12, 24.72, 22.67, 19.29, 14.09; 13C NMR (125 MHz, THF-d8): δ 
139.00, 134.07, 129.71, 129.61, 128.94, 127.25, 83.55, 33.05, 31.73, 30.84, 30.78, 30.76, 
30.48, 30.36, 28.81, 28.16, 23.73, 20.13(br, C-B), 14.60; IR (neat): 2958.2 (m), 2924.6 
(s), 2854.5 (m), 1729.3 (m), 1463.0 (w), 1377.4 (w), 1344.6 (w), 1288.6 (s), 1269.5 (s), 
1138.7 (s), 1072.3 (w), 854.8 (w), 700.0 (w) cm-1; HRMS-(DART+) for 
12C3813C11H6811B216O4 [M+H]+: 624.5416, found: 624.5418. 
 
b) 13C NMR Experiments  
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In the glove box, an oven-dried NMR tube is charged with diboronate ester 3.28 
(31.2 mg, 0.05mmol), KOt-Bu (11.2 mg, 0.1 mmol) and THF-d8 (0.60 mL). The NMR 
tube is then sealed with a rubber septum, removed from the glove box, and monitored by 
13C NMR at 25 oC. After 7 hours, water (2.7 mL, 0.15 mmol) is added via syringe, and 
the mixture again observed by 13C NMR. At this point, the reaction mixture is diluted 
with diethyl ether, filtered through a silica gel plug, rinsed with diethyl ether, and 
concentrated in vacuo. The crude reaction mixture is purified on silica gel (hexanes: ethyl 
acetate = 100:0.6) to afford the desired product 3.30 (19.6 mg, 79% yield, d.r. > 10:1) 
together with protodeborylation byproduct (2.1 mg). 
 
13C NMR Spectra of the Reaction Mixture (125 MHz, THF-d8, δ 10-60 ppm): 
 
i. Diboronate ester 3.28 ii. 3.28 and KOt-Bu for 30 minutes 
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iii. 3.28 and KOt-Bu for 180 minutes iv. 3.28 and KOt-Bu for 7 hours 
  
  
v. 1 minute after H2O was added vi. Isolated product, 3.30 
  
  
 
 
2-(2-benzyl-1-pentadecylcyclopentyl-1-13C)-4,4,5,5-tetrameth
yl-1,3,2-dioxaborolane. (3.30, major diastereomer) 1H NMR 
(500 MHz, CDCl3): δ 7.27 – 7.22 (m, 2H), 7.17 – 7.13 (m, 3H), 
2.99 (dt, J = 13.4, 2.4 Hz, 1H), 2.32 (ddd, J = 13.1, 11.5, 1.4 Hz, 1H), 1.97 (dddd, J = 
13C
B
OO
Me
Me
Me
Me
Ph
C15H31
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C15H31
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12.5, 8.7, 4.7, 1.5 Hz, 1H), 1.82 – 1.74 (m, 1H), 1.73 – 1.56 (m, 3H), 1.52 – 1.41 (m, 1H), 
1.35 – 1.18 (m, 40H), 1.12 – 1.03 (m, 1H), 0.88 (t, J = 6.9 Hz, 3H); 1H NMR (500 MHz, 
THF-d8): δ 7.21 – 7.16 (m, 2H), 7.13 – 7.06 (m, 3H), 2.98 (dt, J = 13.5, 2.6 Hz, 1H), 2.41 
– 2.28 (m, 1H), 2.08 – 1.96 (m, 1H), 1.90 – 1.78 (m, 1H), 1.67 – 1.52 (m, 2H), 1.51 – 
1.41 (m, 2H), 1.37 – 1.23 (m, 38H), 1.22 – 1.14 (m, 2H), 1.11 – 1.02 (m, 1H), 0.89 (td, J 
= 6.9, 2.4 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 143.10, 128.82, 128.04, 125.36, 
82.88, 53.07, 52.83, 46.76, 39.39, 38.80, 38.54, 37.36, 34.42, 34.17, 31.92, 31.33, 31.31, 
30.72, 30.68, 29.72, 29.70, 29.65, 29.64, 29.36, 27.47, 25.16, 24.85, 24.81, 22.68, 22.40, 
14.12; 13C NMR (125 MHz, THF-d8): δ 144.03, 144.00, 129.70, 129.64, 128.98, 128.95, 
126.32, 83.89, 54.63, 54.40, 47.80, 40.44, 40.08, 39.81, 38.41, 35.89, 35.64, 33.06, 32.58, 
32.55, 31.92, 31.88, 30.84, 30.80, 30.76, 30.74, 30.49, 28.63, 23.74, 23.25, 14.61; IR 
(neat): 2956.4 (m), 2923.6 (s), 2853.7 (m), 1728.8 (m), 1462.6 (w), 1378.0 (w), 1287.5 
(m), 1141.5 (m), 1072.2 (w), 743.0 (w), 699.7 (w) cm-1; HRMS-(DART+) for 
12C3213C11H5811B116O2 [M+H]+: calculated: 498.4563, found: 498.4574. 
 
 
3.7.11 Analysis of Reaction Intermediates by 13C-Labeled Experiments II	
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a) Preparation of 13C-Labeled Alkene of 
geminal-Diboronate Ester 
tert-butyldimethyl((7-phenyl-5,5-bis(4,4,5,5-tetrameth
yl-1,3,2-dioxaborolan-2-yl)heptyl)oxy)silane (S3.19). 
The reaction was performed according to Representative 
Procedure (Method C) with diboronate ester 2.1 (372.3 mg, 1.0 mmol), LTMP (155 mg, 
1.05 mmol), (4-bromobutoxy)(tert-butyl)dimethylsilane (294.0 mg, 1.10 mmol) and THF 
(4 mL). The crude reaction mixture was purified by column chromatography on silica gel 
(1% EtOAc/Hexanes, gradient to 3% EtOAc/Hexanes, visualized with CAM stain) to 
afford a clear, colorless oil (522.9 mg, 94%). 1H NMR (500 MHz, CDCl3): δ 7.27 – 7.21 
(m, 2H), 7.21 – 7.17 (m, 2H), 7.16 – 7.10 (m, 1H), 3.62 (t, J = 6.5 Hz, 2H), 2.55 – 2.45 
(m, 2H), 1.94 – 1.84 (m, 2H), 1.76 – 1.66 (m, 2H), 1.58 – 1.49 (m, 2H), 1.38 – 1.27 (m, 
2H), 1.23 (s, 24H), 0.89 (s, 9H), 0.04 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 143.83 (s), 
128.50 (s), 128.07 (s), 125.32 (s), 82.95 (s), 63.52 (s), 33.88 (s), 33.84 (s), 31.91 (s), 
29.01 (s), 26.00 (s), 24.81 (s), 24.70 (s), 23.63 (s), 18.34 (s), -5.22 (s); IR (neat): 2977.0 
(w), 2928.8 (m), 2857.4 (w), 1349.2 (m), 1306.0 (m), 1253.9 (m), 1138.3 (s), 1101.4 (m), 
850.4 (m), 835.8 (m), 775.0 (m), 699.0 (m) cm-1. HRMS-(DART+) for 
12C311H5711B216O528Si1 [M+H]: calculated: 559.4161, found: 559.4183. 
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7-phenyl-5,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)heptan-1-ol (S3.20). A 20 mL vial containing S3.19 
(482 mg, 0.86 mmol, 1.0 equiv) and magnetic stirbar is 
loaded with reagent grade MeOH (6.9 mL, 0.125 M). The 
heterogeneous mixture is set to stir at room temperature, then p-TsOH monohydrate 
added (8.2 mg, 0.04 mmol, 0.05 equiv). The mixture almost immediately becomes 
homogeneous. Allowed to stir 1h at rt then volatile components removed in vacuo. 
Resulting crude oil is then purified by SiO2 chromatography (5% EtOAc/Hexanes, 
gradient to 25% EtOAc/Hexanes, visualized with KMnO4 stain). Product isolated as 
white solid (356.3 mg, 93%). 1H NMR (500 MHz, CDCl3): δ 7.27 – 7.22 (m, 2H), 7.22 – 
7.17 (m, 2H), 7.16 – 7.11 (m, 1H), 3.73 – 3.65 (m, 2H), 2.56 – 2.48 (m, 2H), 1.93 – 1.85 
(m, 2H), 1.75 – 1.64 (m, 3H), 1.64 – 1.56 (m, 2H), 1.44 – 1.31 (m, 2H), 1.23 (s, 24H); 
13C NMR (125 MHz, CDCl3): δ 143.67 (s), 128.45 (s), 128.11 (s), 125.40 (s), 83.07 (s), 
62.33 (s), 33.84 (s), 32.72 (s), 32.13 (s), 27.98 (s), 24.79 (s), 24.66 (s), 23.03 (s); IR 
(neat): 3457.7 (w, br), 2977.0 (w), 2929.0 (w), 2861.0 (w), 1348.8 (m), 1307.5 (s), 1250.7 
(m), 1137.6 (s), 853.2 (m), 699.8 (w) cm-1. HRMS-(DART+) for 12C251H4311B216O5 
[M+H]: calculated: 445.3297, found: 445.3286. 
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7-phenyl-5,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl) heptanal (S31). A flame dried 20 mL vial equipped 
with magnetic stirbar is sealed with rubber septum then 
evacuated/backfilled with N2 3x. The vial is then charged 
with (COCl)2 (71.1 µL, 0.84 mmol, 1.4 equiv) followed by anhydrous DCM (0.3 mL). 
The solution is then set to stir at -78oC and anhydrous DMSO (119 µL, 1.67 mmol, 2.8 
equiv) was added dropwise, significant gas evolution noted. The mixture was allowed to 
stir at -78oC for ca. 10min. A solution of S3.20 in anhydrous DCM (0.3 mL) is then 
added dropwise, followed immediately by the slow addition of freshly distilled NEt3 (507 
µL, 3.64 mmol, 6.1 equiv; salt formation observed). The vessel and contents were then 
allowed to warm to room temperature and stir an additional 3h. Volatiles were then 
removed by high vacuum and the organics redissolved in EtOAc. Organics were washed 
with a saturated, aqueous Na2CO3 solution then concentrated to yield crude oil. Oil 
purified by SiO2 chromatography (5% EtOAc/Hexanes, gradient to 10% EtOAc/Hexanes, 
visualized with CAM stain). Product isolated as white solid (232 mg, 0.52 mmol, 88%). 
1H NMR (600 MHz, CDCl3): δ 9.77 (s, 1H), 7.27 – 7.22 (m, 2H), 7.22 – 7.18 (m, 2H), 
7.18 – 7.11 (m, 1H), 2.55 – 2.49 (m, 2H), 2.46 – 2.40 (m, 2H), 1.95 – 1.89 (m, 2H), 1.75 
– 1.69 (m, 2H), 1.66 – 1.59 (m, 2H), 1.23 (s, 24H); 13C NMR (150 MHz, CDCl3): δ 
203.07 (s), 143.53 (s), 128.48 (s), 128.14 (s), 125.45 (s), 83.12 (s), 44.61 (s), 33.83 (s), 
31.89 (s), 28.98 (s), 24.81 (s), 24.72 (s), 19.86 (s); IR (neat): 2977.3 (w), 2931.7 (w), 
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1708.3 (m), 1454.9 (w), 1310.4 (m), 1252.4 (m), 1137.5 (s), 853.9 (w) cm-1. 
HRMS-(DART+) for 12C251H4111B216O5 [M+H]: calculated: 443.3140, found: 443.3138. 
 
2,2'-(1-phenyloct-7-ene-3,3-diyl-8-13C)bis(4,4,5,5-tetram
ethyl-1,3,2-dioxaborolane) (3.31). A flame dried, 20 mL 
vial equipped with magnetic stirbar is charged with 
Methyl-13C-triphenylphosphonium iodide (212 mg, 0.52 
mmol, 1 equiv) and KOt-Bu (59 mg, 0.52 mmol, 1 equiv) inside an argon-filled glovebox. 
Anhydrous THF is then charged into the vessel (1.5 mL) to give a vivid yellow solution. 
Vessel is sealed with a rubber septum and moved to the fume hood where it is allowed to 
stir for 1h at room temperature. A solution of S31 (231 mg, 0.52 mmol, 1 equiv) in 
anhydrous THF (1.5 mL) is then added to the reaction vessel. The yellow color fades and 
a white suspension remains. The suspension is allowed to stir for 1.5h at room 
temperature at which point it is passed through a pad of SiO2, rinsing with Et2O. The 
resulting clear, colorless solution is concentrated to give a white solid. Product is isolated 
by SiO2 chromatography (1% EtOAc/Hexanes, gradient to 5% EtOAc/Hexanes, 
visualized by CAM stain) to give white solid (208 mg, 0.47 mmol, 91%). 1H NMR (600 
MHz, CDCl3): δ 7.26 – 7.22 (m, 2H), 7.22 – 7.18 (m, 2H), 7.16 – 7.09 (m, 1H), 5.86 (ddt, 
J = 16.8, 10.2, 6.6 Hz, 1H), 5.01 (ddd, J = 153.4, 17.2, 1.8 Hz, 1H), 4.93 (ddd, J = 156.8, 
10.2, 2.0 Hz, 1H), 2.54 – 2.47 (m, 2H), 2.11 – 2.04 (m, 2H), 1.93 – 1.85 (m, 2H), 1.75 – 
1.69 (m, 2H), 1.43 – 1.34 (m, 2H), 1.23 (s, 24H); 13C NMR δ 143.78 (s), 139.33 (d, J = 
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69.2 Hz), 128.49 (s), 128.09 (s), 125.35 (s), 113.98 (s, 13C), 82.98 (s), 34.55 (s), 33.83 (s), 
31.88 (s), 28.66 (s), 26.65 (d, J = 3.6 Hz), 24.80 (s), 24.71 (s); IR (neat): 2977.9 (w), 
2927.4 (w), 2858.9 (w), 1352.9 (w), 1307.7 (2), 1255.5 (w), 1139.2 (m), 855.6 (w) cm-1. 
HRMS-(DART+) for 12C2513C11H4311B216O4 [M+H]: calculated: 442.3381, found: 
442.3388. 
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b) 13C NMR Experiments of 13C-Labeled geminal-Diboronate Ester 
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Figure S3.5 - 13C labeled starting material (3.31) in d8-THF  
Ph
(pin)B B(pin)
13CH2
3.31
211 
 
  
Figure 3.6 – 3.31 with KOt-Bu for 20 minutes in d8-THF (zoomed in on significant 
region for clarity) 
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Figure 7.3 – 1 minute after addition of H2O 
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Figure 3.4 - Isolated major product (non-13C labeled) in d8-THF 
 
3.7.12  X-ray crystallographic data	
X-ray crystallographic data for 
2-((1R,2S)-2-(iodomethyl)-1-phenethylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxabo
rolane (Compound 3.9). 
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Me Me
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Table S3.2. 
Crystal data and structure refinement for 
2-((1R,2S)-2-(iodomethyl)-1-phenethylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxabo
rolane. (Compound 3.9). 
Identification code  C20H30BIO2 
Empirical formula  C20H30BIO2 
Formula weight  440.15 
Temperature  100(2) K 
Wavelength  0.71073 ≈ 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 6.5129(8) ≈ a= 99.987(2)∞. 
 b = 13.4237(16) ≈ b= 95.992(2)∞. 
 c = 23.452(3) ≈ g = 96.163(2)∞. 
Volume 1991.7(4) ≈3 
Z 4 
Density (calculated) 1.468 Mg/m3 
Absorption coefficient 1.617 mm-1 
F(000) 896 
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Crystal size 0.400 x 0.210 x 0.150 mm3 
Theta range for data collection 1.639 to 28.450∞. 
Index ranges -8<=h<=8, -17<=k<=17, -31<=l<=31 
Reflections collected 38081 
Independent reflections 10019 [R(int) = 0.0443] 
Completeness to theta = 25.242∞ 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6368 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10019 / 1 / 500 
Goodness-of-fit on F2 1.014 
Final R indices [I>2sigma(I)] R1 = 0.0315, wR2 = 0.0648 
R indices (all data) R1 = 0.0501, wR2 = 0.0718 
Extinction coefficient na 
Largest diff. peak and hole 1.372 and -0.705 e.≈-3 
 
Table S3.3. 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 
103) 
for C20H30BIO2.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________
________  
 x y z U(eq) 
________________________________________________________________________
________   
I(1) -2688(1) 8964(1) 2686(1) 22(1) 
O(2) 53(3) 6298(1) 3911(1) 20(1) 
B(1) 1532(5) 7128(2) 4056(1) 21(1) 
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C(1) -1455(4) 8104(2) 3314(1) 20(1) 
C(2) 292(4) 8747(2) 3743(1) 18(1) 
C(3) 2305(4) 8995(2) 3486(1) 22(1) 
C(4) 3922(4) 9401(2) 4024(1) 24(1) 
C(5) 3035(4) 8990(2) 4538(1) 20(1) 
C(6) 1022(4) 8255(2) 4272(1) 17(1) 
C(7) -613(4) 8255(2) 4702(1) 20(1) 
C(8) 141(4) 7877(2) 5255(1) 24(1) 
C(9) -1343(4) 7918(2) 5712(1) 20(1) 
C(10) -665(4) 8360(2) 6286(1) 26(1) 
C(11) -1990(5) 8377(2) 6714(1) 30(1) 
C(12) -4042(5) 7939(2) 6566(1) 31(1) 
C(13) -4752(4) 7494(2) 5993(1) 28(1) 
C(14) -3424(4) 7487(2) 5567(1) 22(1) 
O(1) 3490(10) 6911(6) 3899(3) 18(1) 
C(15) 3369(4) 5794(2) 3800(1) 24(1) 
C(16) 971(8) 5454(4) 3569(3) 17(1) 
C(17) 4185(11) 5443(5) 4300(3) 28(2) 
C(18) 4715(9) 5507(5) 3275(3) 26(1) 
C(19) 138(11) 4472(5) 3748(3) 29(2) 
C(20) 314(7) 5426(4) 2926(2) 22(1) 
O(1X) 3508(11) 6877(7) 4129(3) 18(1) 
C(15X) 3369(4) 5794(2) 3800(1) 24(1) 
C(16X) 1111(8) 5382(4) 3915(3) 21(1) 
C(17X) 5083(10) 5330(6) 4167(4) 27(2) 
C(18X) 3761(13) 5791(6) 3223(3) 33(2) 
C(19X) 925(10) 5039(5) 4499(3) 31(2) 
C(20X) 69(12) 4557(6) 3430(4) 37(2) 
I(2) 1188(1) -112(1) 1601(1) 24(1) 
O(3) 7717(3) 2663(1) 800(1) 22(1) 
O(4) 4297(3) 2481(1) 432(1) 21(1) 
B(2) 5722(4) 2670(2) 924(1) 15(1) 
C(21) 2576(4) 1186(2) 1285(1) 20(1) 
C(22) 4214(4) 1849(2) 1738(1) 17(1) 
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C(23) 6177(4) 1364(2) 1884(1) 24(1) 
C(24) 7890(4) 2260(2) 2137(1) 27(1) 
C(25) 6965(4) 3230(2) 2028(1) 22(1) 
C(26) 5057(4) 2869(2) 1558(1) 16(1) 
C(27) 3411(4) 3617(2) 1599(1) 18(1) 
C(28) 4219(4) 4659(2) 1471(1) 21(1) 
C(29) 2722(4) 5441(2) 1529(1) 18(1) 
C(30) 3393(4) 6433(2) 1827(1) 21(1) 
C(31) 2049(4) 7166(2) 1876(1) 25(1) 
C(32) -7(4) 6927(2) 1629(1) 26(1) 
C(33) -689(4) 5951(2) 1328(1) 26(1) 
C(34) 644(4) 5209(2) 1282(1) 23(1) 
C(35) 7617(4) 2262(2) 171(1) 24(1) 
C(36) 5453(4) 2521(2) -69(1) 19(1) 
C(37) 7693(5) 1120(2) 109(1) 40(1) 
C(38) 9428(4) 2782(3) -62(1) 43(1) 
C(39) 5514(5) 3600(2) -188(1) 33(1) 
C(40) 4339(4) 1753(2) -595(1) 30(1) 
________________________________________________________________________
________ 
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X-ray crystallographic data for compound 
2-((1R,2R)-2-benzyl-1-cyclohexylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolan
e (Compound 3.16).  
Table S3.4. 
Crystal data and structure refinement for 
2-((1R,2R)-2-benzyl-1-cyclohexylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolan
e (Compound 3.16). 
Identification code  C24H37BO2 
Empirical formula  C24H37BO2 
Formula weight  368.34 
Temperature  100(2) K 
Wavelength  0.71073 ≈ 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 9.6816(10) ≈ a= 90∞. 
 b = 18.2436(19) ≈ b= 106.083(2)∞. 
 c = 12.6856(13) ≈ g = 90∞. 
Volume 2152.9(4) ≈3 
Z 4 
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Density (calculated) 1.136 Mg/m3 
Absorption coefficient 0.069 mm-1 
F(000) 808 
Crystal size 0.400 x 0.250 x 0.180 mm3 
Theta range for data collection 1.671 to 28.339∞. 
Index ranges -12<=h<=12, -24<=k<=24, -16<=l<=16 
Reflections collected 38756 
Independent reflections 10716 [R(int) = 0.0408] 
Completeness to theta = 25.242∞ 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6888 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10716 / 1 / 496 
Goodness-of-fit on F2 1.057 
Final R indices [I>2sigma(I)] R1 = 0.0443, wR2 = 0.0949 
R indices (all data) R1 = 0.0609, wR2 = 0.1035 
Extinction coefficient na 
Largest diff. peak and hole 0.249 and -0.204 e.≈-3 
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Table S3.5. 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 
103) 
for c24h37bo2.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________
________  
 x y z U(eq) 
________________________________________________________________________
________   
O(1) 6063(2) 4076(1) 7419(1) 19(1) 
O(2) 6763(2) 5252(1) 7239(1) 24(1) 
B(1) 6938(3) 4526(2) 7027(2) 18(1) 
C(1) 11365(3) 2530(1) 8609(2) 25(1) 
C(2) 12672(3) 2314(2) 9307(2) 29(1) 
C(3) 13283(3) 2698(2) 10260(2) 29(1) 
C(4) 12581(3) 3300(2) 10513(2) 28(1) 
C(5) 11273(3) 3523(1) 9810(2) 23(1) 
C(6) 10647(2) 3139(1) 8850(2) 19(1) 
C(7) 9233(2) 3383(1) 8077(2) 21(1) 
C(8) 9426(2) 3951(1) 7244(2) 18(1) 
C(9) 10151(2) 4665(1) 7754(2) 20(1) 
C(10) 9808(2) 5230(1) 6811(2) 23(1) 
C(11) 8642(2) 4870(1) 5868(2) 20(1) 
C(12) 8029(2) 4227(1) 6396(2) 17(1) 
C(13) 7216(2) 3644(1) 5562(2) 18(1) 
C(14) 8149(3) 3167(1) 5037(2) 23(1) 
C(15) 7238(3) 2616(1) 4224(2) 27(1) 
C(16) 6051(3) 2994(2) 3343(2) 31(1) 
C(17) 5109(3) 3456(1) 3861(2) 26(1) 
C(18) 6018(2) 4008(1) 4658(2) 21(1) 
C(19) 5048(2) 4539(1) 7778(2) 21(1) 
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C(20) 5866(3) 5281(1) 7999(2) 24(1) 
C(21) 3694(3) 4582(2) 6819(2) 33(1) 
C(22) 4731(3) 4186(1) 8765(2) 28(1) 
C(23) 4945(3) 5960(2) 7749(2) 38(1) 
C(24) 6899(3) 5330(2) 9148(2) 35(1) 
O(3) 1073(2) 6054(1) 2477(1) 20(1) 
O(4) 1855(2) 4917(1) 2164(1) 23(1) 
B(2) 1950(3) 5655(1) 2006(2) 18(1) 
C(25) 6537(3) 7496(1) 3698(2) 26(1) 
C(26) 7861(3) 7636(2) 4440(2) 33(1) 
C(27) 8243(3) 7291(2) 5448(2) 32(1) 
C(28) 7300(3) 6804(1) 5718(2) 29(1) 
C(29) 5981(3) 6663(1) 4973(2) 24(1) 
C(30) 5581(2) 7007(1) 3951(2) 20(1) 
C(31) 4174(2) 6830(1) 3121(2) 20(1) 
C(32) 4379(2) 6281(1) 2263(2) 18(1) 
C(33) 5108(2) 5562(1) 2723(2) 22(1) 
C(34) 4916(3) 5073(1) 1708(2) 24(1) 
C(35) 3644(2) 5405(1) 814(2) 20(1) 
C(36) 2997(2) 6011(1) 1393(2) 16(1) 
C(37) 2178(2) 6619(1) 607(2) 17(1) 
C(38) 3124(3) 7113(1) 117(2) 22(1) 
C(39) 2237(3) 7686(1) -658(2) 28(1) 
C(40) 1044(3) 7337(2) -1563(2) 32(1) 
C(41) 82(3) 6861(2) -1076(2) 28(1) 
C(42) 968(3) 6282(1) -312(2) 22(1) 
C(43) 556(2) 5554(1) 3189(2) 22(1) 
C(44) 711(3) 4793(1) 2691(2) 23(1) 
C(45) -962(3) 5768(2) 3167(2) 31(1) 
C(46) 1562(3) 5657(2) 4346(2) 33(1) 
C(47) -614(3) 4567(2) 1789(2) 36(1) 
C(48) 1180(3) 4174(2) 3511(2) 35(1) 
________________________________________________________________________ 
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X-ray crystallographic data for compound 
2-((1R,2R)-2-benzyl-1-phenethylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolan
e (Compound 3.21, major diastereomer). 
 
Table S3.6. 
Crystal data and structure refinement for 
2-((1R,2R)-2-benzyl-1-phenethylcyclopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolan
e (Compound 3.21, major diastereomer). 
Identification code  C26H35BO2 
Empirical formula  C26H35BO2 
Formula weight  390.35 
Temperature  100(2) K 
Wavelength  0.71073 ≈ 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 11.0652(19) ≈ a= 90∞. 
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 b = 17.228(3) ≈ b= 98.660(3)∞. 
 c = 11.842(2) ≈ g = 90∞. 
Volume 2231.7(7) ≈3 
Z 4 
Density (calculated) 1.162 Mg/m3 
Absorption coefficient 0.070 mm-1 
F(000) 848 
Crystal size 0.530 x 0.400 x 0.220 mm3 
Theta range for data collection 2.103 to 28.324∞. 
Index ranges -14<=h<=14, -22<=k<=20, -15<=l<=15 
Reflections collected 43822 
Independent reflections 5557 [R(int) = 0.0352] 
Completeness to theta = 25.242∞ 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.7070 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5557 / 0 / 266 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0386, wR2 = 0.0983 
R indices (all data) R1 = 0.0474, wR2 = 0.1046 
Extinction coefficient na 
Largest diff. peak and hole 0.390 and -0.188 e.≈-3 
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Table S3.7. 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 
103) 
for C26H35BO2.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________
________  
 x y z U(eq) 
________________________________________________________________________
________   
B(1) 3744(1) 6957(1) 6459(1) 16(1) 
C(1) 4240(1) 6174(1) 6004(1) 16(1) 
C(2) 3572(1) 5462(1) 6436(1) 20(1) 
C(3) 4263(1) 5252(1) 7628(1) 25(1) 
C(4) 5459(1) 5724(1) 7780(1) 21(1) 
C(5) 5581(1) 6018(1) 6580(1) 17(1) 
C(6) 4146(1) 6187(1) 4692(1) 19(1) 
C(7) 2834(1) 6200(1) 4049(1) 22(1) 
C(8) 2736(1) 6139(1) 2762(1) 19(1) 
C(9) 3493(1) 6557(1) 2143(1) 24(1) 
C(10) 3359(1) 6505(1) 960(1) 28(1) 
C(11) 2472(1) 6028(1) 371(1) 28(1) 
C(12) 1717(1) 5606(1) 971(1) 26(1) 
C(13) 1848(1) 5658(1) 2154(1) 21(1) 
C(14) 2901(1) 8165(1) 6432(1) 17(1) 
C(15) 3167(1) 7859(1) 7684(1) 17(1) 
C(16) 3325(1) 8988(1) 6262(1) 25(1) 
C(17) 1568(1) 8068(1) 5898(1) 23(1) 
C(18) 2107(1) 7938(1) 8356(1) 22(1) 
C(19) 4338(1) 8192(1) 8354(1) 24(1) 
C(20) 6468(1) 6702(1) 6570(1) 19(1) 
C(21) 7791(1) 6466(1) 6917(1) 18(1) 
225 
 
C(22) 8387(1) 6573(1) 8030(1) 22(1) 
C(23) 9608(1) 6368(1) 8336(1) 25(1) 
C(24) 10256(1) 6054(1) 7529(1) 26(1) 
C(25) 9672(1) 5936(1) 6420(1) 26(1) 
C(26) 8448(1) 6137(1) 6121(1) 22(1) 
O(1) 3615(1) 7630(1) 5831(1) 18(1) 
O(2) 3387(1) 7033(1) 7515(1) 18(1) 
________________________________________________________________________
________ 
 
X-ray crystallographic data for 
4,4,5,5-tetramethyl-2-((1R,2R)-1-phenethyl-2-((R)-1-phenylbut-3-en-1-yl)cyclopentyl
)-1,3,2-dioxaborolane (Compound 3.56). 
 
Table S3.8. 
Crystal data and structure refinement for 
4,4,5,5-tetramethyl-2-((1R,2R)-1-phenethyl-2-((R)-1-phenylbut-3-en-1-yl)cyclopentyl
)-1,3,2-dioxaborolane (Compound 3.56). 
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Identification code  C29H39BO2 
Empirical formula  C29 H39BO2 
Formula weight  430.41 
Temperature  173(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.9886(5) ≈ a= 69.073(2)∞. 
 b = 10.2525(5) ≈ b= 84.917(2)∞. 
 c = 13.6756(7) ≈ g = 76.535(2)∞. 
Volume 1272.13(11) ≈3 
Z 2 
Density (calculated) 1.124 Mg/m3 
Absorption coefficient 0.516 mm-1 
F(000) 468 
Crystal size 0.520 x 0.400 x 0.080 mm3 
Theta range for data collection 3.460 to 66.686∞. 
Index ranges -11<=h<=11, -12<=k<=12, -16<=l<=16 
Reflections collected 24493 
Independent reflections 4448 [R(int) = 0.0249] 
Completeness to theta = 66.750∞ 98.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.6785 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4448 / 0 / 293 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0393, wR2 = 0.0981 
R indices (all data) R1 = 0.0407, wR2 = 0.0993 
Extinction coefficient na 
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Largest diff. peak and hole 0.313 and -0.208 e.≈-3
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Table S3.9. 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 
103) 
for C29H39BO2.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________
________  
 x y z U(eq) 
________________________________________________________________________
________   
O(1) 1652(1) 3532(1) 4221(1) 33(1) 
O(2) 3289(1) 1550(1) 4287(1) 28(1) 
B(1) 2635(1) 2887(1) 3680(1) 22(1) 
C(1) 2312(2) 9366(2) 2921(1) 47(1) 
C(2) 3111(1) 8405(1) 2586(1) 38(1) 
C(3) 2640(1) 7591(1) 2017(1) 31(1) 
C(4) 3085(1) 5954(1) 2560(1) 25(1) 
C(5) 2623(1) 5150(1) 1936(1) 24(1) 
C(6) 2891(1) 3481(1) 2455(1) 23(1) 
C(7) 4324(1) 2676(1) 2218(1) 25(1) 
C(8) 4718(1) 2968(1) 1061(1) 36(1) 
C(9) 6021(1) 1925(1) 966(1) 34(1) 
C(10) 5970(2) 619(2) 909(1) 47(1) 
C(11) 7174(2) -372(2) 882(1) 66(1) 
C(12) 8432(2) -70(2) 912(1) 70(1) 
C(13) 8499(2) 1219(2) 968(1) 62(1) 
C(14) 7301(2) 2214(2) 996(1) 45(1) 
C(15) 4629(1) 5496(1) 2730(1) 26(1) 
C(16) 5180(1) 4679(1) 3714(1) 32(1) 
C(17) 6591(1) 4191(2) 3858(1) 42(1) 
C(18) 7480(1) 4540(2) 3019(1) 44(1) 
C(19) 6948(1) 5389(2) 2037(1) 41(1) 
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C(20) 5542(1) 5858(1) 1894(1) 33(1) 
C(21) 1088(1) 5601(1) 1657(1) 31(1) 
C(22) 902(1) 4471(1) 1239(1) 35(1) 
C(23) 1712(1) 3076(1) 1998(1) 30(1) 
C(24) 1417(1) 2419(1) 5208(1) 32(1) 
C(25) 2800(1) 1298(1) 5365(1) 27(1) 
C(26) 222(1) 1858(2) 5013(1) 58(1) 
C(27) 1065(2) 3067(2) 6056(1) 59(1) 
C(28) 2684(2) -255(1) 5849(1) 43(1) 
C(29) 3884(1) 1544(2) 5945(1) 43(1) 
________________________________________________________________________
________ 
 
 
X-ray crystallographic data for compound 
2-((1R,2R)-2-((R)-1,2-diphenylethyl)-1-phenethylcyclopentyl)-4,4,5,5-tetramethyl-1,3
,2-dioxaborolane (Compound 3.15). 
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Table S3.10. 
Crystal data and structure refinement for 
2-((1R,2R)-2-((R)-1,2-diphenylethyl)-1-phenethylcyclopentyl)-4,4,5,5-tetramethyl-1,3
,2-dioxaborolane (Compound 3.15). 
Identification code  C33H41BO2 
Empirical formula  C33H41BO2 
Formula weight  480.47 
Temperature  100(2) K 
Wavelength  0.71073 ≈ 
Crystal system  Orthorhombic 
Space group  Pbca 
Unit cell dimensions a = 13.8342(16) ≈ a= 90∞. 
 b = 17.292(2) ≈ b= 90∞. 
 c = 23.666(3) ≈ g = 90∞. 
Volume 5661.4(11) ≈3 
Z 8 
Density (calculated) 1.127 Mg/m3 
Absorption coefficient 0.067 mm-1 
F(000) 2080 
Crystal size 0.550 x 0.380 x 0.180 mm3 
Theta range for data collection 1.721 to 28.335∞. 
Index ranges -18<=h<=18, -23<=k<=22, -31<=l<=31 
Reflections collected 94700 
Independent reflections 7044 [R(int) = 0.0525] 
Completeness to theta = 25.242∞ 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.7017 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7044 / 821 / 406 
Goodness-of-fit on F2 1.028 
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Final R indices [I>2sigma(I)] R1 = 0.0439, wR2 = 0.1041 
R indices (all data) R1 = 0.0649, wR2 = 0.1172 
Extinction coefficient na 
Largest diff. peak and hole 0.320 and -0.237 e.≈-3 
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Table S3.11. 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 
103) 
for C33H41BO2.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________
________  
 x y z U(eq) 
________________________________________________________________________
________   
O(1) 5645(1) 1765(1) 4124(1) 33(1) 
O(2) 5909(1) 2977(1) 4455(1) 33(1) 
C(6) 5676(1) 1686(1) 4741(1) 27(1) 
C(7) 5546(1) 2534(1) 4940(1) 31(1) 
C(8) 4873(2) 1142(1) 4932(1) 42(1) 
C(9) 6661(2) 1356(2) 4881(1) 72(1) 
C(10) 4480(2) 2753(1) 5008(1) 57(1) 
C(11) 6116(3) 2768(2) 5452(1) 75(1) 
O(1X) 5206(10) 1976(8) 4159(4) 36(3) 
O(2X) 6309(10) 2822(9) 4479(5) 32(3) 
C(6X) 5140(10) 1968(9) 4782(5) 43(3) 
C(7X) 6040(10) 2389(9) 4986(5) 37(3) 
C(8X) 4178(15) 2328(17) 4931(12) 84(7) 
C(9X) 5248(19) 1109(11) 4917(13) 53(6) 
C(10X) 5920(30) 2950(18) 5468(12) 49(5) 
C(11X) 6951(15) 1978(16) 5134(11) 82(6) 
B(1) 5869(1) 2514(1) 3994(1) 21(1) 
C(1) 6077(1) 2810(1) 3372(1) 20(1) 
C(2) 6219(1) 2117(1) 2963(1) 25(1) 
C(3) 5199(1) 1834(1) 2804(1) 29(1) 
C(4) 4509(1) 2497(1) 2966(1) 26(1) 
C(5) 5157(1) 3196(1) 3107(1) 21(1) 
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C(12) 6954(1) 3358(1) 3365(1) 21(1) 
C(13) 7903(1) 2997(1) 3563(1) 24(1) 
C(14) 8758(1) 3546(1) 3539(1) 22(1) 
C(15) 9683(1) 3258(1) 3433(1) 26(1) 
C(16) 10479(1) 3747(1) 3407(1) 31(1) 
C(17) 10366(1) 4538(1) 3484(1) 32(1) 
C(18) 9455(1) 4833(1) 3593(1) 31(1) 
C(19) 8658(1) 4343(1) 3621(1) 28(1) 
C(20) 4625(1) 3832(1) 3443(1) 22(1) 
C(21) 5249(1) 4538(1) 3565(1) 22(1) 
C(22) 5498(1) 4731(1) 4119(1) 25(1) 
C(23) 6105(1) 5355(1) 4232(1) 30(1) 
C(24) 6456(1) 5803(1) 3793(1) 32(1) 
C(25) 6198(1) 5629(1) 3242(1) 30(1) 
C(26) 5598(1) 5003(1) 3128(1) 26(1) 
C(27) 3697(1) 4073(1) 3121(1) 27(1) 
C(28) 3181(1) 4766(1) 3368(1) 25(1) 
C(29) 2927(1) 4793(1) 3938(1) 28(1) 
C(30) 2451(1) 5429(1) 4162(1) 32(1) 
C(31) 2214(1) 6049(1) 3818(1) 33(1) 
C(32) 2465(1) 6032(1) 3253(1) 34(1) 
C(33) 2947(1) 5397(1) 3030(1) 31(1) 
________________________________________________________________________
________ 
 
 
X-ray crystallographic data for 
2-((1S,2S,3R)-3-(benzyloxy)-2-(tert-butoxymethyl)-1-phenethylcyclopentyl)-4,4,5,5-te
tramethyl-1,3,2-dioxaborolane (Compound S3.8). 
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Table S3.12. 
Crystal data and structure refinement for 
2-((1S,2S,3R)-3-(benzyloxy)-2-(tert-butoxymethyl)-1-phenethylcyclopentyl)-4,4,5,5-te
tramethyl-1,3,2-dioxaborolane (Compound S3.8). 
Identification code  C31H45BO4 
Empirical formula  C31H45BO4 
Formula weight  492.48 
Temperature  100(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions a = 26.2433(11) ≈ a= 90∞. 
 b = 17.5408(7) ≈ b= 90∞. 
 c = 6.2731(3) ≈ g = 90∞. 
Volume 2887.7(2) ≈3 
Z 4 
Density (calculated) 1.133 Mg/m3 
Absorption coefficient 0.564 mm-1 
F(000) 1072 
Crystal size 0.360 x 0.240 x 0.180 mm3 
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Theta range for data collection 3.030 to 69.934∞. 
Index ranges -31<=h<=31, -21<=k<=18, -6<=l<=7 
Reflections collected 22546 
Independent reflections 4866 [R(int) = 0.0631] 
Completeness to theta = 67.679∞ 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7533 and 0.5608 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4866 / 393 / 401 
Goodness-of-fit on F2 1.057 
Final R indices [I>2sigma(I)] R1 = 0.0352, wR2 = 0.0899 
R indices (all data) R1 = 0.0368, wR2 = 0.0912 
Absolute structure parameter 0.06(12) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.189 and -0.169 e.≈-3 
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Table S3.13. 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 
103) 
for C31H45BO4.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________
________  
 x y z U(eq) 
________________________________________________________________________
________   
O(1) 3636(1) 6170(1) 3554(2) 21(1) 
O(2) 3680(1) 4596(1) 7018(2) 22(1) 
B(1) 2301(1) 4380(1) 3302(4) 20(1) 
C(1) 3375(1) 5467(1) 3104(3) 19(1) 
C(2) 3037(1) 5197(1) 4987(3) 18(1) 
C(3) 2474(1) 5196(1) 4159(3) 18(1) 
C(4) 2499(1) 5778(1) 2310(3) 21(1) 
C(5) 3011(1) 5617(1) 1255(3) 22(1) 
C(6) 4045(1) 6079(1) 5011(4) 22(1) 
C(7) 4374(1) 6783(1) 5004(3) 20(1) 
C(8) 4436(1) 7217(1) 3181(4) 22(1) 
C(9) 4763(1) 7844(1) 3176(4) 26(1) 
C(10) 5036(1) 8028(1) 5001(4) 27(1) 
C(11) 4976(1) 7596(1) 6831(4) 28(1) 
C(12) 4643(1) 6977(1) 6840(4) 24(1) 
C(13) 3210(1) 4446(1) 5971(3) 20(1) 
C(14) 3998(1) 3956(1) 7578(4) 26(1) 
C(15) 4426(1) 4324(1) 8857(4) 38(1) 
C(16) 4212(1) 3580(1) 5589(4) 38(1) 
C(17) 3708(1) 3388(1) 8954(5) 39(1) 
O(3) 2500(2) 4007(2) 1709(8) 22(1) 
C(18) 2256(2) 3251(2) 1658(8) 25(1) 
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C(19) 1744(2) 3408(2) 2781(6) 22(1) 
O(4) 1884(2) 4016(2) 4264(6) 22(1) 
C(20) 2606(3) 2722(5) 2866(16) 36(2) 
C(21) 2217(8) 3017(12) -680(20) 43(4) 
C(22) 1342(2) 3742(3) 1316(12) 35(1) 
C(23) 1527(7) 2728(7) 3990(30) 36(3) 
O(3X) 2323(2) 4150(2) 1138(7) 24(1) 
C(18X) 2014(2) 3453(2) 974(8) 26(1) 
C(19X) 2053(2) 3127(2) 3272(7) 22(1) 
O(4X) 2122(2) 3817(2) 4544(5) 18(1) 
C(20X) 2218(9) 2932(12) -710(20) 32(3) 
C(21X) 1480(3) 3709(4) 370(12) 36(2) 
C(22X) 1582(6) 2724(7) 4070(20) 28(3) 
C(23X) 2525(3) 2630(5) 3601(14) 26(2) 
C(24) 2109(1) 5444(1) 5954(3) 21(1) 
C(25) 1567(1) 5633(1) 5174(4) 33(1) 
C(26) 1199(1) 5684(1) 7013(4) 27(1) 
C(27) 842(1) 5110(1) 7365(4) 32(1) 
C(28) 530(1) 5128(1) 9155(5) 36(1) 
C(29) 566(1) 5715(1) 10595(4) 32(1) 
C(30) 912(1) 6299(1) 10249(4) 32(1) 
C(31) 1223(1) 6281(1) 8467(4) 29(1) 
________________________________________________________________________
________ 
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Chapter 4 
4 Total Synthesis of Natural Product Arenolide 
 
4.1 Introduction 
Arenolide, a fourteen-membered macrolide, was isolated from the methanolic 
extract of a specimen of Dysidea species from Palau. Faulkner and coworkers 1 
determined its chemical structure through the analysis of NOESY data, which was 
published in 1998. However, neither the relative configuration of the alcohols at carbon 
19 and carbon 21 was clear, nor was the absolute configuration. Arenolide demonstrated 
relatively low cytotoxicity against HCT human colon carcinoma cells (IC50: 21 mM) and 
A2780 human ovarian carcinoma cells (IC50: 9.8 mM). Based on the fact that macrolides 
had never been reported to be isolated from Dysidea specices before, Faulkner and 
coworkers proposed that arenolide might be secreted by other organisms and then 
absorbed by sponges nearby. 
 
 
                                                
 
1 Lu, Q.; Faulkner, D. J. J. Nat. Prod. 1998, 61, 1096-1100. 
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Scheme 4.1 Chemical Structure of Arenolide 
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While there is no reported total synthesis of Arenolide, Dr. Aaron Cullen and Dr. 
Carolynn Arpin in Professor Sammakia’s group attempted its preparation. 2  They 
envisioned that the fourteen-membered ring can be cyclized enantioselectively through an 
intramolecular vinylogous aldol3 reaction from advanced intermediate 4.3, which could 
be constructed from methyl ketone 4.4 and aldehyde 4.5 through a 1,5 anti-aldol reaction. 
To make the synthesis more flexible and modifiable, they simplified the fragment 4.5 into 
much simpler aldehyde 4.6. In their model study, even though fourteen-membered 
cyclized products were detected from mass spectrometry, they could not isolate the 
desired isomer, let alone determine the accurate yield or diastereoselectivity. 
 
                                                
 
2 Arpin, C. C. (2011)  Cross-Metathesis of Electron-Deficient Polyenes and Studies Toward the Total 
Synthesis of Arenolide (PhD’s thesis). Retrieved from ProQuest Dissertations and Theses database. (UMI 
No. 3507956 ) 
3 Abramite, J. A.; Sammakia, T. Org. Lett. 2007, 9, 2103-2106.   
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Scheme 4.2 Original Retrosynthesis of Arenolide Proposed by Sammakia and 
Coworkers 
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To tackle the low diastereoselectivity issue, the Sammakia team devised a 
second-generation synthesis towards arenolide. Instead of employing 1,5 anti-aldol 
reaction, they attempted to apply vinyl metal 4.8 in an addition to an enantioenriched 
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epoxide 4.9. However, no matter how hard they tried (vinyl lithium,4 vinyl magnesium 
bromide5), they never obtained the epoxide-opened product 4.7.  
 
Scheme 4.3 Second Generation Approach to Arenolide by Sammakia and 
Coworkers 
Me HO
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To address this problem, they examined a Suzuki coupling reaction between vinyl 
iodide 4.10 and 1,2-bis(boronic) ester 4.11, and then oxidized the secondary boronic ester 
                                                
 
4 (a) Lipshutz, B. H.; Koerner, M.; Parker, D. A. Tetrahedron Lett. 1987, 28, 945-948. (b) Pattenden, G.; 
González, M. A.; Little, P. B.; Millan, D. S.; Plowright, A. T.;  Tornos, J. A.; Ye, T. Org. Bio. Chem. 2003, 
1, 4173-4208. 
5 (a) Knochel, P.; Dohle, W.; Gommermann, N.; Kneisel, F. F.; Kopp, F.; Korn, T.;  Sapountzis, I.; Vu, V. 
A. Angew. Chem. Int. Ed. 2003, 42, 4302-4320. (b) Ren, H.; Krasovskiy, A.; Knochel, P. Org. Lett. 2004, 6, 
4215-4217. 
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into an alcohol. In this manner, the enantioenriched homoallylic secondary alcohol 4.12 
was furnished in 62% yield. However, when this methodology was applied with the 
substrate for the synthesis of arenolide, no desired product was obtained. 
 
Scheme 4.4 Pd-Catalyzed Cross Coupling of 1,2-Bis(boronic) Esters and Vinyl 
Iodide 
OTBS
(pin)B
B(pin)
Me I
TBSO
1, Pd(PPh3)4,
TlOEt, 40 oC
2, NaOH, H2O2 Me
TBSO OH
OTBS
62% yield
4.10
4.11
4.12
 
 
4.2 Background 
Recently our group developed a series of robust methods to build 
homoallylic/homobenzylic6 (Scheme 4.5) and allylic7/benzylic8 (Scheme 4.6) secondary 
boronic esters in an enantioselective fashion. As shown below, the mono-substituted 
terminal alkene could undergo catalytic enantioselective diboration with a 
phosphoamidite derivative as the chiral ligand to afford 1,2-bis(boronic) ester 4.14. In the 
                                                
 
6 Mlynarski, S. N.; Schuster C. H.; Morken J. P. Nature 2014, 505, 386-390. 
7 Potter, B.; Szymaniak, A. A.; Edelstein, E. K.; Morken. J. P. J. Am. Chem. Soc. 2014, 136, 17918-17921. 
8 Sun, C.; Potter B.; Morken J. P. J. Am. Chem. Soc. 2014, 136, 6534-6537. 
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presence of the secondary boronic ester, only the primary one was coupled with vinyl 
halides or aryl halides to deliver a homoallylic/homobenzylic boronate 4.15 in good 
yields. 
Meanwhile, our group also established that with the combination of Josiphos and 
PdCl2 (L1PdCl2), 1,1-diboryl alkanes and tri-substituted alkenyl halides could be 
merged together through Suzuki coupling reaction, delivering an enantioenriched 
secondary allylic boronic ester 4.18 (Scheme 4.6). 
Scheme 4.5 Diboration and Cross-Coupling Reaction 
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Scheme 4.6 Suzuki Coupling Reaction between 1,1-Diboranes and Alkenyl 
Halides 
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More recently, our group developed a transition metal-free version of the catalytic 
enantioselective diboration of terminal alkenes.9 Subsequently, the allylic secondary 
boronate was then oxidized to alcohol 4.20 in a stereoretentive fashion. This 
transformation was achieved with pseudoenantiomeric glycols 
6-tert-butyldimethylsilyl-1,2-dihydroglucal (TBS-DHG) and dihydrorhamnal (DHR), 
which could be obtained readily from commercial available cheap starting material 
D-glucal and L-rhamnal. Through mechanistic studies, 1,2-bonded B2(TBS-DHG)2 was 
believed to be the reactive intermediate. 
 
                                                
 
9 Fang, L.; Yan, L.; Haeffner, F.; Morken, J. P. J. Am. Chem. Soc. 2016, 138, 2508-2511. 
251 
 
Scheme 4.7 Synthesis of Homoallylic Alcohol Catalyzed by a Carbohydrate 
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Since boronic esters can be easily oxidized, they are regarded as masked alcohols. 
We wondered whether these catalytic methodologies could be well knitted into the total 
synthesis of natural product Arenolide. 
Pursuing this proposal, this project was initiated by previous group member Dr. 
Mlynarski, and Dr Chunrui Sun, who both made significant contributions to this total 
synthesis. However, the two methodologies (Scheme 4.6 and 4.7) mentioned above were 
not available approaches and my research has focused on an alternate route. 
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4.3 Total Synthesis of Natural Product Arenolide 
When we revisited Arenolide, we decided to modify the original synthetic route to 
cyclize the fourteen-membered ring by selective macrolactonization. Also, we altered 
routes to incorporate updated methodologies that reduce the use of toxic reagents and 
make the synthesis more concise.  
Demonstrated below is the retrosynthetic analysis of Arenolide. We envisioned 
that the fourteen-membered ring could be cyclized by Yamaguchi lactonization.10 The 
precursor for the cyclization step could be accessed from the Suzuki coupling reaction 
between 1,2-bis(boronate) 4.22 and alkenyl chloride 4.23.11 The fragment A (4.22) was 
then traced back to another 1,2-diboron 4.24, which was allowed to react with 
1,1-disubstituted alkenyl bromide 4.25. To obtain 1,2-bis(boronic) ester 4.24, readily 
accessible geminal bis(boronate) 4.26 was proposed to cross couple with trisubstituted 
alkenyl bromide 4.27 in a catalytic and enantioselective manner.12 
 
 
 
                                                
 
10 Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 
1989-1993. 
11 Mlynarski, S. N.; Schuster C. H.; Morken J. P. Nature 2014, 505, 386-390. 
12  Potter, B.; Szymaniak, A. A.; Edelstein, E. K.; Morken. J. P. J. Am. Chem. Soc. 2014, 136, 
17918-17921. 
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Scheme 4.8 Retrosynthetic Analysis of Arenolide 
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We began our synthesis journey with readily available 1,1-diboryl methane 4.28. 
After deprotonation of the acidic methylene carbon, alkyl halide 4.29 was added to 
furnish the alkylated product 4.26. The geminal bis(boronic) ester 4.26 was then allowed 
to couple with tri-substituted alkenyl bromide 4.27 in the presence of catalytic amount 
L1PdCl2 to afford allylic boronic ester 4.30 with high enantioselectivity. The possible 
byproducts of Heck reaction, as well as possible byproducts from alkene-isomerization, 
were not observed. The boronic ester 4.30 was then converted into an alcohol (not 
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shown), and protected with silyl ether to deliver diol 4.31. With the terminal alkene 
obtained, we were well positioned to carry out the enantioselective diboration 
regioselectively to give the 1,2-di(boronate) 4.21 in a good yield and with excellent 
diastereoselectivity. A Suzuki coupling between 1,1-disubstituted alkenyl bromide 4.25 
and 1,2-bis(boronic) ester 4.21 was then performed smoothly to give enantioenriched 
secondary boronic ester in 88% yield. The boronate was then oxidized into the desired 
alcohol, followed by protection as a silyl ether to afford triene product 4.32 in a good 
yield. This terminal alkene 4.32 was then subjected to the platinum catalyzed 
enantioselective diboration condition to deliver 1,2-bis(boronic) ester 4.22 in 86% yield 
with over 20:1 diastereoselectivity. 
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Scheme 4.9 Forward Synthesis of Fragment A 
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The alkenyl coupling partners 4.25 and 4.27 (shown in Scheme 4.9) are not 
commercially available and were synthesized in the lab. We envisioned that both 
fragments could be derived from the same starting material 1-penten-4-yne (4.35). As 
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demonstrated in Scheme 4.10 equation 1, cross-coupling between ethynyl magnesium 
bromide (4.33) and allyl bromide 4.34 was carried out.13 Based on the 1H NMR, the 
desired product 1-penten-4-yne 4.35 was formed. However, due to its low boiling point 
(41 °C), isolation by column chromatography was not practical as the pentane solvent has 
a boiling point of 36 °C, which is very similar to the product. Instead, 1-penten-4-yne 
4.35 was distilled out from the reaction mixture, and sealed in a flask with a rubber 
septum in the freezer. However, due to the extreme volatility of this compound, we were 
unable to successfully store it. 
Then bromination-based synthetic route in equation 2 in Scheme 4.10 was 
evaluated. However, the E/Z configuration ratio of the desired product stereoisomer of 
alkenyl bromide 4.37 to the minor compound was only 4:1 after the elimination step, 
which was unsatisfactory for the synthetic utilization.14 
After searching resources again, we considered 1-penten-4-yne 4.35 from GFS as 
a relatively cheap (10 g/ 106.6 $) starting material. With this commercially available 
starting material in hand, we easily synthesized the tri-substituted alkene 4.27 through 
zirconium-catalyzed hydroalumination reaction followed by trapping with 
N-bromosuccinimide to deliver the desired product 4.27 in a relatively good yield.  
                                                
 
13 Zhu, G.; Negishi, E. Chem.-Eur. J. 2008, 14, 311-318. 
14 Taber, D. F.; Sikkander, M. I.; Storck, P. H. J. Org. Chem. 2007, 72, 4098-4101. 
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To obtain diene fragment 4.25, copper-catalyzed cross coupling15 between allyl 
bromide 4.39 and vinyl Grignard 4.40 was attempted. However, the reaction was not 
efficient enough and afforded product 4.25 in more than 10% yield. Delightfully, the 
methodology developed by Hoveyda and coworkers 16  lighted our synthesis. 
Nickel-catalyzed hydroalumination at the internal position, followed by trapping with 
N-bromosuccinimide worked beautifully for our substrate, providing desired alkenyl 
bromide 4.25 in 38% yield. This yield might due to the loss of some fractions during 
isolation, as product 4.25 has a low boiling point around 100 °C. 
 
 
 
 
 
 
 
 
 
 
                                                
 
15 Watanabe, K.; Minato, H.; Murata, M.; Oishi, T. Heterocycles 2007, 72, 207-212. 
16 Gao, F.; Hoveyda A. H. J. Am. Chem. Soc. 2010, 132, 10961-10963. 
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Scheme 4.10 Synthesis of Vinyl Bromide Fragments 
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The synthesis of alkenyl chloride fragment B was more straightforward. Under 
the catalysis of copper iodide, vinyl magnesium bromide could open enantioenriched 
epoxide 4.41 to deliver a secondary alcohol17 (not shown), which was then protected 
with silyl chloride to deliver protected homoallylic alcohol 4.42 in 62% yield. The 
                                                
 
17 Mlynarski, S. N.; Schuster C. H.; Morken J. P. Nature 2014, 505, 386-390. 
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terminal alkene 4.42 could also undergo enantioselective diboration under the catalysis of 
TBS-DHG to establish 1,2-bis(boronate) (not shown). The primary boronic ester was 
then coupled with vinyl bromide in the presence of vicinal secondary boronate, the latter 
was then oxidized into an alcohol to deliver 1,3-trans diol product 4.43. The secondary 
alcohol 4.43 was protected with a silyl group to afford compound 4.44. Hydroboration of 
the terminal alkene 4.44 resulted in the formation of a primary organoborane (not shown), 
which could then undergo Suzuki coupling18 with 1,1-dichloroethene to furnish vinyl 
chloride fragment B in a good yield. 
 
 
 
 
 
 
 
 
 
 
                                                
 
18 Liron, F.; Fosse, C.; Pernolet, A.; Roulland, E. J. Org. Chem., 2007, 72, 2220-2223. 
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Scheme 4.11 Synthesis of Alkenyl Chloride Fragment B 
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With fragment A (4.22) and fragment B (4.23) in hand, we next explored to 
engage the two halves together. The yield for the cross coupling was 50%, which was 
respectable considering the presence of multiple functional groups involved. We 
hypothesized that β−H elimination and palladium-involved deborylation were the two 
major side reactions, which lead to terminal alkenes observed as the byproducts. 
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Scheme 4.12 Cross-Coupling to Engage Fragment A and Fragment B Together 
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With advanced intermediate 4.46 in hand, we proceeded to selectively deprotect 
the primary alcohol to afford compound 4.47. Among the conditions we examined, this 
1N hydrochloric acid in THF reaction condition offered the best yield, even though this 
reaction was sensitive to reaction time (12 hours) and temperature (0 °C). The alcohol 
was then oxidized into aldehyde19 (not shown), which was converted into carboxylic 
acid20 4.48 in a good yield. The boronic ester in 4.48 was then unmasked through 
oxidation, and the generated alcohol esterified with carboxylic acid intramolecularly21 to 
                                                
 
19 (a) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155-4156. (b) Dess, D. B.; Martin, J. C. J. Am. 
Chem. Soc. 1991, 113, 7277-7287. 
20 (a) Lindgren, B. O.; Hilsson, T. Acta Chem. Scand. 1973, 27, 888-890. (b) Kraus, G. A.; Taschner, M. J. 
J. Org. Chem. 1980, 45, 1175-1176. (c) Kraus, G. A.; Roth, B. J. Org. Chem. 1980, 45, 4825-4830. (d) Bal, 
B. S.; Childers, W. E., Jr.; Pinnick, H. W. Tetrahedron 1981, 37, 2091-2096.  
21 Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 
1989-1993. 
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afford the fourteen-membered ring 4.49 exclusively. After global deprotection,22 the 
desired product 4.21 was delivered in 82% yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
 
22 Paterson, I.; Britton, R.; Delgado, O.; Gardner, N. M.; Meyer, A.; Naylor, G. J.; Poullennec, K. G. 
Tetrahedron 2010, 66, 6534-6545. 
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Scheme 4.5 Late Stage Functional Group Manipulation of Isomer 1 
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The route to synthesize the enantiomer of fragment B 4.23 is very similar to the 
strategy mentioned above, with the exception of using the enantiomer of the epoxide 4.41 
and inducing the opposite stereocenter in the catalytic enantioselective diboration step. 
Starting from commercial available (R)-propylene oxide, which was opened by vinyl 
magnesium bromide from the less hindered side to deliver the homoallylic alcohol (not 
shown). The alcohol was then protected with silyl ether to provide ent-4.42. 
Platinum-catalyzed enantioselective diboration of terminal alkene with ent-4.42 then 
delivered 1,2-bis(boronic) ester (not shown) in 50% yield, which then cross coupled with 
vinyl bromide to tether an alkene moiety. The untouched secondary boronate was then 
oxidized to alcohol to give ent-4.43 and protected with silyl ether to deliver 1,3-trans diol 
ent-4.44. Hydroboration of terminal alkene ent-4.44 with 9-BBN dimer afforded primary 
alkyl borane, which underwent cross coupling with 1,1-dichloroethene to furnish the 
enantiomer of fragment B ent-4.23. 
 
 
 
 
 
 
 
265 
 
Scheme 4.14 Construction of Enantiomer of Alkenyl Chloride Fragment B 
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O
(3.0 equiv)ent-4.41 ent-4.42
ent-4.43 ent-4.44
ent-4.23
59% yield
 
 
The palladium/Ruphos-catalyzed Suzuki coupling between fragment A (4.22) and 
ent-fragment B (ent-4.23) with Ruphos as the ligand went very smoothly to deliver the 
advanced synthetic intermediate 4.50 in 51% yield. 
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Scheme 4.15 Cross-Coupling to Piece Fragment A and ent-Fragment B Together 
Cl Me
TBSO OTBS
   5% Pd(OAc)2
  5% Ruphos 
   KOH (3.0 equiv)
  THF/H2O, 70 oC Me (pin)B
TBSO OTBS
OTBS
Me
TBSO OTBS
51% yield
4.50
4.22
Me (pin)B
TBSO OTBS
OTBS
B(pin)
ent-4.23  
 
With the core structure 4.51 in hand, we moved on to selectively deprotect the 
primary alcohol among the five silyl ether protected ones to deliver compound 4.52. The 
exposed alcohol was then converted to aldehyde through Dess-Martin oxidation, which 
was further oxidized to carboxylic acid (not shown) through Pinnick oxidation. The 
masked boronic ester was then unveiled by oxidation. The total yield of these three steps 
was 73%. Yamaguchi lactonization was then carried out to construct the 
fourteen-membered ring core structure 4.54 in a very efficient way. After deprotecting 
the silyl ether globally, isomer 2 (compound 4.55) was accomplished in 51% yield. 
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Scheme 4.16 Late Stage Functional Group Manipulation of Isomer 2 
1N HCl 
THF, 0 oC
Me O
TBSO O
OTBS
Me
TBSO OTBS
61% yield
DMP, NaHCO3
 2),NaBO3 4H2O
 H2O, THF
73% yield over three steps
> 98% yield
HF  pyridine
THF, 0 oC to rt
Me (pin)B
TBSO OH
OTBS
Me
TBSO OTBS
Me (pin)B
TBSO
OTBS
Me
TBSO OTBS
Me (pin)B
TBSO OTBS
OTBS
Me
TBSO OTBS
O
4.51
4.52
4.53
4.54
 1), NaClO2, NaH2PO4
     tBuOH, CH3CN
     2-methyl-2 butene
3), DMAP, NEt3, THF, toluene
2,4,6-trichlorobenzoyl chloride
Me O
HO O
OH
Me
HO OH
4.55
51% yield  
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The other two diastereomers (4.56 and 4.59 as shown in Scheme 4.17) of 
fragment B were also synthesized by applying a very similar strategy, only with different 
combination of enantioenriched epoxides and catalysts for enantioselective diboration in 
the sense of chirality. Both alkenyl chloride diastereomers (4.56 and 4.59) underwent 
Suzuki coupling reaction with fragment A to deliver the advanced intermediate 4.57 and 
4.60. However, as far as late stage functional group manipulations went, we did not have 
enough material to carry forward to the end to obtain isomer 3 and isomer 4. 
 
Scheme 4.17 Attempt to Synthesize Isomer 3 and Isomer 4 
 
Cl Me
TBSO OTBS
Me (pin)B
TBSO OTBS
OTBS
Me
TBSO OTBS
4.57
Me O
HO O
OH
Me
HO OH
4.58
4.56
isomer 3  
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Cl Me
TBSO OTBS
Me (pin)B
TBSO OTBS
OTBS
Me
TBSO OTBS
4.604.59
Me O
HO O
OH
Me
HO OH
4.61
isomer 4  
 
 
4.4 Determination of the Stereostructure of Arenolide among Possible 
Stereoisomers 
The reported 13C NMR data suggests that the alcohols at C19 and C21 position 
are in a trans relationship. 
Hoffman and coworkers 23  found the 13C chemical shifts of 1,3-anti-diols 
normally occur upfield by about 4 ppm comparing to that of 1,3-syn-diols. This is 
probably due to the axial substituent of 1,3-anti-diols resulting from a hydrogen-bonded 
cyclic conformation, while the substituents on 1,3-syn-diols usually adopts an equatorial 
                                                
 
23 Hoffmann, R. W.; Weidmann, U. Chem. Ber. 1985, 118, 3980-3992. 
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position. They also noted that the sum of the two carbinol carbons of anti-1,3-diols is 
usually less than 140 ppm (Table 4.2) and the 13C chemical resonance sum of 
syn-1,3-diols is usually more than 140 ppm. (Data shown in Table 4.1). This theory was 
later adopted by Brückner and coworkers24 in assigning the configuration of the 1,3-diol 
products. 
                                                
 
24 Diehl, J.; Brückner, R. Eur. J. Org. Chem. 2017, 278-286. 
271 
 
Table 4.1. Carbon Chemical Shifts of 1,3-syn-Diols 
R1 R2
HO OH
1 3
 
Entry R1 R2 δC-1 [ppm] δC-3 [ppm] Sum [ppm] 
1 CH3 -CH2-CH=CH2 68.6 71.7 140.3 
2 CH3 -(CH2)3-C(CH3)=CH2 68.8 72.2 141.0 
3 CH3 -C(CH3)2-CH=CH2 69.1 79.3 148.4 
4 CH3 -CH2CH2CH3 68.5 72.1 140.6 
5 CH3 -CH2CH2CH2CH3 69.3 73.3 142.6 
6 cPr CH3 78.0 68.8 146.8 
7 iPr CH3 78.1 69.5 147.6 
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Table 4.2. Carbon Chemical Shifts of 1,3-anti-Diols 
R1 R2
HO OH
1 3
 
Entry R1 R2 δC-1 
[ppm] 
δC-3 [ppm] Sum [ppm] 
1 CH3 -CH2-CH=CH2 65.0 68.0 133.0 
2 CH3 -(CH2)3-C(CH3)=CH2 64.8 68.5 133.3 
3 CH3 -C(CH3)2-CH=CH2 65.5 74.4 139.9 
4 CH3 -CH2CH2CH3 64.9 68.5 133.4 
5 CH3 -CH2CH2CH2CH3 65.7 69.6 135.3 
6 cHex CH3 73.5 65.8 139.3 
7 iPr CH3 74.1 65.8 139.9 
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Our model studies of substrates 27 and 28 also supported this theory. The sum of 
13C chemical shifts of anti-1,3-diols is 134.61 ppm (Table 3, entry 1), while for 
syn-1,3-diols, the sum is 141.86 ppm (Table 3, entry 2). 
 
 
1,3-Diol Substrates δC-1 [ppm] δC-3 [ppm] Sum [ppm] 
Me
HO OH
Cl1 3  
65.61 69.00 134.61 
Me
HO OH
Cl1 3  
69.29 72.57 141.86 
 
The reported 13C chemical shifts of arenolide at C19 and C21 are 69.1 and 65.5 
ppm respectively. The sum of these two numbers is 134.6 ppm. These data indicated that 
the 1,3-diols of C19 and C21 in arenolide are in an anti relationship. 
 
The 1H and 13C NMR spectra of synthesized isomer 1 (4.21) and isomer 2 (4.55) 
were compared with the data collected from the natural product (Scheme 4.19 and 
Scheme 4.20). We found that isomer 1 matches much better with the reported spectra 
than isomer 2, while the latter has two significant differences in chemical shifts in 13C 
NMR spectra (shown in red in Scheme 4.20). We concluded that isomer 1 is more 
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consistent chemical structure as the natural product arenolide. Compared with the 
reported optical rotation number for arenolide ( [α]D +13.0° (c 0.64, CHCl3)), the optical 
rotation number for isomer 1 we synthesized is [α]D +5.997° (c 0.0667, CHCl3). This 
indicated that isomer 1 resembles the most of the naturally occuring arenolide. 
 
Scheme 4.8 Comparison of the 1H and 13C NMR Spectra of Isomer1 (4.21) and 
the Natural Product Arenolide 
Me O
HO O
OH
Me
OH OH
4.21
1
4
23
8
24
12 25
16 19 21
isomer 1  
 δH δC 
 Natural  
(400 MHz) 
Synthetic 
(600 MHz) 
Natural  
(100 
MHz) 
Synthetic 
(150 MHz) 
1   172.5 172.42 
2 2.12, m 
2.33, m 
2.12-2.18, m, 1H 
2.32, dt (14.2, 5.9), 1H 
34.3 34.29 
5 4.36, m 
(11.5, 8, 3.5) 
4.37, ddd 
(10.6, 9, 3.4) 
68.1 68.11 
6 5.10, d (11.5) 5.09, d (9.3) 129.4 129.35 
7   135.7 135.76 
8 1.88, dd (14.5, 10) 
2.64, dd (14.5, 4) 
1.89, dd (14.4, 10) 
2.64, dd (14.8, 4) 
44.6 44.60 
9 3.84, tdd (10, 4, 
1.5) 
3.84, tdd (10.2, 4, 1.8) 68.7 68.70 
10 1.93, dd (14, 10.5) 
2.67, d (14) 
1.94, dd (14.1, 10.5) 
2.67, d (14) 
43.6 43.61 
11   142.5 142.50 
12 2.22, m 
2.42, dd (16, 3.5) 
2.22, m, 1H 
2.42, dd (14.3, 3.5) 
38.4 38.41 
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13 5.21, tt (7, 3.5) 5.21, tt (7.5, 4.3) 71.4 71.32 
14 2.15, m 
2.30, m 
2.12-2.18, m, 1H 
2.27, m, 1H 
39.5 39.46 
15   145.1 145.14 
16 2.05, t (7), 2H 2.04, t (7.9), 2H 35.6 35.56 
19 3.94, pent (6) 3.94, pent (6) 69.1 69.14 
21 4.13, sext (6.5) 4.15, sext (6.0) 65.5 65.56 
22 1.22, d, (6.5), 3H 1.22, d, (6.3), 3H 23.6 23.65 
23 1.77, s, 3H 1.77, d, (1.5), 3H 20.1 20.14 
24 4.95, s 
5.08, s 
4.96, d, (1.9), 1H 
5.08, s, 1H 
117.9 117.96 
25 4.72, s 
4.78, s 
4.72, s, 1H 
4.78, d, (1.7), 1H 
112.6 112.62 
3 1.59, m, 2H 
1.22-1.75, m, 9H 
21.5 21.51 
17 1.48, m, 2H  23.7 23.67 
18 1.46, m, 2H 36.9 36.90 
20 1.58, m, 2H 44.2 44.16 
4 1.44, m 36.5 36.54 
1.88, m 
1.78-1.83, m 
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Scheme 4.20 Comparison of the 1H and 13C NMR Spectra of Isomer2 (4.55) and 
the Natural Product Arenolide 
Me O
HO O
OH
Me
HO OH
4.55
1
4
23
8
24
12 25
16 19 21
isomer 2  
 
 δH δC 
 Natural  
(400 MHz) 
Synthetic 
(600 MHz) 
Natural  
(100 
MHz) 
Synthetic 
(150 MHz) 
1   172.5 172.53 
2 2.12, m 
2.33, m 
2.12-2.19, m, 1H 
2.30-2.35, m 
34.3 34.35 
5 4.36, m 
(11.5, 8, 3.5) 
4.37, td 
(10.4, 3.3)) 
68.1 68.11 
6 5.10, d (11.5) 5.09, d (12.1) 129.4 129.33 
7   135.7 135.77 
8 1.88, dd (14.5, 10) 
2.64, dd (14.5, 4) 
1.89, dd (14.4, 10) 
2.64, dd (13.5, 4.4) 
44.6 44.61 
9 3.84, tdd (10, 4, 
1.5) 
3.84, t (9.1) 68.7 68.71 
10 1.93, dd (14, 10.5) 
2.67, d (14) 
1.94, dd (14.0, 10.5) 
2.68, d (14.2) 
43.6 43.60 
11   142.5 142.51 
12 2.22, m 
2.42, dd (16, 3.5) 
2.22-2.30, m, 1H 
2.43, dd (14.3, 3.5) 
38.4 38.39 
13 5.21, tt (7, 3.5) 5.20, tt (7.7, 3.8) 71.4 71.41 
14 2.15, m 
2.30, m 
2.12-2.19, m, 1H 
2.22-2.30, m, 1H 
39.5 39.48 
15   145.1 145.16 
16 2.05, t (7), 2H 1.97-2.12, m, 2H 35.6 35.25 
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19 3.94, pent (6) 3.96, pent (5.8) 69.1 68.80 
21 4.13, sext (6.5) 4.15, sext (6.0) 65.5 65.54 
22 1.22, d, (6.5), 3H 1.22, d, (6.5), 3H 23.6 23.62 
23 1.77, s, 3H 1.77, d, (1.4), 3H 20.1 20.13 
24 4.95, s 
5.08, s 
4.96, s, 1H 
5.09, s, 1H 
117.9 117.96 
25 4.72, s 
4.78, s 
4.72, s, 1H 
4.79, s 1H 
112.6 112.72 
3 1.59, m, 2H 
1.36-1.75, m, 9H 
21.5 21.50 
17 1.48, m, 2H  23.7 23.62 
18 1.46, m, 2H 36.9 36.84 
20 1.58, m, 2H 44.2 44.23 
4 1.44, m 36.5 36.58 
1.88, m 
1.78-1.83, m 
 
4.5 Conclusions 
In summary, we have accomplished the total synthesis of natural product 
arenolide, whose structure was further determined based on 1H and 13C NMR Spectra of 
synthesized ones. This synthesis features a catalytic enantioselective Suzuki coupling 
between geminal bis(boronic) esters and alkenyl halides, enantioselective diboration at 
terminal mono-substituted alkenes, followed by regioselective Suzuki coupling reaction, 
which is another important tool applied to construct the relatively complicated structure 
arenolide. The convergent synthetic strategy allowed the overall synthesis more efficient 
and modular, which also made it possible to streamline the synthesis of the two possible 
isomers. The data of these two isomers were also collected and compared with the natural 
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product, and the one more resembled to the natural product was determined to be (+) 
arenolide. 
 
 
 
4.6 Experimental Section 
4.6.1 General Information 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), or a 
Varian Inova-500 (500 MHz) spectrometer. Chemical shifts are reported in ppm with the 
solvent resonance as the internal standard (CDCl3: 7.26 ppm, THF-d8: 3.58 ppm). Data 
are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, qi = quintet, sx = sextet, sp = septet, m = multiplet, br = broad), and 
coupling constants (Hz). 13C NMR spectra were recorded on either a Varian Gemini-500 
(125 MHz), or a Varian Inova-500 (125 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm with the solvent resonance as the 
internal standard (CDCl3: 77.0 ppm, THF-d8: 67.57 ppm). Infrared (IR) spectra were 
recorded on a Bruker alpha-P Spectrometer. Frequencies are reported in wavenumbers 
(cm-1) as follows: strong (s), broad (br), medium (m), and weak (w). High-resolution 
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mass spectrometry (DART+) was performed at the Mass Spectrometry Facility, Boston 
College, Chestnut Hill, MA. 
Liquid chromatography was performed using forced flow (flash chromatography) 
on silica gel (SiO2, 230 − 400 Mesh) purchased from Silicycle. Thin layer 
chromatography (TLC) was performed on 25 µm silica gel glass backed plates from 
Silicycle. Visualization was performed using ultraviolet light (254 nm), 
phosphomolybdic acid (PMA) in ethanol and ceric ammonium molybdate (CAM) in 
ethanol. 
Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector.  
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), diethyl ether, dichloromethane 
and toluene were purified using Pure Solv MD-4 solvent purification system, from 
Innovative Technology, Inc., by passing the solvent through two activated alumina 
columns after being purged with argon. 
Bis(pinacolato)diboron was generously donated by Allychem Co., Ltd. and used 
without further purification. Triethylamine was purchased from Alfa Aesar and distilled 
over calcium hydride prior to use. The following reagents were purchased and used 
without purification: copper(I) iodide (CuI) (Aldrich), lithium 
2,2,6,6-tetramethylpiperidide (LTMP) (Aldrich), sodium tert-butoxide (NaOt-Bu) 
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(Strem), palmitic acid-1-13C (Cambridge Isotope Laboratories), and 
N,N-dimethylformamide (DMF) (Acros). All other reagents were purchased from either 
Aldrich, Alfa Aesar or Acros and used without further purification.  
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4.6.2 Full Characterization of Compounds	
LTMP, THF
TBSO
Br
B(pin)
B(pin)TBSO
1% (R, S)-PdCl2Josiphos
KOH, dioxane/H2O
Br
Me
1), NaOH, H2O2, THF
66% yield
(pin)B
TBSO
Me
2), NaBO3, H2O, THF
77% yield
3), TBSCl, imidazole
DMAP, DCM
68% yield
52% yield, 91:9 er
2),TBSCl, imidazole
DMAP, DCM
TBSO
TBSO
Me
83% yield, > 20:1 dr
   1), 5% Pd(OAc)2,  5% Ruphos, 
   KOH (4.5 equiv), THF/H2O, 70 oC
Br 88% yield
    2% Pt(dba)3,
    2.4% (S, S)-Taddol PPh
   B2Pin2 (1.5 equiv), 
THF, 70 oC
86% yield, > 20:1 dr
    1% Pt(dba)3,
    1.2% (R, R)-Taddol PPh
    B2Pin2 (1.05 equiv), 
THF, 70 oC
93% yield
B(pin)
B(pin)
4.28 4.26
4.27
4.30 4.31
4.24
4.32
4.25
89% yield
fragment A
Me (pin)B
TBSO OTBS
OTBS
B(pin)
4.22
Me
TBSO OTBS
OTBS
Me
B(pin)
TBSO OTBS
B(pin)
4.29
 
 
((5,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)pentyl)oxy)(tert-butyl)dimethylsilane (4.26). 
An oven-dried 50 mL round bottom flask was 
added 2,2,6,6-tetramethylpiperidine (1.86 mL, 11 
B
BTBSO
O
O
OO
Me
Me Me
Me
Me
Me
Me Me
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mmol) and THF (10 mL). The resulting solution was cooled down to -78 °C. nBuLi (4.4 
mL, 2.5 M, 11 mmol) was added dropwise into the solution under N2 protection, which 
was then warmed to room temperature gradually and stirred for 20 minutes give in orange 
clear LiTMP (lithium tetramethylpiperidide) solution. Another oven dried 100 mL round 
bottom flask was added bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane 1 (2.68 
g, 10 mmol) and THF (10 mL), The clear colorless solution was cooled to 0 °C. The 
LiTMP was cooled to 0 °C and added dropwise into the methyl diboronate ester solution, 
which lead to the formation of an orange cloudy slurry. The slurry was stirred for 10 
minutes at 0 °C, and then (4-bromobutoxy)(tert-butyl)dimethylsilane (3.47 g, 13 mmol) 
was added slowly. The mixture was stirred overnight, which resulted in orange cloudy 
solution. The reaction mixture was then quenched by diethyl ether, filtered through a 
short pad of silica gel. The filtrate was evaporated in vacuo. The crude reaction mixture 
was purified by column chromatography on silica gel (100:2 hexanes/ethyl acetate, stain 
in CAM) to afford 4.26 as a clear colorless oil (3.1 g, 68%). 1H NMR (600 MHz, CDCl3): 
δ 3.57 (t, J = 6.7 Hz, 2H), 1.57 – 1.53 (m, 2H), 1.50 (p, J = 6.9 Hz, 2H), 1.34 – 1.27 (m, 
2H), 1.22 (s, 12H), 1.22 (s, 12H), 0.88 (d, J = 0.9 Hz, 9H), 0.72 (t, J = 7.9 Hz, 1H), 0.03 
(d, J = 0.8 Hz, 6H); 13C NMR (150 MHz, CDCl3) δ 82.86, 63.42, 33.03, 28.83, 25.98, 
25.59, 24.82, 24.51, 18.34, -5.26; 11B NMR (160 MHz, CDCl3) δ 33.93; IR (neat): 2977.3 
(w), 2929.6 (m), 2857.3 (w), 1462.9 (w), 1359.7 (m), 1310.6 (s), 1264.0 (m), 1215.1 (w), 
1140.2 (s), 1099.6 (s), 1005.3 (w), 969.4 (m), 835.6 (s), 774.5 (m), 668.2 (w) cm-1; 
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HRMS-(DART+) for 12C231H4811B216O528Si123Na1 [M+Na]+: calculated: 477.3355, found: 
477.3371. 
 
(R,E)-tert-butyldimethyl((7-methyl-5-(4,4,5,5-tet
ramethyl-1,3,2-dioxaborolan-2-yl)deca-6,9-dien-
1-yl)oxy)silane (4.30). This compound was 
prepared according to a literature procedure25 with 
slightly modification. In the glove box, an oven dried two dram vial was added 
(R)-1-[(S)-2-(ditertbutylphosphanyl)ferrocenyl]ethyldi[4-(trifluoromethyl)phenyl]phosphi
ne with PdCl2 complex (1.8 mg, 0.002 mmol) and 1,4-dioxane (1 mL). The mixture was 
stirred for five minutes. Then 1,1-diborylalkane (118.1 mg, 0.26 mmol) and 
(E)-1-bromo-2-methylpenta-1,4-diene (32.2 mg, 0.2 mmol) were added. The vial was 
sealed with a Teflon cap, taken outside of the glove box, and injected with degased 8M 
KOH (112 µL, 0.9 mmol ). The orange clear solution was allowed to stir for 24 hours, 
resulting in a brown clear solution. This solution was extracted with diethyl ether, filtered 
through a short pad of silica gel pipet and concentrated in vacuo. The crude reaction 
mixture was then purified on silica gel (hexanes: ethyl acetate = 100:0.4 to 100:2) to 
afford 4.30 as a colorless oil (45.8 mg, 52%, 78% ee). 1H NMR (600 MHz, CDCl3): δ 
                                                
 
25  Potter, B.; Szymaniak, A. A.; Edelstein, E. K.; Morken. J. P. J. Am. Chem. Soc. 2014, 136, 
17918-17921. 
B
TBSO
Me
OO
Me
Me Me
Me
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5.76 (ddt, J = 16.8, 10.0, 6.7 Hz, 1H), 5.08 (dd, J = 9.7, 1.3 Hz, 1H), 5.01 (dq, J = 17.1, 
1.7 Hz, 1H), 4.96 (ddt, J = 10.0, 2.3, 1.2 Hz, 1H), 3.58 (t, J = 6.6 Hz, 2H), 2.70 (d, J = 6.8, 
1.5 Hz, 2H), 1.95 (dt, J = 9.6, 7.5 Hz, 1H), 1.58 (d, J = 1.3 Hz, 3H), 1.55 – 1.45 (m, 3H), 
1.43 – 1.32 (m, 2H), 1.30 – 1.23 (m, 1H), 1.22 (s, 6H),1.21 (s, 6H), 0.88 (s, 9H), 0.03 (s, 
6H); 13C NMR (150 MHz, CDCl3): δ 137.52, 132.56, 126.63, 115.15, 82.87, 63.31, 44.30, 
33.02, 31.32, 25.99, 25.56, 24.69, 24.54, 18.35, 16.34, -5.26; 11B NMR (160 MHz, 
CDCl3) δ 33.98; IR (neat): 2977.1 (w), 2953.6 (w), 2928.7 (m), 2856.7 (m), 1471.6 (w), 
1370.3 (m), 1317.5 (s), 1254.8 (m), 1214.9 (w), 1143.3 (s), 1099.8 (s), 1005.2 (w), 967.5 
(w), 909.7 (w), 835.7 (s), 774.9 (m), 663.2 (w) cm-1; [α]D +2.2° (c 1.14, CHCl3).  
 
 
(R,E)-1-((tert-butyldimethylsilyl)oxy)-7-methyldec
a-6,9-dien-5-ol (S4.1). THF (2 mL) and H2O (1 mL) 
were added into a scintillation vial with 
(R,E)-tert-butyldimethyl((7-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)deca-
6,9-dien-1-yl)oxy)silane (45.8 mg, 0.11 mmol). The vial was cooled to 0 °C and charged 
with sodium perborate monohydrate (109.8 mg, 1.1 mmol). The white cloudy slurry was 
allowed to stir overnight. The crude reaction mixture was purified by column 
chromatography on silica gel (100:1 hexanes/ethyl acetate, stain in CAM) to afford 4.1 as 
a colorless oil (21.7 mg, 66%). 1H NMR (600 MHz, CDCl3): δ 5.77 (ddt, J = 17.0, 10.1, 
HO
TBSO
Me
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6.9 Hz, 1H), 5.20 (ddt, J = 8.7, 2.5, 1.3 Hz, 1H), 5.09 – 5.00 (m, 2H), 4.36 (dt, J = 8.5, 
6.5 Hz, 1H), 3.60 (t, J = 6.5 Hz, 2H), 2.73 (d, J = 6.9 Hz, 2H), 1.67 (s, 3H), 1.64 – 1.57 
(m, 1H), 1.56 – 1.51 (m, 2H), 1.48 – 1.29 (m, 4H), 0.89 (d, J = 0.9 Hz, 9H), 0.04 (d, J = 
0.9 Hz, 6H); 13C NMR (150 MHz, CDCl3): δ 136.95, 136.14, 128.80, 116.28, 68.64, 
63.09, 43.92, 37.42, 32.71, 25.96, 21.74, 18.36, 16.62, -5.29; IR (neat): 3333.1 (br, w), 
2928.7 (m), 2857.2 (m), 1637.3 (w), 1471.7 (w), 1462.1 (w), 1432.9 (w), 1385.9 (w), 
1360.9 (w), 1253.4 (m), 1098.3 (s), 1004.4 (m), 912.3 (m), 833.3 (s), 733.4 (s), 712.6 (w), 
661.4 (m) cm-1; HRMS-(DART+) for 12C171H3416O228Si123Na1 [M+Na]+: calculated: 
321.2226, found: 321.2228; [α]D +5.9° (c 1.09, CHCl3). 
 
  
(R,E)-2,2,3,3,11,11,12,12octamethyl-5-(2-methyl
penta-1,4-dien-1-yl)-4,10-dioxa-3,11-disilatridec
ane (4.31). 
(R,E)-1-((tert-butyldimethylsilyl)oxy)-7-methyldeca-6,9-dien-5-ol (S4.1) (235 mg, 0.79 
mmol), DCM (3 mL), and imidazole (133.9 mg, 1.97 mmol) were added into a 20 mL 
scintillation vial sequentially. The solution was stirred until all solids dissolved, and was 
then cooled to 0 °C.  tert-Butyldimethylsilyl chloride (130 mg, 0.87 mmol) was 
subjected slowly into the above solution. A tip (about 2 mg) of 
4-(dimethylamino)pyridine was then added. The white slurry was allowed to stir 
TBSO
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overnight, which was then quenched by water, extracted with DCM and filtered through a 
sodium sulfate padded pipet. The colorless solution was concentrated in vacuo to give a 
colorless oil. The crude reaction mixture was purified by column chromatography on 
silica gel (100:0.5 – 100:3 hexanes/ethyl acetate, stain in CAM) to afford 5 as a colorless 
oil (290 mg, 89%). 1H NMR (600 MHz, CDCl3): δ 5.81 – 5.68 (m, 1H), 5.15 (dt, J = 8.7, 
1.3 Hz, 1H), 5.08 – 4.94 (m, 2H), 4.31 (td, J = 7.7, 5.0 Hz, 1H), 3.59 (t, J = 6.5 Hz, 2H), 
2.69 (d, J = 7.8 Hz, 2H), 1.60 (s, 3H), 1.53 – 1.46 (m, 2H), 1.39 – 1.33 (m, 2H), 1.32 – 
1.24 (m, 2H), 0.89 (s, 9H), 0.87 (s, 9H), 0.04 (s, 6H), 0.02 (s, 3H), 0.00 (s, 3H); 13C NMR 
(125 MHz, CDCl3): δ 136.46, 132.77, 130.51, 115.94, 69.79, 63.24, 43.99, 38.37, 32.86, 
25.99, 25.92, 21.83, 18.57,18.51, 16.51, -4.17, -4.76, -5.28; IR (neat): 2928.6 (m), 2856.7 
(m), 1252.24 (s), 1096.2 (s), 1004.5 (m), 938.3 (m), 912.9 (m), 832.0 (s), 771.8 (s), 664.0 
(w) cm-1; HRMS-(DART+) for 12C231H4816O228Si223Na1 [M+Na]+: calculated: 435.3091, 
found: 435.3081; [α]D +1.9° (c 1.26, CHCl3). 
 
  
(Z)-2,2'-(6-phenylhex-5-ene-1,1-diyl)
bis(4,4,5,5-tetramethyl-1,3,2-dioxabo
rolane)) (4.24). The reaction was 
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performed according to a previous procedure26 with slightly modification. To an oven 
dried 2-dram vial were added Pt(dba)3 (8.1 mg, 0.009 mmol), 
(R,R)-3,5-di-iso-propylphenyl-TADDOLPPh (9.8 mg, 0.011 mmol), B2(pin)2 (240 mg, 
0.945 mmol) and THF (0.9 mL) in the glove box. The vial was sealed with Teflon cap 
and heated at 70 °C for 20 minutes outside of the glovebox. The mixture was cooled to 
room temperature, and brought back into the glove box again. The solution was charged 
with 
(R,E)-2,2,3,3,11,11,12,12-octamethyl-5-(2-methylpenta-1,4-dien-1-yl)-4,10-dioxa-3,11-d
isilatridecane 4.31 (357mg, 0.9 mmol). The vial was heated at 70 °C outside of the glove 
box for 12 hours. Upon completion, the yellow solution was extracted with diethyl ether, 
filtered through a silica gel pipet and evaporated in vacuo. The crude reaction mixture 
was purified by column chromatography on silica gel (100:1 – 100:3 hexanes/ethyl 
acetate, stain in CAM) to afford 4.24 as a light yellow clear oil (500 mg, 83%). 1H NMR 
(500 MHz, CDCl3): δ 5.12 (d, J = 8.7 Hz, 1H), 4.29 (td, J = 8.0, 5.2 Hz, 1H), 3.58 (t, J = 
6.6 Hz, 2H), 2.20 (dd, J = 13.6, 7.0 Hz, 1H), 1.93 (dd, J = 13.6, 8.2 Hz, 1H), 1.57 (s, 3H), 
1.53 – 1.44 (m, 3H), 1.39 – 1.32 (m, 1H), 1.32 – 1.24 (m, 3H), 1.22 (s, 24H), 0.89 (s, 9H), 
0.86 (s, 9H), 0.77 (dd, J = 13.5, 7.5 Hz, 2H), 0.04 (s, 6H), 0.00 (d, J = 8.6 Hz, 6H); 13C 
NMR (125 MHz, CDCl3): δ 134.06, 130.36, 82.82, 82.74, 69.85, 63.31, 43.14, 38.50, 
                                                
 
26 Mlynarski, S. N.; Schuster, C. H.; Morken, J. P. Nature 2014, 505, 386-390. 
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32.90, 25.99, 25.93, 24.91, 24.88, 24.83, 24.76, 21.88, 18.37, 18.22, 16.08, -4.17, -4.82, 
-5.28; 11B NMR (160 MHz, CDCl3) δ 34.08; IR (neat): 2976.9 (w), 2954.6 (m), 2929.3 
(s), 2856.9 (m), 1471.8 (w), 1370.4 (m), 1315.3 (m), 1253.8 (m), 1143.2 (m), 1095.8 (m), 
968.9 (w), 834.9 (s), 774.1 (s) cm-1; HRMS-(DART+) for 12C351H7611B216O628Si214N1 
[M+NH4]+: calculated: 684.5397, found: 684.5419; [α]D +6.9° (c 1.35, CHCl3). 
 
 
(5R,9R,E)-9-((tert-butyldimethylsilyl)ox
y)-2,2,3,3,7,15,15,16,16-nonamethyl-5-(
2-methylenepent-4-en-1-yl)-4,14-dioxa-
3,15-disilaheptadec-7-ene (4.32). The reaction was performed according to a previous 
procedure27 with slightly modification. In the glove box, an oven dried 20 mL vial was 
added Pd(OAc)2 (7.52 mg, 0.0335 mmol), Ruphos (15.63 mg, 0.0335 mmol) and THF (6 
mL). The mixture was allowed to stir for 5 minutes before adding 4.24 (445 mg, 0.67 
mmol), and 2-bromopenta-1,4-diene (394 mg, 2.68 mmol) sequentially. The vial was 
sealed and brought outside of the glove box. Degassed 8M KOH (0.376 mL, 3.02 mmol) 
and degassed H2O (0.6 mL) were added into the vial. The vial was heated at 70 °C 
overnight. The solution changed color from orange red to black. The reaction mixture 
                                                
 
27 Mlynarski, S. N.; Schuster, C. H.; Morken, J. P. Nature 2014, 505, 386-390. 
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was then extracted with diethyl ether, dried over Na2SO4 and evaporated in vacuo. The 
crude reaction mixture was purified by column chromatography on silica gel (100:1 – 
100:3 hexanes/ethyl acetate, stain in CAM) to afford 
(R)-2,2,3,3,11,11,12,12-octamethyl-5-((R,E)-2-methyl-6-methylene-4-(4,4,5,5-tetramethy
l-1,3,2-dioxaborolan-2-yl)nona-1,8-dien-1-yl)-4,10-dioxa-3,11-disilatridecane S4.2 as a 
yellow clear oil (358 mg, 88%).  
This compound S4.2 was oxidized as follows: A 20 mL scintillation vial was added 
boronic ester S4.2, THF (8 mL) and H2O (8 mL). The solution was cooled to 0 °C, and 
then subjected with sodium perborate monohydrate (439.9 mg, 4.4 mmol). The mixture 
was allowed to stir overnight. The solution was quenched by H2O, extracted with diethyl 
ether, dried over Na2SO4 and evaporated in vacuo. The crude reaction mixture was 
purified by column chromatography on silica gel (100:1 – 100:3 hexanes/ethyl acetate, 
stain in CAM) to afford 
(6R,10R,E)-10,14-bis((tert-butyldimethylsilyl)oxy)-8-methyl-4-methylenetetradeca-1,8-d
ien-6-ol S4.3 as a colorless oil (335 mg, 77%). 
The alcohol S4.3 was protected as shown: alcohol S4.3 (277 mg, 0.56 mmol), DCM (2 
mL) and imidazole (95 mg, 1.4 mmol) were added into a 20 mL scintillation vial 
sequentially. The mixture was stirred until all solids dissolved, and was then cooled to 
0 °C.  tert-Butyldimethylsilyl chloride (92.4 mg, 0.61 mmol) was added slowly into the 
above solution. A tip (about 2 mg) of 4-(dimethylamino)pyridine was then added. The 
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white slurry was allowed to stir overnight, which was then quenched by water, extracted 
with DCM and dried over Na2SO4. The colorless solution was concentrated in vacuo to 
give a colorless oil. The crude reaction mixture was purified by column chromatography 
on silica gel (100:0 – 100:6 pentane/diethyl ether stain in CAM) to afford 4.32 as a 
colorless oil (316 mg, 93%). 1H NMR (600 MHz, CDCl3): δ 5.85 – 5.74 (m, 1H), 5.16 (d, 
J = 8.7 Hz, 1H), 5.08 – 5.00 (m, 2H), 4.81 (d, J = 11.6 Hz, 2H), 4.31 (td, J = 7.7, 4.8 Hz, 
1H), 3.99 – 3.86 (m, 1H), 3.59 (t, J = 6.5 Hz, 2H), 2.76 (d, J = 7.1 Hz, 2H), 2.21 – 2.14 
(m, 2H), 2.09 (ddd, J = 16.6, 13.7, 7.0 Hz, 2H), 1.63 (s, 3H), 1.54 – 1.47 (m, 3H), 1.45 – 
1.32 (m, 2H), 1.33 – 1.23 (m, 1H), 0.89 (d, J = 0.8 Hz, 9H), 0.87 (d, J = 0.7 Hz, 9H), 0.87 
(d, J = 0.8 Hz, 9H), 0.05 – -0.00 (m, 18H); 13C NMR (150 MHz, CDCl3): δ 145.17, 
136.34, 132.53, 131.34, 116.19, 113.06, 69.77, 69.63, 63.22, 47.83, 43.62, 41.08, 38.31, 
32.86, 25.98, 25.90, 25.88, 21.81, 18.37, 18.20, 18.06, 17.07, -4.21, -4.41, -4.45, -4.75, 
-5.29; IR (neat): 2928.6 (m), 2856.4 (m), 1471.9 (w), 1361.0 (w), 1252.1 (s), 1089.8 (s), 
1004.7 (m), 938.5 (m), 912.5 (m), 831.3 (s), 771.4 (s), 735.4 (m), 663.2 (m) cm-1. 
HRMS-(DART+) for 12C341H7116O328Si3 [M+H]+: calculated: 611.4711, found: 611.4717; 
[α]D +7.6° (c 0.95, CHCl3). 
 
 
(E)-2,2'-(1,8-diphenyloct-7-
ene-3,3-diyl)bis(4,4,5,5-tetr
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amethyl-1,3,2-dioxaborolane) (4.22). An oven dried 2-dram vial was added Pt(dba)3 
(9.3 mg, 0.01 mmol), (S,S)-3,5-di-iso-propylphenyl-TADDOLPPh (11.4 mg, 0.013 
mmol), B2(pin)2 (198 mg, 0.78 mmol) and THF (1 mL) in the glove box. The vial was 
sealed with Teflon cap, taken outside of the glove box and heated at 70 °C for twenty 
minutes. The vial was cooled to room temperature, and brought back into the glove box 
again to add 4.32 (316 mg, 0.52 mmol). The vial was then heated at 70 °C outside of the 
glove box for 12 hours. Upon completion, the yellow solution was extracted with diethyl 
ether, filtered through a silica gel pipet and evaporated in vacuo. The crude reaction 
mixture was purified by column chromatography on silica gel (100:1 – 100:4 
hexanes/ethyl acetate, stain in CAM) to afford 4.22 as a light yellow clear oil (385 mg, 
86%). 1H NMR (600 MHz, CDCl3): δ 5.15 (d, J = 8.5 Hz, 1H), 4.78 (d, J = 1.9 Hz, 1H), 
4.73 (d, J = 1.9 Hz, 1H), 4.37 – 4.25 (m, 1H), 3.91 (p, J = 6.3 Hz, 1H), 3.59 (t, J = 6.6 Hz, 
2H), 2.23 (dd, J = 14.5, 7.2 Hz, 1H), 2.19 – 2.04 (m, 4H), 1.98 (dd, J = 14.5, 8.4 Hz, 1H), 
1.62 (s, 3H), 1.53 – 1.46 (m, 2H), 1.44 – 1.24 (m, 5H), 1.24 – 1.15 (m, 24H), 0.92 – 0.84 
(m, 27H), 0.83 – 0.79 (m, 2H), 0.07 – -0.03 (m, 18H); 13C NMR (125 MHz, CDCl3): δ 
146.38, 132.35, 131.66, 112.50, 82.78, 70.17, 69.69, 63.28, 47.38, 43.77, 40.25, 38.27, 
32.87, 31.57, 25.99, 25.96, 25.90, 24.86, 24.84, 24.80, 24.78, 22.64, 21.85, 18.37, 18.20, 
18.05, 16.98, 14.09, -4.13, -4.31, -4.48, -4.77, -5.28; 11B NMR (160 MHz, CDCl3) δ 
34.76; IR (neat): 2980.1 (w), 2927.0 (w), 1731.8 (s), 1494.7 (w), 1453.7 (w), 1367.9 (m), 
1149.3 (m), 1029.9 (m), 968.2 (w), 923.2 (w), 762.1 (w), 700.3 (s) cm-1; 
292 
 
HRMS-(DART+) for 12C461H9411B216O728Si323Na1 [M+Na]+: calculated: 887.6391, found: 
887.6410; [α]D +6.7° (c 0.86, CHCl3). 
 
Br
3% Ni(dppp)Cl2
DIBAL-H (1.3 equiv)
then NBS (2.0 equiv)
38% yield
Br
MeAlMe3 (3.0 equiv)
20% ZrCp2Cl2
then NBS (3.0 equiv)
57% yield
4.27
4.25
4.35
4.35
 
 
 (E)-1-bromo-2-methylpenta-1,4-diene (4.27). The reaction was 
performed according to a previous procedure 28  with slightly 
modification. An oven dried 100 mL three necked round bottom 
flask was charged with bis(pentamethylcyclopentadienyl)zirconium dichloride (2.92g, 10 
mmol) and DCM (15 mL). The mixture was then allowed to stir for 10 minutes. AlMe3 
(3.16 mL, 33 mmol) was added into the flask dropwise at room temperature under 
nitrogen protection. The mixture was stirred at room temperature for 30 minutes before 
being cooled to -78 °C. 1-Penten-4-yne (0.9 mL, 10 mmol) was added into the above 
mixture slowly at -78 °C. The solution was allowed to warm up to room temperature 
gradually and stirred overnight. The flask was cooled to -78 °C again, and NBS (5.3 g, 30 
                                                
 
28 Zhu, G.; Negishi, E. I. Chem. - Eur. J. 2008, 14, 311-318. 
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mmol) dissolved in diethyl ether (60 mL) was added as a slurry into the flask under 
nitrogen protection. The solution was allowed to warm up to room temperature and 
stirred for another three hours. Upon completion, the reaction mixture was poured into a 
beaker (containing 2 M HCl (30 mL) and ice chips), the layers were separated and the 
aqueous layer was extracted with pentane three times. The organic layers were combined, 
dried over Na2SO4 and evaporated in vacuo. The crude reaction mixture was purified by 
column chromatography on silica gel (pure pentane, stain in CAM) to afford 4.27 as a 
clear colorless oil (920 mg, 57%). 1H NMR (600 MHz, CDCl3): δ 5.95 (s, 1H), 5.75 (ddt, 
J = 18.6, 9.5, 6.8 Hz, 1H), 5.13 – 4.94 (m, 2H), 2.83 (d, J = 6.8 Hz, 2H), 1.79 (s, 3H); 13C 
NMR (150 MHz, CDCl3): δ 140.08, 134.69, 117.14, 102.30, 42.50, 19.16; IR (neat): 
2978.9 (m), 2924.1 (s), 2869.2 (s), 2854.7 (s), 1457.1 (w), 1380.6 (w), 1142.2 (s), 419.5 
(w) cm-1; HRMS-(DART+) for 12C61H1079Br [M+H]+: calculated: 160.9966, found: 
160.9966. 
 
2-bromopenta-1,4-diene (4.25). The reaction was performed 
according to a previous procedure29 with slightly modification. An 
oven dried 100 mL three necked round bottom flask was charged with nickel(II) chloride 
(Ni(dppp)Cl2, 162.6 mg, 0.3 mmol) in the glove box. Outside of the glove box, THF (10 
                                                
 
29 Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10961-10963. 
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mL) and diisobutylaluminum hydride (neat, 2.32 mL, 13 mmol) were added sequentially 
into the flask under nitrogen protection. The mixture was stirred for ten minutes at room 
temperature before being cooled to 0 °C. Then 1-penten-4-yne (0.9 mL, 10 mmol) was 
added dropwise into the flask. The solution was allowed to warm up to room temperature 
gradually, and stirred for another two hours to resulting in a black slurry. The flask was 
cooled to 0 °C again, and subjected with N-bromosuccinimide (3.2 g, 18 mmol), which 
was dissolved in diethyl ether (30 mL). The solution was then warmed up to room 
temperature gradually, and stirred for another three hours. The reaction mixture was then 
poured into a separatory funnel containing Rochelle’s salt (50 mL) and Et2O (50 mL). 
The aqueous layer was then extracted with Et2O (50 mL) twice. Organic layers were 
combined, dried over Na2SO4, and evaporated in vacuo. The crude reaction mixture was 
purified by column chromatography on silica gel (pure pentane, stain in KMnO4) to 
afford 4.25 as a colorless oil (558 mg, 38%). 1H NMR (600 MHz, CDCl3): δ 5.88 – 5.79 
(m, 1H), 5.62 (d, J = 1.5 Hz, 1H), 5.45 (d, J = 1.6 Hz, 1H), 5.22 – 5.15 (m, 2H), 3.18 (d, J 
= 6.7 Hz, 2H); 13C NMR (150 MHz, CDCl3): δ 133.78, 131.90, 117.98, 117.15, 45.68; IR 
(neat): 2955.9 (m), 2930.5 (m), 2870.1 (m), 1716.1 (w), 1630.7 (w), 1435.3 (w), 1379.2 
(w), 1363.3 (w), 1251.1 (w) , 1141.8 (s), 1076.4 (m), 918.4 (w), 852.1 (w), 647.0 (w) 
cm-1. 
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(((2S,4S)-4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan
-2-yl)pentan-2-yl)oxy)(tert-butyl)dimethylsilane (S4.4). 
To an oven dried 2-dram vial was added Pt(dba)3 (2.7 mg, 
0.003 mmol), (S,S)-3,5-di-iso-propylphenyl-TADDOLPPh 
(2.9 mg, 0.0036 mmol), B2(pin)2 (80 mg, 0.315 mmol) and THF (0.3 mL) in the glove 
box. The vial was sealed with Teflon cap, taken outside of the glove box, and heated at 
70 °C for twenty minutes. The mixture was cooled to room temperature, and returned to 
the glove box again to add (S)-tert-butyldimethyl(pent-4-en-2-yloxy)silane 4.42 (60 mg, 
0.3 mmol). The vial was then heated at 70 °C outside of the glove box for 12 hours. Upon 
completion, the yellow solution was extracted with diethyl ether, filtered through a silica 
gel pipet and evaporated in vacuo. The crude reaction mixture was purified by column 
chromatography on silica gel (100:3 to 100:5 hexanes/ethyl acetate, stain in CAM) to 
afford S3 as a colorless oil (130 mg, 95%). 1H NMR (600 MHz, CDCl3): δ 3.85 (h, J = 
6.2 Hz, 1H), 1.54 (dt, J = 13.9, 7.1 Hz, 1H), 1.42 (dt, J = 13.6, 7.0 Hz, 1H), 1.22 (s, 24H), 
1.26 – 1.16 (m, overlap, 1H), 1.10 (d, J = 6.1 Hz, 3H), 0.88 (s, 9H), 0.83 (d, J = 7.5 Hz, 
2H), 0.04 (d, J = 4.5 Hz, 6H); 13C NMR (150 MHz, CDCl3): δ 82.82, 82.71, 68.25, 43.30, 
25.98, 24.87, 24.81, 24.74, 23.74, 18.15, -4.38, -4.61; IR (neat): 2976.6 (m), 2928.6 (w), 
2856.7 (w), 1437.9 (w), 1369.8 (s), 1313.2 (s), 1252.8 (m), 1213.8 (w), 1139.9 (s), 
1068.8 (m), 1003.2 (m), 968.6 (m), 834.1 (s), 808.1 (m), 773.4 (s), 671.8 (w) cm-1; 
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HRMS-(DART+) for 12C231H4811B216O528Si123Na1 [M+Na]+: calculated: 477.3355, found: 
477.3374; [α]D +0.2° (c 1.12, CHCl3). 
 
1), 17% CuI, THF
MgBr
Me
OTBS
1), B2(neo)2 (1.0 equiv),
     10% DBU, 10% TBS-DHG, 60 oC
2), 5% Pd(OAc)2, 5% Ruphos,
     KOH (4.5 equiv), THF/H2O, 70 oC
Br
3), H2O2, NaOH
Me
TBSO OH
1), 9-BBN, THF
2), 5% Pd2(dba)3
     10% Ruphos
     CsF (3.0 equiv) 
    Cs2CO3 (3.0 equiv)
Cl Cl
Me
TBSO OTBS
Cl
45% yield, dr > 20:1
(1.2 equiv)
62% yield
2), TBSCl, imidazole
TBSCl, imidazole
DMAP, DCM
Me
TBSO OTBS
86% yield
quantitative
Me
O
(3.0 equiv)4.41 4.42
4.43 4.44
4.23
4.45
 
 
(4S,6S)-6-((tert-butyldimethylsilyl)oxy)hept-1-en-4-ol (4.43). 
The reaction was performed according to a previous procedure30 
with slightly modification. In the glovebox, to an oven-dried 50 mL round bottom flask 
was added with pseudoenantiomeric glycols 6-tert-butyldimethylsilyl-1,2-dihydroglucal 
(TBS-DHG) catalyst (79 mg, 0.3 mmol), bis(neopentylglycolato)diboron (677 mg, 3.0 
                                                
 
30 Fang, L.; Yan, L.; Haeffner, F.; Morken, J. P. J. Am. Chem. Soc. 2016, 138, 2508-2511. 
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mmol), (S)-tert-butyldimethyl(pent-4-en-2-yloxy)silane (800 mg, 3.0 mmol, prepared 
according to literature31) and THF (3.0 mL). The mixture was allowed to stir for five 
minutes before adding DBU (0.045 mL, 0.3 mmol). The vial was then sealed with rubber 
septum, and removed from the glove box. The mixture was stirred at 60 °C for 24 hours. 
The flask was cooled to room temperature, returned to the glove box, and charged with 
Pd(OAc)2 (7.52 mg, 0.0335 mmol) and Ruphos (15.63 mg, 0.0335 mmol). The vial was 
then taken outside of the glove box. THF (15 mL), 1M vinyl bromide in THF (9 mL, 9.0 
mmol) and 8M KOH (1.69 mL, 13.5 mmol) were added sequentially into the flask. The 
reaction mixture was heated at 70 °C for 12 hours. Upon completion, the flask was 
cooled to room temperature, subjected with 3 M NaOH (4 mL), and 33% wt H2O2 
dropwise at 0 °C. After three hours, the flask was cooled to 0 °C, Na2S2O3 (aq, 4 mL) 
was added carefully to quench the reaction. The layers were separated, and the aqueous 
layer was extracted with diethyl ether twice. The combined organic layers were dried 
over Na2SO4 and evaporated in vacuo. The crude reaction mixture was purified by 
column chromatography on silica gel (100:1-100:10 pentane/diethyl ether, stain in 
KMnO4) to afford 4.43 as a yellow clear oil (330 mg, 45%, > 20:1 dr). The spectra were 
in accordance with a previous report.32 1H NMR (500 MHz, CDCl3) δ 5.84 (ddt, J = 17.3, 
10.3, 7.1 Hz, 1H), 5.17 – 5.04 (m, 2H), 4.21 (pd, J = 6.1, 3.8 Hz, 1H), 4.05 – 3.96 (m, 
                                                
 
31 Mlynarski, S. N.; Schuster, C. H.; Morken, J. P. Nature 2014, 505, 386-390. 
32 Amans, D.; Bellosta, V.; Cossy, J. Org. Lett. 2007, 9, 1453-1456. 
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1H), 3.30 (d, J = 2.3 Hz, 1H), 2.33 – 2.11 (m, 2H), 1.63 (ddd, J = 13.9, 9.9, 3.7 Hz, 1H), 
1.53 (ddd, J = 14.3, 5.5, 2.3 Hz, 1H), 1.22 (d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.09 (d, J = 
4.3 Hz, 6H). 
 
(5S,7S)-5-(4-chloropent-4-en-1-yl)-2,2,3,3,7,9,9,10,10-no
namethyl-4,8-dioxa-3,9-disilaundecane (4.44). 
(4S,6S)-6-((tert-Butyldimethylsilyl)oxy)hept-1-en-4-ol (4.43) (900 mg, 3.68 mmol), 
DCM (12 mL) and imidazole (626 mg, 9.2 mmol) were added into a 50 mL round bottom 
flask sequentially. The mixture was stirred until all solids dissolved, and was then cooled 
to 0 °C. tert-Butyldimethylsilyl chloride (610 mg, 4.05 mmol) was subjected slowly into 
the above solution. Lastly, a tip (about 2 mg) of 4-(dimethylamino)pyridine was added. 
The white slurry was allowed to stir overnight, which was then quenched by water, 
extracted with DCM, and dried over Na2SO4. The colorless solution was concentrated in 
vacuo to give a colorless oil. The crude reaction mixture was purified by column 
chromatography on silica gel (100:1-100:2 pentane/diethyl ether, stain in CAM) to afford 
(5S,7S)-5-allyl-2,2,3,3,7,9,9,10,10-nonamethyl-4,8-dioxa-3,9-disilaundecane 4.44 as a 
colorless oil (1.14 g, 86%).  
Me
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This compound (4.23) was prepared according to a previous procedure with slightly 
modification.33 In the glove box, to a four dram vial was added 9-BBN dimer (122.0 mg, 
0.5 mmol), THF (2 mL) and 
(5S,7S)-5-allyl-2,2,3,3,7,9,9,10,10-nonamethyl-4,8-dioxa-3,9-disilaundecane 4.44 (358.7 
mg, 1.0 mmol). The mixture was allowed to stir for 1.5 hours to result in yellow clear 
solution. Pd2(dba)3 (45.8 mg, 0.05 mmol), Ruphos (46.6 mg, 0.1 mmol), THF (6 mL), 
CsF (455.7 mg, 3.0 mmol), and Cs2CO3 (977.5 mg, 3.0 mmol) were then added 
sequentially into the vial. The vial was then sealed with a Teflon cap, and taken outside 
of the glove box. 1,1-Dichloroethylene (0.32 mL, 4.0 mmol) was added into the reaction 
solution. The vial was then heated at 70 °C for 12 hours. Upon completion, the reaction 
mixture was diluted with diethyl ether, filtered through a silica gel pipet, and evaporated 
in vacuo. The crude reaction mixture was purified by column chromatography on silica 
gel (100:0-100:3 pentane/diethyl ether, stain in CAM) to afford 4.23 as a yellow clear oil 
(421 mg, quantitative). 1H NMR (600 MHz, CDCl3) δ 5.14 (d, J = 1.0 Hz, 1H), 5.11 (dt, J 
= 1.0 Hz, 1H), 3.88 (h, J = 6.4 Hz, 1H), 3.76 (p, J = 5.8 Hz, 1H), 2.32 (t, J = 7.4 Hz, 2H), 
1.65 – 1.57 (m, 3H), 1.54 – 1.39 (m, 3H), 1.14 (d, J = 6.2 Hz, 3H), 0.88 (s, 18H), 0.09 – 
0.01 (m, 12H); 13C NMR (150 MHz, CDCl3): δ 142.89, 111.89, 69.76, 66.34, 47.87, 
39.19, 36.61, 25.91, 24.52, 22.63, 18.08, -3.88, -4.11, -4.23, -4.48; IR (neat): 2953.8 (m), 
                                                
 
33 Liron, F.; Fosse, C.; Pernolet, A.; Roulland, E. J. Org. Chem., 2007, 72, 2220-2223. 
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2928.8 (m), 2885.8 (w), 2856.6 (m), 1471.9 (w), 1374.9 (w), 1253.3 (m), 1118.7 (m), 
1062.2 (m), 1004.8 (m), 938.9 (w), 872.2 (m), 832.6 (s), 805.6 (m), 771.1 (s), 704.8 (w), 
663.9 (w) cm-1; HRMS-(DART+) for 12C211H4535Cl116O228Si223Na1 [M+Na]+: calculated: 
443.2544, found: 443.2545; [α]D +6.9° (c 1.43, CHCl3). 
 
Cl Me
TBSO OTBS
   5% Pd(OAc)2
  5% Ruphos 
   KOH (3.0 equiv)
  THF/H2O, 70 oC Me
(pin)B
TBSO OTBS
OTBS
Me
TBSO OTBS
50% yield
4.22
4.23
Me (pin)B
TBSO OTBS
OTBS
B(pin)
4.46
 
 
(9R,13R,17S,23S,25S,E)-9,13,23-tris((tert-b
utyldimethylsilyl)oxy)-2,2,3,3,11,25,27,27,2
8,28-decamethyl-15,19-dimethylene-17-(4,4
,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4
,26-dioxa-3,27-disilanonacos-10-ene. (4.16) 
The reaction was performed according to a 
Me
B
TBSO OTBS
TBSO
Me
TBSO
TBSO
O O
Me
Me
Me
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previous procedure34 with slightly modification. In the glove box, an oven dried 20 mL 
vial was added Pd(OAc)2 (7.52 mg, 0.0335 mmol), Ruphos (15.63 mg, 0.0335 mmol) and 
THF (3 mL). The mixture was allowed to stir for 5 minutes before adding 
(E)-2,2'-(1,8-diphenyloct-7-ene-3,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
4.22 (290 mg, 0.335 mmol) and 4.23 (141.2 mg, 0.335 mmol) sequentially. The vial was 
sealed and brought outside of the glove box. Degased 8M KOH (0.19 mL, 1.5 mmol) and 
degassed H2O (0.3 mL) were added into the vial. The vial was heated at 70 °C overnight. 
The solution changed color from orange red to black. The reaction mixture was extracted 
with diethyl ether, dried over Na2SO4 and evaporated in vacuo. The crude reaction 
mixture was purified by column chromatography on silica gel (100:0.5-100:1 
hexanes/ethyl acetate, stain in CAM) to afford 4.16 as a colorless oil (219 mg, 66%). 1H 
NMR (600 MHz, CDCl3): δ 5.16 (d, J = 8.5 Hz, 1H), 4.84 (d, J = 1.9 Hz, 1H), 4.75 (s, 
1H), 4.74 (s, 1H), 4.69 (s, 1H), 4.30 (td, J = 8.1, 4.7 Hz, 1H), 3.96 – 3.84 (m, 2H), 3.77 – 
3.71 (m, 1H), 3.59 (t, J = 6.6 Hz, 2H), 2.17 – 2.01 (m, 8H), 1.97 (d, J = 7.6 Hz, 2H), 1.67 
– 1.56 (m, overlap, 1H), 1.61 (d, J = 1.3 Hz, 3H), 1.53 – 1.45 (m, 6H), 1.45 – 1.33 (m, 
6H), 1.18 (s, 12H), 1.14 (d, J = 6.0 Hz, 3H), 0.91 – 0.82 (m, 45H), 0.08 – -0.04 (m, 30H); 
13C NMR (150 MHz, CDCl3): δ 149.09, 146.49, 132.46, 131.46, 112.15, 109.38, 82.89, 
70.22, 70.03, 69.66, 66.34, 63.27, 48.00, 47.49, 43.98, 38.46, 38.27, 37.82, 37.57, 36.12, 
                                                
 
34 Mlynarski, S. N.; Schuster, C. H.; Morken, J. P. Nature 2014, 505, 386-390. 
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32.87, 25.99, 25.95, 25.93, 25.90, 24.87, 24.81, 24.51, 23.14, 21.86, 19.90 (broad, C-B 
bond), 18.38, 18.20, 18.10, 18.06, 16.94, -3.88, -4.02, -4.14, -4.21, -4.36, -4.46, -4.75, 
-5.27; IR (neat): 2953.2 (m), 2928.5 (m), 2886.1 (w), 2856.6 (m), 1471.9 (w), 1380.2 (w), 
1253.1 (m), 1143.7 (m), 1091.4 (m), 1065.7 (m), 1005.2 (w), 833.7 (s), 807.4 (m), 772.9 
(s), 664.7 (w) cm-1; HRMS-(DART+) for 12C611H13111B116O714N128Si5 [M+NH4]+: 
calculated: 1140.8865, found: 1140.8893; [α]D +4.5° (c 0.33, CHCl3). 
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(5R,9R,13S,19S,21S,E)-5,9,19,21-tetrakis((t
ert-butyldimethylsilyl)oxy)-7-methyl-11,15-
dimethylene-13-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)docos-6-en-1-ol (4.47). 
To a 20 mL scintillation vial was added 4.46 
(80 mg, 0.08 mmol) and THF (8 mL). The 
solution was cooled to 0 °C and stirred for 15 minutes. HCl (0.08 mL, 1 M, 0.08 mmol) 
was added dropwise into the mixture, and the solution was stirred at 4 °C (cold room) 
overnight. The solution was cooled to 0 °C, Na2S2O3 (0.5 mL) was added to quench the 
reaction. The mixture was extracted with diethyl ether, filtered through a pipet of 
Na2S2O4, and evaporated in vacuo. The crude reaction mixture was then purified by 
column chromatography on silica gel (100:1-85:15 hexanes/ethyl acetate, stain in CAM) 
to afford 4.47 as a clear colorless oil (35 mg, 50%). 1H NMR (500 MHz, CDCl3): δ 5.16 
(d, J = 8.4 Hz, 1H), 4.84 (d, J = 1.8 Hz, 1H), 4.75 (s, 1H), 4.74 (s, 1H), 4.70 (d, J = 1.8 
Hz, 1H), 4.33 (td, J = 7.6, 4.4 Hz, 1H), 3.94 – 3.86 (m, 2H), 3.78 – 3.70 (m, 1H), 3.63 (t, 
J = 6.7 Hz, 2H), 2.16 – 2.01 (m, 8H), 2.01 – 1.94 (m, 2H), 1.62 (d, J = 1.3 Hz, 3H), 1.60 
–1.22 (m, 13H), 1.19 (s, 12H), 1.14 (d, J = 6.1 Hz, 3H), 0.92 – 0.80 (m, 36H), 0.10 – 
-0.03 (m, 24H); 13C NMR (100 MHz, CDCl3): δ 149.09, 146.45, 132.21, 131.77, 112.21, 
109.40, 82.93, 70.24, 70.04, 69.52, 66.35, 62.97, 47.99, 47.45, 43.90, 38.46, 38.18, 37.81, 
Me
B
TBSO OH
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Me
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Me
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37.57, 36.14, 32.79, 29.70, 25.95, 25.90, 24.87, 24.80, 24.52, 23.14, 21.59, 19.89 (broad, 
C-B bond), 18.20, 18.10, 17.09, -3.87, -4.01, -4.13, -4.20, -4.37, -4.45, -4.74; IR (neat): 
2953.3 (m), 2928.7 (s), 2884.4 (m), 2856.7 (s), 1472.0 (w), 1462.1 (w), 1380.2 (m), 
1253.5 (m), 1143.3 (s), 1086.8 (m), 1067.3 (m), 1005.2 (w), 891.3 (w), 834.7 (s), 807.1 
(m), 773.5 (s) cm-1; HRMS-(DART+) for 12C551H11711B116O714N128Si4 [M+NH4]+: 
calculated: 1026.8000, found: 1026.7988; [α]D +3.6° (c 0.23, CHCl3). 
 
(5R,9R,13S,19S,21S,E)-5,9,19,21-tetrakis((t
ert-butyldimethylsilyl)oxy)-7-methyl-11,15-
dimethylene-13-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)docos-6-enoic acid (4.48). 
To a 20 mL scintillation vial was added 
alcohol 4.47 (35 mg, 0.04 mmol) and DCM 
(1 mL). The mixture was cooled to 0°C, Dess-Martin periodinane (20 mg, 0.048 mmol) 
and NaHCO3 (16.6 mg, 0.198 mmol) were added. After 4 hours, the reaction mixture was 
concentrated in vacuo, then extracted by 1:1 hexane/Et2O, filtered through silica gel 
padded sintered funnel, rinsed with 1:1 hexane/Et2O and evaporated in vacuo. The crude 
reaction mixture was purified by column chromatography on silica gel (100:2-100:3 
hexanes/ethyl acetate, stain in CAM) to afford 
(5R,9R,13S,19S,21S,E)-5,9,19,21-tetrakis((tert-butyldimethylsilyl)oxy)-7-methyl-11,15-d
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imethylene-13-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)docos-6-enal S4.5 as a clear 
colorless oil (31 mg, 88%).  1H NMR (500 MHz, CDCl3): δ 9.75 (t, J = 1.9 Hz, 1H), 
5.16 (d, J = 8.4 Hz, 1H), 4.84 (s, 1H), 4.74 (s, 1H), 4.74 (s, 1H), 4.70 (s, 1H), 4.34 (td, J 
= 7.8, 5.0 Hz, 1H), 3.96 – 3.83 (m, 2H), 3.74 (p, J = 4.7 Hz, 1H), 2.41 (td, J = 7.5, 2.0 Hz, 
2H), 2.17 – 1.95 (m, 10 H), 1.76 – 1.68 (m, 1H), 1.62 (s, 3H), 1.58– 1.23 (m, 10 H), 1.18 
(s, 12H), 1.14 (d, J = 6.1 Hz, 3H), 0.91 – 0.83 (m, 36H), 0.10 – -0.03 (m, 24H).  
(5R,9R,13S,19S,21S,E)-5,9,19,21-Tetrakis((tert-butyldimethylsilyl)oxy)-7-methyl
-11,15-dimethylene-13-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)docos-6-enoic acid 
4.48 was prepared according to a previous procedure35 with slightly modification. A 20 
mL scintillation vial was added aldehyde S4.5 (4 mg, 0.0045 mmol), tBuOH (0.438 mL) 
and 2- methyl-2-butene (0.05 mL, 0.046 mmol) sequentially. The mixture was cooled to 
0°C. A solution of NaClO2 (4.92 mg, 0.055 mmol) and NaH2PO4 (5.99 mg, 0.046 mmol) 
in H2O (0.14 mL) was added into the vial. THF (0.4 mL) was added last. The solution 
was then allowed to warm up to room temperature and stirred for another hour. The 
reaction mixture was quenched by H2O, extracted with diethyl ether, filtered through a 
Na2S2O4 pipet and evaporated in vacuo. The crude reaction mixture was then purified by 
column chromatography on silica gel (100:8-100:20 hexanes/ethyl acetate, stain in CAM) 
to afford 4.48 as a clear colorless oil (3 mg, 74%). 1H NMR (500 MHz, CDCl3): δ 5.14 (d, 
                                                
 
35 Paterson, I.; Paquet, T. Org. Lett. 2010, 12, 2158-2161. 
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J = 8.7 Hz, 1H), 4.84 (s, 1H), 4.75 (s, 1H), 4.74 (s, 1H), 4.70 (s, 1H), 4.41 – 4.32 (m, 1H), 
4.00 – 3.84 (m, 2H), 3.78 – 3.71 (m, 1H), 2.38 – 2.31 (m, 2H), 2.25 – 1.94 (m, 10H), 1.65 
(d, J = 1.4 Hz, 3H), 1.63 –1.24 (m, 11H), 1.20 (s, 12H), 1.14 (d, J = 6.2 Hz, 3H), 0.91 – 
0.84 (m, 36H), 0.14 – -0.01 (m, 24H); 13C NMR (150 MHz, CDCl3): δ 174.83, 149.07, 
146.35, 132.32, 131.70, 112.44, 109.43, 83.17, 70.29, 70.10, 69.20, 66.40, 47.95, 43.52, 
37.78, 37.70, 37.57, 36.17, 33.71, 33.50, 31.93, 29.70, 29.36, 25.94, 25.88, 24.82, 24.76, 
24.53, 23.12, 22.70, 20.97, 18.17, 18.12, 18.07, 17.36, 14.12, -3.87, -4.00, -4.15, -4.20, 
-4.41, -4.44, -4.78.; IR (neat): 2954.6 (s), 2926.0 (s), 2855.3 (s), 1714.2 (w), 1557.1 (w), 
1462.4 (m), 1380.3 (m), 1361.1 (m), 1254.1 (m), 1142.4 (s), 1086.5 (m), 835.6 (m), 807.1 
(w), 774.4 (m) cm-1; HRMS-(DART+) for 12C551H11511B116O814N128Si4 [M+NH4]+: 
calculated: 1040.7793, found: 1040.7843. [α]D -3.6° (c 0.4, CHCl3).  
 
(6R,10R,14S,E)-14-((6S,8S)-6,8-bis(
(tert-butyldimethylsilyl)oxy)-2-met
hylenenonyl)-6,10-bis((tert-butyldi
methylsilyl)oxy)-8-methyl-12-meth
yleneoxacyclotetradec-7-en-2-one (4.49). To a 20 mL scintillation vial was added (4.48) 
(6 mg, 0.0067 mmol), THF (1 mL) and H2O (1 mL). The solution was cooled to 0°C, and 
sodium perborate monohydrate (30 mg, 0.2 mmol) was added. The mixture was allowed 
to stir overnight. The solution was quenched by H2O, extracted with diethyl ether, dried 
Me O
TBSO O
TBSO
Me
TBSO OTBS
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over Na2SO4 and evaporated in vacuo. The crude reaction mixture was purified by 
column chromatography on silica gel (100:0 – 100:20 hexanes/ethyl acetate, stain in 
CAM) to afford 
(5R,9R,13S,19S,21S,E)-5,9,19,21-tetrakis((tert-butyldimethylsilyl)oxy)-13-hydroxy-7-me
thyl-11,15-dimethylenedocos-6-enoic acid S4.6 as a colorless oil (5.5 mg, 90 %).  
The Yamaguchi esterification was performed according to a previous procedure.36 An 
oven dried 20 mL scintillation vial (charged with a stirring bar, cooled under vacumn) 
was charged with carboxylic acid S4.6 (5.5 mg, 6 µmol), THF (1 mL), triethyl amine (6.1 
mg, 8.36 µmol) and 2,4,6-trichlorobenzoylchloride (8.8 mg, 72 µmol). The solution was 
allowed to stir at room temperature for two hours before toluene (4 mL) was added. Then 
above mixture was then transferred into a syringe. The solution was added into an oven 
dried 50 mL round bottom flask (precharged with DMAP (8.8 mg, 72 µmol) and toluene 
(12 mL)) via syringe pump at 80 °C over three hours. The mixture was heated at 80 °C 
overnight, then cooled to room temperature and evaporated in vacuo. The crude reaction 
mixture was purified by column chromatography on silica gel (100:0-100:2 
pentane/diethyl ether, stain in CAM) to afford 4.49 as a clear colorless oil (3.8 mg, 71%). 
1H NMR (600 MHz, CDCl3): δ 5.23 – 5.17 (m, 1H), 5.05 (d, J = 8.9 Hz, 1H), 4.98 (s, 1H), 
4.83 (d, J = 2.1 Hz, 1H), 4.76 (d, J = 1.8 Hz, 1H), 4.72 (s, 1H), 4.29 (ddd, J = 10.3, 8.7, 
                                                
 
36 Williams, D. R.; Patnaik, S.; Plummer, S. V. Org. Lett. 2003, 5, 5035-5038. 
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3.2 Hz, 1H), 3.91 – 3.84 (m, 2H), 3.74 (p, J = 5.4 Hz, 1H), 2.45 (td, J = 14.2, 3.1 Hz, 2H), 
2.40 – 2.28 (m, 2H), 2.22 (dd, J = 14.3, 6.0 Hz, 2H), 2.18 – 2.08 (m, 2H), 2.01 (td, J = 
9.9, 3.8 Hz, 3H), 1.92 (dd, J = 14.0, 8.9 Hz, 1H), 1.72 (d, J = 1.3 Hz, 3H), 1.60 (ddd, J = 
13.6, 7.1, 5.4 Hz, 2H), 1.54 – 1.46 (m, 1H), 1.46 – 1.39 (m, 5H), 1.33 – 1.24 (m, 2H), 
1.13 (d, J = 6.2 Hz, 3H), 0.91 – 0.83 (m, 36H), 0.09 – -0.02 (m, 24H); 13C NMR (150 
MHz, CDCl3): δ 172.34, 145.69, 141.95, 132.97, 130.73, 128.00, 117.54, 112.03, 71.69, 
71.17, 69.96, 69.24, 66.36, 47.96, 46.66, 43.47, 39.68, 39.15, 38.16, 37.39, 35.91, 34.83, 
25.94, 25.93, 25.87, 24.50, 23.01, 21.30, 20.11, 18.20, 18.14, 18.10, -3.89, -4.06, -4.20, 
-4.36, -4.39, -4.46, -4.66, -4.76; IR (neat): 2954.0 (m), 2928.7 (s), 2856.4 (m), 1735.7 (m), 
1472.1 (w), 1462.0 (w), 1374.2 (w), 1361.2 (w), 1253.6 (s), 1144.5 (w), 1117.0 (w), 
1087.9 (m), 1050.5 (m), 1005.5 (w), 895.1 (w), 834.9 (s), 807.9 (w), 773.6 (s) cm-1; 
HRMS-(DART+) for 12C491H10216O614N128Si4 [M+NH4]+: calculated: 912.6784, found: 
912.6762; [α]D +10.1° (c 1.03, CHCl3). 
 
 
(6R,10R,14S,E)-14-((6S,8S)-6,8-dihydr
oxy-2-methylenenonyl)-6,10-dihydrox
y-8-methyl-12-methyleneoxacyclotetra
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dec-7-en-2-one (4.21). The global deprotection was performed according to a previous 
procedure. 37  To a Teflon vial was added 
(6R,10R,14S,E)-14-((6S,8S)-6,8-bis((tert-butyldimethylsilyl)oxy)-2-methylenenonyl)-6,1
0-bis((tert-butyldimethylsilyl)oxy)-8-methyl-12-methyleneoxacyclotetradec-7-en-2-one 
4.49 (4.5 mg, 5 µmol) and THF (0.5 mL). The mixture was cooled to 0 °C, and 
HFpyridine (20 µL) was added dropwise into it. Three more portions of HFpyridine 
(20 µL) were added slowly into the vial in the following three days at room temperature. 
Upon completion, the reaction mixture was added carefully into a 20 mL scintillation vial 
containing saturated NaHCO3 solution (3 mL) at 0 °C, which was then allowed to warm 
to room temperature and stirred for another twenty minutes. The aqueous layer was 
extracted with ethyl acetate (5×3 mL). The organic layers were combined, dried over 
Na2SO4 and concentrated in vacuo. The crude reaction mixture was purified by column 
chromatography on silica gel (100:10-10:90 hexanes/ethyl acetate, then, 100:10-100:20 
hexane/MeOH stain in CAM) to afford 4.21 as a white solid (1.8 mg, 82%). 1H NMR 
(600 MHz, CDCl3): δ 5.21 (tt, J = 7.5, 4.3 Hz, 1H), 5.09 (d, J = 9.3 Hz, 1H), 5.08 (s, 1H), 
4.96 (d, J = 1.9 Hz, 1H), 4.78 (d, J = 1.7 Hz, 1H), 4.72 (s, 1H), 4.37 (ddd, J = 10.6, 9.0, 
3.4 Hz, 1H), 4.15 (h, J = 6.0 Hz, 1H), 3.94 (p, J = 6.0 Hz, 1H), 3.84 (tdd, J = 10.2, 4.0, 
1.8 Hz, 1H), 2.67 (d, J = 14.0 Hz, 1H), 2.64 (d, J = 14.8 Hz, 4.0 Hz, 1H), 2.42 (dd, J = 
                                                
 
37 Paterson, I.; Britton, R.; Delgado, O.; Gardner, N. M.; Meyer, A.; Naylor,G. J.; Poullennec, K. G. 
Tetrahedron 2010, 66, 6534-6545. 
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14.3, 3.5 Hz, 1H), 2.32 (dt, J = 14.2, 5.9 Hz, 1H), 2.27 – 2.22 (m, 2H), 2.18 – 2.12 (m, 
2H), 2.04 (t, J = 7.9 Hz, 2H), 1.94 (dd, J = 14.1, 10.5 Hz, 1H), 1.89 (dd, J = 14.4, 10.0 Hz, 
1H), 1.83 – 1.78 (m, 1H), 1.77 (d, J = 1.5 Hz, 3H), 1.75 – 1.22 (m, 9H), 1.22 (d, J = 6.3 
Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 172.42, 145.14, 142.50, 135.76, 129.35, 117.96, 
112.62, 71.32, 69.14, 68.70, 68.11, 65.56, 44.60, 44.16, 43.61, 39.46, 38.41, 36.90, 36.54, 
35.56, 34.29, 23.67, 23.65, 21.51, 20.14; IR (neat): 3375 (broad, O-H stretch, w), 2924.1 
(s), 2869.7 (s), 2854.8 (s), 1731.6 (m), 1716.9 (m), 1556.2 (m), 1488.1 (m), 1456.8 (m), 
1436.6 (m), 1380.7 (m), 1296.7 (w), 1243.9 (w), 1142.5 (s), 1075.5 (m), 908.2 (w) cm-1; 
HRMS-(DART+) for 12C251H4116O5 [M+H-H2O]+: calculated: 421.2954, found: 421.2955; 
+5.997° (c 0.0667, CHCl3). 
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1), 17% CuI, THF
MgBr
Me
OTBS
1), 1% Pt(dba)3,
    1.2% (R, R)-Taddol PPh
    B2Pin2 (1.05 equiv), 70 oC
50% yield
2), 5% Pd(OAc)2, 5% Ruphos,
     KOH (4.5 equiv), THF/H2O, 70 oC
Br
3), NaBO3 H2O
Me
TBSO OH
1), 9-BBN, THF
2), 5% Pd2(dba)3
     10% Ruphos
     CsF (3.0 equiv) 
    Cs2CO3 (3.0 equiv)
Cl Cl
Me
TBSO OTBS
Cl
62% yield, dr > 20:1
(1.2 equiv)
65% yield
2), TBSCl, imidazole
TBSCl, imidazole
DMAP, DCM Me
TBSO OTBS
90% yield
76% yield
Me
O
(3.0 equiv)ent-4.41 ent-4.42
ent-4.43 ent-4.44
ent-4.23
59% yield
 
 
(((2R,4R)-4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborola
n-2-yl)pentan-2-yl)oxy)(tert-butyl)dimethylsilane 
(ent-S4.4) To an oven dried 2-dram vial was added 
Pt(dba)3 (2.7 mg, 0.003 mmol), 
(R,R)-3,5-di-iso-propylphenyl-TADDOLPPh (2.9 mg, 0.0036 mmol), B2(pin)2 (80 mg, 
0.315 mmol) and THF (0.3 mL) in the glove box. The vial was sealed with Teflon cap, 
taken outside of the glove box, and heated at 70 °C for twenty minutes. The mixture was 
cooled to room temperature and returned to the glove box again. The solution was then 
Me
TBSO B
B
OO
O
O
Me
Me Me
Me
Me Me
Me
Me
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charged with (R)-tert-butyldimethyl(pent-4-en-2-yloxy)silane (60 mg, 0.3 mmol). The 
vial was then heated at 70 °C outside of the glove box for 12 hours. Upon completion, the 
yellow solution was extracted with diethyl ether, filtered through a silica gel pipet and 
evaporated in vacuo. The crude reaction mixture was purified by column chromatography 
on silica gel (100:3 to 100:5 hexanes/ethyl acetate, stain in CAM) to afford ent-S4.4 as a 
colorless oil (68 mg, 50%). 1H NMR (500 MHz, CDCl3): δ 3.85 (h, J = 6.2 Hz, 1H), 1.54 
(ddd, J = 13.2, 6.5, 5.3 Hz, 1H), 1.46 – 1.37 (m, 1H), 1.22 (s, 24H), 1.18 (t, J = 7.5 Hz, 
1H), 1.10 (d, J = 6.0 Hz, 3H), 0.87 (s, 9H), 0.83 (d, J = 7.5 Hz, 2H), 0.04 (d, J = 3.8 Hz, 
6H); 13C NMR (125 MHz, CDCl3): δ 82.82, 82.72, 68.27, 43.33, 25.99, 24.89, 24.84, 
24.82, 24.76, 23.76, 18.17, -4.37, -4.59; IR (neat): 2977.5 (m), 2929.3 (m), 2857.6 (m), 
1370.9 (s), 1315.4 (s), 1254.2 (m), 1141.9 (s), 1070.6 (w), 835.7 (m), 774.2 (m) cm-1; 
HRMS-(DART+) for 12C231H4911B216O528Si1 [M+H]+: calculated: 455.3535, found: 
455.3538; [α]D -0.8° (c 1.05, CHCl3). 
 
 (4R,6R)-6-((tert-butyldimethylsilyl)oxy)hept-1-en-4-ol 
(ent-4.43) In the glovebox, to an oven dried two dram vial was 
added Pd(OAc)2 (1.12 mg, 0.005 mmol), Ruphos (2.33 mg, 0.005 mmol), 
1,2-bis(boronic) ester (ent-S4.4) (45.4 mg, 0.1 mmol) and THF (0.35 mL). The vial was 
taken outside of the glove box, 1M vinyl bromide (0.15 mL, 0.15 mmol) and 8M KOH 
(56 µL, 0.45 mmol) were added sequentially. The reaction mixture was heated at 70 °C 
Me
TBSO OH
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for 12 hours. Upon completion, the reaction mixture was cooled to room temperature, 
diluted with diethyl ether, filtered through a silica gel pipet and evaporated in vacuo. The 
crude reaction mixture was purified by column chromatography on silica gel 
(100:3-100:10 pentane/diethyl ether, stain in CAM) to afford 
tert-butyldimethyl(((2R,4R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hept-6-en-2-y
l)oxy)silane S4.7 as a colorless clear oil (21 mg, 59%, > 20:1 dr). 1H NMR (500 MHz, 
CDCl3) δ 5.79 (ddt, J = 17.0, 10.1, 6.9 Hz, 1H), 5.01 (ddt, J = 17.1, 2.2, 1.6 Hz, 1H), 4.94 
(ddt, J = 10.2, 2.3, 1.2 Hz, 1H), 3.81 (ddt, J = 13.5, 11.8, 6.1 Hz, 1H), 2.22 – 2.09 (m, 
2H), 1.51 – 1.41 (m, 2H), 1.27 – 1.19 (m, overlap, 1H), 1.23 (s, 12H), 1.12 (d, J = 6.0 Hz, 
3H), 0.88 (d, J = 2.7 Hz, 9H), 0.05 (d, J = 4.2 Hz, 6H). 
To a 20 mL scintillation vial was added boronic ester S4.7 (260 mg, 0.73 mmol), 
THF (2 mL) and H2O (2 mL). The solution was cooled to 0 °C, and then sodium 
perborate monohydrate (366 mg, 3.67 mmol) was added. The mixture was then allowed 
to stir overnight. The solution was quenched by H2O, extracted with diethyl ether, dried 
over Na2SO4 and evaporated in vacuo. The crude reaction mixture was purified by 
column chromatography on silica gel (100:2 – 100:20 pentane/diethyl ether, stain in 
CAM) to afford ent-4.43 as a colorless clear oil (110 mg, 62%). The spectra were in 
accordance with a previous report.38 1H NMR (500 MHz, CDCl3) δ 5.84 (ddt, J = 17.3, 
                                                
 
38 Amans, D.; Bellosta, V.; Cossy, J. Org. Lett. 2007, 9, 1453-1456. 
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10.3, 7.1 Hz, 1H), 5.17 – 5.05 (m, 2H), 4.21 (pd, J = 6.1, 3.8 Hz, 1H), 4.02 (dddd, J = 9.6, 
7.7, 5.2, 2.5 Hz, 1H), 3.30 (d, J = 2.3 Hz, 1H), 2.30 – 2.13 (m, 2H), 1.63 (ddd, J = 13.9, 
9.9, 3.7 Hz, 1H), 1.53 (ddd, J = 14.2, 5.5, 2.2 Hz, 1H), 1.22 (d, J = 6.3 Hz, 3H), 0.89 (s, 
9H), 0.09 (d, J = 4.3 Hz, 6H). 
 
(5R,7R)-5-(4-chloropent-4-en-1-yl)-2,2,3,3,7,9,9,10,10-
nonamethyl-4,8-dioxa-3,9-disilaundecane (ent-4.23). 
Terminal alkene ent-4.43 (110 mg, 0.45 mmol), DCM (2 
mL), and imidazole (76.6 mg, 1.12 mmol) were added into a 20 mL scintillation vial 
sequentially. The mixture was stirred until all solids dissolved, and was then cooled to 
0 °C. tert-Butyldimethylsilyl chloride (75 mg, 0.5 mmol) was added slowly into the 
above solution. Lastly, a tip (about 2 mg) of 4-(dimethylamino)pyridine was added. The 
white slurry was allowed to stir overnight, which was then quenched by water, extracted 
with DCM and dried over Na2SO4. The colorless solution was concentrated in vacuo to 
give a colorless oil. The crude reaction mixture was purified by column chromatography 
on silica gel (100:0-100:2 pentane/diethyl ether, stain in CAM) to afford 
(5R,7R)-5-allyl-2,2,3,3,7,9,9,10,10-nonamethyl-4,8-dioxa-3,9-disilaundecane (ent-4.44) 
as a colorless oil (145 mg, 90%).  
Me
TBSO OTBS
Cl
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ent-4.23 was prepared according to a previous literature with slightly modification.39 In 
the glove box, to an oven dried four-dram vial were added 9-BBN dimer (48.8 mg, 0.2 
mmol), THF (1 mL) and ent-4.44 (145 mg, 0.4 mmol). The mixture was allowed to stir 
for 1.5 hours to resulting in yellow clear solution. Pd2(dba)3 (18.3 mg, 0.02 mmol), 
Ruphos (18.7 mg, 0.04 mmol), THF (3 mL), CsF (182.3 mg, 1.2 mmol) and Cs2CO3 (391 
mg, 1.2 mmol) were added sequentially into the solution. The vial was sealed with a 
Teflon cap and taken outside of the glove box. 1,1-Dichloroethylene (0.128 mL, 1.6 
mmol) was added into the reaction solution. The solution was then heated at 70 °C for 12 
hours. Upon completion, the reaction mixture was diluted with diethyl ether, filtered 
through a silica gel pipet and evaporated in vacuo. The crude reaction mixture was 
purified by column chromatography on silica gel (100:2-100:3 pentane/diethyl ether, 
stain in CAM) to afford ent-4.23 as a colorless clear oil (128 mg, 76 %).  1H NMR (600 
MHz, CDCl3) δ 5.14 (d, J = 1.2 Hz, 1H), 5.11 (t, J = 1.2 Hz, 1H), 3.88 (h, J = 6.3 Hz, 1H), 
3.76 (p, J = 6.7 Hz, 1H), 2.32 (t, J = 7.4 Hz, 2H), 1.67 – 1.56 (m, 3H), 1.53 – 1.38 (m, 
3H), 1.14 (dd, J = 6.1, 1.2 Hz, 3H), 0.88 (s, 18H), 0.09 – 0.02 (m, 12H); 13C NMR (125 
MHz, CDCl3): δ 142.90, 111.87, 69.77, 66.34, 47.88, 39.19, 36.61, 25.91, 24.51, 22.63, 
18.08, -3.88, -4.12, -4.23, -4.48; IR (neat): 2954.0 (m), 2928.9 (m), 2886.8 (w), 2856.6 
(m), 1472.1 (w), 1374.7 (w), 1253.2 (m), 1118.0 (m), 1061.8 (m), 1004.8 (m), 938.9 (w), 
                                                
 
39 Liron, F.; Fosse, C.; Pernolet, A.; Roulland, E. J. Org. Chem., 2007, 72, 2220-2223. 
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878.0 (m), 832.4 (s), 805.5 (s), 770.9 (s), 703.6 (w), 663.4 (w) cm-1; HRMS-(DART+) for 
12C211H4635Cl116O228Si2 [M+H]+: calculated: 421.2725, found: 421.2745; [α]D -7.0° (c 
1.16, CHCl3). 
 
 
Cl Me
TBSO OTBS
   5% Pd(OAc)2
  5% Ruphos 
   KOH (3.0 equiv)
  THF/H2O, 70 oC Me (pin)B
TBSO OTBS
OTBS
Me
TBSO OTBS
51% yield
4.50
4.22
Me (pin)B
TBSO OTBS
OTBS
B(pin)
ent-4.23  
 
(9R,13R,17S,23R,25R,E)-9,13,23-tris((tert-
butyldimethylsilyl)oxy)-2,2,3,3,11,25,27,27
,28,28-decamethyl-15,19-dimethylene-17-(
4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-y
l)-4,26-dioxa-3,27-disilanonacos-10-ene. 
(4.50) The reaction was performed 
Me
B
TBSO OTBS
TBSO
Me
TBSO
TBSO
O O
Me
Me
Me
Me
318 
 
according to a previous procedure40 with slightly modification. In the glove box, an oven 
dried 20 mL vial was added Pd(OAc)2 (6.7 mg, 0.03 mmol), Ruphos (14 mg, 0.03 mmol) 
and THF (3 mL). The mixture was allowed to stir for 5 minutes before adding 4.22 (260 
mg, 0.3 mmol) and ent-4.23 (128 mg, 0.3 mmol) sequentially. The vial was sealed and 
taken outside of the glove box. Degassed 8M KOH (0.17 mL, 1.35 mmol) and degassed 
H2O (0.3 mL) were added into the vial. The mixture was then heated at 70 °C overnight. 
The solution changed color from orange red to black. The reaction mixture was extracted 
by diethyl ether, dried over Na2SO4 and evaporated in vacuo. The crude reaction mixture 
was purified by column chromatography on silica gel (100:0.5-100:5 hexanes/ethyl 
acetate, stain in CAM) to afford 4.50 as a colorless oil (152 mg, 51%). 1H NMR (600 
MHz, CDCl3): δ 5.16 (d, J = 8.5 Hz, 1H), 4.84 (s, 1H), 4.75 (s, 1H), 4.74 (s, 1H), 4.69 (s, 
1H), 4.31 (td, J = 7.9, 4.6 Hz, 1H), 3.94 – 3.85 (m, 2H), 3.74 (p, J = 5.4 Hz, 1H), 3.59 (t, 
J = 6.6 Hz, 2H), 2.19 – 2.00 (m, 8H), 2.01 – 1.95 (m, 2H), 1.61 (s, 3H), 1.66 – 1.58 (m, 
overlap, 1H), 1.54 – 1.23 (m, 12H), 1.18 (s, 12H), 1.14 (dd, J = 6.0, 1.2 Hz, 3H), 0.91 – 
0.83 (m, 45H), 0.08 – -0.03 (m, 30H); 13C NMR (150 MHz, CDCl3): δ 149.09, 146.50, 
132.46, 131.46, 112.16, 109.41, 82.89, 70.22, 70.05, 69.66, 66.35, 63.27, 48.00, 47.49, 
43.98, 38.46, 38.27, 37.83, 37.59, 36.12, 32.87, 25.99, 25.95, 25.93, 25.90, 24.87, 24.81, 
24.53, 23.16, 21.86, 19.90, 18.38, 18.20, 18.10, 18.06, 16.94, -3.88, -4.01, -4.14, -4.21, 
                                                
 
40 Mlynarski, S. N.; Schuster, C. H.; Morken, J. P. Nature 2014, 505, 386-390. 
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-4.36, -4.45, -4.75, -5.27; IR (neat): 2953.6 (m), 2928.5 (m), 2856.4 (m), 1471.9 (w), 
1462.1 (w), 1380.0 (w), 1361.2 (w), 1252.8 (m), 1144.1 (m), 1090.8 (m), 1064.9 (m), 
1005.1 (w), 938.6 (w), 890.9 (w), 832.9 (s), 807.0 (m), 772.1 (s), 665.1 (w) cm-1; 
HRMS-(DART+) for 12C611H13111B116O714N128Si5 [M+NH4]+: calculated: 1140.8865, 
found: 1140.8897; [α]D +1.1° (c 1.63, CHCl3). 
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1N HCl 
THF, 0 oC
Me O
TBSO O
OTBS
Me
TBSO OTBS
61% yield
DMP, NaHCO3
 2),NaBO3 4H2O
 H2O, THF
73% yield over three steps
quantitative
HF  pyridine
THF, 0 oC to rt
Me
B(pin)
TBSO OH
OTBS
Me
TBSO OTBS
Me
B(pin)
TBSO
O
OTBS
Me
TBSO OTBS
Me
B(pin)
TBSO OTBS
OTBS
Me
TBSO OTBS
H
4.51
4.52
4.53
4.54
 1), NaClO2, NaH2PO4
     tBuOH, CH3CN
     2-methyl-2 butene
3), DMAP, NEt3, THF, toluene
2,4,6-trichlorobenzoyl chloride
Me O
HO O
OH
Me
HO OH
4.55
51% yield  
 
321 
 
(5R,9R,13S,19R,21R,E)-5,9,19,21-tetraki
s((tert-butyldimethylsilyl)oxy)-7-methyl-
11,15-dimethylene-13-(4,4,5,5-tetrameth
yl-1,3,2-dioxaborolan-2-yl)docos-6-en-1-
ol (4.52). A 20 mL scintillation vial was 
charged with 4.51 (60 mg, 0.06 mmol) and 
THF (6 mL). The solution was cooled to 0 °C, and allowed to stir at 0 °C for 15 minutes. 
HCl (0.06 mL, 1 M, 0.06 mmol) was added dropwise into the mixture, and the mixture 
was allowed to stir at 4 °C (cold room) overnight. The vial was cooled to 0 °C again, and 
then quenched by adding one pipet of saturated Na2S2O3 (0.5 mL). The reaction mixture 
was extracted with diethyl ether, filtered through a Na2S2O4 pipet and evaporated in 
vacuo. The crude reaction mixture was then purified by column chromatography on silica 
gel (100:2-80:20 hexanes/ethyl acetate, stain in CAM) to afford 4.52 as a clear colorless 
oil (32.3 mg, 61%). 1H NMR (600 MHz, CDCl3): δ 5.16 (d, J = 8.5 Hz, 1H), 4.84 (s, 1H), 
4.75 (s, 1H), 4.74 (s, 1H), 4.70 (s, 1H), 4.33 (td, J = 7.9, 4.5 Hz, 1H), 3.92 (p, J = 5.9 Hz, 
1H), 3.88 (h, J = 6.0 Hz, 1H), 3.75 (p, J = 5.5 Hz, 1H), 3.63 (q, J = 6.1 Hz, 2H), 2.18 – 
2.01 (m, 8H), 1.97 (q, J = 7.3 Hz, 2H), 1.62 (s, 3H), 1.59 – 1.23 (m, 13H), 1.18 (s, 12H), 
1.14 (d, J = 6.1 Hz, 3H), 0.92 – 0.82 (m, 36H), 0.12 – -0.04 (m, 24H); 13C NMR (150 
MHz, CDCl3): δ 149.10, 146.46, 132.21, 131.78, 112.22, 109.42, 82.93, 70.25, 70.07, 
69.52, 66.37, 62.97, 48.00, 47.46, 43.91, 38.46, 38.19, 37.83, 37.60, 36.14, 32.80, 29.70, 
Me
B
TBSO OH
TBSO
Me
TBSO
TBSO
O O
Me
Me
Me
Me
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25.96, 25.90, 24.87, 24.81, 24.54, 23.17, 21.59, 19.95, 18.21, 18.11, 18.08, 17.09, -3.87, 
-4.00, -4.12, -4.20, -4.37, -4.44, -4.74; IR (neat): 2952.7 (m), 2928.4 (s), 2856.4 (m), 
1472.1 (w), 1462.1 (w), 1380.1 (m), 1361.5 (w), 1253.4 (m), 1144.2 (m), 1086.9 (m), 
1064.2 (m), 1005.2 (w), 938.7 (w), 891.5 (w), 834.3 (s), 806.8 (m), 773.2 (w) cm-1; 
HRMS-(DART+) for 12C551H11711B116O714N128Si4 [M+NH4]+: calculated: 1026.8000, 
found: 1026.8042; [α]D +1.4° (c 1.33, CHCl3). 
 
(5R,9R,13S,19R,21R,E)-5,9,19,21-tetrakis(
(tert-butyldimethylsilyl)oxy)-7-methyl-11,
15-dimethylene-13-(4,4,5,5-tetramethyl-1,
3,2-dioxaborolan-2-yl)docos-6-enal (4.53) 
To a 20 mL scintillation vial was added 
(4.52) (10 mg, 9.9 µmol) and DCM (1 mL). 
The mixture was cooled to 0 °C, Dess-Martin periodinane (5 mg, 11.9 µmol) and 
NaHCO3 (4.2 mg, 49.6 µmol) were added. After 4 hours, the reaction mixture was 
concentrated in vacuo, then extracted with 1:1 hexane/Et2O, filtered through a silica gel 
padded sintered funnel, and then rinsed with 1:1 hexane/Et2O, and evaporated in vacuo. 
The crude reaction mixture was purified by column chromatography on silica gel 
(100:2-100:3 hexanes/ethyl acetate, stain in CAM) to afford 4.53 as a clear colorless oil 
(8 mg, 80%). 1H NMR (600 MHz, CDCl3): δ 9.75 (td, J = 1.0, 1.0 Hz, 1H), 5.16 (d, J = 
Me
B
TBSO O
TBSO
Me
TBSO
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O O
Me
Me
Me
Me
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8.1 Hz, 1H), 4.84 (s, 1H), 4.75 (s, 1H), 4.74 (s, 1H), 4.70 (s, 1H), 4.34 (td, J = 7.9, 4.8 Hz, 
1H), 3.92 (p, J = 5.8 Hz, 1H), 3.88 (h, J = 5.9 Hz, 1H), 3.74 (p, J = 5.5 Hz, 1H), 2.41 (tt, 
J = 7.3, 1.4 Hz, 2H), 2.20 – 2.00 (m, 8H), 1.97 (q, J = 7.8 Hz, 2H), 1.73 (tdd, J = 12.8, 
10.3, 6.1 Hz, 1H), 1.68 – 1.57 (m, 1H), 1.62 (s, 3H), 1.52 – 1.44 (m, 1H), 1.45 – 1.23 (m, 
7H), 1.21 (td, J = 6.5, 5.9, 1.3 Hz, 1H), 1.18 (s, 12H), 1.14 (d, J = 6.1 Hz, 3H), 0.91 – 
0.83 (m, 36H), 0.10 – -0.03 (m, 24H); 13C NMR (150 MHz, CDCl3): δ 202.64, 149.09, 
146.42, 132.17, 131.82, 112.23, 109.42, 82.91, 70.13, 70.06, 69.26, 66.36, 48.01, 47.43, 
44.06, 43.85, 38.44, 37.82, 37.78, 37.60, 36.15, 29.70, 25.96, 25.94, 25.87, 24.88, 24.82, 
24.54, 23.17, 19.89, 18.27, 18.16, 18.11, 18.07, 16.96, -3.87, -4.00, -4.10, -4.20, -4.33, 
-4.45, -4.46, -4.79; IR (neat): 2953.4 (m), 2928.5 (s), 2856.4 (m), 1731.6 (w), 1472.3 (w), 
1462.1 (w), 1380.0 (m), 1361.8 (m), 1253.5 (m), 1144.3 (m), 1088.1 (m), 1065.32 (m), 
1005.4 (w), 971.1 (w), 938.7 (w), 890.7 (w), 834.5 (s), 807.7 (m), 773.5 (s) cm-1; 
HRMS-(DART+) for 12C551H11511B116O714N128Si4 [M+NH4]+: calculated: 1024.7844, 
found: 1024.7869. [α]D +2.1° (c 0.14, CHCl3). 
 
 
(6R,10R,14S,E)-14-((6R,8R)-6,8-bis(
(tert-butyldimethylsilyl)oxy)-2-met
hylenenonyl)-6,10-bis((tert-butyldi
methylsilyl)oxy)-8-methyl-12-meth
Me O
TBSO O
TBSO
Me
TBSO OTBS
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yleneoxacyclotetradec-7-en-2-one (4.54). 
(5R,9R,13S,19R,21R,E)-5,9,19,21-tetrakis((tert-butyldimethylsilyl)oxy)-7-methyl-11,15-
dimethylene-13-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)docos-6-enoic acid S4.8 
was prepared according to a previous procedure41 with slightly modification. A 20 mL 
scintillation vial was charged with aldehyde 4.53 (32 mg, 31.8 µmol), tBuOH (1 mL), 
CH3CN (1 mL) and 2- methyl-2-butene (0.75 mL, 2.2 mmol) sequentially. The vial was 
then cooled to 0 °C. A solution of NaClO2 (28.8 mg, 0.32 mmol) and NaH2PO4 (43.6 mg, 
0.32 mmol) in H2O (1 mL) was added into the vial. The solution was then allowed to 
warm up to room temperature and stir for four hours. The reaction mixture was quenched 
by H2O, extracted with diethyl ether, then filtered through a Na2S2O4 pipet and 
evaporated in vacuo. The crude reaction mixture was then purified by column 
chromatography on silica gel (100:6-60:40 hexanes/ethyl acetate, stain in CAM) to afford 
S4.8 as a clear colorless oil (48 mg, quantitative, with slight impurity) which was used 
directly in the next step. 
 
To a 20 mL scintillation vial were added carboxylic acid S4.8 (48 mg, 47.7 µmol), 
THF (2 mL) and H2O (2 mL). The solution was cooled to 0 °C, and treated with sodium 
perborate tetrahydrate (220 mg, 1.43 mmol). The mixture was then allowed to stir 
                                                
 
41 Paterson, I.; Paquet, T. Org. Lett. 2010, 12, 2158-2161.  
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overnight. The solution was quenched by H2O, extracted with diethyl ether, dried over 
Na2SO4, evaporated in vacuo. The crude reaction mixture was purified by column 
chromatography on silica gel (100:0 – 100:20 hexanes/ethyl acetate, stain in CAM) to 
afford 
(5R,9R,13S,19R,21R,E)-5,9,19,21-tetrakis((tert-butyldimethylsilyl)oxy)-13-hydroxy-7-m
ethyl-11,15-dimethylenedocos-6-enoic acid S4.9 as a colorless oil (21.5 mg, 73 % over 
three steps).  
The Yamaguchi esterification was performed according to a previous procedure.42 
To an oven dried 20 mL scintillation vial (charged with stirring bar, cooled under 
vacumn) was added 
(5R,9R,13S,19S,21S,E)-5,9,19,21-tetrakis((tert-butyldimethylsilyl)oxy)-13-hydroxy-7-me
thyl-11,15-dimethylenedocos-6-enoic acid S4.9 (21.5 mg, 23.5 µmol), THF (3 mL), 
triethyl amine (23.8 mg, 235 µmol) and 2,4,6-trichlorobenzoylchloride (34.4 mg, 141 
µmol). The solution was allowed to stir at room temperature for two hours before toluene 
(20 mL) was added. The solution was transferred into a syringe. The above solution was 
added into an oven dried 100 mL round bottom flask (precharged with DMAP (34.5 mg, 
282 µmol) and toluene (24 mL)) via syringe pump at 80°C over nine hours. The solution 
was heated at 80°C overnight, which was then cooled to room temperature and 
                                                
 
42 Williams, D. R.; Patnaik, S.; Plummer, S. V. Org. Lett. 2003, 5, 5035-5038.  
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evaporated in vacuo. The crude reaction mixture was purified by column chromatography 
on silica gel (100:0-100:2 hexanes/ethyl acetate, stain in CAM) to afford 4.54 as clear 
colorless oil (23 mg, quantitative). 
1H NMR (500 MHz, CDCl3): δ 5.23 – 5.17 (m, 1H), 5.05 (d, J = 8.7 Hz, 1H), 4.98 (s, 1H), 
4.83 (d, J = 2.1 Hz, 1H), 4.76 (d, J = 1.6 Hz, 1H), 4.72 (s, 1H), 4.29 (ddd, J = 10.2, 8.7, 
3.2 Hz, 1H), 3.94 – 3.82 (m, 2H), 3.77 – 3.69 (m, 1H), 2.45 (t, J = 14.2 Hz, 2H), 2.36 – 
2.29 (m, 2H), 2.23 (dd, J = 14.1, 6.0 Hz, 2H), 2.18 – 2.12 (m, 2H), 2.02 (tt, J = 9.0, 4.6 
Hz, 3H), 1.92 (dd, J = 14.0, 9.0 Hz, 1H), 1.72 (d, J = 1.3 Hz, 3H), 1.64 – 1.57 (m, 2H), 
1.53 –1.37 (m, 5H), 1.33 – 1.19 (m, 3H), 1.14 (d, J = 6.1 Hz, 3H), 0.92 – 0.83 (m, 36H), 
0.10 – -0.04 (m, 24H); 13C NMR (151 MHz, CDCl3) δ 172.34, 145.71, 141.94, 132.96, 
130.73, 127.99, 117.54, 111.95, 71.68, 71.16, 70.02, 69.24, 66.36, 47.98, 46.66, 43.47, 
39.71, 39.12, 38.16, 37.43, 35.94, 34.83, 25.93, 25.86, 24.49, 23.11, 21.29, 20.11, 18.19, 
18.14, 18.10, -3.90, -4.07, -4.21, -4.36, -4.39, -4.47, -4.67, -4.77; IR (neat): 2954.5 (s), 
2928.2 (s), 2856.3 (s), 1734.0 (m), 1472.4 (m), 1458.4 (m), 1253.7 (s), 1087.0 (m), 
1050.5 (m), 835.2 (s), 806.7 (m), 807.9 (w), 774.0 (s) cm-1; HRMS-(DART+) for 
12C491H9816O628Si423Na1 [M+Na]+: calculated: 917.6338, found: 917.6335; [α]D +2.4° (c 
0.72, CHCl3). 
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(6R,10R,14S,E)-14-((6R,8R)-6,8-dihy
droxy-2-methylenenonyl)-6,10-dihyd
roxy-8-methyl-12-methyleneoxacyclo
tetradec-7-en-2-one (4.55) The global 
deprotection was performed according to a previous procedure.43 To a Teflon vial was 
added 4.54 (4 mg, 4.5 µmol) and THF (0.5 mL). The solution was cooled to 0 °C and 
HFpyridine (18 µL) was added dropwise into it. Three more portions of HFpyridine 
(13 µL) were added slowly in the following three days at room temperature. Upon 
completion, the reaction mixture was added carefully into a 20 mL scintillation vial 
containing 2.2 mL saturated NaHCO3 solution at 0 °C, after which the solution was then 
allowed to warm to room temperature and stirred for another twenty minutes. The 
aqueous layer was extracted with ethyl acetate (5×3 mL). The organic layers were 
combined,  dried over Na2SO4 and concentrated in vacuo. The crude reaction mixture 
was purified by column chromatography on silica gel (100:10-10:90 hexanes/ethyl 
acetate, then, 100:10-100:20 DCM/MeOH stain in CAM) to afford 4.55 as a white solid 
(1 mg, 51%). 1H NMR (500 MHz, CDCl3): δ 5.20 (tt, J = 7.7, 3.8 Hz, 1H), 5.10 (d, J = 
12.1 Hz, 1H), 5.09 (s, 1H), 4.96 (s, 1H), 4.79 (s, 1H), 4.72 (s, 1H), 4.37 (td, J = 10.4, 3.3 
Hz, 1H), 4.15 (h, J = 6.0 Hz, 1H), 3.96 (p, J = 5.8 Hz, 1H), 3.84 (t, J = 9.1 Hz, 1H), 2.68 
                                                
 
43 Paterson, I.; Britton, R.; Delgado, O.; Gardner, N. M.; Meyer, A.; Naylor,G. J.; Poullennec, K. G. 
Tetrahedron 2010, 66, 6534-6545. 
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(d, J = 14.2 Hz, 1H), 2.64 (dd, J = 13.5, 4.4 Hz, 1H), 2.43 (dd, J = 14.3, 3.5 Hz, 1H), 2.35 
– 2.30 (m, 1H), 2.30 – 2.22 (m, 2H), 2.19 – 2.12 (m, 2H), 2.12 – 2.07 (m, 1H), 2.05 – 
1.97 (m, 1H), 1.94 (dd, J = 14.0, 10.5 Hz, 1H), 1.89 (dd, J = 14.4, 10.0 Hz, 1H), 1.84 – 
1.79 (m, 1H), 1.77 (d, J = 1.4 Hz, 3H), 1.72 – 1.36 (m, 9H), 1.22 (d, J = 6.5 Hz, 3H); 13C 
NMR (125 MHz, CDCl3): δ 172.53, 145.16, 142.51, 135.77, 129.33, 117.96, 112.72, 
71.41, 68.80, 68.71, 68.11, 65.54, 44.61, 44.23, 43.60, 39.48, 38.39, 36.84, 36.58, 35.25, 
34.35, 23.62, 23.58, 21.50, 20.13; IR (neat): 3385.4 (broad, O-H stretch, m), 2924.3 (s), 
2853.3 (m), 1731.8 (s), 1716.0 (m), 1557.3 (s), 1488.6 (s), 1456.4 (s), 1435.5 (s), 1418.3 
(s), 1386.8 (m), 1289.3 (m), 1243.9 (m), 1154.9 (m), 1077.0 (m) cm-1; HRMS-(DART+) 
for 12C251H4216O623Na1 [M+Na]+: calculated: 461.2879, found: 461.2868; [α]D -7.49° (c 
0.0267, CHCl3). 
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